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1.0	  Introduction	  
1.1	  Nitroso	  compounds	  	  The	  nitroso	  functional	  group	  was	  first	  synthesized	  in	  1874	  by	  Baeyer,1	  that	  being	  nitroso	  benzene	  2.	  It	  was	  prepared	  from	  the	  reaction	  between	  diphenyl	  mercury	  1	  and	  nitrosyl	  bromide	  (Scheme	  1).	  	  
	  
Scheme	  1.	  The	  first	  nitroso	  compound	  synthesis.	  	  Since	   then,	   the	   nitroso	   functional	   group	   has	   attracted	   attention	   from	   synthetic	  chemists	  due	  to	  its	  useful	  properties,	  especially	  for	  application	  in	  the	  synthesis	  of	  natural	   products.2	   They	   can	   undergo	   the	   Ehrlich-­‐Sachs	   reaction,3	   nitroso-­‐aldol	  reaction,4	   nitroso-­‐Diels-­‐Alder	   reaction,1,5	   ene	   reaction6	   and	   other	   organic	  processes.7	  	  
1.1.1	  Preparation	  of	  nitroso	  compounds	  Nitroso	   compounds	   can	   be	   prepared	   by	   several	   methods,	   depending	   upon	   the	  nature	  of	  the	  group	  attached	  to	  them.	  	  	  	  
1.1.1.1 Direct	  nitrosation	  Bosch	   and	   Kochi	   reported	   a	   successful,	   direct	   substitution	   of	   some	   polymethyl-­‐substituted	  benzenes	  3	  using	  nitrosonium	  tetrafluoroborate	  in	  acetronitrile	  under	  argon	  to	  give	  the	  nitroso	  arene	  4	  (Eq.	  1.).8	  
	  Nitrosation	   of	   alkanes	   and	   cycloalkanes	   can	   be	   also	   be	   carried	   out	   by	   using	   a	  radical	  trapping	  reaction	  with	  nitric	  oxide.9	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1.1.1.2 Nitroso-­demetalation	   	  The	   use	   of	   nitroso-­‐demetalation	   is	   the	   reaction	   between	   an	   organometallic	  compound	  and	  nitrosyl	  halide.	  The	  first	  nitroso	  compound,	  nitrosobenzene	  2,	  was	  generated	  by	  the	  above	  reaction	  (Eq.	  2).1	  The	  reaction	  between	  phenylmagnesium	  bromide	   and	   nitrosyl	   chloride	   also	   gives	   nitroso	   benzene	   2.10	   Various	   other	  organometallic	   species	   studied	  have	   included:	   Sn,11	   Li,12	   Tl,13	   Si,14	   	   Al15	   and	  Cr.16	  These	   studies	   concluded	   that	   this	   is	   a	   successful	   reaction	   if	   the	   metal	   cation	   is	  stabilized	  by	  a	  leaving	  group	  .	  	  
1.1.1.3 Oxidation	  of	  hydroxamic	  acids	  
	  The	  oxidation	  of	   the	  hydroxamic	  acids	  5	   is	  widely	  used	   in	   the	  preparation	  of	   the	  corresponding	  nitroso	   compounds	  6	   (Eq.	   3).	   It	   has	   been	   achieved	  under	   various	  oxidation	   conditions,	   including	   periodate,17	   Swern	   oxidation,18	   Dess-­‐Martin	  periodinane,19	  lead	  and	  silver	  oxides,20	  transition	  metal-­‐catalyzed	  oxidation	  in	  the	  presence	  of	  peroxide21	  and	  recently,	  copper-­‐catalyzed	  aerobic	  oxidation.22	  	  	  
1.1.1.4 Oxidation	  of	  nitrile	  oxide	  The	   formation	  of	   acylnitroso	   compounds	  9	   by	  oxidising	  nitrile	  oxides	  7	   using	  N-­‐methylmorpholine-­‐N-­‐oxide	   (NMO)	   was	   reported	   by	   Quadrelli	   et	   al.23	   The	  electrophilic	  carbon	  of	  the	  nitrile	  oxide	  was	  attacked	  by	  the	  nucleophilic	  oxygen	  on	  the	   tertiary	  amine.	  The	  N-­‐oxide	   forms	  a	  zwitterionic	   intermediate	  8,	  which	  gives	  an	  acyl	  nitroso	  species	  7	  and	  the	  tertiary	  amine	  (Scheme	  2).	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Scheme	  2.	  	  Oxidation	  of	  nitrile	  oxide	  by	  NMO	  	  
1.1.1.5 Reduction	  of	  nitro	  compounds	  The	  direct	   formation	  of	  nitrosobenzene	  from	  nitrobenzene	  was	  reported	   in	  1911	  by	   Zerewitinoff	   and	   Ostromisslensk.	   In	   their	   study,	   barium	   oxide	  was	   used	   as	   a	  reducing	   agent,24	   together	   with	   sodium	   as	   a	   source	   of	   electrons.	   Potassium,	  calcium,	   strontium,	   barium,	   magnesium	   and	   zinc	   were	   also	   used	   as	   reducing	  agents.25	  	  	  	   The	   photoreduction	   of	   a	   ternary	   complex	   of	   β-­‐cyclodextrin	   with	   a	  nitrophenyl	   ether	  10	   and	   1-­‐phenylethylamine	  under	   irradiation	  with	   a	  mercury	  lamp	   in	   the	   solid	   state	   gave	   >95%	   of	   corresponding	   nitroso	   compounds	   1126	  (Scheme	  3).	  	  
	  
Scheme	  3.	  Direct	  nitroso	  formation	  from	  nitrobenzene	  by	  photoreduction.	  	  
1.1.1.6 Diazo	  compound	  rearrangement	  The	   use	   of	   diazo	   compounds	  12	   to	   form	   nitrocarbene	   species	  13	  was	   reported	  1988	  by	  Bannon	  and	  Williams27	  going	   through	  a	   facile	   [1,2]-­‐oxygen	  shift	  using	  a	  rhodium(II)	  catalyst	  or	  upon	  gentle	  heating,	  to	  yield	  the	  acylnitroso	  14	  (Scheme	  4).	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Scheme	  4.	  Diazo	  compound	  rearrangement	  route	  to	  acylnitroso	  species.	  
	  
1.1.1.7 Cycloreversion	  of	  9,10-­dimethylantracene	  cycloadducts	  9,10-­‐Dimethylantracene	   cycloadducts	   15	   are	   well	   documented	   to	   undergo	  cycloreversion	   to	   give	   9,10-­‐dimethylanthracene	   and	   nitroso-­‐species	   16	   upon	  heating.28	   However,	   it	   was	   necessary	   to	   have	   a	   trapping	   species	   present	   in	   the	  reaction	   mixture,	   otherwise	   nitrous	   oxide	   could	   be	   formed,	   as	   well	   as	   the	  corresponding	  anhydride	  and	  9,10-­‐dimethylantracene	  (Scheme	  5).	  	  
	  	  	  
Scheme	  5.	  The	  cycloreversible	  of	  the	  9,10-­‐dimethylantracene	  cycloadducts.	  	  
1.1.2 Nitroso	  compounds	  as	  dienophiles	  Hyponitrous	  acid	  (HNO)	  is	  the	  simplest	  nitroso	  species	  known,	  however,	  due	  to	  its	  instability,29	   it	   readily	   forms	   nitrous	   oxide	   and	   its	   use	   as	   a	   dienophile	   in	   the	  nitroso-­‐Diels-­‐Alder	   reaction	   has	   been	   limited.	   Therefore,	   C-­‐nitroso	   compounds	  have	   been	   employed	   and	   studied	   in	   the	   nitroso-­‐Diels-­‐Alder	   reaction.	   This	   has	  included	   alkylnitroso	  17,	   cyanonitroso	  18,	  α-­‐halonitroso	  19,	   acetoxynitroso	  20,	  vinylnitroso	  21,	   iminonitroso	  22,	   arylnitroso	  23,	   pyridylnitroso	  24,	   	   acylnitroso	  	  
25	  and	  nitrosoformate	  ester	  derivatives	  26	  (Figure	  1).	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Figure	  1.	  General	  structures	  of	  C-­‐nitroso	  compounds.	  	  The	   reactivity	   of	   these	   nitroso	   compounds	   as	   dienophiles	   depends	   upon	   the	  substituent	  group	  present.	  An	  electron-­‐withdrawing	  group	  adjacent	  to	  the	  nitroso	  group	   greatly	   increases	   the	   rate	   of	   reaction as	   the	   LUMO	   energy	   level	   of	   the	  dienophile	  is	  lowered	  relative	  to	  the	  HOMO	  of	  the	  diene.5,	  30	  	   Nitroso	  compounds	  are	  also	  known	  to	  exist	  in	  equilibrium	  in	  two	  forms,	  i.e.	  a	  monomer	  and	  dimer	  species	  (Scheme	  6).31	  	  	  
	  
Scheme	  6.	  Monomer-­‐dimer	  equilibrium	  of	  nitroso	  species.	  
	  Cyanonitroso	  18,	   iminonitroso	  22,	   acylnitroso	  25	   and	   nitrosoformate	   esters	  26	  are	  the	  most	  reactive	  nitroso	  dienophiles	  used	  in	  the	  nitroso-­‐Diels-­‐Alder	  reaction.	  The	  latter	  are	  the	  most	  popular	  among	  all	  of	  these	  due	  to	  the	  formate	  group	  being	  readily	   removed,	   allowing	   the	   adducts	   to	   be	   used	   in	   natural	   product	   synthesis	  more	  readily.32	  	   There	  are	  important	  effects	  in	  having	  a	  heteroatom	  attached	  to	  the	  nitroso	  group.	   Reactivity	   can	   be	   reduced	   due	   to	   resonance	   stabilization	   of	   the	  π-­‐orbital	  
N N ORO
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depending	  upon	  the	  heteroatom.	  Where	  the	  lone	  pair	  is	  strongly	  donating	  (Figure	  2),	  this	  results	  in	  reduction	  of	  its	  dienophilic	  properties.	  This	  can	  be	  overcome	  by	  substituents	   where	   lone	   pair	   donation	   is	   prevented,	   as	   can	   be	   observed	   with	  nitroso-­‐phosphoramide	  27	  and	  nitroso-­‐sulfonate	  28	  compounds,	   though	   in	  these	  cases,	  σ-­‐bond	  electron	  withdrawal	  still	  occurs	  resulting	  in	  a	  reactive,	  electrophilic	  nitroso	  function.33	  
	  	  
Figure	  2.	  Example	  of	  resonance	  stabilization	  of	  hetero-­‐nitroso	  compounds	  and	  
σ-­‐bond	  activated	  nitroso	  species.	  	  	  
1.	  2	  Nitroso-­Diels-­Alder	  reaction	  The	  Diels–Alder	  (DA)	  reaction	  has	  been	  studied	   for	  nearly	  a	  century	  since	   it	  was	  first	  discovered	  by	  Wichterle.34	  It	  is	  one	  of	  the	  most	  useful	  methods	  for	  making	  six-­‐membered	  carbocycles.	  A	  typical	  [4+2]-­‐cycloaddition	  involves	  adding	  a	  diene	  to	  a	  dienophile	  to	  afford	  a	  six-­‐membered	  ring	  cycloadduct.	  However,	  the	  diene	  needs	  to	  be	   in	   the	  s-­‐cis-­‐conformation	   in	  order	   to	  allow	  the	  π-­‐orbitals	   in	   the	  diene	   to	  align	  with	  the	  π-­‐orbitals	  in	  the	  dienophile.	  With	  the	  s-­‐trans-­‐conformation,	  which	  is	  more	  stable,	  orbital	  overlap	  is	  not	  possible	  with	  a	  dienophile.	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Figure	  3.	  Cisoid	  conformation.	  
	  
Figure	  4.	  Transoid	  conformation.	  	  A	   concerted	   suprafacial	   [π4s	   +	   π2s]-­‐cycloaddition	   of	   a	   diene	   and	   a	   dienophile	   is	  allowed	   according	   to	   the	  Woodward–Hoffmann	   rules.35	   This	   states	   that	   the	   rate	  and	  regiochemistry	  of	  cycloadditions	  are	  controlled	  by	  the	  HOMO	  of	  the	  diene	  and	  the	   LUMO	   of	   the	   dienophile	   in	   a	   normal	   DA	   reaction.	   An	   electron	   withdrawing	  group	   on	   the	   dienophile	   can	   lower	   the	   LUMO	   level	   whilst	   an	   electron	   donating	  group	  on	  diene	  can	  increase	  the	  HOMO	  level.	  Therefore,	  the	  rate	  of	  reaction	  could	  increase	  due	  to	  the	  dienophile	  being	  more	  electron-­‐deficient	  and	  the	  diene	  being	  more	   electron-­‐rich.	   	   An	   inverse	   electron	   demand	   DA	   reaction	   is	   the	   reaction	  between	   the	  LUMO	  of	   the	  diene	   and	   the	  HOMO	  of	   the	  dienophile.	  Therefore,	   the	  rate	  of	  reaction	  can	  be	  increased	  by	  lowering	  the	  LUMO	  on	  the	  diene	  using	  electron	  withdrawing	  group	  and	  the	  increasing	  HOMO	  on	  the	  dienophile	  by	  the	  use	  of	  the	  electron	  donating	  group.	  However,	  neither	  the	  HOMO	  nor	  LUMO	  has	  any	  effect	  on	  the	  neutral	  DA	  reaction	  (Scheme	  7).36	  	  	   When	  a	  Lewis	  acid	  is	  used	  to	  complex	  with	  an	  electron	  withdrawing	  group	  on	  the	  dienophile,	  the	  rate	  of	  reaction	  is	  increased.	  This	  is	  due	  to	  the	  amplification	  of	   the	   electron	  withdrawing	   effect	   on	   the	   dienophile	   in	   the	   normal	   DA	   reaction,	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and	   on	   the	   diene	   in	   the	   inverse	   electron	   demand	   DA.	   As	   a	   result,	   the	   LUMO	   is	  lowered	  in	  both	  cases.	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Scheme	   8.	   [4+2]-­‐Cycloaddition	   reaction	   of	   a	   nitroso-­‐compound	   with	   1,3-­‐cyclohexadiene.	  	  The	   diene	   used	   in	   the	   nitroso-­‐Diels-­‐Alder	   reaction	   is	   most	   often	   symmetric,	  however,	  with	   unsymmetric	   dienes,	   the	   regiochemistry	   of	   the	   product	   formed	   is	  uncertain.	   Computational	   studies	   of	   this	   particular	   reaction	   was	   carried	   out	   by	  Leach	   and	   Houk.39	   	   Their	   results	   showed	   that	   the	   nitroso-­‐Diels-­‐Alder	   reaction	  strongly	   prefers	   the	   endo-­‐path,	   which	   arises	   from	   a	   combination	   of	   repulsion	  between	  the	  lone	  pair	  on	  the	  nitroso	  species	  with	  the	  electron	  rich	  diene	  and	  the	  interaction	  between	  the	  n-­‐HOMO	  of	  the	  nitroso	  compound	  and	  the	  π-­‐HOMO	  of	  the	  diene	  (Figure	  5).	  	  	  
	  
Figure	  5.	  Transition	  state	  energies	  calculated	  for	  the	  nitroso-­‐Diels-­‐Alder	  reaction.	  	  The	   regioselectivities	   of	   1-­‐	   and	   2-­‐substituted	   dienes	   were	   also	   studied.	   It	   was	  concluded	  that	  substitution	  at	   the	  2-­‐position	  of	   the	  diene	  36	  had	  a	  smaller	  effect	  compared	  with	   a	   1-­‐substituted	   diene	  32.	   The	   1-­‐substituted-­‐1,3-­‐diene,	   both	  with	  electron	  withdrawing	  and	  electron	  donating	  groups,	  generally	  gives	  a	  higher	  yield	  of	   proximal	   isomer	   34	   (6-­‐substituted)	   than	   distal	   isomer	   35	   (3-­‐substituted).	  Whereas	   2-­‐substituted	   dienes	  36	   give	  moderate	   selectivity	   for	  37	   over	  38	   (see	  Scheme	  9).	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Scheme	  9.	  The	  regioselectivity	  of	  1-­‐	  and	  2-­‐substituted	  dienes	  in	  nitroso-­‐Diels-­‐Alder	  reactions.	  	  This	  study	  was	  found	  to	  be	  in	  good	  agreement	  with	  the	  experiments	  carried	  out	  in	  1965	  by	  Kresze	   and	  Firl.40	   It	  was	   found	   that	   unsymmetric	   dienes	  with	   either	   an	  electron	   donating	   39a	   or	   an	   electron	   withdrawing	   group	   39b	   gave	   the	   same	  regioisomers	  41a	  and	  41b	  respectively,	  with	  p-­‐chloronitrosobenzene	  40	  (Scheme	  10).	  	  	  
	  
Scheme	  10.	  The	  regioselectivity	  of	  the	  nitroso-­‐Diels–Alder	  reaction	  with	  electron	  rich	  and	  electron	  deficient	  diene.	  	  	  This	  result	  (Scheme	  10)	  can	  be	  explained	  by	  the	  interaction	  between	  the	  HOMO	  of	  diene	   and	   LUMO	   of	   the	   dienophile.	   The	   C(4)	   of	   the	   1-­‐substitution	   diene	   has	   the	  
R
+ ON R 1 N
O NO
R
R 1 R R 1Proximal(60substituted) Distal(30substituted)32
+ ON R 1 N
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largest	   HOMO	   coefficient,	   which	   matches	   the	   largest	   LUMO	   at	   nitrogen	   of	   the	  nitroso	  species	  (the	  NO	  π*	  orbital)	  	  	   2-­‐Substituted	  dienes	  have	  the	  largest	  HOMO	  coefficient	  at	  C(1)	  resulting	  in	  the	  formation	  of	  a	  distal	  isomer.	  However,	  the	  direction	  of	  the	  selectivity	  depends	  upon	   the	   nature	   of	   the	   dienophile	   due	   to	   the	   weak	   directing	   effect	   of	   the	   2-­‐substituted	  diene.	  	   	  
1.2.1	  Catalytic	  Nitroso-­Diels-­Alder	  Reactions	  	  To	  overcome	  the	  toxicity	  of	  many	  oxidants	  used	  for	  generating	  nitroso	  compounds,	  Whiting	  et	  al.41	   and	   Isawa	  et	  al.42	   independently	   reported	  a	   ruthenium-­‐catalyzed	  hydrogen	   peroxide	   oxidation	   of	   hydroxamic	   acids	   and	   subsequent	   hetero-­‐Diels–Alder	  reaction	  with	  a	  diene.	  In	  Isawa’s	  system,	  10	  mol%	  of	  ruthenium	  catalyst	  46	  and	  4	  equivalents	  of	  oxidant	  were	  required	  in	  the	  reaction	  in	  order	  to	  achieve	  good	  yields	   (Scheme	   11).	   However,	   Whiting’s	   system	   required	   only	   0.1	   mol%	   of	  ruthenium	  catalyst	  43	  and	  although	  this	  system	  required	  less	  catalyst,	  yields	  were	  poor	  to	  good	  (Scheme	  12).	  
	  
Scheme	   11.	   Ruthenium-­‐salen	   catalyzed	   nitroso-­‐Diels–Alder	   reaction	  reported	  by	  Whiting	  et	  al.	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Scheme	   12.	   Rhuthenium-­‐pybox	   catalyzed	   nitroso-­‐Diels–Alder	   reaction	  reported	  by	  Iwasa	  et	  al.	  	  Adamo	   and	   Bruschi43	   reported	   the	   use	   of	   copper,	   iron	   and	   nickel	   with	   amine	  ligands	  as	  catalysts	  in	  the	  oxidation	  of	  hydroxamic	  acids	  using	  hydrogen	  peroxide.	  This	  reaction	  was	  carried	  out	  in	  a	  similar	  fashion	  to	  Isawa’s	  reaction.	  They	  found	  that	   the	   reaction	   of	   nickel	   takes	   a	   longer	   time	   to	   complete	   (up	   to	   8	   days)	  while	  Cu(I),	  Cu(II)	  and	  Fe(III)	  showed	  high	  levels	  of	  activity	  (Scheme	  13).	  	  
	  
Scheme	   13.	   Metal-­‐catalyzed	   oxidation	   of	   hydroxamic	   acids	   with	   hydrogen	  peroxide	  reported	  by	  Amado	  and	  Bruschi.	  	  The	  use	  of	  copper	  in	  the	  Diels–Alder	  reaction	  was	  first	  reported	  by	  Bota	  et	  
al.44	   in	   1961.	   In	   this	   study,	   cyclopentadiene	   and	   acetylene	   were	   used	   in	   the	  presence	  of	  CuCl/NH4Cl/activated	  carbon	  catalyst	  to	  achieve	  the	  formation	  of	  2,5-­‐norbornadiene,	  however,	  the	  role	  of	  the	  copper	  catalyst	  was	  not	  clear.	  	  	   The	   first	   copper-­‐catalyzed	  nitroso–Diels–Alder	   reaction	  was	   first	   reported	  by	   Kalita	   and	   Nicholas.45	   Nitroso-­‐compounds	   can	   be	   formed	   from	   the	  corresponding	  hydroxamic	  acids	  using	  Cu-­‐catalysts	  such	  as	  CuBr·Me2S.	  Scheme	  14	  shows	   that	   when	   Boc-­‐NHOH	   42	   was	   treated	   with	   10	   mol%	   of	   CuBr.Me2S,	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acylnitroso	  48	  was	  trapped	  by	  1,3-­‐cyclohexadiene	  to	  form	  cycloadduct	  44	  after	  65	  h	  in	  41%	  yield.	  The	  efficiency	  of	  this	  reaction	  was	  improved	  dramatically	  by	  using	  stoichiometric	  quantities	  of	  oxidant	  such	  as	  hydrogen	  peroxide.	  	  The	  mechanism	  is	  not	   clear;	   however,	   a	   proposed	   mechanism	   starts	   with	   a	   Cu-­‐induced	  disproportionation	  of	  Boc-­‐NHOH	  42	   to	  form	  Boc-­‐NO	  48	  and	  Boc-­‐NH2	  47.	  Boc-­‐NO	  can	   undergo	   a	   Diels-­‐Alder	   reaction	   with	   the	   corresponding	   diene	   to	   give	   the	  cycloadduct	  44.	   However,	   in	   the	   presence	   of	  H2O2,	   Cu(I)	   is	   oxidized	   to	   Cu(II)	   by	  H2O2	   instead	   of	   being	   oxidized	   by	   Boc-­‐NHOH	   42	   (Scheme	   15).	   This	   obviously	  increases	   the	   yield	   as	   there	   is	   more	   starting	   material	   available	   to	   form	   the	  corresponding	  nitroso	  species	  for	  the	  DA	  reaction	  and	  no	  disproportionation.	  	  
	  	  
Scheme	  14.	  CuBr·Me2S	  catalyzed	  the	  oxidation	  of	  the	  hydroxamic	  acid.	  
	   	  
	  
Scheme	  15.	  A	  proposed	  mechanism	  of	  Cu-­‐catalyzed	  nitroso-­‐Diels-­‐Alder	  reaction.	  	  Tusun	  and	  Lu46	  reported	  the	  use	  of	  0.1	  mol%	  of	  dirhodium(II)	  caprolactamate	  	  50	  with	   tert-­‐butyl	   hydroperoxide	   for	   catalyzing	   the	   in	   situ	   oxidative	   formation	   of	  acylnitroso	  48	  from	  hydroxamic	  acid	  42	  at	  room	  temperature.	  The	  acylnitroso	  48	  was	   trapped	  by	   a	  diene	   to	   form	   the	   corresponding	   cycloadduct	   product	  44	  with	  moderate	  to	  high	  yield	  (Scheme	  16).	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Scheme	   16.	   Dirhodium(II)	   caprolactamate	   catalyzed	   in	   situ	   oxidative	   of	  hydroxamic	  acid	  reported	  by	  Tusun	  and	  Lu.	  	  
1.2.2	  Asymmetric	  nitroso-­Diels-­Alder	  reactions	  A	   catalytic	   asymmetric	   nitroso-­‐Diels-­‐Alder	   reaction	   using	   antibody	   309-­‐1G7	  was	  reported	   in	   1995	   by	   Pandit	   et	   al.,47	   by	   reacting	   the	   nitroso	   compound	   51	   with	  unsymmetric	   diene	  52.	   The	   product	  53	   was	   obtained	   with	   >95%	   regioisomeric	  control	  and	  82%	  ee	  of	  the	  cycloadduct	  (Scheme	  17).	  	  
	  
Scheme	  17.	  Antibody	  309-­‐1G7	  catalyzed	  the	  nitroso-­‐Diels-­‐Alder	  reaction.	  	  Evans	  et	  al.48	  investigated	  the	  use	  of	  chiral	  bis(oxazoline)copper(II)	  complexes	  56	  	  to	   catalyze	   the	   enantioselective	   hetero–Diels–Alder	   reaction	   of	   α,β–unsaturated	  carbonyl	  compounds	  54	  with	  electron	  rich	  alkenes	  55	  resulting	  in	  cycloadduct	  57	  (Scheme	   18).	   The	   high	   level	   of	   enantioselectivity	   was	   claimed	   to	   be	   due	   to	   the	  coordination	   of	   the	   substrate	   to	   the	   chiral	   bis(oxazoline)copper(II)	   catalysts	   to	  form	  chiral	  complexes	  58	  (Figure	  6).49	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Scheme	   18.	   Chiral	   bis(oxazoline)copper(II)	   	   catalyzed	   enantioselective	   hetero–Diels–Alder	  reaction.	  	  	  
	  
Figure	  6.	  Chiral	  bis(oxazoline)	  copper(II)	  complexes	  58.	  	  There	  have	  been	  a	  number	  of	  attempts	  to	  perform	  enantioselective	  nitroso–Diels–Alder	   reactions.	   In	   2003	   Watkinson	   and	   Whiting	   et	   al.50	   employed	   an	  enantiomerically	  pure	  ligand	  59	  (Figure	  7)	  and	  CuCl2	  in	  this	  reaction.	  However,	  no	  enantioselectivity	   was	   detected.	   It	   was	   concluded	   from	   these	   results	   that	   the	  dissociation	   of	   the	   nitroso-­‐compound	   from	   the	   chiral	   metal	   complex	   occured	  before	   the	   [4+2]-­‐cycloaddition.	   The	   difficulties	   of	   enatioselective	   nitroso–Diels–Alder	   reactions	   of	   nitroso	   compounds	   could	   be	   due	   to	   the	   fact	   that	   nitroso	  compounds	  exist	  in	  a	  monomer-­‐azodioxide	  dimer	  equilibrium.31	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Figure	  7.	  Ligand	  59.	  	  In	  2004,	  however,	  Yamamoto	  et	  al.51	  achieved	  an	  enantioselective	  nitroso–Diels–Alder	   reaction,	   using	   2-­‐nitrosopyridine	   derivative	  61	   reacting	  with	   dienes	  60	   in	  the	  presence	  of	   copper(I)	  with	   chiral	   ligands	  63	   or	  64.	  As	  a	   result,	   this	  gave	   the	  corresponding	   cycloadducts	   62	   with	   good	   enatiomeric	   excesses	   (up	   to	   99%)	  	  (Scheme	  19).	  	  
	  	  
Scheme	  19.	  Enantioselective	  nitroso–Diels–Alder	  reaction	  reported	  by	  Yamamoto.	  	  	  Stüder	   et	   al.52	   reported	   the	   enantioselective	   nitroso–Diels–Alder	   reaction	   of	   2-­‐nitrosopyridine	  65	  with	  various	  dienes	  using	  [CuPF6(MeCN)4]/Walphos-­‐CF3	  66	  as	  catalyst.	   This	   gave	   the	   corresponding	   cycloadducts	  67a	   and	  67b,	   in	   quantitative	  yield	  and	  with	  good	  to	  excellent	  enatioselectivities	  (up	  to	  99%	  yield	  and	  93%	  ee)	  (Scheme	  20).	  However,	  due	  to	  the	  sensitivity	  of	  the	  catalyst,	  the	  reactions	  needed	  to	   be	   carried	   in	   the	   absence	   of	   air	   and	   moisture.	   The	   reason	   for	   the	   high	  enantioselectivity	   of	   2-­‐nitrosopyridine	   is	   due	   to	   its	   ability	   to	   form	   a	   plausible	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chelate	   intermediate	   68	   (Figure	   8),	   which	   was	   proposed	   to	   explain	   the	  configuration	  of	  the	  resulting	  stereogenic	  centres.51	  	  	  	   	  	  
	  
Scheme	  20.	  Enantioselective	  nitroso–Diels–Alder	  reaction	  of	  2-­‐nitrosopyridine	  65	  using	  [CuPF6(MeCN)4]/Walphos-­‐CF3	  66	  catalyst.	  
	  
Figure	  8.	  A	  plausible	  chelate	  intermediate	  68	  for	  the	  reaction	  shown	  in	  Scheme	  20.	  
	  
1.2.3	  Nitroso-­Diels-­Alder	  adducts	  in	  modern	  organic	  synthesis	  The	  nitroso-­‐Diels-­‐Alder	  has	  proved	  to	  be	  very	  useful	  in	  modern	  organic	  synthesis	  due	   to	   the	   attractive	   building	   block	   nature	   of	   the	   cycloadducts.	   These	   types	   of	  cycloadducts	  have	  been	  attractive	  in	  total	  synthesis	  because	  the	  N-­‐O	  bond	  can	  be	  easily	  cleaved	  via	  reduction	  giving	  an	  alcohol	  and	  amine	  with	  a	  syn-­‐orientation.53	  They	   can	   also	   undergo	   ring	   contraction	   to	   form	   the	   corresponding	   pyrroles.54	  There	  are	  several	  reports	  of	  the	  application	  of	  the	  nitroso-­‐Diels-­‐Alder	  reaction	  in	  the	  total	  synthesis	  of	  natural	  products.	  This	  review	  will	  focus	  on	  work	  from	  2008	  onwards.	  	   In	   2008,	   Stüder	   et	   al.	   reported	   the	   total	   synthesis	   of	   (+)-­‐trans-­‐dihydronarciclasine	   71,	   which	   is	   a	   biologically	   active	   natural	   product	   of	   the	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Amaryllidaceae	  group,55	  and	  has	  potential	  antitumor	  and	  antiviral	  properties.	  The	  enantioselective,	   regiodivergent	   Diels–Alder	   reaction	   of	   diene	   69	   and	   2-­‐nitrosopyridine	   65	   using	   10	   mol	   %	   of	   [CuPF6(MeCN)4]/Walphos-­‐CF3	   66	   as	  catalyst,	   gave	   the	  cycloadducts	   	  70a	   and	  70b	   (Scheme	  21).	  The	  cycloadduct	  70a	  was	   then	  used	  as	   the	  precursor	   for	   the	  next	  steps,	  which	  gave	   the	  desired	   target	  product	  71	  at	  the	  final	  step	  (Scheme	  22).	  	  	  
	  
Scheme	  21.	  The	  enantioselective	  regiodivergent	  Diels–Alder	  reaction	  reported	  by	  Stüder	  et	  al.	  	  
	  
	  
Scheme	  22.	  The	  synthesis	  pathway	  of	  (+)-­‐trans-­‐dihydronarciclasine	  71.	  	  A	  year	  later,	  the	  same	  group	  reported	  the	  use	  of	  this	  system	  in	  the	  synthesis	  of	  (-­‐)-­‐peracetylated	  conduramine	  A-­‐1	  74,	  which	  belongs	  to	  biologically	  active	  molecules,	  the	   amioconduritols.56	   The	   best	   diastereoselectivity	   and	   enantioselectivity	   was	  achieved	  using	  the	  reaction	  of	  diene	  72	  with	  2-­‐nitrosopyridine	  65	  using	  the	  same	  catalytic	  system	  of	   [CuPF6(MeCN)4]/Walphos-­‐CF3	  66	   to	  yield	   the	  desired	  product	  
73	  with	  99%	  yield,	  d.r.	  >	  99:1	  and	  93%	  ee	  (Scheme	  23).	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Scheme	  23.	  Synthesis	  of	  (-­‐)-­‐peracetylated	  conduramine	  A-­‐1	  74	  via	  cycloadduct	  73	  intermediate.	  
 Miller	   et	   al.	   reported	   the	   use	   of	   an	   acylnitroso	   Diels–Alder	   reaction	   in	   the	  diastereoselective	   synthesis	   of	   spironorasisteromycin	   77	   in	   2009,	   which	   has	  potential	  due	  to	  biological	  activities	  such	  as	  anticancer,	  antibacterial	  and	  	  antiviral	  agents.57	  The	  first	  step	  involved	  the	  reaction	  of	  tert-­‐butyl-­‐N-­hydroxycarbamate	  42	  using	  NaIO4	  as	  oxidant	  to	  form	  the	  corresponding	  nitroso	  species	  48,	  followed	  by	  [4+2]-­‐cycloaddition	  with	  N-­‐Cbz-­‐protected	  spirocyclic	  diene	  75,	  which	  gave	  a	  61%	  yield	   of	   cycloadduct	   product	   76.	   This	   intermediate	   underwent	   several	   reaction	  steps	  to	  obtain	  the	  desired	  product	  77	  (Scheme	  24).	  
	   20	  	  	  	  
	  
Scheme	  24.	  The	  disterioselective	  synthesis	  of	  spironorasisteromycin	  77.	  
	  In	  the	  same	  year,	  ergosterol	  81	  was	  synthesised	  by	  the	  same	  group,	  which	  also	  has	  anticancer	   properties.	   This	   compound	   was	   prepared	   by	   reacting	   acylnitroso	   or	  heterocyclenitroso	  compounds	  of	  type	  79,	  with	  diene	  78	  to	  give	  the	  corresponding	  cycloadduct	  80,	  which	  was	  subjected	  to	  N-­‐O	  bond	  reduction	  to	  give	  the	  product	  81	  (Scheme	  25).58	  	  	  
 
Scheme	  25.	  The	  synthesis	  of	  ergosterol	  81	  
 Marchand-­‐Brynaert	  et	  al.	  published	  the	  use	  of	  the	  nitroso-­‐Diels–Alder	  reaction	  of	  1-­‐phosphono-­‐1,3-­‐butadienes	  82	  with	  various	  nitroso	  compounds	  to	  access	  	  amino-­‐phosphonic	  derivatives	  85,	  which	  showed	  promising	  activities	  in	  agricultural	  and	  medicinal	   areas.59	   The	   phosphono	   group	   attached	   to	   the	   diene	   at	   the	   1-­‐position	  
	   21	  	  	  	  
played	  an	  important	  role	  in	  the	  regioselectivity,	  and	  as	  a	  result,	  gave	  the	  proximal	  isomer.	   They	   concluded	   that	   aryl	   nitroso	   compounds	   were	   suitable	   for	   reacting	  with	  1-­‐phosphono-­‐1,3-­‐butadienes	  because	   they	  were	   stable	   at	  high	   temperature,	  while	  the	  acyl	  and	  α-­‐chloro	  nitroso	  compounds	  were	  too	  reactive	  and	  were	  prone	  to	   degradation.	   The	   reactions	   of	   the	   arylnitroso	   83	   and	   1-­‐phosphono-­‐1,3-­‐butadiene	  82	  was	  carried	  out	  at	  100	   oC	  under	  microwave	  heating	   for	  an	  hour	   to	  yield	  up	  to	  95%	  of	  84.	  The	  cycloadduct	  84	  was	  used	   in	   further	  reactions,	   to	  give	  rise	  to	  the	  desired	  aminophosphonic	  product	  85	  (Scheme	  26).	  	  
 
Scheme	   26.	   Aminophosphonic	   derivatives	   85	   synthesis	   via	   the	   nitroso-­‐Diels	   –	  Alder	  reaction.	  	  Kouklovsky	   and	   Vincent	   synthesized	   racemic	   8-­‐epihalosaline	   89	   and	  porantheridine	   90	   via	   the	   nitroso-­‐Diels–Alder	   reaction.	   This	   was	   achieved	   by	  reacting	  the	  nitroso	  compound	  86	  with	  cyclopentadiene	  to	  give	  the	  corresponding	  cycloadduct	  87,	  which	  was	  then	  treated	  with	  Grubb’s	  II	  metathesis	  catalyst	  in	  the	  presence	  of	  an	  external	  alkene	  in	  order	  to	  induce	  ring-­‐opening	  methathesis	  (ROM)	  followed	   by	   ring-­‐closing	   methathesis	   (RCM),	   cross	   methathesis	   (CM)	   and	   ring-­‐rearrangement	  metathesis	  gave	  rise	  to	  isoxazolopyridinones.60	  These	  were	  used	  as	  precursors	  for	  the	  next	  few	  steps	  to	  achieve	  the	  synthesis	  of	  the	  alkaloids	  89	  and	  
90	  (Scheme	  27).	  	  
	   22	  	  	  	  
 
Scheme	  27.	  The	  synthesis	  of	  8-­‐epihalosaline	  89	  and	  porantheridine	  90.	  	  
 
1.3	  Hyrdoxamic	  acids	  synthesis	  Hydroxamic	  acids	  were	  discovered	   in	  1869	  by	  Lossen.61	  They	  became	  popular	   in	  the	   1980s	   due	   to	   their	   properties	   in	   biomedical	   applications	   such	   as	   antibiotics,	  antiasthmatics	   etc.;62	   metal	   ligands	   and	   in	   synthesis.63	   Various	   methods	   of	  hydroxamic	   acid	   synthesis	   have	   been	   reported.	   This	   report	   will	   focus	   on	   the	  methods	  that	  have	  been	  widely	  used	  in	  synthesis.	  	  
1.3.1	  Synthesis	  of	  hydroxamic	  acids	  from	  aldehyde	  Angeli	   and	   Rimini	   reported	   the	   reaction	   of	   aldehyde	   91	   and	   N-­‐hydroxyben-­‐zenesulfonamide	  92	  in	  the	  presence	  of	  a	  base	  to	  give	  hydroxamic	  acids	  93	  in	  good	  to	  fair	  yield	  (Scheme	  28).64	  	  
	  
Scheme	  28.	  The	  synthesis	  of	  hydroxamic	  acid	  from	  aldehyde.	  	  Unfortunately,	   the	   side-­‐product	   of	   this	   reaction	   was	   the	   sulfinic	   acid	   94,	   which	  caused	   difficulties	   in	   the	   purification	   process.	   To	   overcome	   this	   problem,	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Porcheddu	   and	   Giacomelli	   reported	   the	   use	   of	   solid	   supported	   N-­‐hydroxy-­‐benzenesulfonamide	  95	  as	  a	  source	  of	  NHOH.	  This	  method	  gave	  good	  to	  excellent	  yields	  and	  purities	  by	  simple	  filtration	  and	  evaporation	  (Scheme	  29).65	  	  
	  
Scheme	   29.	   The	   synthesis	   of	   hydroxamic	   acid	   from	   aldehyde	   using	   solid	  supported	  N-­‐hydroxybenzenesulfonamide	  95	  	  
1.3.2 Synthesis	  of	  hydroxamic	  acids	  from	  an	  ester	  The	   reaction	   of	   ester	   96	   with	   hydroxylamine	   hydrochloride	   in	   the	   presence	   of	  alkali	  has	  been	  used	  as	  an	  important	  reaction	  for	  hydroxamic	  acid	  synthesis.	  The	  reaction	  can	  be	  carried	  out	  at	  0	  oC	  to	  room	  temperature	  for	  4	  to	  12	  hours,	  giving	  moderate	  to	  good	  yields	  (Scheme	  30).66	  	  
	  	  
Scheme	  30.	  The	  synthesis	  of	  hydroxamic	  acids	  from	  esters.	  	  Massaro	   et	   al.	   reported	   the	   use	   of	  microwave	   irradiation	   to	   reduce	   the	   reaction	  time	   to	   6	   minutes.	   It	   is	   noteworthy	   that	   this	   method	   was	   employed	   with	  enantiomerically	  pure	  esters,	  which	  retained	  their	  stereochemistry.67	  	  
1.3.3 Synthesis	  of	  hydroxamic	  acid	  from	  acid	  chloride	  An	   acid	   chloride	  98	   was	   readily	   reacted	  with	   hydroxylamine	   in	   the	   presence	   of	  base	  (Scheme	  31).68	  
	  
Scheme	  31.	  The	  synthesis	  of	  hydroxamic	  acid	  from	  an	  acid	  chloride.	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  However,	   this	  method	  could	  not	  be	  applied	   to	  N-­‐protected	  α-­‐amino	  acids	  except	  those	   with	   Fmoc	   protecting	   groups.	   Babu	   et	   al.	   demonstrated	   the	   reaction	   of	  Fmoc–amino	  acid	  chlorides	  99	  with	  hydroxylamine	  hydrochloride	  in	  the	  presence	  of	  magnesium	  oxide	  to	  give	  Fmoc-­‐protected	  amino	  acid	  hydroxamate	  100	  in	  good	  yields	  and	  purity	  (Scheme	  32).69	  	  	  
	  
Scheme	  32.	  Fmoc	  protected	  amino	  acid	  hydroxamate	  100	  synthesis.	  	  
1.3.4 Synthesis	  of	  hydroxamic	  acid	  from	  carboxylic	  acid	  Although	  the	  reaction	  of	  esters	  and	  acid	  chlorides	  with	  hydroxylamine	  is	  the	  most	  economic	  method	  for	  preparing	  hydoxamic	  acids,	  the	  limitation	  of	  this	  reaction	  is	  the	  pH	  that	  needs	  to	  be	  used,	  i.e.	  basic	  conditions	  (pH>10).	  Therefore,	  it	  could	  not	  be	   applied	   to	   any	   base	   sensitive	   groups.	   Reddy	   et	   al.	   suggested	   a	   method	   to	  overcome	  this	  issue	  by	  reacting	  a	  carboxylic	  acid	  101	  with	  ethyl	  chloroformate	  to	  form	   mixed	   anhydride	   102,	   followed	   by	   reaction	   with	   hydroxylamine	   under	  neutral	  conditions	  (Scheme	  33).70	  	  	  
	  
Scheme	  33.	  The	  hydroxamic	  acid	  synthesis	  from	  carboxylic	  acid.	  	  However,	   the	   use	   of	   ethyl	   chloroformate	   as	   a	   carboxylic	   acid	   activator	   has	   a	  disadvantage	   due	   to	   its	   irritant	   vapour.	   Giacomelli	   et	   al.	   reported	   a	   one-­‐pot	  hydoxamic	  acid	  reaction	  of	  a	  carboxylic	  acid	  with	  hydroxylamine	  hydrochloride	  in	  the	   presence	   of	   2,4,6-­‐trichloro[1,3,5]triazine	   (cyanuric	   chloride)	   and	   DMAP	   as	  catalyst	   at	   room	   temperature.	   This	   reaction	  was	   shown	   to	   be	   successful	   for	   the	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synthesis	  of	  enantiomerically	  pure	  carboxylic	  acids	  and	  N-­‐protected	  amino	  acids.	  Surprisingly,	  this	  was	  done	  without	  deprotection,	  even	  with	  the	  less	  stable	  Boc-­‐N-­‐protected	  group	  (Scheme	  34).71	  	  
	  
Scheme	  34.	  One-­‐pot	  synthesis	  of	  hydroxamic	  acid	  from	  carboxylix	  acid.	  	  
1.3.5 N-­hydroxy	  urea	  synthesis.	  
N-­‐Hydroxy	  ureas	  106	  were	  originally	   synthesized	  by	   acylation	  of	   an	   amine	  with	  phosgene	  or	  triphosgene	  to	  yield	  carbamoyl	  chloride	  or	  isocyanate	  105,	   followed	  by	  the	  reaction	  with	  hydroxyalamine	  to	  give	  the	  corresponding	  N-­‐hydroxy	  ureas.72	  However,	   phosgene	   is	   very	   toxic,	   therefore,	   isocyanates	   are	   better	   to	   use	   as	  starting	  materials	  (Scheme	  35).73	  	  	  
	  
Scheme	  35.	  N-­‐hydroxy	  ureas	  synthesis	  from	  isocyanate.	  	  Muñoz	   et	   al.	   suggested	   a	   preparative	   method	   for	   the	   N-­‐hydroxy	   ureas	   106	   by	  reacting	   carbamoyl	   azides	   107	   with	   hydroxylamine	   under	   basic	   conditions	  (Scheme	  36).74	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Scheme	  36.	  N-­‐hydroxy	  ureas	  synthesis	  from	  carbamoyl	  azides.	  	  
1.4 Copper-­catalyzed	  aerobic	  oxidation	  The	   chemistry	   of	   Cu(I)-­‐dioxygen	   109	   adduct	   is	   of	   great	   interest	   due	   to	   its	  properties	   as	   a	   mild	   oxidant.	   Cu(I)	   108	   reacts	   with	   O2	   to	   form	   Cu(II)-­‐peroxo	  species	  109,	  which	  can	  bind	   in	   two	  different	  positions;	   either	  end-­‐on	   (µ-­‐1,2-­‐)	  or	  side	  on	  (µ-­‐η2-­‐η2)	  position.	  The	  binding	  site	  on	  the	  copper	  depends	  upon	  the	  nature	  of	  the	  ligands.	  A	  Cu(II)-­‐peroxo	  species	  could	  readily	  oxidise	  a	  variety	  of	  substrates	  to	   form	   the	   corresponding	   2-­‐electron	   product	   and	   (LnCu(II)-­‐OH)2	   species	   110	  (Scheme	  37).75	  	  
	  	  
Scheme	  37.	  The	  formation	  of	  Cu(I)-­‐dioxygen	  109	  adduct.	  	  Makó	  et	  al.	  reported	  the	  use	  of	  Cu(I)Cl/1,10-­‐phenantholine	  (5	  mol%)	  and	  di-­‐tert-­‐butyl	  azodicarboxylate	   (5	  mol%)	  with	  N-­‐methylimidazole	   (7	  mol%),	  which	  acted	  as	   the	  additive	   in	   the	  oxidation	  of	  primary	  alcohol	  111	   to	  aldehyde	  112	   in	  good	  yields	  (Scheme	  38).	  76	  	  	  
	  
Scheme	  38.	  Oxidation	  of	  primary	  alcohols	  to	  aldehydes	  using	  copper(I)	  catalyst.	  	  Zhang	  and	  Jiao	  reported	  the	  use	  of	  copper(I)	  bromide	  (6	  mol%)	  with	  pyridine	  (18	  mol%)	  as	  a	  catalyst	  in	  the	  dehydrogenative	  coupling	  of	  anilines	  113	  and	  114.	  This	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gave	   rise	   to	   an	   aromatic	   azo-­‐compound	  115	   using	   oxygen	   in	   air	   as	   the	   oxidant.	  This	  reaction	  was	  carried	  out	  in	  toluene	  at	  60	  0C	  for	  20	  hours,	  which	  gave	  a	  yield	  of	  96%	   for	   the	   symmetric	   azo-­‐compounds	   and	   up	   to	   73%	   for	   asymmetric	   azo-­‐compounds	  (Scheme	  39).	  77	  	  
	  
Scheme	  39.	  The	  dehydrogenative	  coupling	  of	  anilines	  to	  aromatic	  azo	  compound.	  	  They	   conducted	   two	   experiments	   using	   Cu(I)Br	   and	   Cu(II)Br2	   under	   nitrogen	   to	  see	  whether	   oxygen	  was	   the	   real	   oxidant,	   but	   both	   reactions	  were	   unsuccessful.	  Therefore,	   they	   postulated	   that	   O2	   was	   acting	   as	   an	   initiator	   that	   triggered	   the	  catalytic	  process,	  as	  well	  as	  being	  an	  oxidant	  (Scheme	  40).	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A	   plausible	   mechanism	   involves	   a	   reaction	   which	   starts	   by	   the	   chelation	   of	  pyridine	  to	  Cu(I),	  then	  oxidation	  by	  O2	  to	  form	  the	  active	  catalyst	  species	  µ-­‐η2-­‐η2	  peroxo	  complex	  109.	  The	  copper	  species	  then	  achieves	  single-­‐electron	  oxidation	  of	  aniline	  116	  to	  form	  intermediate	  117,	  followed	  by	  coupling	  with	  another	  aniline	  to	  form	   a	   three-­‐electron	   σ-­‐bond	   species	   118.	   The	   loss	   of	   two	   protons	   and	   one	  electron	   gives	  hydrazine	  119	   formation,	  which	  was	   further	   oxidised	   to	   yield	   the	  azo-­‐compounds	  120	  and	  regenerate	  the	  active	  catalyst	  species.	  	  Ho	  and	  Lau	  reported	  the	  use	  of	  CuCl2.H2O	  as	  a	  catalyst	  in	  the	  amination	  of	  alkenes	   121	   and	   ketones	   by	   phenylhydroxylamine	   122,	   which	   gave	   good	  regioselectivity	  of	  allylamines	  	  123	  with	  moderate	  yields	  (Scheme	  41).	  22	  	  	  
	  
Scheme	  41.	  The	  amination	  of	  alkenes	  by	  phenylhydroxylamine.	  	  The	  Cu(II)-­‐catalyzed	  oxidation	  of	  phenylhydroxylamine	  122	  was	   the	   first	   step	   in	  the	   catalytic	   process	   to	   form	   nitroso	   benzene	   2,	   followed	   by	   reaction	   with	   the	  alkene	  to	  give	  an	  allylhydoxylamine	  125.	  This	  species	  was	  then	  reduced	  by	  Cu(I)	  to	  form	  allylamine	  126	  (Scheme	  42).	  Presumably,	   the	  reaction	  proceeds	  by	  an	  ene-­‐reaction	  mechanism	  for	  the	  reaction	  of	  PhNO	  with	  propene.	  	  
	  
Scheme	  42.	  A	  plausible	  mechanism	  for	  allylamine	  formation.	  	  Accoring	  to	  the	  study	  of	  Ho	  and	  Lau,	  they	  could	  form	  phenylnitroso	  2	  by	  reacting	  2	  mole	  equivalent	  of	  CuCl2.H2O	  with	  phenylhydroxylamine	  122	  at	  room	  temperature	  in	  dioxane	  for	  3	  minutes	  to	  give	  70%	  of	  nitroso	  benzene	  2	  was	  formed	  with	  10%	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phenylamine	  116	   and	   10%	   azoxybenzene	   as	   side-­‐products.	   They	   suggested	   that	  nitroso	  compounds	  could	  be	  formed,	  as	  shown	  in	  the	  Eq	  4.	  	  	  
	  	  	  The	   Eq.	   5	   illustrates	   that	   an	   amine	   is	   formed	   by	   the	   deoxygenation	   of	  phenylhydroxylamine	  by	  Cu(I)	  catalysis.	  	  
	  	  The	  overall	  reaction	  is	  shown	  in	  Eq.	  6.	  	  
	  	  Under	  certain	  thermal	  conditions,	  the	  disproportionation	  of	  phenylhydroxylamine	  can	   occur.	   However,	   when	   copper	   was	   present,	   the	   rate	   of	   reaction	   was	   much	  higher.	  	  The	  azoxybenzene	  124	  was	  formed	  by	  the	  reaction	  of	  the	  nitroso	  benzene	  2	  and	  phenylamine	  species	  116	  (Eq.	  7).	  	  	  
	  	  Read	   de	   Alaniz	   et	   al.	   reported	   the	   use	   of	   Cu(I)Cl	   in	   acylnitroso	   ene	   reactions	   in	  2011.	  The	  reaction	  was	  carried	  out	  using	  5	  mol%	  CuCl	  and	  1.25	  mol%	  pyridine	  in	  THF	  to	  achieve	  aerobic-­‐oxidation	  of	  hydroxamic	  acids	  to	  the	  corresponding	  nitroso	  species,	   which	   readily	   reacted	   with	   an	   alkene	   to	   form	   ene-­‐products.	   Both	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intramolecular	  (Scheme	  43)	  and	  intermolecular	  (Scheme	  44)	  reactions	  took	  place	  to	  give	  moderate	  to	  high	  yields.78	  	  
	  
Scheme	  43.	  Intramolecular	  ene-­‐reaction	  involving	  an	  aryl	  nitroso	  species.	  	  	  
	  
Scheme	  44.	  Intermolecular	  ene-­‐reaction	  involving	  an	  aryl	  nitroso	  species.	  	  A	   year	   later,	   they	   reported	   a	   similar	   catalytic	   system	   for	   the	   nitroso-­‐Diels-­‐Alder	  reaction,	  however,	  higher	  catalyst	   loading	  of	  20%	  CuCl	  and	  5	  mol%	  pyridine	  was	  required	   to	   oxidize	   the	   hydroxamic	   acids	   129	   to	   the	   corresponding	   nitroso	  compounds,	   which	   were	   trapped	   by	   diene	   132	   to	   form	   the	   cycloadducts	   133	  (Scheme	  45).	  The	  yields	  varied	  from	  moderate	  to	  high,	  which	  depended	  upon	  the	  hydroxamic	  acid.	  This	  procedure	  worked	  best	   for	   the	   corresponding	  hydroxamic	  acid	  forming	  nitrosoformate,	  nitrosoformamide	  and	  acylnitroso	  derivatives.	  79	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For	  a	  number	  of	  years,	  studies	  in	  the	  Whiting	  group	  have	  involved:	  a)	  developing	  new,	   greener	   oxidative	   methods	   for	   the	   generation	   of	   nitroso	   species;80	   b)	  demonstrating	  the	  first	  efficient,	  catalytic	  asymmetric	  arylnitroso	  DA	  reaction;	  and	  c)	  application	  of	  the	  adducts	  in	  the	  synthesis	  of	  bioactive	  compounds.	  To	  date,	  no	  highly	   enantioselective	   reaction	   of	   acylnitroso	   compounds	   has	   been	   reported,	  though	   the	   Whiting	   group	   has	   reported	   up	   to	   15%	   e.e.	   using	   R-­‐PROPHOS	   and	  RuCl2(PPh3)3	  (Scheme	  46).	  Hence,	  the	  development	  of	  an	  enantiomerically	  benign,	  highly	  efficient	  catalytic	  asymmetric	  version	  is	  highly	  attractive.	  	  
	  
	  
Scheme	  46.	  Acylnitroso	  DA	  reaction	  using	  R-­‐PROPHOS	  	  and	  Ru	  catalyst	  to	  achieve	  up	  to	  15%	  e.e
	  
	   	   i	  
Chapter	  2.	  Results	  and	  discussion	  
























	   32	  	  	  	  
2.0	  Results	  and	  discussion	  
	  
2.1	  Introduction	  Recently,	  chiral	  thiourea	  oxazolines	  have	  drawn	  the	  attention	  of	  synthetic	  chemists	  as	   they	   appear	   to	   be	   important	   ligands	   for	   several	   transition	   metal-­‐catalyzed	  reactions.81	   In	   particular,	   palladium-­‐thiourea	   oxazoline	   complexes	   have	   been	  reported	  as	  new	  catalysts	  in	  synthesis	  due	  to	  their	  properties	  of	  air	  and	  moisture	  stability.	   They	   are	   resistant	   to	   oxidation,	   which	   means	   they	   can	   be	   used	   in	  oxidative	  catalytic	  reactions.	  These	  complexes	  were	  synthesized	  and	  characterized	  in	   collaboration	   between	   the	   Marder	   and	   Yang	   groups81	   and	   they	   used	   these	  complexes	  in	  the	  chiral	  synthesis	  of	  bis(methoxycarbonylation)	  products,	  i.e.	  from	  the	  oxidative	  carbonylation	  of	  terminal	  olefins	  to	  give	  >	  90%	  	  yields	  and	  up	  to	  84%	  
ees.	  	  	  	   From	  some	  very	  preliminary	  previous	  studies	  from	  the	  Whiting	  group,	  the	  oxidation	  of	  hydroxamic	  acid	  138 to	  nitroso-­‐species	  139	  was	  claimed	  to	  have	  been	  achieved,	  which	  then	  reacted	  with	  1,3-­‐cyclohexadiene	  to	  form	  cycloadduct	  140	  at	  room	  temperature	  (see	  below).	   	   It	  was	  also	  claimed	  (by	   Ilyashenko)	   that	  using	  1	  mol%	  of	   a	   palladium	   catalysts	  with	   thiourea-­‐oxazoline	   chiral	   ligands	  141	   -­‐	  144,	  (Scheme	  47)	  resulted	  in	  a	  very	  low	  yield	  but	  high	  enantioselectivities	  (up	  to	  98%	  
ee).	   However,	   for	   these	   highly	   preliminary	   studies,	   only	   a	   very	   small	   amount	   of	  catalyst	   was	   available	   and	   therefore,	   the	   reactions	   were	   carried	   out	   on	   an	  exceptionally	   small	   scale.	   The	   questions	   were	   therefore,	   whether	   these	   results	  could:	  1)	  be	  reproduced	  on	  a	  larger	  scale;	  and	  2)	  be	  demonstrated	  to	  indeed	  derive	  cycloadducts	  of	  type	  140	  with	  high	  asymmetric	  induction.	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Scheme	   47.	   The	   nitroso-­‐Diels-­‐Alder	   reaction	   using	   palladium	   catalysts	   with	  thiourea-­‐oxazoline	  ligands.	  	  
2.2	  Preliminary	  Studies	  With	  the	  questions	  in	  mind	  from	  the	  preliminary	  results	  shown	  in	  Scheme	  47,	  the	  initial	   aims	   of	   this	   project	   were	   therefore	   to	   repeat	   this	   type	   of	   reaction	   and	  determine	   if	   the	   results	   were	   reliable,	   whether	   they	   could	   be	   scaled	   up	   and	  whether	   they	   could	  be	  applied	   to	  other	   substrates,	   and	  hence	   in	   the	  asymmetric	  synthesis	   of	   chiral,	   bioactive	   compounds.	   The	   starting	   point	   in	   this	   project	   was	  therefore	  re-­‐examining	  the	  reaction	  shown	  in	  Scheme	  47	  in	  an	  attempt	  to	  improve	  the	   yield	   of	   the	   cycloadduct	   	  140	   by	   increasing	   the	   catalyst	   loading	   to	   5	  –	   10%,	  using	  both	  oxygen	  and	  air.	  These	  reactions	  were	  also	  carried	  out	  together	  with	  the	  addition	   of	   copper	   to	   assist	   in	   any	   oxidation	   process,	   and	   with	   copper	   alone	   to	  check	  on	  the	  effect	  of	  palladium	  versus	  copper	  as	  catalysts.	  The	  results	  are	  shown	  in	  the	  Table	  1	  with	  the	  comparable	  periodate-­‐based	  reaction	  also	  reported.	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Table	   1.	   The	   reaction	   of	   hydroxamic	   acid	   138	   with	   1,3-­‐cyclohexadiene	   with	  various	  catalyst	  systems	  based	  on	  palladium	  and	  copper.	  
Entry	   Catalyst	  
(mol%)	   Co	  catalyst	  (mol%)	   Oxidant	   Solvent	   Yield	  %	  
1	   -­‐	   -­‐	   NaIO4	   MeOH	   70	  
2	   Pd-­‐141(1)	   -­‐	   O2	   MeOH	   0	  
3	   Pd-­‐141	  (1)	   -­‐	   Air	   MeOH	   0	  
4	   Pd-­‐141	  (5)	   -­‐	   Air	   MeOH	   0	  
5	   Pd-­‐141	  (10)	   -­‐	   Air	   MeOH	   0	  
6	   Pd-­‐141	  (1)	   CuI	  (2)	   Air	   MeOH	   20	  
7	   Pd-­‐141	  (5)	   CuI	  (5)	   O2	   MeOH	   39	  
8	   Pd-­‐141	  (5)	   CuI	  (10)	   O2	   MeOH	   42	  
9	   Pd-­‐141	  (1)	   CuI	  (2)	   O2	   MeOH	  /Et3N	   58	  
10	   CuI	  (10)	   -­‐	   O2	   MeOH	   77	  	  	  Table	  1	   shows	   the	   results	  of	  a	   catalytic	   study	  of	  Pd-­‐141	  complexes	   in	   the	  model	  reaction	   (Scheme	   47)	   carried	   out	   in	   order	   to	   confirm	   that	   the	   reaction	   of	   N-­‐(benzyloxy-­‐carbonyl)hydroxylamine	  138	  and	  1,3-­‐cyclohexadiene	  can	  actually	  take	  place	  through	  nitroso	  generation.	  The	  oxidation	  of	  the	  hydroxamic	  acid	  138	  using	  the	  NaIO4	   as	   the	   oxidant	   in	   the	   presence	   of	   1,3-­‐cyclohexadiene	   in	  methanol	  was	  conducted	  initially.	  The	  reaction	  was	  complete	  in	  4	  hours	  giving	  70%	  isolated	  yield	  (Entry	   1,	   Table	   1).	   The	   cycloadduct	   product	   140	   was	   confirmed	   by	   NMR.	   The	  reason	   for	   using	   1,3-­‐cyclohexadiene	   in	   the	   model	   reaction	   was	   because	   it	   is	  commercially	   available,	   easy	   to	   handle	   and	   does	   not	   dimerize	   at	   room	  temperature,	  unlike	  cyclopentadiene.	  
	   35	  	  	  	  
	   Upon	   the	   premixing	   1	   mol%	   of	   Pd-­‐141	   in	   methanol	   for	   5	   minutes,	   the	  colour	   of	   the	   solution	   was	   yellow.	   After	   adding	   N-­‐(benzyloxycarbonyl)	  hydroxylamine	  138	   and	   1,3-­‐cyclohexadiene,	   the	   colour	   stayed	   the	   same.	   After	   7	  days,	  the	  mixture	  turned	  black	  but	  there	  was	  no	  desired	  product	  spot	  on	  the	  TLC.	  The	   black	   colour	   of	   the	   catalyst	   suggested	   the	   formation	   of	   Pd(0)	   colloid.	   This	  catalyst	   is	  moisture	  and	  air	  stable,	   therefore,	   the	  reduction	  of	   the	  Pd(II)	  complex	  could	   take	   place	   either	   by	   reduction	   from	   hydroxamic	   acid	   138	   or	   1,3-­‐cyclohexadiene.	   Entries	   2	   and	   3,	   Table	   1	  were	   carried	   out	   at	   room	   temperature	  under	  O2	  and	  air	  respectively.	  However,	  there	  was	  no	  reaction	  even	  with	  5	  and	  10	  mol%	  catalyst	  loadings	  (Entries	  4	  and	  5,	  Table	  1).	  From	  the	  study	  of	  using	  Pd-­‐141	  complexes	  catalyst	   in	   the	  enatioselective	  bis(methoxycarbonylation)s	  of	   terminal	  olefins	  under	  mild	  conditions,81	   it	  was	  found	  that a copper	  salt	  was	  important	   in	  this	  reaction.	  	  Therefore,	  the	  addition	  of	  	  2	  mol%	  CuI	  as	  a	  co-­‐catalyst	  in	  the	  reaction	  with	  1	  mol%	  of	  Pd-­‐141	   (Entry	  6,	   Table	  1)	  was	   carried	  out	   in	  methanol	   at	   room	  temperature.	  The	  desired	  product	   spot	  appeared	  on	   the	  TLC	  after	  1	  day	  and	   the	  reaction	  was	  complete	  in	  4	  days,	  giving	  the	  product	  140	  in	  20%	  yield.	  Increasing	  the	  catalyst	  and	  co-­‐catalyst	  loading	  helped	  to	  increase	  the	  yield	  of	  the	  cycloadduct	  product	   (Entries	   7	   and	   8,	   Table	   1).	   	   Adding	   Et3N	   as	   base	   helped	   to	   increase	   the	  yield	  further	  to	  58%	  using	  the	  same	  reaction	  timescale.	  However,	  there	  were	  some	  unidentified	   impurities	   on	   the	  TLC	  and	   in	   the	  NMR	  spectrum	   (Entry	  9,	  Table	  1).	  The	  use	  of	  CuI	  as	  catalyst	  alone	  in	  the	  model	  reaction	  was	  also	  carried	  out	  using	  10	  mol%	  CuI	  in	  methanol;	  the	  cycloadduct	  spot	  appeared	  on	  the	  TLC	  after	  1	  day	  and	  the	  reaction	  finished	  in	  4	  days	  giving	  77%	  isolated	  yield	  of	  product	  140	  (Entry	  10,	  Table	   1).	   This	   reaction	   confirmed	   that	   copper	   plays	   a	  major	   role	   in	   the	   catalytic	  cycle	   in	   the	  oxidation	  of	  hydroxamic	  acid	  138	   to	  nitroso	  species	  and	   that	   the	  Pd	  complexes	  are	  unreactive.	  Ru-­‐based	   catalysts	   have	   been	   reported	   to	   catalyze	   oxidative	   nitroso	  dienophile	  formation,	  especially	  using	  Ru-­‐pybox	  complexes	  as	  catalyst	  and	  tBuOOH	  or	  H2O2	  as	  co-­‐oxidant.41,42	  Therefore,	  experiments	  were	  carried	  out	  using	  1	  mol%	  RuCl3	  and	  2	  mol%	   ligand	   [tetramethylthiourea	   (TMTU)	  or	  2-­‐ethyl-­‐2-­‐oxazoline	  or	  
141]	  using	  tBuOOH	  as	  co-­‐oxidant	  in	  DCM	  at	  room	  temperature	  for	  96	  hours	  in	  the	  reaction	   shown	   in	   Scheme	  47.	   The	   results	   are	   summarized	   in	  Table	   2	   and	   show	  that	   the	   reaction	   did	   not	   proceed	   under	   aerobic	   conditions	   (Entries	   1,	   2	   and	   3,	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Table	  2)	  showing	  that	  ruthenium	  was	  not	  able	  to	  accomplish	  aerobic	  oxidations	  of	  the	   type	  desired,	  and	  hence,	   copper-­‐based	  oxidants	   look	   like	   the	  most	  promising	  for	  further	  development.	  	  
	  
Table	  2.	  RuCl3	  with	   thiourea	  and	  oxazoline	  catalysts	   in	   the	  model	  reaction,	  as	   in	  Scheme	  47.	  
Entry	   Catalyst	  
(mol%)	   Time	   Yield	  %	  
1	   RuCl3(1)/TMTU	  (2)	   96	  h	   0	  
2	   RuCl3(1)/2-­‐ethyl-­‐2-­‐oxazoline	  (2)	   96	  h	   0	  
3	   RuCl3(1)/141	  (2)	   96	  h	   0	  	  	  
2.3.	  Copper	  salt	  screening	  From	  the	  results	  reported	  in	  Table	  1	  showing	  that	  copper	  salts	  could	  mediate	  the	  require	   hydroxamic	   acid	   oxidation	   in	   air,	   copper	   salt	   screening	   reactions	   with	  different	   solvents	   were	   conducted	   using:	   CuI;	   CuCl2;	   CuBr2;	   and	   Cu(OAc)2	   in	  methanol,	   toluene,	  acetonitrile,	  THF,	  a	  mixed	  solvent	  system	  of	  methanol:toluene	  (1:4)	   and	   chloroform	   in	   the	   absence	   of	   any	   additional	   ligands.	   The	   results	   are	  shown	  in	  Table	  3.	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Table	   3.	   Screening	   of	   both	   copper	   salts	   and	   solvents	   for	   the	   oxidation	   of	   138,	  trapping	  with	  1,3-­‐cyclohexadiene	  to	  give	  140.	  
Entry	   Catalyst	  (mol%)	   Time*	   Solvent	   Yield	  %#	  
1	   CuI	  (5)	   4	  d	   MeOH	   32	  
2	   CuCl2	  (5)	   15	  h	   MeOH	   47	  
3	   CuBr2	  (5)	   15	  h	   MeOH	   40	  
4	   Cu(OAc)2	  (5)	   5	  d	   MeOH	   21	  
5	   CuI	  (5)	   6	  d	   Toluene	   35	  
6	   CuCl2	  (5)	   4	  d	   Toluene	   50	  
7	   CuBr2	  (5)	   4	  d	   Toluene	   44	  
8	   Cu(OAc)2	  (5)	   7	  d	   Toluene	   23	  
9	   CuI	  (5)	   2	  d	   MeCN	   10	  
10	   CuCl2	  (5)	   22	  h	   MeCN	   27	  
11	   CuBr2	  (5)	   2	  d	   MeCN	   21	  
12	   Cu(OAc)2	  (5)	   2	  d	   MeCN	   5	  
13	   CuI	  (5)	   26	  h	   THF	   20	  
14	   CuCl2	  (5)	   26	  h	   THF	   28	  
15	   CuBr2	  (5)	   26	  h	   THF	   25	  
16	   Cu(OAc)2	  (5)	   26	  h	   THF	   11	  
17	   CuI	  (5)	   20	  h	   MeOH/Toluene	  1:4	   72	  
18	   CuCl2	  (5)	   15	  h	   MeOH/Toluene	  1:4	   75	  
19	   CuBr2	  (5)	   20	  h	   MeOH/Toluene	  1:4	   69	  
20	   Cu(OAc)2	  (5)	   4	  d	   MeOH/Toluene	  1:4	   50	  
21	   CuI	  (5)	   21	  h	   CHCl3	   70	  
22	   CuCl2	  (5)	   15	  h	   CHCl3 77	  
23	   CuBr2	  (5)	   21	  h	   CHCl3	   68	  
24	   Cu(OAc)2	  (5)	   3	  d	   CHCl3 52	  *Time	  =	  reaction	  time	  (as	  defined	  by	  100%	  consumption	  of	  hydroxamic	  acid	  by	  TLC	  analysis).	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#	  Yield	  =	  isolated	  yield	  after	  SiO2	  chromatography.	  	  The	  reactions	  outlined	  in	  Entries	  1-­‐4,	  Table	  3	  were	  carried	  out	  in	  methanol.	  After	  mixing	  CuI	  with	  methanol,	  the	  solution	  was	  colourless,	  but	  upon	  the	  addition	  of	  the	  diene	  and	  hydroxamic	  acid,	  the	  mixture	  turned	  a	  milky	  colour	  due	  to	  the	  diene	  not	  dissolving	  fully	  in	  the	  methanol.	  The	  mixture	  turned	  colourless	  when	  the	  reaction	  was	   completed	   after	   4	   days	   (Entry	   1,	   Table	   3),	   though	   only	   low	   yields	   of	   the	  adducts	   (32%)	  was	  obtained.	  For	  Entry	  2	   (Table	  3),	   after	  dissolving	   the	  CuCl2	   in	  methanol,	   the	   colour	   changed	   to	   yellow-­‐green.	   Addition	   of	   the	   diene	   and	  hydroxamic	  acid	  changed	  the	  reaction	  mixture	  colour	  to	  a	  cloudy-­‐pale	  yellow.	  The	  reaction	   completed	   in	   15	  hours	  with	  47%	   isolated	   yield	   and	   the	   colour	   changed	  back	   to	   the	   yellow-­‐green	   of	   CuCl2.	   This	   colour	   change	   showed	   that	   the	   reaction	  seemed	  to	  be	  self-­‐indicating.	  For	  Entry	  3	  (Table	  3),	  the	  colour	  of	  CuBr2	  in	  methanol	  was	   yellow	   and	   the	   colour	   changed	   to	   a	   cloudy-­‐pale	   yellow	  when	   the	   diene	   and	  hydroxamic	  acid	  were	  added.	  The	  reaction	  was	  completed	   in	  15	  hours	  with	  40%	  isolated	   yield	   and	   the	  mixture	   changed	   back	   to	   the	   starting	   colour.	   For	   Entry	   4	  (Table	  3),	  when	  dissolving	  Cu(OAc)2	   in	  methanol,	   the	   colour	   of	   the	   solution	  was	  pale	  blue.	  Addition	  of	  diene	  and	  hydroxamic	  acid	  changed	  the	  colour	  to	  a	  cloudy-­‐yellow-­‐green.	  The	  reaction	  was	  completed	  in	  5	  days	  the	  lowest	  isolated	  yields	  was	  obtained,	  being	  21%.	  	  	   When	  the	  copper	  salt	  screenings	  were	  conducted	  using	  toluene	  as	  solvent,	  they	  gave	  a	  similar	  trend	  to	  the	  methanol	  reactions,	  but	  the	  solubility	  of	  the	  copper	  salts	  was	  very	   low	  and	  hence,	   the	   reaction	   times	  were	   the	   longest	  among	  all	   the	  solvents	  that	  were	  used	  (Entries	  5	  –	  8,	  Table	  3),	  with	  reaction	  times	  up	  to	  7	  days.	  The	   isolated	   yield	   of	   the	   cycloadduct	   products	   was	   low	   to	   moderate	   (23-­‐50%).	  CuCl2	  gave	  the	  highest	  yield,	   followed	  by	  CuBr2,	  CuI	  and	  Cu(OAc)2.	   In	  acetonitrile	  solvent,	   the	   copper	   salts	   were	   readily	   dissolved	   and	   different	   colours	   were	  produced	  in	  the	  different	  solvents,	  except	  for	  CuI,	  which	  gave	  a	  colourless	  solution	  in	  all	  solvents.	  The	  CuCl2-­‐based	  mixtures	  gave	  yellow	  solutions,	  in	  all	  cases	  which	  darkened	  upon	   the	  addition	  of	   the	  diene	  and	  hydroxamic	  acid.	  The	   reaction	  was	  complete	  in	  22	  hours	  and	  the	  colour	  changed	  back	  to	  the	  original	  colour	  of	  yellow	  giving	   27%	   isolated	   yield	   (Entry	   10,	   Table	   3).	   CuBr2	  mixtures	  were	   dark	   green,	  which	   turned	   jade	   green	   upon	   adding	   the	   starting	   materials.	   The	   reaction	   was	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stirred	  and	  completed	  in	  2	  days	  and	  the	  colour	  of	  the	  mixture	  changed	  to	  brownish	  green	  giving	  21%	  isolated	  yield	  (Entry	  11,	  Table	  3).	  Cu(OAC)2	  in	  acetronitrile	  was	  blue	  and	  this	  changed	  to	  yellow-­‐green	  after	  the	  staring	  materials	  were	  added.	  The	  completion	  of	  the	  reaction	  took	  2	  days	  with	  the	  lowest	  isolated	  yield	  of	  2%	  (Entry	  12,	  Table	  3).	   	  By	  using	  THF	  as	   solvent	   (Entries	  13-­‐16,	  Table	  3),	   all	   the	   reactions	  were	  completed	   in	  26	  hours.	  The	   isolated	  yields	  were	   low	  (11	  –	  28%),	  however.	  From	  these	  results,	  it	  can	  be	  summarized	  that	  methanol	  gave	  the	  shortest	  reaction	  times	  among	  all	   the	   solvents,	  with	  generally	  good	  copper	   salt	   solubility.	  Toluene	  gave	   the	   best	   isolated	   yield	   among	   the	   four	   solvent	   systems	   but	   the	   copper	  solubility	  was	   the	   lowest	   and	   solubilisation	   appeared	   to	   be	   the	   slow	   part	   of	   the	  reaction.	  Therefore,	  the	  mixed	  solvent	  system	  of	  methanol	  and	  toluene	  (1:4)	  were	  conducted	  (Entries	  17-­‐20,	  Table	  3).	  The	  isolated	  yields	  of	  the	  cycloadduct	  product	  were	  improved	  in	  all	  cases	  (up	  to	  75%).	  The	  reaction	  times	  for	  CuI	  and	  Cu(OAc)2	  were	   also	   improved	   compared	   with	   both	   single	   solvent	   systems.	   The	   CuCl2	  reaction	  time	  was	  15	  hours,	  which	  was	  the	  same	  as	  the	  reaction	  time	  in	  methanol.	  However,	   the	   CuBr2	   catalyst	   in	   the	   mixed	   solvent	   system	   was	   slower	   than	   the	  reaction	   in	  methanol.	  Although	   the	   chlorinated	   solvent	  was	  not	   the	   ideal	   solvent	  for	   this	   system	   because	   even	   with	   a	   trace	   can	   damage	   chiral	   HPLC	   column	  supports,	   chloroform-­‐d	  was	   used	   as	   the	  NMR	   solvent	   and	   the	   copper	   salts	  were	  screened	  in	  chloroform	  (Entries	  21–24,	  Table	  3).	  The	  CuCl2	  reaction	  time	  could	  be	  monitored	   as	   the	   colour	   changed	   from	   green	   to	   yellow	   and	   then	   back	   to	   green	  when	  the	  reaction	  completed	  (15	  hours),	  which	  was	  the	  fastest	  among	  them	  all	  the	  reactions.	  It	  also	  gave	  the	  highest	  isolated	  yield	  of	  the	  cycloadduct	  product	  (77%).	  The	   CuI	   and	   CuBr2	   reactions	   were	   completed	   in	   21	   hours	   with	   70%	   and	   68%	  isolated	  yields	  respectively.	  	   Overall,	  CuCl2	  was	  the	  best	  copper	  catalyst	   in	   the	  model	  reaction.	  CuCl2	   in	  MeOH/toluene	  (1:4,	  v/v)	  gave	  the	  second	  best	  yield	  of	  75%.	  With	  only	  MeOH,	  even	  though	   the	   reaction	  was	   fast,	   there	  was	   a	   side-­‐product	   formed.	   A	   problem	  with	  using	  toluene	  as	  the	  only	  solvent	  was	  the	  solubility	  of	  the	  hydroxamic	  acid,	  which	  caused	  the	  reaction	  to	  be	  slower.	  With	  a	  combination	  of	  the	  two	  solvents,	  we	  can	  overcome	  this	  problem	  to	  some	  extent.	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2.4	  Ligand	  screening	  
2.4.1	  Chiral	  thiourea	  oxazoline	  ligand	  screening	  The	  effect	  of	  CuCl2	  with	  thiourea-­‐oxazoline	  ligands	  141	  -­‐	  144	  in	  the	  model	  reaction	  (Scheme	   47)	   in	   MeOH/toluene	   (1:4,	   v/v)	   was	   next	   examined	   in	   air	   in	   order	   to	  probe	   the	   effect	   of	   these	   ligand	   systems,	   if	   any.	   This	   solvent	   system	  was	   chosen	  because	  the	  cycloadduct	  product	  140	  could	  then	  be	  directly	  examined	  using	  chiral	  HPLC	  to	  check	  if	  there	  was	  any	  asymmetric	  induction.	  The	  results	  of	  this	  study	  are	  reported	  in	  Table	  4.	  	  
	  
	  	  
Table	  4.	  CuCl2	  with	  thiourea-­‐oxazoline	  ligands	  in	  the	  model	  reaction	  (Scheme	  47)	  carried	  out	  in	  toluene-­‐MeOH	  in	  air.	  
Entry	   Catalyst	  (mol%)	   Time	   Yield	  of	  140	  %	  (ee) 
1	   CuCl2(5)	   15	  h	   75	  (0)	  
2	   CuCl2(5)	  
141	  (5)	   10	  h	   81	  (0)	  
3	   CuCl2(5)	  
142	  (5)	   18	  h	   70	  (0)	  
4	   CuCl2(1)	  
143	  (1)	   15	  h	   75	  (0)	  
5	   CuCl2(5)	  
144	  (5)	   24	  h	   77	  (0)	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Entry	  1,	  Table	  4	   is	   the	   standard	   reaction	  with	  5	  mol%	  CuCl2	  without	  any	   ligand.	  The	   reaction	   was	   completed	   in	   15	   hours	   with	   75%	   isolated	   yield.	   Therefore,	   5	  mol%	  thiourea-­‐oxazoline	  ligand	  141	  with	  5	  mol%	  CuCl2	  was	  tested	  (Entry	  2,	  Table	  4)	  and	  upon	  the	  mixing	  of	  the	  copper	  salt	  with	  ligand,	  the	  colour	  was	  yellow	  and	  the	  mixture	   turned	  colourless	  upon	   the	  additional	  of	  diene	  and	  hydroxamic	  acid.	  The	  reaction	  was	  completed	  in	  10	  hours,	  confirmed	  by	  the	  TLC.	  This	  reaction	  was	  very	   easily	   purified	   by	   flash	   column	   chromatrography.	   The	   cycloadduct	   product	  
140	  obtained	  was	  very	  pure	  and	  crystallized.	  The	  crystal	  structure	  was	  confirmed	  by	  the	  X-­‐ray	  diffraction	  techniques	  (Figure	  9).	  	  
	  
Figure	  9.	  X-­‐ray	  crystal	  structure	  of	  140	  from	  Entry	  2,	  Table	  4.	  	  	  Ligand	  142	  is	  an	  atropoisomer	  of	  the	  ligand	  141,	  which	  was	  also	  used	  as	  a	  ligand	  in	   the	   standard	   reaction	   (Scheme	   47).	   These	   atropoisomers	   differ	   in	   the	  conformation	   of	   the	   iPr	   substituent	   on	   the	   phenyl	   ring.	   Use	   of	   5	  mol%	   thiourea	  oxazoline	   ligand	  142	   with	   5	  mol%	   CuCl2	   as	   catalyst	   in	   the	  model	   reaction	   took	  longer	   to	   complete	   (18	   hours)	   and	   lower	   yield	   (70%)	   compared	   to	   CuCl2-­‐141	  system	   (Entry	   3,	   Table	   4).	   Ligand	   143	   has	   the	   anthracene	   substituent	   on	   the	  phenyl	  ring	  and	  with	  only	  1	  mol%	  of	  this	  ligand	  and	  1	  mol%	  CuCl2	  could	  be	  used	  due	  to	  the	  small	  quantity	  of	  this	  ligand	  that	  was	  supplied.	  The	  reaction	  time	  of	  this	  reaction	   was	   15	   hours	   and	   which	   gave	   75%	   isolated	   yield	   of	   the	   cycloadduct	  product	  140	  (Entry	  4,	  Table	  4).	  	  The	  last	  entry	  in	  Table	  5	  used	  5	  mol%	  CuCl2	  and	  5	  mol%	   ligand	   144;	   a	   ligand	   which	   has	   no	   substituent	   on	   the	   phenyl	   ring.	   The	  reaction	  was	  completed	   in	  24	  hours	  giving	  77%	  isolated	  yield.	  From	  this	  table,	   it	  can	   be	   concluded	   that	   the	   thiourea-­‐oxazoline	   ligands	   141	   and	   143	   can	   help	   to	  improve	   the	   rate	   of	   the	   reaction	   compared	   to	   the	   CuCl2	   with	   no	   ligand	   added,	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whereas	   142	   and	   144	   lowered	   the	   reaction	   rate	   marginally.	   However,	   these	  reactions	  were	  easily	  purified	  and	  gave	  high	  purity	  cycloadduct	  product	  140	  with	  a	   simple	   purification	   technique.	   Unfortunately,	   in	   all	   cases,	   there	   was	   no	  asymmetric	   induction,	   and	   therefore,	   in	   order	   to	   understand	   the	   catalytic	  properties	  of	  the	  catalyst	  system	  in	  more	  detail,	  the	  next	  set	  of	  experiments	  were	  conducted	   using	   both	   tetramethylthiourea	   (tmtu)	   and	   2-­‐ethyl-­‐2-­‐oxazoline	   as	  ligands	  separately	  in	  the	  model	  reaction	  as	  in	  Scheme	  47.	  	  The	  results	  are	  shown	  in	  Table	  5.	  	  
	  
2.4.2	  Thiorea	  and	  oxazoline	  ligand	  screening	  
	  
Table	  5.	   The	   reaction	  of	  hydroxamic	   acid	  138	  with	  1,3-­‐cyclohexadiene	  using	  10	  mol%	  CuCl2	  in	  methanol	  with	  various	  ligands	  to	  give	  140.	  
Entry	   Ligand	  (mol%)	   Time	  (h)	   Yield	  %	   ee	  
1	   -­‐	   15	   48	   0	  
2	   TMTU	  (10)	   15	   60	   0	  
3	   TMTU	  (20)	   15	   55	   0	  
4	   2-­‐ethyl-­‐2-­‐oxazoline	  (10)	   15	   53	   0	  
5	   2-­‐ethyl-­‐2-­‐oxazoline	  (20)	   3	   86	   0	  
6	   TMTU	  (10),	  2-­‐ethyl-­‐2-­‐oxazoline	  (10)	   15	   68	   0	  
7	   	  
145	  (10)	  
2	   70	   0	  
	  	  Entry	  1	   (Table	  5)	   is	   a	   reaction,	  which	   is	   a	   control	   reaction	  using	  10	  mol%	  CuCl2	  with	   no	   ligand	   present	   in	   the	   reaction	   mixture.	   The	   reaction	   completed	   in	   15	  hours,	   giving	   compound	   140	   in	   48%.	   For	   Entries	   2	   and	   3	   (Table	   5),	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tetramethylthiourea	   (TMTU)	   was	   employed	   as	   ligand	   (10	   and	   20	   mol%	  respectively).	   These	   reactions	   also	   completed	   in	   15	   hours,	   which	   was	   the	   same	  reaction	  time	  as	  with	  no	  ligand	  present.	  The	  isolated	  yields	  of	  these	  reactions	  were	  slightly	  increased	  (60	  and	  55%	  respectively).	  For	  Entry	  4	  (Table	  5),	  the	  use	  of	  10	  mol%	  2-­‐ethyl-­‐2-­‐oxazoline	   in	   the	   standard	   reaction	  was	   carried	  out.	  The	   reaction	  completed	  in	  15	  hours,	  giving	  in	  cycloadduct	  140	  in	  53%.	  Increasing	  the	  2-­‐ethyl-­‐2-­‐oxazoline	   ligand	   to	  20	  mol%	  helped	   to	   increase	   the	  yield	   (86%)	  and	  speeded	  up	  the	  reaction	  to	  give	  completion	  in	  3	  hours	  (Entry	  5,	  Table	  5).	  in	  Entry	  6	  (Table	  5),	  10	  mol%	  TMTU	  and	  10	  mol%	  2-­‐ethyl-­‐2-­‐oxazoline	  were	  both	  used	  as	   ligands	  and	  the	   reaction	   completed	   in	   15	   hours	   giving	   cycloadduct	   140	   in	   68%.	   It	   can	   be	  concluded	   that	   the	  optimal	   reaction	  conditions	  were	  achieved	   in	   the	  presence	  of	  the	  20	  mol%	  oxazoline	  ligand	  and	  10	  mol%	  CuCl2,	  which	  gave	  the	  shortest	  reaction	  time	  with	   the	  highest	   yield	   and	   the	  product	  140	  was	  obtained	  most	   readily	   in	   a	  clean	  state.	   	   It	   can	  also	  be	  concluded	   that	   thiourea	  has	  no	  major	  bebeficial	  effect	  upon	   this	   reaction,	   and	   generally,	   there	   were	   no	   side-­‐products	   formed	   in	   the	  reactions	   either.	   These	   results	   represent	   a	   new	   methodology	   which	   results	   in	  fewer	   complications	   in	   product	   purification	   and	   presents	   no	   hazards	   due	   to	   the	  toxicity	  of	  the	  oxidant.4,5	  	  	   After	  having	  established	  that	   the	  Cu-­‐oxazoline	  catalyst	  system	  works	  well,	  chiral	  bis-­‐oxazolines	  were	  tested	  with	  1:1	  copper/ligand	  ratio,	  i.e.	  the	  same	  as	  that	  found	  to	  be	  optimal	  for	  the	  ration	  of	  the	  copper:ligand	  ration	  in	  Table	  5,	  Entry	  5.	  It	  was	   found	   that	   this	   system,	   involving	   CuCl2,	   in	   methanol	   with	   ligand	   145	  proceeded	  even	  faster	  (2	  hours)	  that	  using	  two	  equivalents	  of	  the	  mono-­‐oxazoline	  (Entry	  7,	  Table	  5).	  However,	  there	  was	  still	  no	  enantioelectivity	  according	  to	  chiral	  HPLC,	  even	  though	  an	  enantiomerically	  pure	  bis-­‐oxazoline	  145	  was	  employed.	  	  	  
Determination	  of	  enantiomeric	  excess	  The	   enantiomeric	   excess	   of	   cycloadduct	   140	   was	   determined	   by	   HPLC	   using	   a	  Chiralcel	  OD	  column	  using	  IPA/hexane,	  1:9	  v/v.	  However,	  there	  were	  no	  ees	  found	  in	  any	  cases	  in	  either	  Table	  4	  or	  5.	  With	  these	  results,	   it	  might	  be	  concluded	  that	  the	   dissociation	   of	   the	   nitroso	   compound	   from	   the	   metal	   oxidation	   catalyst	  (copper-­‐oxazoline	   system)	   is	   fast	   and	   takes	   place	   before	   the	   hetero-­‐DA	   reaction	  can	  occur.	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2.5	  Methodology	  testing	  with	  various	  dienes	  
2.5.1	  Reactions	  in	  chloroform	  Even	  though	  the	  use	  of	  10	  mol%	  CuCl2	  and	  20	  mol%	  2-­‐ethyl-­‐2-­‐oxazoline	  catalyst	  system	  did	  not	  give	  any	  enantioselectivity,	  it	  worked	  well	  in	  term	  of	  reaction	  rate	  and	   giving	   clean	   product	   with	   the	   model	   reaction	   of	   N-­‐(benzyloxy-­‐carbonyl)hydroxylamine	   138	   and	   1,3-­‐cyclohexadiene	   giving	   good	   yields.	  Therefore,	  the	  reaction	  of	  N-­‐(benzyloxy-­‐carbonyl)hydroxylamine	  138	  with	  various	  dienes	  was	  tested	  in	  chloroform.	  The	  results	  are	  shown	  in	  Table	  6	  and	  Eq.	  8.	  
	  	  
Table	  6.	  Reaction	  of	  N-­‐(benzyloxy-­‐carbonyl)hydroxylamine	  138	  with	  various	  dienes	  	  in	  chloroform	  using	  the	  copper-­‐oxazoline	  catalyst	  and	  air	  system.	  	  Entry	   Diene	   Product	   Time	   Yields	  %	  	  	  1	   	   	  
	  
146	  
4	  h	   99	  
	  2	  	   	   	   140	   3	  h	   86	  	  3	  	   	  
147 148	  
24	  h	   	  86	  (ratio	  of	  
147:	  148	  =	  7:1)	  	  	  4	  	  
	  	   	  	   149	   5	  h	   83	  
	  	  	  5	  	  





73	  (ratio	  of	  
150	  and	  
150’	  :	  151	  =	  9:1	  and	  	  
150:150’	  =	  2:1)	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  6	  	  
	  
	   152	   24	  h	   86	  	  	  	  7	  	  
	  	   	  	   153	   24	  h	   74	  	  	  8	   	   	   154	   72	  h	   0	  	  	  9	  	  
	   	  	   155	   72	  h	   0	  	  	  10	  	  
	  
	  	   156	   72	  h	   0	  	  	  Entry	   1	   (Table	   6)	   shows	   the	   reaction	   of	   the	   hydroxamic	   acid	   138	   with	   freshly	  cracked	  cyclopentadiene.	  The	   colour	  of	   the	   copper-­‐ligand	  complex	   in	   chloroform	  was	   initially	   dark	   green,	   which	   changed	   to	   yellow	   upon	   adding	   the	   hydroxamic	  acid	  138	   and	   diene.	   The	   reaction	  was	   stirred	   at	   the	   room	   temperature	   and	   the	  completion	   time	  was	  4	  hours,	  which	  was	   confirmed	  by	   the	  disappearance	  of	   the	  starting	   material	   spot	   on	   the	   TLC	   and	   the	   colour	   of	   the	   reaction	   mixture	   also	  changing	  back	  to	  dark	  green.	  This	  confirmed	  again	  the	  self-­‐indicating	  nature	  of	  the	  reaction.	  The	  reaction	  product	  was	  purified	  by	  flash	  silica	  gel	  chromatography	  to	  yield	  99%	  of	  the	  cycloadduct	  product	  146.	  The	  structure	  of	  146	  was	  confirmed	  by	  1H	  and	  13C	  NMR	  (Figures	  10	  and	  11).	  	  	   Figure	  10	  shows	  the	  1H	  NMR	  spectrum	  of	  the	  cycloadduct	  146.	  The	  peaks	  at	  1.71	   and	  1.98	   ppm	  are	   the	   protons	   at	   the	   CH2	   group	   of	   the	   bicyclic	   system.	   The	  peaks	   in	   the	  region	  of	  5.02-­‐	  5.21	  ppm	  have	   integrals	   for	  4	  protons,	   two	  of	  which	  correspond	   to	   the	   protons	   of	   the	   CH	   group	   at	   the	   bridge	   and	   the	   rest	   are	   the	  protons	  of	  the	  CH2	  of	  the	  benzyl	  group.	  The	  peak	  at	  6.35	  ppm	  belongs	  to	  the	  two	  protons	  on	  the	  alkene.	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  Figure	  10.	  1H	  NMR	  of	  the	  cycloadduct	  146.	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O	  respectively.	  Three	  peaks	  at	  128.2,	  128.3	  and	  128.5	  ppm	  are	  the	  carbons	  in	  the	  ring	   and	   a	   peak	   at	   133.0	   ppm	   is	   the	   ipso-­‐carbon.	   Two	  peaks	   at	   134.5	   and	   135.7	  ppm	   are	   alkene	   carbons.	   The	   peak	   at	   159.3	   ppm	   is	   the	   carbonyl	   carbon.	   All	   the	  analytical	  data	  match	  with	  the	  literature.17c	  	  	   Entry	  2	  (Table	  6)	  was	  the	  standard	  reaction	  discussed	  previously,	  i.e.	  using	  1,3-­‐cyclohexadiene	   as	   in	   Scheme	   47,	   which	   was	   repeated	   for	   comparison.	   This	  result	  agreed	  with	  the	  previous	  result	  from	  Entry	  5,	  Table	  5.	  For	  the	  reaction	  of	  the	  hydroxamic	   acid	   138	   with	   2,3-­‐dimethyl-­‐1,3-­‐butadiene,	   however,	   there	   was	   a	  competing	  ene-­‐reaction	  as	  well	  as	  the	  nitroso-­‐Diels-­‐Alder	  reaction	  (Entry	  3,	  Table	  6)	  resulting	  in	  a	  mixture	  of	  147	  and	  148.	  This	  occurred	  because	  2,3-­‐dimethyl-­‐1,3-­‐butadiene	  contains	  both	  alkene	  π-­‐bonds	  and	  allylic	  σ-­‐bonds,	  which	  can	  react	  with	  the	  nitroso-­‐group	  to	  form	  the	  ene-­‐product	  	  as	  in	  Scheme	  48.	  	  	  
	  
Scheme	   48.	   The	   competing	   reactions	   of	   nitroso	   species	  139	   with	   2,3-­‐dimethyl-­‐1,3-­‐butadiene.	  	  The	  reaction	  was	  completed	   in	  24	  hours	  with	  an	  overall	  yield	  of	  86%	  after	   flash	  silica	   gel	   chromatography.	   The	   ratio	   of	   the	   cycloadduct	  147	   to	   ene-­‐product	  148	  was	  7:1	  by	  the	  integration	  of	  the	  signals	  at	  δ	  1.66	  and	  1.58	  (CH3	  signals	  for	  147)	  
versus	  the	  signal	  at	  δ	  1.92	  (CH3	  for	  148)	  (see	  Figure	  12).	  After	  further	  purification	  by	  column	  chromatography,	  the	  ene-­‐product	  could	  not	  be	  separated	  out	  in	  a	  pure	  enough	  state	  to	  do	  further	  analysis.	  The	  cycloadduct	  147	  was,	  however,	  isolated	  in	  75%	  yield	  as	  a	  pure	  compound.	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Figure	  12.	  The	  crude	  1H	  NMR	  spectrum	  of	  the	  reaction	  of	  Z-­‐hydroxamic	  acid	  138	  with	  2,3-­‐dimethyl-­‐1,3-­‐butadiene	  from	  Entry	  3,	  Table	  6	  under	  oxidative	  conditions	  	  The	  reaction	  of	  the	  Z-­‐hydroxamic	  acid	  138	  with	  2,4-­‐hexadiene	  was	  also	  conducted	  (Entry	  4,	  Table	  6)	  and	  even	   though	   this	  diene	  has	  alkene	   	  π-­‐bonds	  and	  allylic	  σ-­‐bonds,	  no	  ene	  side-­‐product	  was	  observed.	  The	  reaction	  was	  completed	  in	  5	  hours	  to	  give	  cycloadduct	  149	  with	  in	  a	  high	  isolated	  yield	  of	  83%.	  	  	   In	  contrast,	  Entry	  5	  (Table	  6)	  shows	  the	  reaction	  of	  the	  Z-­‐hydroxamic	  acid	  
138	  with	   isoprene.	   The	   nitroso	   species	   139	  was	   generated	   as	   usual	   and	   then	  trapped	  by	  the	  isoprene	  (Scheme	  49).	  The	  reaction	  was	  completed	  within	  24	  hours	  yielding	  regioisomeric	  cycloadducts	  150	  and	  150’	  and	  ene-­‐product	  151.	  The	  ratio	  of	  cycloadducts	  to	  ene	  product	  was	  9:1,	  and	  the	  ratio	  of	  cycloadduct	  150	   to	  150’	  was	  2:1.	  The	  ratio	  of	  150	  to	  150’	  to	  151	  was	  determined	  from	  the	  crude	  product	  by	  1H	  NMR	  (Figure	  13)	  using	  the	  signals	  at	  δ	  4.10	  to	  4.02	  (CH2	  resonances	  in	  150	  and	  150’	  respectively)	  to	  4.70	  (CH2	  in	  151).	  The	  overall	  yield	  was	  81%,	  however,	  after	  column	  chromatography,	  only	  cycloadducts	  150	  and	  150’	  were	  separated	  out	  together	   in	  73%	   isolated	  yield.	  The	   regioselectivity	   study	   reported	  by	  Leach	  and	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Houk39	  stated	  that	  the	  direction	  of	  the	  selectivity	  depends	  upon	  the	  nature	  of	  the	  dienophile	  due	  to	  the	  weak	  directing	  effect	  of	  the	  2-­‐substituent	  of	  the	  diene.	  	  
	  
Scheme	  49.	  The	  reaction	  of	  the	  nitroso	  species	  139	  with	  isoprene.	  	  
	  
Figure	   13.	   The	   crude	   1H	   NMR	   spectrum	   of	   the	   ene	   and	   cycloadducts	   product	  between	  Z-­‐hydroxamic	  acid	  138	  with	  isoprene	  (Entry	  5,	  Table	  6).	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Figure	   14.	   The	   two	   regioisomer	   cycloadducts	   from	   the	   reaction	   of	   138	   with	  isoprene	  under	  oxidative	  conditions.	  	  The	  assignment	  of	  the	  peaks	  for	  the	  two	  regioisomers	  of	  150	  and	  150’	  (Figure	  14)	  can	   be	   obtained	   from	   the	   1H	   NMR,	   and	   2D	   NMR	   techniques	   of	   COSY,	   HSQC	   and	  HMBC	  NMR	  spectrum	  (see	  Figure	  15).	  	  	  
	  
Figure	   15.	   1H	   NMR	   of	   150	   and	   150’	   after	   purification	   by	   silica	   gel	  chromatography.	  	  From	  the	  1H	  NMR	  of	  150	  and	  150’	  shown	  in	  Figure	  15,	  there	  are	  two	  sets	  of	  peaks	  in	  the	  non-­‐aromatic	  region	  (i.e.	  at	  166	  and	  1.73	  ppm)	  which	  can	  be	  assigned	  to	  the	  CH3	   groups	   of	   He	   and	   He’.	   The	   four	   peaks	   in	   the	   4.50-­‐4.00	   ppm	   region	   can	   be	  assigned	  to	  the	  CH2	  proton	  signals	  of	  Ha,	  Ha’,	  Hd	  and	  Hd’	  and	  the	  peak	  at	  5.22	  ppm	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can	  be	  assigned	  to	  the	  CH2	  of	  the	  benzyl	  group	  (Hf	  and	  Hf’).	  The	  ene	  protons	  of	  c	  and	  b’	  appeared	  at	  5.53	  ppm	  (see	  Figure	  15).	  However,	   this	   information	  was	  not	  sufficient	   to	   distinguish	   the	   two	   regioisomers	  150	   and	  150’,	   therefore,	   2D	  NMR	  spectra	  were	  required	  for	  a	  more	  detailed	  analysis.	  	  
	  	  
	  
Figure	  16.	  COSY	  NMR	  of	  the	  mixture	  of	  regioisomers	  150	  and	  150’.	  	  The	   COSY	   NMR	   for	   the	   mixture	   of	   150	   and	   150’	   is	   shown	   in	   Figure	   16	   which	  confirmed	  the	  correlation	  of	  the	  protons	  and	  also	  allowed	  the	  classification	  of	  the	  two	  sets	  of	  protons.	  From	  the	  fact	  that	  the	  proton	  next	  to	  oxygen	  will	  shift	  to	  lower	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field	  than	  the	  one	  next	  to	  nitrogen,	  therefore,	  the	  CH2	  protons	  next	  to	  oxygen	  was	  assigned	  at	  4.39	  ppm	  	  (major)	  and	  4.28	  ppm	  (minor),	  and	  the	  CH2	  proton	  next	  to	  nitrogen	  at	  4.02	  ppm	  (major)	  and	  4.11	  ppm	  (minor).	  The	  major	   regioisomer	  has	  the	  non-­‐aromatic	  peaks	  at	  1.73	  (He),	  4.02	  (Ha),	  4.39	  (Hd),	  5.22	  (Hf)	  and	  5.53	  (Hc)	  ppm.	  The	  minor	  regioisomer	  has	  1.66	  (He’),	  4.11	  (Ha’),	  4.28	  (Hd’),	  5.21	  (Hf’)	  and	  5.53	   (Hb’)	   ppm.	   The	   peaks	   at	   5.21	   and	   5.22	   ppm	   do	   not	   correlate	   with	   any	   of	  protons	  in	  the	  non-­‐aromatic	  region,	  which	  could	  be	  confirmed	  to	  be	  the	  Hf	  and	  Hf’	  protons.	  
	  
	  
Figure	  17.	  HSQC	  NMR	  of	  150	  and	  150’.	  	  From	   all	   the	   information	   from	   the	   1H	  NMR	   and	   13C	  NMR	   spectra,	   all	   the	   signals	  could	  be	  assigned	  using	  the	  HSQC	  NMR	  spectra	  (Figure	  17).	  The	  signals	  due	  to	  the	  protons	   attached	   to	   different	   carbons	   were	   considered,	   which	   allowed	   the	  differentiation	  of	  the	  carbon	  peaks	  of	  each	  regioisomer.	  The	  major	  regioisomer	  has	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peaks	  at	  19.7	  (Ce),	  48.5	  (Ca),	  67.7	  (Cf),	  68.5	  (Cd)	  and	  118.0	  (Cb	  and	  Cc)	  ppm.	  The	  minor	   regioisomer	   has	   peaks	   at	   18.2	   (Ce’),	   44.8	   (Ca’),	   67.7	   (Cf’),	   71.6	   (Cd’)	   and	  116.3	   (Cb’	   and	   Cc’)	   ppm.	   Even	   though	   all	   the	   peaks	   can	   be	   assigned,	   which	  regioisomer	  is	  the	  major	  product	  was	  still	  unsolved,	  therefore,	  the	  HMBC	  NMR	  was	  employed	  (Figure	  18).	  	  	  	  	  
	  
Figure	  18.	  HMBC	  NMR	  of	  150	  and	  150’.	  	  The	   long-­‐range	   correlation	   spectrum	   shown	   in	   Figure	   18	   shows	   that	   the	   major	  peak	  due	  to	  the	  CH3	  protons	  (He)	  correlated	  to	  the	  carbon	  peak	  at	  48.5	  ppm,	  which	  corresponds	   to	   the	  CH2	   carbon	  next	   to	  nitrogen	   in	   the	   ring.	  The	  minor	  CH3	  peak	  correlated	  to	  the	  carbon	  peak	  at	  71.6	  ppm,	  which	  is	  the	  peak	  of	  CH2	  carbon	  next	  to	  oxygen.	  From	   these	   sources	  of	   information,	   the	   two	  regioisomers	  were	  assigned.	  The	  major	  regioisomer	  was	  150	  and	  the	  minor	  regioisomer	  was	  150’.	  	  	   The	   reaction	   of	   in	   situ	   generated	   nitroso	   species	   139	   with	   9,10-­‐dimethylantracene	   under	   the	   Cu-­‐oxazoline	   catalytic	   conditions	   was	   then	   tested	  
	   54	  	  	  	  
(Entry	   6,	   Table	   6).	   The	   reaction	   completed	   in	   24	   hours	   and	   it	   was	   noteworthy	  because	   this	   reaction	  was	   fluorescent	  under	  UV	   light	   at	   the	  beginning.	  However,	  when	   the	   reaction	   completed,	   the	   fluorescence	   disappeared	   due	   to	   the	   reduced	  conjugation	   in	   the	   cycloadduct	  152.	   Upon	   completion	   and	  work	   up,	   the	   product	  was	   isolated	   in	   an	   impressive	   yield	   of	   86%.	   The	   cycloadduct	  152	  was	   pure	   and	  crystallized	   upon	   isolation	   to	   give	   crystals	   suitable	   for	   single	   crystal	   X-­‐ray	  diffraction	   analysis.	   The	   X-­‐ray	   structure	   confirmed	   the	   connectivity	   and	   is	   as	  shown	  in	  Figure	  19.	  	  
Figure	  19.	  Crystal	  structure	  of	  cycloadduct	  152.	  	  The	   reaction	   of	   the	   Z-­‐hydroxamic	   acid	  138	  with	   2,3-­‐diphenyl-­‐1,3-­‐butadiene	  was	  conducted	  with	   this	  oxidative	   catalytic	   system	  (Entry	  7,	  Table	  6).	   In	   this	   system,	  the	   diene	   was	   not	   volatile	   and	   was	   therefore	   difficult	   to	   separate	   from	   the	  cycloadduct	   product.	   In	   order	   to	   circumvent	   this	   problem,	   an	   excess	   of	   the	  hydroxamic	   acid	   138	   (1.2	   equivalents)	   was	   employed.	   The	   reaction	   was	   then	  completed	  in	  24	  hours,	  yielding	  cycloadduct	  153	  as	  a	  colourless	  viscous	  oil	  in	  74%	  isolated	  yield	  after	  purification.	  	   Furan,	   thiophene	   and	   N-­‐methylpyrrole	   were	   also	   used	   as	   dienes	   in	   this	  copper-­‐based	  oxidation	  system,	  as	  shown	  in	  Entries	  8-­‐10,	  Table	  6.	  However,	  there	  was	  no	  desired	  cycloadduct	  product	  observed	  even	  after	  72	  hours,	  even	  when	  all	  the	   hydroxamic	   acid	   138	   spot	   disappeared	   according	   to	   TLC	   and	   the	   reaction	  mixture	   changed	   to	   a	   black	   colour.	   This	   suggested	   that	   decomposition	   of	   the	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nitroso	   species	   was	   occurring	   rather	   than	   reaction	   with	   the	   dienes.	   The	   rate	   of	  reaction	  of	  the	  nitroso	  species	  (after	  it	  was	  generated	  by	  the	  copper	  catalyst)	  must	  be	   lower	   than	   the	   rate	   of	   decomposition	   (Scheme	   50)	   or	   that	   the	   cycloaddition	  occurs	   but	   this	   could	   be	   reversible.	   Hence,	   the	   reason	   for	   these	   unsuccessful	  systems	   is	   still	  unclear,	   it	   could	  be	  explained	  by	   the	  gap	  between	   the	  HOMO	  and	  LUMO	  of	  the	  diene	  and	  dienophile,	  which	  may	  be	  too	  large	  for	  efficient	  formation	  of	   the	   required	   Diels-­‐Alder	   transition	   state	   allowing	   decomposition	   of	   the	   acyl	  nitroso	  species,	  or	  the	  reaction	  is	  indeed	  too	  reversible	  and	  eventually	  dienophile	  decomposition	  consumes	  the	  nitroso	  species.	  	  	  
	  
Scheme	   50.	   Reaction	   pathway	   of	   nitroso	   compound	   139	   with	   furan,	   thiophene	  and	  N-­‐methylpyrrole.	  	  
2.5.2	  Reaction	  in	  methanol	  In	  order	  to	  examine	  the	  effect	  of	  solvent	  polarity	  and	  H-­‐bonding	  upon	  the	  reaction,	  we	   decided	   to	   compare	   the	   reactions	   carried	   out	   in	  methanol	  with	   those	   run	   in	  chloroform.	   Because	   the	   use	   of	   chloroform	   as	   a	   solvent	   is	   less	   desirable,	   being	  environmentally	  unfriendly,	  methanol	  was	  used	  as	   the	   solvent	   in	   a	   repeat	  of	   the	  earlier	  experiments.	  	  The	  results	  are	  shown	  in	  Table	  7	  and	  Eq.	  9.	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7	  	   	  	   	  	   	  
153	  
18	  h	   79	  
8	  	   	  	   	   	  154	   72	  h	   0	  9	  	   	   	  	   	  155	   72	  h	   0	  
10	  	   	   	  	   	  156	   72	  h	   0	  	  	  The	   result	   of	   the	   reaction	   of	   Z-­‐hydroxamic	   acid	   138	   with	   freshly	   cracked	  cyclopentadiene	  is	  shown	  in	  Entry	  1,	  Table	  7.	  The	  reaction	  time	  in	  methanol	  was	  one	   hour	   shorter	   than	   in	   chloroform	   and	   the	   isolated	   yield	   of	  146	   was	   slightly	  lower	  (only	  2%	  less)	  but	  was	  still	  high	  (97%).	  Entry	  2	  (Table	  7)	  shows	  the	  reaction	  of	  the	  Z-­‐hydroxamic	  acid	  138	  with	  1,3-­‐cyclohexadiene.	  The	  reaction	  time	  was	  the	  same	  as	  the	  reaction	  in	  chloroform	  but	  the	  isolated	  yield	  of	  140	  was	  improved	  by	  6%	  (from	  86%	  to	  92%)	  and	  there	  was	  a	  major	  improvement	  in	  the	  reaction	  time	  of	  Z-­‐hydroxamic	   acid	   138	   with	   2,3-­‐dimethyl-­‐1,3-­‐butadiene,	   as	   shown	   in	   Entry	   3,	  Table	  7,	   from	  24	  hours	   in	  chloroform	  to	  2	  hours	   in	  methanol.	  However,	   the	  ratio	  between	  the	  cycloaduct	  147	  and	  the	  ene-­‐product	  148	  was	  lower	  at	  5:1	  (compared	  to	  7:1	   in	   chloroform).	  The	   reason	   for	   this	   lower	   ratio	   is	   still	  unclear,	  however,	   it	  may	   due	   to	   the	   rate	   of	   the	   nitroso	   generation	   in	   this	   system;	   the	   faster	   the	  generation	  rate,	   the	  better	   the	  ene	  can	  compete	  with	   the	  NDA.	  However,	   the	  ene	  product	  could	  not	  be	  separated	  using	  silica	  gel	  column	  chromatography,	  only	  the	  cycloadduct	  was	   obtained	   in	   83%	   isolated	   yield	   as	   a	   pure	   product.	   The	   reaction	  between	  Z-­‐hydroxamic	  acid	  138	  and	  2,4-­‐hexadiene	  (Entry	  4,	  Table	  7)	  showed	  an	  improvement	  in	  the	  isolated	  yield	  of	  149	  compared	  to	  the	  reaction	  in	  chloroform	  (from	  83%	  to	  97%)	  and	  the	  reaction	  time	  was	  also	  reduced	  from	  five	  to	  two	  hours.	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The	   reaction	   of	   Z-­‐hydroxamic	   acid	  138	   and	   isoprene	   to	   yield	   cycloadducts	  150,	  
150’	  and	  eneproduct	  151	  is	  shown	  in	  Entry	  5,	  Table	  7.	  The	  reaction	  time	  was	  three	  times	   shorter	   than	   the	   reaction	   in	   chloroform	   and	   the	   yield	   was	   slightly	   higher	  (6%).	  The	  ratio	  between	  the	  cycloadducts	  and	  ene-­‐product	  was	  slightly	  lower	  (9:1	  in	   chloroform	   versus	   8.5:1	   in	  methanol)	   but	   the	   ratio	   between	   the	   cycloadducts	  
150	   and	   150’	   stayed	   the	   same	   (i.e	   2:1	   respectively).	   This	   suggested	   that	   the	  solvent	  and/or	  the	  rate	  of	  the	  nitroso	  generation	  does	  not	  have	  any	  major	  effect	  on	  the	  regioselectivity	  for	  this	  system.	  The	  reaction	  in	  methanol	  of	  Z-­‐hydroxamic	  acid	  and	  9,10-­‐dimethylantracene	  (Entry	  6,	  Table	  7)	  to	  give	  152	  was	  also	  improved,	  in	  terms	   of	   the	   reaction	   time	   from	   24	   to	   10	   hours	   and	   isolated	   yield	   from	   86%	   to	  88%.	  Entry	  7,	  Table	  7	  shows	  that	   the	  cycloadduct	  153	  was	   isolated	   in	  79%	  with	  the	  reaction	  time	  of	  18	  hours	  from	  the	  reaction	  of	  Z-­‐hydroxamic	  acid	  138	  with	  1,4-­‐diphenylbutadiene.	  The	  reactions	  of	  Z-­‐hydroxamic	  acid	  with	  furan,	  thiophene	  and	  
N-­‐methylpyrrole	  were	  also	  conducted,	  however,	  none	  of	  the	  desired	  cycloadducts	  were	   observed	   in	   any	   cases.	   These	   observations	   reactions	   are	   similar	   to	   the	  reactions	   in	   chloroform	   and	   confirm	   either	   the	   lack	   of	   reactivity	   of	   the	   nitroso	  species	  with	  these	  dienes,	  or	  that	  the	  addition	  is	  indeed	  reversible.	  	  	   Overall,	   the	   reaction	   of	   Z-­‐hydroxamic	   acid	   138	   with	   various	   dienes	   in	  methanol	   can	  proceed	   faster	   than	   in	   chloroform	  and	  with	   higher	   isolated	   yields.	  This	  may	  be	   explained	  by	   the	   improved	   solubility	   of	   the	   Z-­‐hydroxamic	   acid	  138	  and	  CuCl2	  in	  methanol,	  which	  is	  better	  than	  in	  chloroform,	  therefore,	  there	  is	  faster	  nitroso	   generation	   which	   is	   readily	   trapped	   by	   the	   dienes	   before	   it	   can	   either	  dimerize,	  decompose	  or	  react	  with	  the	  solvent.	  From	  Entry	  3,	  Table	  6	  and	  Entry	  3,	  Table	  7,	  it	  can	  be	  seen	  that	  by	  changing	  the	  reaction	  solvent,	  the	  ratio	  between	  the	  cycloadduct	   and	   ene-­‐product	   changed.	   Hence,	   a	   set	   of	   solvent	   screening	  experiments	   for	   the	   reaction	   between	   Z-­‐hydroxamic	   acid	  138	   and	   2,3	   dimethyl-­‐1,3-­‐butadiene	   using	   copper-­‐oxazoline	   catalytic	   system	   was	   conducted	   and	   the	  results	  are	  shown	  in	  Table	  8.	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2.6	  Solvent	  effects	  on	  the	  rate	  of	  NDA	  versus	  ene-­reaction	  	  
	  
Table	  8.	  The	  solvent	  screening	  of	  the	  reaction	  of	  Z-­‐hydroxamic	  acid	  138	  and	  2,3	  dimethyl-­‐1,3-­‐butadiene.	  Entry	  	   Solvent	  	   Time	  (h)	   Ratio	  147:148	   Yield	  %	  	  1	   MeOH	  	   2	   5:1	   84	  2	   MTBE	  	   20	   15:1	   85	  3	   MeCN	  	   144	   25:1	   80	  4	   EtOH	  	   7	   4:1	   83	  5	   EtOAc	  	   7	   4:1	   81	  6	   IPA	  	   48	   13:1	   89	  7	   MTHF	  	   20	   12:1	   88	  8	   Toluene	  	   4	   12:1	   82	  9	   4:1	  Toluene/MeOH	  	   3	   5:1	   82	  10	   Chloroform	  	   3	   7:1	   82	  	  	  Table	   8	   shows	   the	   results	   of	   the	   solvent	   screening	   which	   focused	   on	   the	   ratio	  between	  the	  cycloadduct	  147	  and	  ene-­‐product	  148.	  Entry	  1	  (Table	  8)	  shows	  the	  reaction	  in	  methanol,	  which	  has	  the	  highest	  polarity	  among	  all	  the	  solvents	  used	  in	  this	  table.	  The	  reaction	  completed	  in	  2	  hours,	  giving	  84%	  overall	  yield	  and	  was	  the	  fastest	   reaction,	  giving	  a	  5:1	   ratio	  of	  147:148,	  which	  matched	  Entry	  3	   (Table	  7).	  MTBE,	   which	   is	   a	   good	   solvent	   for	   microwave	   reactions,	   was	   tested	   in	   Entry	   2	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(Table	  8).	  This	  reaction	  completed	  in	  20	  hours	  and	  gave	  a	  147:148	  ratio	  of	  15:1,	  in	  85%	   overall	   yield.	   Acetonitrile,	   which	   is	   known	   to	   form	   complexes	  with	   copper	  was	  also	  tested,82	  resulted	  in	  the	  the	  slowest	  reaction	  (144	  hours).	  However,	  it	  also	  gave	   the	  best	   ratio	   of	  147:148,	   i.e.	   of	   25:1.	   This	   long	   reaction	   time	   and	   yet	   high	  chemoselectivity	  may	  be	  explained	  by	  the	  fact	  that	  acetonitile	  can	  chelate	  with	  the	  copper	  to	  form	  complexes	  and	  this	  complexation	  may	  compete	  with	  the	  2-­‐ethyl-­‐2-­‐oxazoline	   ligand,	   which	   is	   the	   active	   catalyst	   species.	   Therefore,	   the	   rate	   of	  acylnitroso	   generation	  may	   become	   slow.	   The	   rate	   of	   NDA	   reaction	   is	   probably	  higher	  than	  the	  rate	  of	  the	  ene-­‐reaction	  and	  hence,	  with	  a	  low	  concentration	  of	  the	  acylnitroso	  compound,	  it	  can	  be	  more	  efficiently	  trapped	  by	  the	  diene,	  and	  only	  a	  small	   amount	   undergoes	   ene-­‐reaction.	   Both	   ethanol	   and	   ethyl	   acetate	   gave	   very	  similar	  results,	  even	  though	  ethanol	  is	  more	  polar	  that	  ethyl	  acetate	  (Entry	  4	  and	  5,	  Table	  8).	  These	  two	  reactions	  completed	  in	  7	  hours,	  giving	  a	  4:1	  ratio	  of	  147:148.	  In	   the	  high	  polarity	  solvent	   isopropanol	  (Entry	  6,	  Table	  8),	   the	  reaction	  rate	  was	  surprisingly	  low	  (48	  hours	  for	  complete	  reaction)	  but	  the	  ratio	  of	  the	  two	  products	  (NDA	  to	  ene)	  was	  good	  (13:1)	  giving	  89%	  overall	  yield.	  	  2-­‐Methyltetrahydrofuran	  was	   also	   tested	   in	   Entry	   7	   (Table	   8)	   being	   a	   widely	   used	   green	   solvent.	   The	  reaction	  time	  was	  20	  hours	  with	  the	  chemoselectivity	  ratio	  of	  12:1	  and	  giving	  an	  88%	   overall	   yield.	   Even	   though	   the	   solubility	   of	   the	   hydroxamic	   acid	   138	   in	  toluene	  was	  not	  good,	  the	  reaction	  was	  complete	   in	  4	  hours	  with	  an	  82%	  overall	  yield	  and	  12:1	  ratio	  of	  147:148	  (Entry	  8,	  Table	  8).	  Due	  to	  the	  solubility	   issues	  of	  the	  hydroxamic	  acid	  138	   in	  toluene,	   the	  mixed	  solvent	  of	   toluene:methanol	  (4:1)	  was	  employed	  in	  the	  Entry	  9	  (Table	  8).	  The	  reaction	  was	  faster	  than	  pure	  toluene,	  however,	   the	   ratio	   between	   147:148	   decreased	   from	   12:1	   to	   5:1,	   which	   is	   the	  same	  ratio	  as	   that	   carried	  out	   in	  pure	  methanol.	  The	   reaction	   in	   chloroform	  was	  also	  tested	  and	  the	  result	  matched	  the	  earlier	  experiment	  (see	  Entry	  3,	  Table	  6).	  	  	   From	  Table	   8	   it	   can	   be	   concluded	   that	   the	   reaction	   of	   Z-­‐hydroxamic	   acid	  
138	  with	  2,3-­‐dimethyl-­‐1,3-­‐butadiene	  in	  various	  solvents	  gave	  overall	  yields	  from	  80-­‐89%	  with	  different	  ratios	  of	  cycloadduct	  to	  ene-­‐product.	  The	  solvent	  that	  gave	  the	  highest	  ratio	  of	  the	  NDA	  adduct	  was	  acetonitrile,	  whereas	  MTBE,	  IPA,	  toluene	  and	  MTHF	  gave	  good	  chemoselectivities.	  Chloroform,	  methanol,	  toluene:methanol	  (4:1),	   ethanol	   and	   ethyl	   acetate	   gave	   lower	   selectivity.	   In	   general,	   the	   longer	   the	  reaction	  time,	  the	  better	  the	  chemoselectivity	  in	  term	  of	  NDA	  versus	  ene-­‐reaction.	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2.7	  Effect	  of	  chiral	  ligand	  on	  the	  NDA	  reaction	  Success	   in	   the	   use	   of	   copper	   with	   the	   achiral	   oxazoline	   ligand	   system	   in	   the	  oxidation	  of	  the	  Z-­‐hydroxamic	  acid	  138	  to	  give	  the	  acylnitroso	  species	  139,	  which	  was	   trapped	  by	   the	  various	  dienes	  was	  now	  established,	  hence,	   the	  use	  of	   chiral	  ligands	   in	  this	  reaction	  was	  conducted.	  The	  results	  are	  shown	  in	  the	  Table	  9	  and	  Eq.	  11.	  	  
	  
Table	  9.	  Reaction	  of	  hydroxamic	  acid	  138	  with	  1,3-­‐cyclohexadiene	  using	  chiral	  ligands.	  	  Entry	   Ligand	   Time	  (h)	   Yield	  %	   ee	  1	  
157	  
2	   98	   0	  
2	  
145	  
2	   99	   0	  
3	  
158	  
2	   96	   0	  
	  	  The	   use	   of	   10	  mol%	   chiral	   bisoxazoline	   ligand	  157	   with	   10	  mol%	   CuCl2	   in	   the	  model	  reaction	  of	  Z-­‐hydroxamic	  acid	  138	  and	  1,3-­‐cyclohexadiene	  was	  conducted.	  The	   result	   is	   shown	   in	   Entry	   1	   (Table	   9).	   The	   reaction	   was	   stirred	   at	   room	  temperature,	   the	   colour	   of	   the	   pre-­‐mixed	   copper-­‐ligand	   complex	  was	   green	   and	  turned	   pale	   yellow	   upon	   adding	   the	   Z-­‐hydroxamic	   acid	   138.	   This	   indicated	   a	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change	   in	   oxidation	   state	   of	   the	   copper.	   The	   reaction	   completed	   in	   2	   hours	   and	  after	   purification,	   the	   isolated	   yield	   was	   high	   (98%).	   However,	   there	   was	   no	   ee	  observed	  as	  determined	  by	  HPLC	  using	  a	  Chiralcel	  OD	  column	  using	  IPA/hexane,	  1:9	   v/v.	   	   Entry	   2	   (Table	   9)	   shows	   the	   model	   reaction	   with	   10	   mol%	   chiral	  bisoxazoline	   ligand	  145	  with	  10	  mol%	  CuCl2.	  The	  reaction	  completed	   in	  2	  hours	  again,	  giving	  99%	  isolated	  yield.	  and	  again,	  there	  was	  no	  ee	  observed	  in	  this	  case.	  The	  use	  of	  10	  mol%	  pybox	   ligand	  158	  with	  10	  mol%	  CuCl2	   in	   the	  same	  reaction	  was	   also	   tested.	   The	   result	   shown	   in	   Entry	   3	   (Table	   9)	   shows	   that	   the	   reaction	  completed	  in	  2	  hours	  and	  the	  cycloadduct	  140	  was	  isolated	  in	  96%	  though	  with	  no	  
ee	  after	  chiral	  HPLC.	  	   From	  these	  results,	  even	  when	  pure	  chiral	   ligands	  were	  used	  in	  the	  model	  reaction,	  there	  was	  no	  ee	  observed	  which	  suggests	  that	  dissociation	  of	  the	  nitroso	  dienophile	   from	  copper	  after	   it	   is	  generated	   is	   fast	  and	   it	  does	  not	  stay	  bound	  to	  the	  copper	  so	  that	  it	  can	  be	  trapped	  by	  the	  diene.	  	  
	  
2.8	  Hydroxamic	  acid	  synthesis	  After	   establishing	   that	   the	   copper-­‐oxazoline	   catalyzed	   oxidation	   NDA	   reaction	  worked	  well,	  but	  did	  not	  give	  any	  enantioselectivity,	  we	  can	  speculate	  that	  this	  is	  due	  to	  the	  rapid	  dissociation	  of	  the	  nitroso	  dienophile	  from	  the	  metal.	  Therefore,	  the	   hypothesis	   of	   having	   a	   nitroso	   species	   that	   can	   chelate	   to	   copper	   after	   the	  oxidation	   may	   help	   to	   increase	   the	   enantioselectivity.	   Hence,	   we	   decided	   to	  examine	   different	   hydroxamic	   acids,	   which	   after	   the	   oxidation,	   might	   chelate	   to	  copper,	   as	   shown	   by	   species	   such	   as	  159	   or	  160	   (Figure	   20)	   and	   hence,	   might	  provide	  a	  method	  by	  which	  we	  could	  control	  the	  enantioselectivity.	  We	  therefore	  examined	  the	  synthesis	  of	  the	  hydroxamic	  acids	  shown	  in	  Figure	  21.	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Figure	   20.	   Proposed	   chelation	  model	   structures	   of	   hydroxamic	   acids	   that	  might	  chelate	  to	  copper.	  
	  
Figure	   21.	   Examples	   of	   possible	   hydroxamic	   acids	   for	   use	   in	   acylnitroso	  generation.	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The	   hydroxamic	   acids	   shown	   in	   Figure	   21	   were	   synthesized	   according	   to	   the	  literature.66-­‐73	   There	   are	   three	   different	   methods	   that	   have	   been	   used	   for	   the	  hydroxamic	   acid	   syntheses,	   depending	   upon	   the	   availability	   of	   the	   starting	  materials.	   The	   simplest	   synthesis	   method	   is	   the	   reaction	   of	   an	   ester	   or	   acid	  chloride	  with	   hydroxylamine	   hydrochloride	   and	   sodium	  hydroxide	   (Scheme	  51).	  The	  reaction	  was	  stirred	  for	  4	  hours	  and	  completion	  of	  the	  reaction	  was	  confirmed	  by	  TLC.	  The	  mixture	  was	   then	  acidified	  and	  most	  of	   the	  hydroxamic	  acid	  usually	  precipitated	  out	  directly	   from	  the	  reaction,	  giving	  the	  hydroxamic	  acids	  161-­‐167	  and	  170.	  	  	  
	  
Scheme	  51.	  Hydroxamic	  acid	  synthesis	  from	  simple	  aliphatic	  ester.	  	  Compound	  161,	  which	   is	  a	  2-­‐pyridinehydroxamic	  acid	  and	  contains	   the	  pyridine	  ring	  as	  a	   chelating	  group	   for	   copper,	  which,	  we	  surmised	   that	   it	  may	  help	   in	   the	  chiral	  selectivity	  as	  it	  could	  form	  either	  5-­‐	  or	  6-­‐membered	  ring	  chelates	  by	  acting	  as	  a	  bidentate	  ligand.	  Compound	  162	  is	  an	  isomer	  of	  161,	  with	  the	  carbonyl	  group	  on	  the	  3-­‐position	  and	  this	  compound	  could	  only	  chelate	  as	  a	  monodentate	  ligand.	  Structure	  163	  was	   synthesized	  with	   a	   CH2	   group	   attached	   to	   the	   2-­‐position	   and	  next	  to	  the	  carbonyl	  group.	  The	  aim	  of	  this	  compound	  was	  to	  prove	  the	  chelation	  position	   on	   the	   nitroso	   group,	   based	   on	   the	   hypothesis	   that	   if	   it	   chelated	   on	   N,	  chiral	   selectivity	   should	   be	   observed.	   On	   the	   other	   hand,	   if	   there	   was	   no	  enantiomeric	   excess,	   the	   chelation	   would	   likely	   be	   on	   O	   or	   no	   chelation	   on	   the	  nitroso	  group	  occurs	  at	  all.	  Compound	  164	  has	  the	  NH2	  on	  the	  phenyl	  ring	  in	  the	  2-­‐position,	   next	   to	   the	   carbonyl	   hydroxamic	   acid	   group.	   This	  NH2	   could	   chelate	   to	  copper	  to	  help	  to	  lock	  the	  nitroso	  species	  in	  place,	  which	  could	  then	  be	  trapped	  by	  the	   diene.	   The	   phenyl	   carbonyl	   hydroxamic	   acid	   species	   were	   also	   synthesized	  with	  a	  CnH2n	  chain,	  where	  n	  =	  0-­‐4	  away	  from	  the	  ring	  (165	  –	  169).	  	  	   Compound	  168	  did	  not	  have	  an	  ester	  derivative	  commercially	  available	  as	  a	  starting	   material,	   only	   the	   4-­‐phenylbutyric	   acid	   compound	   was	   available.	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Therefore,	   an	   alternative	   procedure	   needed	   to	   be	   used.	   There	   are	   two	   synthetic	  pathways	   reported	   that	   could	   be	   used	   to	   synthesize	  168:	   One	   is	   converting	   the	  acid	   to	   the	   corresponding	  ester	   and	   then	   following	   the	  procedure	   in	   Scheme	  51;	  and	   the	   other	   employs	   a	   one	   pot	   synthesis	   using	   the	   acid	   as	   a	   starting	  material	  using	   DMAP	   as	   catalyst	   with	   NMM,	   cyanuric	   chloride	   and	   hydroxylamine	  hydrochloride.	   When	   this	   was	   carried	   out,	   the	   reaction	   completed	   in	   24	   hours	  (Scheme	  52),	  however,	  the	  yield	  was	  low	  (25%)	  and	  it	  was	  difficult	  to	  separate	  the	  desired	   product	   from	   the	   other	   impurities.	   Moreover,	   the	   cyanuric	   acid	   was	  difficult	  to	  work	  with	  because	  the	  vapour	  is	  irritating.	  	  	  
 
Scheme	  52.	  Hydroxamic	  acid	  104	  synthesis	  using	  an	  acid	  as	  starting	  material.	  	  Compound	  169	  was	  synthesized	  by	  the	  first	  pathway	  using	  the	  procedure	  shown	  in	  Scheme	  53.	  The	  reaction	  involved	  the	  esterification	  of	  5-­‐phenylvaleric	  acid	  with	  methanol	  using	  hydrogen	  chloride	  gas	  generated	  by	  dropping	  36%	  HCl	   into	  98%	  H2SO4.	  The	  reaction	  was	  completed	  in	  15	  minutes,and	  the	  ester	  was	  used	  without	  any	   further	   purification.	   Sodium	   hydroxide	   and	   hydroxylamine	   hydrochloride	  solution	  were	  then	  added	  dropwise	  in	  the	  same	  fashion	  as	  the	  Scheme	  51,	  which	  provided	  169	  in	  67%	  isolated	  yield.	  	  
	  
Scheme	   53.	   Hydroxamic	   acid	   synthesis	   via	   estrification	   followed	   by	  hydroxylamination.	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The	  phenyl	  hydroxycarbamate	  170,	  which	  has	  an	  O	  next	   to	   the	  phenyl	   ring,	  was	  employed	   in	   order	   to	   study	   the	   effect	   of	   the	   heteroatom	   next	   to	   the	   carbonyl	  hydroxamic	  acid	  group	  in	  the	  copper-­‐oxazoline	  oxidation	  system.	  This	  compound	  
170	   was	   synthesized	   by	   reacting	   phenyl	   chloroformate	   with	   sodium	   hydroxide	  and	  hydroxylamine	  hydrochloride.	  The	  reaction	  completed	  in	  4	  hours,	  giving	  59	  %	  isolated	  yield	  hydroxamic	   acid	  170.	   The	  1-­‐hydroxy-­‐3-­‐phenylurea	  171	   and	   (S)-­‐1-­‐hydroxy-­‐3-­‐(1-­‐phenylethyl)urea	  172,	   both	   of	   which	   contain	   nitrogen	   heteroatom	  next	   to	   the	   hydroxamic	   acid	   group,	   were	   synthesized	   from	   the	   isocyanate	   with	  sodium	  hydroxide	  and	  hydroxylamine	  hydrochloride	   (Scheme	  54).	  The	   reactions	  both	   completed	   in	   3	   hours	   to	   give	   52%	   and	   49%	   of	  171	   and	  172	   respectively.	  Compound	  171	  was	  recrystalized	  from	  diethyl	  ether	  to	  give	  a	  crystal	  suitable	  for	  single	  crystal	  X-­‐ray	  analysis.	  The	  X-­‐ray	  crystal	  structure	  is	  shown	  in	  Figure	  22.	  	  
	  
Figure	  22.	  X-­‐ray	  crystal	  structure	  of	  hydroxamic	  acid	  171.	  	  Compound	   172	   is	   a	   chiral	   compound,	   which	   was	   synthesized	   based	   on	   the	  hypothesis	  that	  if	  the	  chiral	  hydroxamic	  acid	  was	  used	  as	  a	  starting	  material,	  with	  a	  chiral	  ligand	  system,	  it	  would	  be	  interesting	  to	  see	  if	  was	  capable	  of	  controlling	  the	  absolute	   stereochemistry	  of	   the	  NDA	  product,	   and	   it	  would	  be	  possible	   to	  probe	  both	   the	   use	   of	   a	   chiral	   dienophile,	   together	  with	   a	   chiral	   catalyst	   to	   investigate	  whether	  there	  was	  any	  interaction	  between	  the	  two	  (see	  below).	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Scheme	  54.	  Hydroxy	  urea	  synthesis	  from	  an	  isocyanate.	  	  Compound	  172	  was	  synthesized	  by	  the	  same	  method	  as	  in	  Scheme	  54,	  however,	  in	  this	  reaction	  there	  was	  a	  side-­‐product	  172s	  (Figure	  21)	  formed	  by	  the	  reaction	  of	  the	   hydroxamic	   acid	  172	   with	   excess	   isocyanate	   (see	   Scheme	   55).74	   Compound	  
172	   was	   recrystalized	   from	   diethyl	   ether	   to	   give	   a	   crystals	   suitable	   for	   single	  crystal	  X-­‐ray	  analysis.	  The	  X-­‐ray	  crystal	  structure	  is	  shown	  in	  Figure	  23.	  	  	  
	  
Scheme	   55.	   The	   reaction	   of	   hydroxamic	   acid	   172	   with	   the	   iscyanate	   forming	  compound	  172s.	  	  	  
	  






+ N C O
(R)'(+)'α'Methylbenzyl2isocyanate 172s
	   68	  	  	  	  
	  Figure	  23	  shows	  the	  X-­‐ray	  crystal	  structure	  of	  hydroxamic	  acid	  172,	  which	  shows	  hydrogen	  bonding	  between	   the	  OH	  and	  NH	  of	   the	  urea	  groups.	   It	  also	  shows	   the	  two	  conformations	  that	  these	  type	  of	  system	  can	  adopt,	  one	  with	  the	  C=O	  s-­trans	  to	  the	  CH3	  group	  and	  the	  other	  with	  the	  C=O	  s-­cis	  to	  the	  CH3	  group.	  Interestingly,	  it	  is	  between	   these	   two	   conformations	   that	   the	   hydrogen	   bonding	   occurs,	   suggesting	  that	   the	   energy	   difference	   between	   these	   is	   relatively	   minimal	   and	   that	   facile	  interconversion	  occurs	  during	  crystalization.	  	  
2.9	  NDA	  reaction	  of	  hydroxamic	  acids	  with	  1,3-­cyclohexadiene	  using	  NaIO4	  as	  
oxidant	  Having	  prepared	  all	   the	  hydroxamic	   acids	  161	   –	  172,	   they	  were	   tested	   for	   their	  ability	   to	   undergo	   the	   NDA	   reaction,	   and	   initially	   this	   was	   carried	   out	   by	   using	  NaIO4	  as	   the	  oxidant.	  Trapping	  was	  carried	  out	  with	  1,3-­‐cychohexadiene	  and	   the	  results	  are	  shown	  in	  Table	  10	  and	  Eq.	  12..	  	  
	  
	  
Table	   10.	   Reaction	   of	   different	   hydroxamic	   acids	  with	   1,3-­‐cyclohexadiene	   using	  NaIO4	  as	  the	  oxidant.	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Entries	  1	  and	  2	  (Table	  10)	  show	  the	  reactions	  of	  hydroxamic	  acids	  161	  and	  162,	  which	   contained	   a	   pyridine	   ring	   in	   the	   structure.	   Both	   reactions	   completed	   in	   4	  hours	   and	   upon	   the	   mixing	   the	   reagents,	   both	   reactions	   turned	   yellow	   and	   the	  colour	  got	  darker	  when	  the	  reaction	  completed.	  The	  products	  173	  and	  174	  were	  isolated	  as	  off-­‐white	  solids	  with	  low	  to	  moderate	  yields.	  For	  compounds	  163	  and	  
164,	  however,	  there	  was	  no	  cycloadduct	  175	  or	  176	  observed	  even	  after	  4	  hours	  and	  the	  colour	  of	  the	  mixture	  changed	  from	  yellow	  to	  dark	  brown	  (Entry	  4,	  Table	  10).	   This	   suggested	   decomposition	   of	   the	   starting	   material	   or	   nitroso	   species	  rather	  than	  reaction	  with	  the	  diene	  (Entries	  3	  and	  4,	  Table	  10).	  Entries	  5	  –	  9	  (Table	  10)	   show	   the	   reactions	   between	   the	   acyl	   hydroxamic	   acids	   (each	   of	  which	   have	  CnH2n	  chains	  attached	  to	  the	  ring)	  with	  1,3-­‐cyclohexadiene.	  All	  these	  reactions	  also	  all	  completed	  in	  4	  hours	  and	  compounds	  177	  and	  178	  were	  isolated	  as	  off-­‐white	  solids,	  which	  after	  recrytalization	  gave	  suitable	  crystals	  for	  the	  X-­‐ray	  analysis.	  The	  X-­‐ray	  structures	  of	  both	  compounds	  are	  shown	  in	  Figure	  24.	  	  
177	  
178	  
Figure	  24.	  X-­‐ray	  crystal	  structures	  of	  cycloadducts	  177	  and	  178.	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2.10	   NDA	   reaction	   of	   hydroxamic	   acids	   with	   2,3-­dimethyl-­1,3-­butadiene	  
using	  NaIO4	  as	  oxidant	  The	  reaction	  of	  these	  hydroxamic	  acids	  with	  2,3-­‐dimethyl-­‐1,3-­‐butadiene	  was	  also	  conducted,	  the	  purpose	  being	  to	  see	  the	  chemoselectivity	  between	  the	  NDA	  versus	  ene-­‐reaction.	  The	  results	  are	  shown	  in	  Table	  11	  and	  Eq.	  13.	  	  
	  	  
Table	   11.	   Reaction	   of	   hydroxamic	   acids	   with	   2,3-­‐dimethyl-­‐1,3-­‐butadiene	   using	  NaIO4	  as	  the	  oxidant	  









































 Entries	  1	  and	  2	  	  (Table	  11)	  show	  the	  reaction	  of	  the	  hydroxamic	  acid	  161	  and	  162	  which	  contain	  a	  pyridine	  ring	  in	  2-­‐	  and	  3-­‐position	  respectively,	  with	  2,3-­‐dimethyl-­‐1,3-­‐butadiene.	  All	  reactions	  finished	  in	  2	  hours,	  giving	  cycloadducts	  185	  and	  186	  as	   off-­‐white	   solids	   in	   low	   yields.	   The	   cycloadduct	   185	   was	   recrystalized	   from	  diethyl	  ether	  to	  give	  a	  crystal	  suitable	  for	  the	  X-­‐ray	  crystal	  analysis.	  The	  structure	  is	  shown	  in	  Figure	  25.	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Figure	  25.	  X-­‐ray	  crystal	  structures	  of	  cycloadduct	  185.	  
	  From	   the	  X-­‐ray	   structure	  of	   cycloadduct	  177	   shown	   in	  Figure	  25,	   it	   can	  be	   seen	  that	  the	  C-­‐N	  bond	  of	  the	  pyridine	  ring	  and	  C-­‐N	  bond	  in	  cycloadduct	  is	  in	  an	  s-­‐trans	  position	  relative	  to	  both	  the	  C-­‐N	  and	  N-­‐O	  bonds.	  	  	   Entry	  3	  (Table	  11)	  shows	  the	  unsuccessful	  reaction	  of	  the	  hydroxamic	  acid	  
163	  with	  2,3-­‐dimethyl-­‐1,3-­‐butadiene.	  The	  reaction	  was	  stirred	  and	  monitored	  by	  TLC	  and	  the	  starting	  material	  was	  consumed	  in	  2	  hours,	  however,	  no	  cycloadduct	  
187	   was	   observed.	   The	   black	   sticky	   oil	   obtained	   did	   not	   give	   any	   useful	  information	  by	  1H	  NMR	  and	  this	  suggested	  decomposition	  of	  the	  nitroso	  species,	  as	  mentioned	  for	  Entry	  3,	  Table	  10.	  	  	   Entry	   4	   (Table	   11)	   shows	   the	   reaction	  between	   the	   hydroxamic	   acid	  164	  with	  2,3-­‐dimethyl-­‐1,3-­‐butadiene.	  Upon	  the	  mixing,	  the	  mixture	  colour	  was	  yellow	  and	  after	  4	  hours,	  the	  TLC	  showed	  that	  the	  starting	  material	  spot	  had	  disappeared.	  However,	  there	  was	  no	  desired	  product	  formed,	  only	  one	  long	  stripe	  could	  be	  seen,	  indicating	   of	   compete	   decomposition.	   The	   result	   of	   the	   oxidation	   of	   hydroxamic	  acid	  165,	  however,	  to	  form	  the	  corresponding	  nitroso	  species	  and	  then	  trapping	  by	  2,3-­‐dimethyl-­‐1,3-­‐butadiene	   is	   shown	   in	  Entry	  5	   (Table	  11).	  The	  cycloadduct	  189	  was	   obtained	   as	   a	   white	   solid	   in	   46%	   isolated	   yield.	   Surprisingly,	   there	   no	   ene	  product	   observed	   in	   the	  NMR,	   only	   unidentified	   impurities	   present	   in	   the	   crude	  product.	   This	   suggested	   that	   some	   decomposition	   of	   the	   nitroso	   species	   had	  occurred	  before	  it	  could	  be	  trapped	  by	  the	  diene.	  Entries	  6-­‐9	  (Table	  11)	  all	  worked	  in	  a	  very	  similar	   fashion	  but	   the	  cycloadducts	  of	   these	  reactions	  were	  colourless,	  viscous	   oils	   and	   isolated	   in	   moderate	   yields.	   In	   all	   of	   these	   oxidations,	   methyl	  
	   75	  	  	  	  
carbamate	   side-­‐products	   were	   also	   separated,	   most	   likely	   as	   a	   result	   of	  methanolysis	  after	  the	  hydroxamic	  acid	  was	  oxidized	  to	  form	  the	  reactive	  nitroso	  species.	   The	   acylnitroso	   species	   can	   react	   with	   methanol	   to	   form	   the	  corresponding	  methyl	   carbamate	  with	   loss	   of	  HNO	   (see	   Scheme	  56).	   The	   reason	  for	   proposing	   this	   reaction	   scheme,	   rather	   than	   direct	   methanolysis	   of	   the	  hydroxamic	   acid,	   is	   because	   the	   hydroxamic	   acid	   group	   is	   stable	   in	   methanol	  whereas	  acyl	  nitroso	  species	  are	  known	  to	  react	  readily	  with	  mild	  nucleophiles.83	  	  
 
Scheme	  56.	  Methanolysis	  mechanism	  for	  an	  acylnitroso	  compound	  after	  oxidation	  of	  the	  of	  hydroxamic	  acid.	  	  	  Entry	  10	  (Table	  11)	  shows	  the	  reaction	  of	  hydroxamic	  acid	  170,	  which	  contains	  an	  oxygen	  as	  the	  heteroatom.	  The	  reaction	  completed	  in	  4	  hours	  and	  the	  product	  194	  was	  obtained	  as	  a	  white	  solid	  in	  47%	  yield.	  Again,	  surprisingly,	  there	  was	  no	  ene	  product	  observed	  and	  no	  evidence	  of	  methanolysis	  product	  present	  in	  the	  crude	  1H	  NMR	  spectrum.	  Compound	  195	  was	  obtained	  in	  a	  similar	  fashion	  in	  a	  yield	  of	  45%	  and	   again,	   there	  was	   no	   ene-­‐product	   and	  methanolysis	   product	   observed	   in	   the	  crude	  1H	  NMR	  spectrum,	  only	  unidentified	  impurities.	  This	  suggested	  that	  in	  these	  two	  cases,	  there	  was	  no	  decomposition	  of	  the	  acylnitroso	  species	  or	  methanolysis,	  and	  the	  ene-­‐reaction	  could	  not	  compete	  with	  the	  NDA	  reaction.	  	  	   Entry	  12	  (Table	  11)	  shows	  the	  reaction	  of	  the	  chiral	  hydroxamic	  acid	  172	  with	   2,3-­‐dimethyl-­‐1,3-­‐butadiene.	   The	   reaction	   completed	   in	   4	   hours	   giving	  cycloadduct	  	  196	  as	  colourless	  oil	  in	  low	  yield	  (13%).	  However,	  the	  purification	  of	  this	  crude	  reaction	  product	  was	  difficult	  due	  to	  the	  presence	  of	  impurities,	  which	  were	  not	  identifiable.	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2.11	   NDA	   reaction	   of	   hydroxamic	   acids	   with	   1,3-­cyclohexadiene	   using	   Cu-­
oxazoline	  catalyst	  From	  the	  results	  shown	  in	  Table	  11,	  we	  can	  draw	  the	  conclusions	  that	  the	  different	  hydroxamic	   acids	   are	   readily	   oxidized	   to	   acylnitroso	   species,	  which	   can	  undergo	  NDA	  reactions	  efficiently.	  Therefore,	  we	  decided	  to	  conduct	  similar	  experiments	  by	  reacting	  these	  hydroxamic	  acids	  with	  1,3-­‐cyclohexadiene	  using	  10	  mol%	  CuCl2	  and	  20	  mol%	  2-­‐ethyl-­‐2-­‐oxazoline	  in	  methanol	  oxidation	  system,	  rather	  than	  periodate.	  The	  results	  are	  shown	  in	  Table	  12	  and	  Eq.	  14.	  
	  
	  
Table	  12.	  Reaction	  of	  hydroxamic	   acids	  with	  1,3-­‐cyclohexadiene	  using	  10	  mol%	  CuCl2	  and	  20	  mol%	  2-­‐ethyl-­‐2-­‐oxazoline	  as	  oxidation	  catalyst	  system.	  Entry	   Hydroxamic	  acid	   Product	   Yield	  %	  
1	  
	   	  
0	  
2	  
	   	  
0	  
3	   	   	   0	  
4	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5	  
	   	  
0	  
6	   	   	   0	  
7	  
	   	  
0	  
8	   	   	   0	  
9	  
	   	  
0	  
10	   	   	   98	  
11	   	   	   98	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failed	  to	  produce	  any	  reaction.	  The	  turquoise	  precipitate	  suggested	  that	  there	  was	  strong	  chelation	  between	  copper	  and	  161,	  which	  agrees	  with	  the	  work	  reported	  by	  	  Lisowski	  et	   al.84	   Indeed,	   they	   reacted	  a	   copper	   salt	  with	  161	   in	  methanol,	  which	  gave	  a	  metallacrown	  structure	  as	  shown	  in	  Figure	  26,	  with	  a	  copper	  to	  hydroxamic	  acid	  ratio	  of	  5:4.	  	  	  
	  
Figure	  26.	  Copper-­‐2-­‐pyridinehydroxamic	  acid	  metallacrown	  complex.	  	  Entry	  2	   (Table	  12)	   shows	   the	   reaction	  of	  3-­‐pyridinehydroxamic	   acid	  162,	  which	  because	   the	   hydroxamic	   acid	   group	   is	   in	   the	   3-­‐position,	   cannot	   form	   bidentate	  chelation	  complexes	  with	  copper.	  However,	  even	  in	  this	  case	  there	  was	  no	  product	  
174	  formed	  and	  there	  was	  a	  green	  precipitate,	  which	  formed	  slowly	  over	  4	  hours.	  The	   addition	   of	   hydrogen	   peroxide	   also	   did	   not	   help	   the	   reaction	   to	   proceed.	  Moreover,	  increasing	  the	  temperature	  to	  40	  oC	  or	  heating	  the	  reaction	  under	  reflux	  conditions	   did	   not	   make	   the	   reaction	   proceed.	   The	   green	   precipitate	   formation	  again	   suggested	   that	   strong	  chelation	  between	   the	  pyridine	   ring	  and	  copper	  was	  occurring.	  	  	   Entry	   3	   (Table	   4)	   shows	   the	   reaction	   between	   hydroxamic	   acid	  163	   and	  1,3-­‐cyclohexadiene.	   The	   reaction	   was	   stirred	   and	   monitored	   by	   TLC,	   however,	  there	   was	   no	   desired	   cycloadduct	   175	   formed	   even	   after	   72	   hours.	   However,	   a	  green	   precipitate	   was	   again	   observed,	   which	   did	   not	   dissolve	   in	   any	   organic	  solvent.	  Also,	  the	  addition	  of	  hydrogen	  peroxide	  and	  heating	  at	  40	  oC	  again	  failed	  to	  show	  any	  product	   spot	   by	  TLC.	  When	   the	   reaction	  of	   hydroxamic	   acid	  164	  with	  	  cyclohexadiene	  with	   the	  copper-­‐oxazoline	   system	  was	  conducted	   (Entry	  4,	  Table	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12),	   there	   was	   no	   cycloadduct	  176	   formed,	   as	   with	   the	   previous	   reactions	   (e.g.	  Entry	  4,	  Table	  10).	  The	  reaction	  colour	  did	  change	  to	  dark	  brown	  and	  the	  starting	  material	   disappeared	   by	   TLC,	   which	   confirmed	   the	   consumption	   of	   the	  	  hydroxamic	  acid	  and	  most	  likely	  through	  acylnitroso	  decomposition.	  	  	   Entries	   5-­‐9	   (Table	   12)	   show	   the	   reactions	   of	   1,3-­‐cycloheadiene	   with	   the	  hydroxamic	   acids	   with	   the	   CnH2n	   (n	   =	   0-­‐4)	   chains	   between	   the	   phenyl	   ring	   and	  hydroxamic	   acid	   group,	   and	   again	   using	   the	   copper-­‐oxazoline	   and	   air	   system	   as	  catalyst.	  The	  reaction	  mixtures	  were	  stirred	  and	  monitored	  by	  TLC,	  however,	  there	  were	   no	   cycloadducts	   formed	   in	   any	   of	   these	   reactions.	   Even	   when	   hydrogen	  peroxide	  was	   added	  with	   heating	   under	   reflux	  was	   employed,	   the	   reactions	   still	  did	  not	  proceed.	  Interestingly,	  the	  reaction	  mixtures	  stayed	  the	  same	  green	  colour	  even	  after	  72	  hours,	  which	  reinforced	  that	  there	  was	  no	  oxidation	  taking	  place.	  	  	   The	  hydroxamic	  acid	  170,	  which	  contains	  an	  oxygen	  heteroatom	  between	  the	  carbonyl	  group	  and	  phenyl	   ring,	  was	   tested	  with	  cyclohexadiene	   in	   the	  same	  air	  and	  copper-­‐oxazoline	  conditions	  (Entry	  10,	  Table	  12).	  Upon	  mixing	  the	  copper	  with	  the	  oxazoline	  ligand,	  the	  colour	  of	  the	  mixture	  was	  green,	  it	  then	  changed	  to	  yellow	  upon	  the	  addition	  of	  the	  hydroxamic	  acid	  170.	  The	  reaction	  completed	  after	  2	   hours	   and	   gave	   the	   cycloadduct	   182	   in	   high	   yield	   (98%).	   After	   slow	  recrystalization	  of	  the	  compound	  182,	  a	  single	  crystal	  which	  was	  suitable	  for	  the	  X-­‐ray	   crystal	   analysis	   was	   obtained.	   The	   structure	   of	   this	   cycloadduct	   182	   was	  confirmed	  and	  is	  shown	  in	  Figure	  27.	  	  
 
Figure	  27.	  X-­‐ray	  crystal	  structure	  of	  cycloadduct	  182.	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The	   crystal	   structure	   of	   compound	  182	   shows	   co-­‐planarity	   of	   the	   C=O	   and	   N-­‐O	  bonds.	  However,	   and	   in	   contrast	   to	   structures	   such	   as	  178	   (vide	   supra),	   an	   s-­‐cis	  conformation	   is	   preferred	   of	   the	   C-­‐O	   double	   bond	   to	   the	   N-­‐O	   bond	   and	   the	   O-­‐phenyl	  ring	  has	  to	  rotate	  from	  sterically	  clashing	  with	  the	  carbonyl	  group.	  	   Compound	   171,	   which	   contains	   the	   corresponding	   nitrogen	   as	   the	  heteroatom	   in	   the	   same	   position	   compared	   with	   Entry	   10	   (Table	   12),	   was	  employed	  under	  the	  same	  conditions	  (Entry	  11,	  Table	  12).	  This	  reaction	  proceeded	  in	  a	  similar	  fashion	  to	  compound	  170,	  but	  the	  reaction	  time	  was	  twice	  as	  long	  (4	  hours).	   The	   isolated	   yield	   of	   the	  white	   solid	   product	   cycloadduct	  183	   was	   98%	  again.	  After	  recrystalization,	  a	  single	  crystal	  was	  obtained	  and	  was	  analyzed	  using	  X-­‐ray	  diffraction	  analysis.	  The	  structure	  of	  this	  cycloadduct	  183	  is	  shown	  in	  Figure	  28.	  	  
	  
Figure	  28.	  X-­‐ray	  crystal	  structure	  of	  cycloadduct	  183.	  	  Interestingly,	   the	  preferred	  conformation	  of	  the	  C=O	  to	  N-­‐O	  bonds	  swaps	  back	  to	  an	   s-­‐trans	   arrangement,	   compared	  with	  Fig.	   27.	  This	   arrangement	   appears	   to	  be	  less	   sterically	   encumbered	   and	   more	   conjugated	   compared	   to	   Figure	   24	  (compound	   182).	   In	   that	   case,	   the	   phenyl	   ring	   is	   not	   fully	   co-­‐planar	   with	   the	  carbamate	  moiety.	  However,	   in	  183	   (Figure	  28),	   the	   s-­‐trans	   conformation	  of	   the	  urea	   C=O	   to	   N-­‐O	   bond	   of	   the	   cycloadduct,	   places	   the	   aniline-­‐derived	   N-­‐H	   and	  phenyl	  ring	  in	  a	  vertually	  co-­‐planar	  and	  ‘extended’	  conformation.	  	   The	  reaction	  of	  chiral	  hydroxamic	  acid	  172	  with	  1,3-­‐cyclohexadiene	  under	  the	   model	   conditions	   was	   then	   conducted	   (Entry	   12,	   Table	   12).	   This	   reaction	  completed	  in	  4	  hours	  as	  well,	  yielding	  cycloadduct	  184	  in	  an	  excellent	  97%	  yield.	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The	  cycloadduct	  was	  analyzed	  by	  chiral	  HPLC	  and	  1H	  NMR.	  However,	  there	  was	  no	  diastereocontrol	  and	  a	  1:1	  mixture	  of	  distereoisomers	  was	  obtained.	  	  	   From	   the	   results	   in	   Table	   12,	   it	   can	   be	   concluded	   that	   in	   the	   copper-­‐oxazoline	   catalytic	   intermolecular	   NDA	   reaction,	   the	   heteroatom	   between	   the	  phenyl	  ring	  and	  hydroxamic	  group	  seems	  to	  be	  necessary	  for	  the	  oxidation	  of	  the	  hydroxamic	   acid	   to	   acylnitroso	   to	   take	  place.	   	  Why	   this	  might	   be	   the	   case	   is	   not	  clear,	  but	  presumably	  it	  is	  an	  electronic	  effect	  that	  affects	  the	  ease	  of	  oxidation	  of	  hydroxamic	  acid.	  	  




Table	  13.	  The	  reaction	  of	  hydroxamic	  acid	  170	  with	  various	  dienes	  according	  to	  Eq.	  15.	  Entry	   Diene	   Product	   Time	  (h)	   Yield	  %	  
1	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90	  (200	  and	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201	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  =	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1.5	   93	  (ratio	  of	  
204:204’	  1:1)	  
	  	  Entry	  1	  (Table	  13)	  shows	  the	  reaction	  of	  hydroxamic	  acid	  170	  with	  freshly	  cracked	  cyclopentadiene	   using	   10	   mol%	   CuCl2	   and	   20	   mol%	   2-­‐ethyl-­‐2-­‐oxazoline	   in	  methanol.	  The	  copper-­‐oxazoline	  solution	  was	  dark	  green,	  which	  suddenly	  changed	  to	  pale	  yellow	  upon	  the	  adding	  of	  hydroxamic	  acid	  and	  turned	  back	  to	  the	  original	  colour	   when	   the	   reaction	   completed	   after	   2	   hours.	   The	   cycloadduct	   197	   was	  isolated	   as	   a	  white	   solid,	   which	   formed	   crystals	   suitable	   for	   single	   crystal	   X-­‐ray	  analysis	  from	  diethyl	  ether,	  as	  shown	  in	  Figure	  29.	  
	  
Figure	  29.	  X-­‐ray	  crystal	  structure	  of	  cycloadduct	  197.	  	  Figure	   29	   shows	   the	   conformation	   of	   the	   compound	  197,	   which	   shows	   an	   s-­‐cis	  conformation	   of	   the	   C-­‐O	   double	   bond	   to	   the	   N-­‐O	   bond,	   which	   agrees	   with	   the	  conformation	  observed	  in	  compound	  182.	  	  	   The	  result	  of	  the	  oxidation	  of	  hydroxamic	  acid	  170	  to	  form	  the	  acylnitroso	  species,	  which	  was	  then	  trapped	  by	  1,3-­‐cyclohexadiene	  is	  shown	  in	  Entry	  2	  (Table	  13).	  This	  result	  agrees	  with	  the	  previous	  reaction	  in	  Entry	  10,	  Table	  12.	  The	  result	  of	  copper-­‐oxazoline	  catalyzed	  oxidation	  of	  compound	  170	  to	  form	  the	  acylnitroso	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intermediate,	  which	  was	   then	   reacted	  with	  2,3-­‐dimethyl-­‐1,3-­‐butadiene,	   is	   shown	  in	  Entry	  3	  (Table	  13).	  The	  reaction	  was	  completed	  in	  3	  hours	  and	  again,	  it	  was	  self-­‐indicated	  by	  the	  colour	  changes.	  After	  work	  up,	  a	  colourless	  oil	  was	  obtained	  which	  characterized	  by	  1H	  NMR,	  and	  which	  indicated	  that	  two	  compounds	  were	  present	  in	  the	  crude	  product.	  This	  included	  two	  cycloadducts	  194	  and	  ene	  product	  198,	  in	  a	   6:1	   ratio.	   The	   overall	   yield	   was	   an	   excellent	   95%.	   After	   silica	   gel	   column	  chromatography,	  the	  cycloadduct	  194	  was	  separated	  and	  was	  pure	  enough	  to	  do	  a	  full	  analysis.	  The	  ene	  fraction	  contained	  other	  unidentified	  impurities,	  which	  could	  not	  be	  separated.	  	  	   The	   reaction	   of	   hydroxamic	   acid	   170	   with	   2,4-­‐hexadiene	   under	   these	  catalytic	   conditions	   completed	   in	   3	   hours.	   There	   was	   no	   ene-­‐product	   observed;	  only	  cycloadduct	  199	  was	  obtained	  as	  colourless	  oil	  in	  93%	  isolated	  yield	  (Entry	  4,	  Table	   13).	   The	   result	   of	   the	   NDA	   reaction	   of	   the	   acylnitroso	   species,	  which	  was	  formed	  from	  the	  Cu-­‐oxidation	  of	  the	  hydroxamic	  acid	  170,	  with	  isoprene	  is	  shown	  in	   Entry	   5	   (Table	   13).	   This	   reaction	   completed	   in	   3.5	   hours	   and	   there	   were	   3	  products	  observed	  in	  the	  crude	  1H	  NMR	  spectrum;	  cycloadducts	  200	  and	  200’	  and	  the	   ene	   product	   201.	   The	   ratio	   of	   the	   cycloadducts	   200	   and	   200’	   to	   the	   ene-­‐product	   201	  was	   3:1,	   and	   the	   ratio	   between	   200	   and	   200’	   was	   1.79:1.	   These	  cycloadducts	  were	   inseparable	   by	   chromatography,	   therefore,	   the	   assignment	   of	  these	   two	   regioisomers	   was	   achieved	   using	   2D	   NMR	   techniques,	   as	   mentioned	  previously.	  The	  ene-­‐product	  201,	  however,	  could	  not	  be	  separated	  pure	  enough	  to	  do	  further	  analysis.	  	  	   The	   reaction	   of	   compound	   170	   with	   9,10-­‐dimethylantacene	   in	   the	   Cu-­‐oxazoline	  catalytic	  conditions	  was	  also	  conducted	  and	  the	  result	  is	  shown	  in	  Entry	  6	  (Table	  13).	  This	  reaction	  completed	   in	  24	  hours	  and	  was	  monitored	  by	  TLC	  by	  the	  disappearance	  of	  the	  starting	  material	  or	  by	  the	  fluorescent	  properties	  of	  the	  diene.	  The	  cycloadduct	  202	  has	  no	  fluorescence	  under	  UV	  light	  due	  to	  the	  reduced	  conjugation.	  The	   cycloadduct	  202	  was	  obtained	   as	   a	   colourless	   oil	   in	  80%	  yield.	  Entry	  7	  (Table	  13)	  shows	  the	  result	  of	   the	  reaction	  of	  hydroxamic	  acid	  170	  with	  1,4-­‐diphenyl-­‐1,3-­‐butadiene	   under	   the	   model	   catalyst	   conditions.	   The	   reaction	  completed	  in	  24	  hours	  yielding	  cycloadduct	  203	  as	  colourless	  oil	  in	  82%.	  Entry	  8	  (Table	  13)	  demonstrates	  the	  reaction	  of	  hydroxamic	  acid	  170	  with	  the	  asymmetric	  diene,	   2,4-­‐hexadien-­‐1-­‐ol,	   under	   the	  model	   conditions.	   The	   reaction	   completed	   in	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1.5	   hours	   giving	   the	   cycloadducts	  204	   and	  204’	   according	   to	   the	   crude	   1H	  NMR	  spectrum,	  which	  also	  showed	  that	  no	  ene-­‐product	  was	  formed.	  The	  ratio	  between	  these	   two	   cycloadducts	   was	   1:1,	   surprisingly.	   However,	   these	   two	   regioisomers	  could	   not	   be	   separated	   from	   one	   another	   by	   chromatography.	   Therefore,	   the	  proton	   and	   carbon	   spectra	   for	   each	   regioisomer	   could	   not	   be	   easily	   assigned.	   In	  addition	   the	   2D	   NMR	   spectra	   did	   not	   give	   any	   useful	   information	   in	   this	   case.	  However,	   the	  assignment	  of	  204	  and	  204’	  was	  possible	  after	  the	  similar	  systems	  	  
212	  and	  212’	  were	  assigned.	  More	  details	  will	  be	  discussed	  later	  in	  this	  thesis.	  	  	   From	   the	   results	   shown	   in	   Table	   13,	   it	   can	   be	   concluded	   that	   the	  hydroxamic	  acid	  170	  with	  an	  oxygen	  heteroatom	  between	  the	  phenyl	  ring	  and	  the	  hydroxamic	   acid	   group	   can	   react	   readily	   with	   various	   dienes	   under	   the	   Cu-­‐oxazoline	   catalytic	   system,	   giving	   good	   yields	   of	   products,	   though	   the	   levels	   of	  either	  regiocontrol	  in	  the	  NDA	  reaction	  or	  chemoselectivity	  between	  the	  NDA	  and	  ene	  reaction	  were	  not	  particularly	  impressive.	  	  	  




Table	  14.	  The	  reaction	  of	  hydroxamic	  acid	  171	  with	  various	  dienes	  according	  to	  Eq.	  16.	  Entry	   Diene	   Product	   Time	  (h)	   Yield	  %	  	  	  1	  
	  





















	   86	  	  	  	  
	  2	  	  
	  
	   	  	  	  	  	   	  	   4	   98	  
	  3	  	  
	  
	   	  	  
6	   90	  (ratio	  of	  195:206	  =	  9:1)	  	  
4	  	  
	  	   	  	   	  	  
4	   97	  







95	  (208	  and	  208’	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  =	  9:1	  and	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  =	  4.45:1)	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48	   10*	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  recovery	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30*	  after	  purified	  the	  diphenylbutadidne	  shows	  on	  the	  NMR	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3	   90	  (ratio	  of	  212:212’	  =	  1.5:1)	  
	  	  Entry	   1	   (Table	   14)	   shows	   the	   result	   of	   the	   reaction	   between	   freshly	   cracked	  cyclopentadiene	   with	   hydroxamic	   acid	   171,	   using	   the	   Cu-­‐oxazoline	   catalytic	  system	   in	  methanol.	   This	   reaction	  was	  monitored	  by	   the	   colour	   change	   and	  was	  also	   confirmed	   by	   TLC.	   It	   completed	   in	   4	   hours,	   yielding	   cycloadduct	   205	   as	   a	  white	  solid	  in	  an	  efficient	  96%.	  The	  similar	  experiment	  of	  the	  hydroxamic	  acid	  171	  with	  1,3-­‐cyclohexadiene	  under	  the	  same	  conditions	  also	  gave	  a	  high	  isolated	  yield	  of	  the	  cycloadduct	  183	  (Entry	  2,	  Table	  14),	  which	  agreed	  with	  the	  result	  reported	  in	  Entry	  11,	  Table	  12.	  	  	   The	   nitroso-­‐Diels-­‐Alder	   versus	   ene	   reaction	   was	   studied	   using	   the	  compound	   170	   with	   2,3-­‐dimethyl-­‐1,3-­‐butadiene	   under	   the	   standard	   conditions.	  The	  reaction	  completed	  in	  6	  hours	  and	  after	  the	  flash	  chromatography,	  the	  crude	  product	   was	   analyzed	   by	   1H	   NMR,	   showing	   that	   it	   contained	   two	   compounds:	  cycloadduct	  195	   and	   ene-­‐product	  206.	   The	   ratio	   between	   cycloadduct	  195	   and	  ene	  product	  206	  was	  9:1,	  which	  is	  the	  best	  chemoselectivity	  observed,	  especially	  compared	  to	  the	  reaction	  of	  the	  hydroxamic	  acid	  with	  oxygen	  heteroatom	  product,	  
i.e.	  170	   (cycloadduct:ene	   ratio	   =	   6:1).	   The	   reason	   for	   the	   improved	   selectivity	   is	  still	  unknown,	  however,	  one	  possibility	   is	   that	   the	  nitrogen	  heteroatom,	  which	   is	  less	   electronegative	   than	   oxygen,	   makes	   the	   nitroso	   group	   less	   electrophilic.	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Therefore,	   the	   preferred	   pathway	   is	   the	   NDA	   reaction,	   compared	   to	   the	   ene	  reaction.	   Whether	   this	   is	   indeed	   the	   reason	   requires	   further	   investigation	   and	  especially	   using	   theoretical	   studies.	   The	   crude	   product	   was	   purified	   by	  chromatography	   to	   yield	   the	   pure	   cycloaduuct	  195,	   which	   after	   recrystalization	  gave	  a	  crystal	  suitable	  for	  single	  crystal	  X-­‐ray	  diffraction	  analysis.	  The	  structure	  is	  shown	   in	  Figure	  30.	  The	  ene	  product,	  however,	  could	  not	  be	  separated	   in	  a	  pure	  enough	  state	  to	  do	  further	  analysis.	  	  
	  
Figure	  30.	  X-­‐ray	  crystal	  structure	  of	  cycloadduct	  195.	  	  	  Compound	  195,	  as	  with	   the	  previous	  urea-­‐like	  NDA	  adducts,	  shows	  a	  preference	  for	  an	  s-­‐trans	  conformation	  of	  N-­‐O	  to	  C=O	  arrangement.	  Also	  as	  before,	  this	  allows	  the	  urea	  N-­‐H	  function	  to	  be	  co-­‐planar	  with	  the	  benzene	  group.	  	   The	  reaction	  of	  hydroxamic	  acid	  171	  with	  2,4-­‐hexadiene,	  which	  has	  methyl	  groups	   in	   the	   1-­‐	   and	   4-­‐positions,	   using	   the	   model	   reaction,	   was	   studied.	   The	  reaction	   completed	   in	   4	   hours	  with	   only	   cycloaduuct	  207	   being	   observed	   in	   the	  crude	   product	   1H	   NMR	   spectrum.	   After	   the	   purification,	   a	   colourless	   oil	   was	  obtained	  in	  97%	  isolated	  yield	  (Entry	  4,	  Table	  14).	  	  	   Entry	   5	   (Table	   14)	   shows	   the	   result	   of	   the	   reaction	   between	   hydroxamic	  acid	   171	   with	   isoprene	   under	   the	   copper(II)-­‐catalyzed	   conditions.	   The	   reaction	  completed	   in	   6	   hours,	   with	   3	   products	   being	   shown	   by	   1H	   NMR.	   The	   products	  consisted	  of	   cycloadducts	  208	   and	  208’,	   and	   ene	  product	  209,	  with	   a	   combined	  the	  yield	  of	  95%.	  The	   ratio	  of	   cycloadducts	   to	  ene-­‐product	  was	  9:1,	  which	   is	   the	  highest	  observed	  and	  far	  better	  than	  the	  oxygen	  heteroatom	  version	  (3:1)	  (Entry	  5,	  Table	   13).	   The	   ratio	   between	   the	   two	   cycloadducts	   208	   and	   208’	   was	   4.45:1,	  which	   again	   is	   better	   than	   the	   oxygen	   heteroatom	   containing	   system.	   After	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purification	  by	   silica	   gel	   chromatography,	   the	   cycloadducts	  were	   separated	   from	  the	  ene-­‐product.	  However,	  the	  separation	  of	  the	  two	  cycloadducts	  was	  not	  possible	  due	  to	  them	  having	  the	  same	  rf.	  The	  ene	  product	  209,	  as	  with	  the	  others,	  could	  not	  be	  separated	  in	  a	  pure	  enough	  state	  to	  characterize	  it	  fully.	  	  	  	   Entries	  6	  and	  7	  (Table	  14)	  show	  the	  reaction	  between	  the	  hydroxamic	  acid	  
171	   with	   9,10-­‐dimethylantracene	   and	   1,4-­‐diphenyl-­‐1,3-­‐butadiene,	   respectively,	  under	   the	  model	   conditions.	   These	   reactions	  were	   stirred	   and	  monitored	   for	   48	  hours,	  however,	  the	  reactions	  did	  not	  go	  to	  completion.	  The	  crude	  1H	  NMRs	  of	  both	  cycloadducts	   210	   and	   211	   showed	   that	   the	   desired	   products	   were	   formed,	  however,	  after	  purification	  of	  both	  cycloadducts,	  diene	  starting	  material	  was	  still	  present	   in	   the	   1H	   NMR	   spectra.	   Even	   repeating	   the	   column	   chromatography	  several	  times	  did	  not	  give	  pure	  enough	  product	  to	  be	  characterized.	  This	  suggested	  that	  the	  cycloadducts	  were	  undergoing	  cyclo-­‐reversion	  upon	  standing,	  to	  give	  back	  the	  dienes	  and	  nitroso	  species,	  which	  then	  decompose	  leaving	  the	  diene.	  	  	   Entry	   8	   (Table	   14)	   shows	   the	   reaction	   of	   the	   asymmetric	   diene,	   2,4-­‐hexadien-­‐1-­‐ol,	   with	   hydroxamic	   acid	   171.	   The	   reaction	   completed	   in	   3	   hours	  giving	   a	  90%	  yield	  of	   cycloadducts	  212	   and	  212’	  with	   a	   ratio	   of	   1.5:1.	  Although	  this	  is	  not	  a	  major	  level	  of	  regiocontrol,	  it	  is	  an	  improvement	  compared	  to	  Entry	  8,	  Table	  12,	  which	  was	  only	  1:1.	  This	  ratio	  can	  be	  obtained	  from	  the	   integral	  of	   the	  NH	  proton	   in	   the	  crude	  1H	  NMR	  spectrum	  shown	   in	  Figure	  31.	  The	  structures	  of	  
212	  and	  212’	  are	  shown	  in	  Figure	  32.	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Figure	  31.	  Crude	  1H	  NMR	  of	  the	  cycloadduct	  212	  and	  212’.	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 1H	  NMR 
 13C	  NMR 
Figure	  33.	  1H	  and	  13C	  NMR	  of	  the	  mixture	  of	  cycloadducts	  212	  and	  212’.	  	  	  Figure	  33	  shows,	  that	  after	  purification	  by	  chromatography,	  the	  product	  consisted	  of	  only	  two	  regioisomers	  and	  with	  a	  reduced	  ratio	  of	  1:1.1	  in	  this	  column	  fraction.	  COSY	   (Figure	  34)	   showed	   the	   correlation	  of	   the	  methyl	   group	   f	   and	  a’	   to	   the	  CH	  
	   92	  	  	  	  
group	  of	  b,	  b’,	  e	  and	  e’.	  Protons	  b	  and	  e’	  correlated	  with	  the	  CH2	  protons	  a	  and	  f’	  respectively.	  The	  protons	  b,	  b’,	  e	  and	  e’	  also	  correlated	  to	  the	  alkene	  protons	  of	  c,	  c’,	  d	  and	  d’.	  One	  regioisomer	  had	  the	  alkene	  proton	  signals	  well	  separated,	  while	  the	  other	  had	  them	  close	  together.	  	  
	  
212	  and	  212’	  
	  	  
Figure	  34.	  COSY	  NMR	  of	  cycloadducts	  212	  and	  212’.	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The	  NOESY	  of	   this	  mixture	  of	   two	   regioisomers	  212	   and	  212’,	   however,	   did	  not	  give	   any	   useful	   information	   for	   the	   assignment	   of	   these	   compounds.	   Therefore,	  separation	  of	   the	   two	  cycloadducts	  was	  attempted	  again.	  Even	   though	   these	   two	  could	  not	  be	   separated	   completely,	   the	  best	   separation	  was	   from	  a	   fraction	  with	  the	   majority	   component	   being	   one	   regioisomer.	   This	   sample	   was	   then	  characterized	   by	   the	   2D	   NMR	   to	   give	   useful	   information	   in	   the	   long-­‐range	  correlation.	  The	  NOESY	  of	  this	  sample	  showed	  (Figure	  35)	  a	  correlation	  between	  the	  NH	  proton	   to	   the	   CH3	   group	   and	   the	   CH	  proton.	   Therefore,	   the	   peak	   at	   4.62	  ppm	  belongs	  to	  the	  CH	  group	  next	  to	  the	  CH3.	  This	  confirms	  that	  the	  regioisomer	  that	  was	   separated	   out	   in	   this	   sample	  was	  212’.	   From	   the	  NOESY	   spectrum,	   the	  structure	  was	  confirmed	  as	  shown	  in	  Figure	  36.	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Figure	  37.	  COSY	  NMR	  of	  212’.	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Figure	  38.	  HSQC	  NMR	  of	  212’.	  	  The	  HSQC	  correlation	  between	  the	  protons	  and	  carbons	  of	  this	  compound	  ensured	  the	  confirmation	  of	   the	  position	  of	   the	  carbons.	  For	  the	  CH	  (e’)	  next	  to	  oxygen	  in	  the	  cycloadduct	  212’,	  the	  carbon	  peak	  appeared	  at	  74.5	  ppm,	  which	  was	  at	  lower	  field	  than	  the	  CH	  (b’)	  next	  to	  nitrogen	  (54.5	  ppm).	  This	  information	  is	  very	  useful	  in	  order	  to	  assign	  the	  structure	  of	  this	  and	  other	  compounds.	  All	  the	  cycloadducts	  that	  had	  been	   synthesized	  and	   characterized	  previously,	   the	   assignment	  of	   them	  based	  on	  the	  theory	  that	  carbons	  next	  to	  the	  oxygen	  would	  shift	  to	  lower	  field	  than	  carbons	  next	  to	  the	  nitrogen.	  However,	  there	  was	  not	  enough	  information	  to	  prove	  this	  until	  compounds	  212	  and	  212’	  were	  characterized.	  All	  the	  carbons	  connected	  to	   protons	  were	   assigned,	   however,	   the	   ipso	   and	   carbonyl	   carbons	   could	   not	   be	  assigned	  by	  this	  HSQC	  analysis,	  therefore,	  HMBC	  NMR	  was	  performed.	  The	  result	  is	  shown	  in	  Figure	  39.	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Figure	  39.	  HMBC	  NMR	  of	  compound	  212’	  	  The	  HMBC	  (Figure	  39)	  shows	  the	  long-­‐range	  correlation	  of	  the	  aromatic	  proton	  of	  the	  ipso-­‐carbon	  at	  137.8	  ppm,	  therefore,	  the	  peak	  at	  155.1	  ppm	  corresponds	  to	  the	  carbonyl	   carbon.	   After	   the	   ipso-­‐carbon	   was	   assigned,	   this	   then	   allowed	   the	  assignment	   of	   the	   protons	   in	   the	   aromatic	   region.	   The	   peak	   at	   7.23	   ppm	  corresponds	  to	  the	  two	  protons	  at	  the	  h’	  position,	  7.40	  ppm,	  which	  corresponds	  to	  the	  two	  protons	  at	  i,	  and,	  that	  at	  7.00	  ppm	  corresponds	  to	  one	  proton	  at	  j.	  After	  all	  the	   proton	   and	   carbon	   peaks	   for	   compound	  212’	   were	   assigned,	   the	   rest	   of	   the	  peaks	  in	  Figure	  30	  had	  to	  belong	  to	  compound	  212,	  which	  could	  also	  be	  assigned	  using	  the	  same	  logic.	  With	  all	  the	  information	  obtained	  from	  the	  NMR	  spectra,	  the	  regioselectivity	   of	   the	   reaction	   could	   be	   confirmed	   as	   compound	  212	   being	   the	  major	  regioisomer	  over	  compound	  212’	  (1.5:1).	  	  	  
2.14	  Asymmetric	  synthesis	  attempt	  
2.14.1	  Chiral	  ligand	  in	  reaction	  of	  compound	  171	  with	  1,3-­cyclohexadiene	  Hydroxamic	  acid	  171,	  with	  the	  nitrogen	  heteroatom	  between	  the	  phenyl	  ring	  and	  hydroxamic	  acid	  group,	  has	  the	  potential	  to	  be	  chelated	  to	  the	  copper	  in	  a	  milder	  fashion	   than	   the	   nitrogen	   on	   pyridine	   ring	   as	   with	   compounds	   161-­‐163.	   The	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proposed	   chelation	   is	   shown	   in	  Figure	  40,	  possibly	  occurring	  as	   shown	   in	  either	  structures	   A	   or	   B.	   Such	   chelation	   might	   result	   in	   chiral	   selectivity	   in	   the	   NDA	  system	   using	   chiral	   copper-­‐oxazoline	   catalytic	   systems.	   Therefore,	   experiments	  using	   the	   hydroxamic	   acid	   171	   as	   the	   starting	   material	   were	   conducted	   under	  copper-­‐chiral	  ligand	  conditions.	  The	  results	  are	  shown	  in	  Table	  15	  and	  Eq.	  17.	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Table	   15.	   The	   reaction	   of	   hydroxamic	   acid	   171	   with	   1,3-­‐cyclohexadiene	   using	  CuCl2	  and	  chiral	  ligand	  .	  Entry	   Ligand	   Time	  (h)	   Yield	  %	  of	  183	   ee	  of	  183	  
1	  
157	   4	   95	   0	  
2	  
145	  
3	   98	   0	  
	   99	  	  	  	  
3	   	  
158	  
4	   96	   0	  
	  	  Entry	  1	  (Table	  15),	  shows	  the	  result	  of	  the	  reaction	  between	  hydroxamic	  acid	  171	  with	  1,3-­‐cyclohexadiene	  using	  10	  mol%	  CuCl2	  and	  10	  mol%	  2,2′-­‐bis[(4S)-­‐4-­‐benzyl-­‐2-­‐oxazoline]	  157.	  The	  reaction	  completed	  in	  4	  hours,	  yielding	  the	  cycloadduct	  183	  in	  95%.	  The	  white	  crystalline	  solid	  cycloadduct	  183	  was	  analyzed	  by	  chiral	  HPLC	  using	  an	  OD	  chiral	  HPLC	  column,	  using	  6.5:3.5	  hexane	  :IPA.	  However,	  there	  was	  no	  asymmetric	  induction	  observed.	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  For	   the	   Entry	   2	   (Table	   15),	   the	   same	   experiment	   was	   carried	   out	   with	  10mol%	  CuCl2and	  10	  mol%	  (+)-­‐2,2′-­‐isopropylidenebis[(4R)-­‐4-­‐benzyl-­‐2-­‐oxazoline]	  
145.	  The	  reaction	  completed	  in	  3	  hours,	  which	  was	  an	  hour	  faster	  than	  the	  achiral	  oxazoline	  (Entry	  2,	  Table	  14)	  showing	  that	  bidentate	  ligands	  speed	  up	  the	  reaction.	  The	   isolated	   yield	   of	   this	   reaction	  was	  98%,	  however,	   there	  was	  no	  ee	   observed	  after	  the	  cycloadduct	  183	  as	  determined	  by	  chiral	  HPLC.	  	  The	   pybox	   ligand	   158	   was	   also	   used	   as	   a	   chiral	   ligand	   in	   this	   reaction	  system	  (Entry	  3,	  Table	  15).	  The	  reaction	  completed	  in	  4	  hours,	  giving	  96%	  isolated	  yield	   of	   product	   183,	   which	   was	   then	   analyzed	   by	   the	   chiral	   HPLC.	   This	   again	  showed	  that	  the	  racemic	  product	  was	  obtained.	  	  From	   all	   the	   results	   shown	   in	   Table	   15,	   it	   was	   clear	   that	   there	   was	   no	  enantioselectivity	   produced,	   even	   though	   pure	   chiral	   ligands	   were	   employed	   in	  this	  aerobic	  oxidation,	  copper-­‐catalyzed	  system.	  The	  reactions	  were	  clean	  and	  fast,	  which	  shows	  that	  the	  acylnitroso	  compound	  did	  not	  chelate	  to	  the	  copper	  during	  the	   NDA	   step	   of	   the	   reaction,	   however,	   the	   oxidation	   reaction	   was	   improved	  compared	  with	  the	  monodentate	  ligand	  system.	  	  
2.14.2	  Chiral	  ligand	  in	  reaction	  of	  compound	  172	  with	  1,3-­cyclohexadiene	  	  Reactions	  of	  chiral	  hydroxamic	  acid	  172	  with	  1,3-­‐cyclohexadiene	  using	  CuCl2	  and	  the	   different	   chiral	   ligands	   was	   also	   studied.	   This	   study	   was	   based	   on	   the	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Table	   16.	   The	   reaction	   of	   chiral	   hydroxamic	   acid	   172	   with	   1,3-­‐cyclohexadiene	  using	  CuCl2	  and	  chiral	  ligand.	  	   Entry	   Ligand	   Time	  (h)	   Yield	  (%)	   d.e.	  (%)	  
1	  
157	   2	   98 13	  
2	  
145	   2	   99	   13	  
3	   	  
158	  




2	   99	   13	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Entry	  1,	  Table	  16	  shows	  the	  result	  of	   the	  reaction	  of	  chiral	  hydroxamic	  acid	  172	  with	  1,3-­‐cyclohexadiene	  with	  10	  mol%	  CuCl2	  and	  chiral	  bis-­‐oxazoline	  ligand	  157.	  The	  reaction	  completed	  in	  2	  hours,	  which	  was	  half	  the	  time	  of	  the	  reaction	  using	  2-­‐ethyl-­‐2-­‐oxazoline	  as	  a	  ligand	  (Entry	  12,	  Table	  12).	  The	  white	  solid	  cycloadduct	  184	  was	   obtained	   in	   98%	   isolated	   yield	   and	  was	   analyzed	   by	   chiral	   HPLC	   using	   the	  same	   OD	   column	   which	   was	   used	   to	   separate	   both	   possible	   the	   related	  enantiomers.	   However,	   there	  was	   only	   low	   asymmetric	   control	   observed	   in	   this	  reaction	   and	   shown	   by	   a	   de	   of	   13%	   (i.e.	   a	   ration	   of	   1.3:1	   for	   the	   two	  diastereoisomers).	  When	  chiral	  ligand	  145	  was	  also	  employed	  in	  this	  study	  (Entry	  2,	  Table	  16),	  the	  reaction	  completed	  in	  2	  hours	  giving	  compound	  184	  in	  99%.	  This	  pure	  compound	  was	  again	  analyzed	  by	  the	  chiral	  HPLC	  but	  again	  showed	   low	  de	  	  (13%).	  Entry	  3	  (Table	  16)	  shows	  the	  effect	  of	  the	  ligand	  158	  on	  the	  same	  reaction,	  since	   this	   ligand	   helped	   the	   reaction	   to	   proceed	   and	   complete	   in	   2	   hours	   also,	  yielding	   the	   cycloadduct	   in	   98%.	  However,	   there	  was	   still	   low	  de	   observed	   after	  chiral	   HPLC	   analysis	   was	   performed,	   which	   was	   notably	   the	   same	   13%	   The	  cycloadduct	   184	   was	   also	   recrystalized	   by	   a	   slow	   evaporation	   technique	   using	  diethyl	   ether	   to	   give	   crystals	   suitable	   for	   the	   single	   crystal	   X-­‐ray	   diffraction	  analysis.	  The	  result	  is	  shown	  in	  Figure	  41.	  
	  
Figure	  41.	  X-­‐ray	  structure	  of	  cycloadduct	  184.	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Figure	  41	  shows	  the	  X-­‐ray	  structure	  of	  cycloadduct	  184,	  which	  confirmed	  that	  the	  product	  was	   a	   1.3:1	  mixture	  of	   diastereoisomers,	   using	   the	   enatiomerically	   pure	  starting	  material	   and	   chiral	   Cu	   ligands	  were	   used	   in	   the	   reaction.	   This	   confirms	  that	  there	  must	  be	  rapid	  dissociation	  of	  the	  acylnitroso	  compound	  of	  the	  Cu	  before	  it	  can	  be	  trapped	  by	  the	  diene,	  resulting	  in	  no	  major	  stereocontrol	  effects.	  Entry	  4	  (Table	  16)	  shows	  the	  result	  of	  the	  reaction	  of	  chiral	  hydroxamic	  acid	  172	  with	  1,3-­‐cyclohexadiene	   with	   10	   mol%	   CuCl2	   and	   chiral	   pybox	   ligand	   213,	   which	   is	   the	  opposite	   absolute	   stereochemistry	   ligand	   to	   the	   ligand	   158.	   The	   reaction	  completed	  in	  2	  hours	  giving	  cycloadduct	  184	  in	  99%.	  However,	  there	  was	  still	  only	  the	  same	  low	  de	  observed	  (13%).	  This	  experiment	  confirmed	  therefore	  that	  there	  was	   no	   double	   diastereocontrol	   in	   this	   system	   and	   essentially	   proves	   that	   there	  was	  no	  chelation	  between	  the	  copper	  complex	  and	  nitroso-­‐species	  during	  the	  NDA	  reaction.	  	  	  
2.15	  Chemoselectivity	  of	  hydroxamic	  acid.	  From	  the	  study	  of	  the	  reaction	  of	  the	  different	  hydroxamic	  acids	  and	  2,3-­‐dimethyl-­‐1,3-­‐butadiene	  under	   the	  copper-­‐oxazoline	  catalytic	   system,	   the	   results	   show	  that	  the	   ratio	   between	   the	   NDA	   and	   ene	   reaction	   depends	   upon	   the	   nature	   of	   the	  hydroxamic	  acid.	  The	  highest	  ratio	  of	  NDA:ene	  reaction	  that	  can	  be	  obtained	  so	  far	  was	  obtained	  from	  using	  hydroxamic	  acid	  171	  (9:1).	  These	  studies	  also	  show	  that	  the	   stronger	   electron	   withdrawing	   group	   attached	   to	   the	   NHOH	   function,	   the	  better	   the	   NDA	   reaction,	   presumably	   due	   to	   the	   lower	   LUMO	   of	   the	   nitroso	  species.5,30	  This	  assumes	  that	  with	  the	  stronger	  EWG	  next	  to	  the	  NHOH	  group,	  the	  ratio	  between	   the	  NDA	  and	  ene	   reaction	   is	   increased.	   In	  order	   to	  prove	   this,	   the	  hydroxamic	  acid	  172,	  which	  contained	  stronger	  electron	  withdrawing	  groups	  than	  compund	  171	  was	   tested.	   The	   result,	   as	   expected,	   shows	   that	   there	  was	   no	   ene	  product	  observed,	  only	  the	  desired	  cycloadduct	  196	  was	  obtained	  in	  99%.	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2.16	  Conclusions	  From	   the	  work	   shown	   in	   this	   thesis,	   the	   following	   conclusions	   can	  be	  drawn:	  1)	  that	   the	   copper-­‐oxazoline	   complex	   is	   an	   excellent	   catalyst	   for	   the	   arerobic	  oxidation	   of	   acyl	   hydroxamic	   acid	   to	   generate	   the	   corresponding	   acyl	   nitroso	  species;	  2)	  that	  this	  system	  can	  only	  be	  used	  with	  the	  hydroxamic	  acid	  containing	  a	  hetero-­‐atom	   between	   the	   aryl	   and	   carbonyl	   group;	   3)	   that	   the	   nitroso	   species	  generated	   in	   situ	   can	   be	   trapped	   by	  most	   dienes	   resulting	   in	   the	   corresponding	  cycloadducts;	   4)	   the	   yield	   of	   the	   products	  were	   variable	   from	  high	   to	  moderate,	  depending	  upon	  the	  reaction	  time	  because	  there	  was	  decomposition	  of	  the	  nitroso	  species	   competing	  with	   the	  NDA	   reaction.	   The	   longer	   the	   trapping	   time	   (slower	  NDA	  reaction),	  the	  lower	  the	  yield	  generally;	  5)	  when	  using	  diene	  containing	  both	  alkene	  π-­‐bonds	  and	  allylic	  σ-­‐bonds,	  which	  can	  react	  with	  the	  nitroso-­‐group	  to	  form	  the	  ene-­‐product,	  the	  solvent	  plays	  a	  major	  role	  in	  the	  chemoselectivity.	  Acetonitrile	  gave	   the	   longest	   reaction	   time	  but	   the	  best	   result	   in	   the	  chemoselectivity;	  6)	   the	  chemoselectivity	  of	  this	  system	  depends	  upon	  the	  reactivity	  of	  the	  hydroxamic	  acid	  -­‐	   the	   higher	   the	   reactivity,	   the	   lower	   the	   chemoselectivity.	   	   Overall	   this	   catalytic	  aerobic	   oxidation	   is	   a	   particularly	   efficient,	   mild,	   clean,	   simple	   and	  environmentally	   benign	   for	   generating	   acyl	   nitroso	   species	   in	   situ	   and	   trapping	  them	  via	  a	  NDA	  reaction.	  	  
	  
2.17	  Future	  Work	  	  
	   The	   oxidation	   of	   the	   hydroxamic	   acids	   under	   the	   copper-­‐oxazoline	   and	   air	  system	  to	  form	  the	  corresponding	  nitroso	  species	  and	  then	  trapping	  them	  using	  a	  diene	  was	  accomplished.	  However,	  the	  asymmetric	  synthesis	  of	  the	  NDA	  reaction	  adducts	   failed.	   Therefore,	   computational	  work	   on	   the	  NDA	   reaction	   is	   needed	   in	  order	  to	   find	  out	   the	   likely	  mechanism(s)	  operating	   in	  the	  reaction,	  which	  would	  allow	  us	  to	  understand	  the	  nature	  of	  the	  reaction	  between	  the	  nitroso	  species	  and	  the	   diene.	   This	   will	   lead	   to	   the	   catalytic	   design	   for	   an	   asymmetric	   synthesis	  perhaps	  in	  future.	  	  	   The	  catalytic	  aerobic	  oxidation	  of	  the	  hydroxamic	  acids	  is	  clean	  and	  simple,	  therefore,	   it	  can	  be	  used	  in	  the	  natural	  product	  synthesis	  of	  alkaloids.	  This	   in	  situ	  oxidation	   of	   the	   hydroxamic	   acids	   has	   an	   advantage	   over	   the	   nitroso	   species	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because	   it	   is	  more	   stable.	   Some	   examples	   of	   this	   system	  were	   employed	   by	   the	  Shea	  group,	  who	  showed	  the	  utility	  of	  this	  reaction	  in	  intra-­‐molecular	  NDA.	  They	  also	   tested	   this	   methodology	   with	   a	   hydrazide	   to	   form	   the	   corresponding	   azo-­‐compound	  and	  the	  trapped	  by	  the	  diene.	  This	  leads	  to	  the	  future	  work	  of	  studying	  the	  oxidation	  of	  hydrazides	  to	  form	  the	  azo	  compounds	  and	  their	  applications.	  	  
	   	   0	  
Chapter	  3.	  Experimental	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3.0	  Experimental	  	  General	  All	   reactions	  were	  performed	   in	   the	  presence	  of	   air,	   unless	   otherwise	   stated.	  All	  reagents	  were	  purchased	  from	  Aldrich	  and	  TCI	  and	  were	  used	  as	  received	  without	  further	   purification	   unless	   otherwise	   stated.	   Solvents	   (AR	   grade)	   were	   used	   as	  received.	   Thiourea-­‐oxazoline	   ligands	   were	   prepared	   by	   the	   group	   of	   Professor	  Yang	   of	   Peking	   University	   as	   reported	   in	   the	   literature.81	   1H	   NMR	   and	   13C{1H}	  spectra	  were	  recorded	  using	  Bruker	  Avance	  400	  operating	  at	  400	  MHz	  for	  1H	  NMR	  and	   13C	  NMR	  at	  101	  MHz,	  Varian	  VNMRS	  700	  operating	  at	  700	  MHz	   for	   1H	  NMR	  and	  13C	  NMR	  at	  176	  MHz,	  or	  for	  1H	  NMR	  recorded	  at	  500	  MHz	  using	  a	  Bruker	  DRX	  500	   spectrometer	   or	   at	   600	   MHz	   using	   an	   Advance	   600	   spectrometer,	   with	  corresponding	   13C	  NMR	  at	  125	  MHz	  using	  a	  Bruker	  DRX	  500	   spectrometer	  or	   at	  150	  MHz	  using	  an	  Advance	  600	  spectrometer.	  CDCl3	  and	  DMSO-­‐d6	  was	  used	  as	  the	  solvent	  for	  all	  NMR	  samples.	  1H	  NMR	  chemical	  shifts	  are	  reported	  with	  reference	  to	   TMS	   using	   residual	   proton	   on	   non	   deuterated	   solvent	   (CDCl3:	   7.26	   ppm)	  whereas	   13C	   NMR	   spectra	   are	   reported	  with	   reference	   to	   TMS	   using	   the	   carbon	  signals	   of	   the	   deuterated	   solvent	   (CDCl3:	   77.23	   ppm)	   Elemental	   analysis	   was	  performed	   using	   an	   Exeter	   Analytical	   E440	  machine	   by	   departmental	   service	   at	  Durham	  University.	  All	  chromatography	  was	  carried	  out	  using	  silica	  gel	  (Silica	  gel	  LC60A	  40-­‐63	  μm),	  which	  obtained	  from	  Fluorochem.	  The	  removal	  of	  solvent	  was	  performed	  on	  a	  rotary	  evaporator	  under	  vacuum.	   IR	  spectra	  were	  recorded	  on	  a	  Perkin-­‐Elmer	  1615	  FTRIR	  spectrometer.	  Melting	  points	  were	  determined	  using	  an	  Electrothermal	  melting	  point	  apparatus	  and	  are	  uncorrected.	  Low	  resolution	  mass	  spectrometry	  was	  carried	  out	  on	  a	  Waters	  TQD	  equipped	  with	  Acquity	  UPLC	  and	  an	  electrospray	  ion	  source,	  and	  high	  resolution	  mass	  spectrometry	  was	  carried	  out	  on	   a	   Waters	   LCT	   Premier	   XE	   equipped	   with	   Acquity	   UPLC	   and	   a	   lock-­‐mass	  electrospray	  ion	  source.	  	  
3.1	  Palladium	  catalyst	  screening	  	  	  	  
Entry	  1,	  Table	  1	  
N-­‐(Benzyloxycarbonyl)hydroxylamine	  (210	  mg,	  1.26	  mmol)	  dissolved	  in	  methanol	  (10	  mL)	  was	   added	   dropwise	   to	   a	  mixture	   of	   1,3-­‐cyclohexadiene	   (150	  mg,	   1.87	  
	   106	  	  	  	  
mmol),	   sodium	   periodate	   (269	  mg,	   1.26	  mmol)	   and	  methanol	   (20	  mL)	   at	   room	  temperature.	  The	  reaction	  mixture	  was	  stirred	  for	  4	  hours	  and	  monitored	  by	  TLC.	  Then	   the	   solvent	  was	   removed	   in	   vacuo.	   and	   the	   crude	   product	  was	   purified	   by	  silica	   gel	   chromatography	   (6:1	   v/v,	   	   hexane/EtOAc)	   to	   obtain	   the	   product	   as	   a	  white	  solid.	  Product	  yield:	  216	  mg	  (70%);	  m.p.	  84-­‐86	  °C;	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  7.45	  –	  7.28	  (m,	  5H),	  6.67	  –	  6.46	  (m,	  2H),	  5.24	  –	  5.17	  (m,	  1H),	  5.13	  (d,	  J	  =	  12.3	  Hz,	  1H),	  4.82	  (dt,	  J	  =	  7.9,	  2.8	  Hz,	  1H),	  4.76	  (ddd,	  J	  =	  5.5,	  3.8,	  1.8	  Hz,	  1H),	  2.26	  –	  2.17	  (m,	  1H),	  2.12	  (ddt,	  J	  =	  12.4,	  9.0,	  3.1	  Hz,	  1H),	  1.53	  –	  1.44	  (m,	  1H),	  1.42	  –	  1.34	  (m,	  1H);	  13C{1H}	  NMR	   (101	  MHz,	   CDCl3)	   δ	   158.1,	   136.0,	   132.0,	   131.6,	   128.5,	   128.2,	   128.1,	  71.0,	  67.7,	  50.2,	  23.5,	  20.6;	  FTIR	  (thin	  film)	   inter	  alia	  1698,	  1265,	  1049,	  744,	  696	  cm-­‐1;	  LRMS	  (ESI+)	  m/z	  268.1	  (M+	  +	  Na);	  HRMS	  (ESI+)	  m/z	  Calcd	  for	  C14H15NO3Na	  268.0950	   found	   268.0928;	   Anal.	   Calcd	   for	   C14H15NO3:	   C	   68.55,	   H	   6.16,	   N	   5.71,	  found:	  C	  68.59,	  H,	  6.22,	  N	  5.6017c	  	  
GP	  1:	  General	  procedure	  for	  the	  nitroso-­Diels-­Alder	  reaction	  forming	  benzyl	  2-­oxa-­3-­
azabicyclo[2.2.2]oct-­5-­ene-­3-­carboxylate	  140	  	  1,3-­‐Cyclohexadiene	  (5	  equivalents)	  and	  catalyst	  were	  added	  to	  a	  microwave	  tube	  followed	  by	  toluene	  (4	  mL).	  N-­‐(Benzyloxycarbonyl)hydroxylamine	  in	  methanol	  (1	  mL)	  was	   added	   and	   the	   resulting	   solution	  was	   stirred	   at	   room	   temperature	   and	  monitored	   by	   TLC.	   The	   completion	   of	   the	   reaction	   was	   confirmed	   by	   the	  disappearance	   of	   the	   starting	  material	   spot	   by	   TLC.	   The	   solvents	  were	   removed	  under	   reduced	   pressure	   and	   the	   crude	   product	   purified	   by	   silica	   gel	  chromatography	  (hexane:	  ethyl	  acetate,	  6:1	  v/v	  as	  the	  eluent)	  to	  give	  the	  product	  
140	  as	  a	  white	  solid.	  	  
Entry	  6,	  Table	  1	  According	  to	  GP1:	  N-­‐(Benzyloxycarbonyl)hydroxylamine	  (91	  mg,	  0.54	  mmol),	  1,3-­‐cyclohexadiene	   (60	  mg,	  0.75	  mmol),	  PdL2up	  (4	  mg,	  0.007	  mmol)	  and	  CuI	   (2	  mg,	  0.011	  mmol).	  The	   reaction	  was	   stirred	   for	  2	  days	  and	  a	  white	   solid	  product	  was	  obtained.	  Product	  140	  yield:	  27	  mg	  (20%).	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Entry	  7,	  Table	  1	  According	  to	  GP1:	  N-­‐(Benzyloxycarbonyl)hydroxylamine	  (57	  mg,	  0.34mmol)	  1,3-­‐cyclohexadiene	   (97	  mg,	   1.21	  mmol),	   PdL2up	   (10	  mg,	   0.02	  mmol)	   and	  CuI	   (3	  mg,	  0.02	  mmol).	  The	  tube	  was	  sealed	  and	  O2	  gas	  was	  injected	  to	  the	  mixture.	  The	  reaction	  was	  stirred	  for	  2	  days.	  The	  product	  	  140	  was	  obtained	  in	  a	  yield	  of	  33	  mg	  (39%).	  	  
Entry	  8,	  Table	  1	  According	  to	  GP1:	  N-­‐(Benzyloxycarbonyl)hydroxylamine	  (57	  mg,	  0.34	  mmol)	  1,3-­‐cyclohexadiene	  (100	  mg,	  1.25	  mmol),	  PdL2up	  (10	  mg,	  0.02	  mmol)	  and	  CuI	  (7	  mg,	   0.03	  mmol).	   The	   tube	  was	   sealed	   and	  O2	   gas	  was	   injected	   into	   the	   reaction	  mixture.	  The	  reaction	  was	  stirred	  for	  2	  days.	  Product	  	  140	  yield:	  35	  mg	  (42%).	  	  
Entry	  9,	  Table	  1	  According	  to	  GP1:	  N-­‐(Benzyloxycarbonyl)hydroxylamine	  (57	  mg,	  0.34	  mmol)	  1,3-­‐cyclohexadiene	  (137	  mg,	  1.71	  mmol),	  PdL2up	  (2	  mg,	  0.004	  mmol),	  CuI	  (1	  mg,	  0.007	  mmol)	  and	  Et3N	  (1	  mL).	  The	   tube	  was	  sealed	  and	  O2	  gas	  was	   injected	   into	  the	  reaction	  mixture.	  The	  reaction	  was	  stirred	  for	  2	  days.	  Product	  	  140	   	  yield:	  49	  mg	  (58%).	  	  
Entry	  10,	  Table	  1	  According	  to	  GP1:	  N-­‐(Benzyloxycarbonyl)hydroxylamine	  (68	  mg,	  0.41	  mmol),	  1,3-­‐cyclohexadiene	  (100	  mg,	  1.25	  mmol)	  and	  CuI	  (8	  mg,	  0.04	  mmol).	  The	  tube	  was	  sealed	  and	  O2	  gas	  was	  injected	  into	  the	  reaction	  mixture.	  The	  reaction	  was	  stirred	  for	  2	  days.	  Product	  	  140	  yield:	  77	  mg	  (77%).	  	  
3.2	  Copper	  salts	  and	  solvents	  screening	  
GP	  2:General	  procedure	  for	  the	  nitroso-­Diels-­Alder	  reaction	  forming	  Benzyl	  2-­oxa-­3-­
azabicyclo[2.2.2]oct-­5-­ene-­3-­carboxylate	  140	  	  1,3-­‐Cyclohexadiene	  was	  added	  to	  a	  microwave	  tube,	  which	  contained	  the	  catalyst	  (5	   mol%)	   in	   the	   solvent(s)	   (5	   mL).	   N-­‐(Benzyloxycarbonyl)hydroxylamine	   was	  added	   to	   the	   solution.	  The	   resulting	   solution	  was	   stirred	   and	  monitored	  by	  TLC.	  The	  completion	  of	  the	  reaction	  was	  confirmed	  by	  the	  disappearance	  of	  the	  starting	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material	   spot	   on	   the	   TLC.	   The	   solvent(s)	  was	   removed	   under	   reduced	   pressure.	  The	   crude	   product	   was	   purified	   by	   silica	   gel	   column	   chromatography	  (hexane/EtOAc,	  6:1	  v/v,	  as	  the	  eluent)	  to	  obtain	  the	  product	  of	  white	  solid.	  	  	  
Entry	  1,	  Table	  3	  According	  to	  GP2:	  N-­‐(Benzyloxycarbonyl)hydroxylamine	  (56	  mg,	  0.33	  mmol)	  1,3-­‐cyclohexadiene	  (134	  mg,	  1.66	  mmol)	  and	  CuI	  (3	  mg,	  0.02	  mmol)	  in	  MeOH.	  The	  reaction	  was	  stirred	  for	  4	  days.	  Product	  	  140	  	  yield:	  26	  mg	  (32%).	  	  
Entry	  2,	  Table	  3	  According	  to	  GP2:	  N-­‐(Benzyloxycarbonyl)hydroxylamine	  (57	  mg,	  0.34	  mmol)	  1,3-­‐cyclohexadiene	   (137	  mg,	   1.71	  mmol)	   and	   CuCl2	   (2	  mg,	   0.02	  mmol)	   in	  MeOH	  The	  reaction	  was	  stirred	  for	  15	  hours.	  Product	  	  140	  yield:	  40	  mg	  (47%).	  	  
Entry	  3,	  Table	  3	  According	  to	  GP2:	  N-­‐(Benzyloxycarbonyl)hydroxylamine	  (56	  mg,	  0.33	  mmol)	  1,3-­‐cyclohexadiene	  (134	  mg,	  1.66	  mmol)	  and	  CuBr2	  (4	  mg,	  0.02	  mmol)	  in	  MeOH.	  The	  reaction	  was	  stirred	  for	  15	  hours.	  Product	  	  140	  	  yield:	  33	  mg	  (40%).	  	  
Entry	  4,	  Table	  3	  According	  to	  GP2:	  N-­‐(Benzyloxycarbonyl)hydroxylamine	  (55	  mg,	  0.33	  mmol)	  1,3-­‐cyclohexadiene	   (131	   mg,	   1.64	   mmol)	   and	   Cu(OAc)2	   (3	   mg,	   0.02	   mmol)	   in	  MeOH.	  The	  reaction	  was	  stirred	  for	  5	  days.	  Product	  	  140	  yield:	  17	  mg	  (21%).	  	  
Entry	  5,	  Table	  3	  According	  to	  GP2:	  N-­‐(Benzyloxycarbonyl)hydroxylamine	  (55	  mg,	  0.33	  mmol),	  1,3-­‐cyclohexadiene	   (132	  mg,	   1.64	  mmol)	   and	   CuI	   (3	  mg,	   0.02	  mmol)	   in	   toluene.	  The	  reaction	  was	  stirred	  for	  6	  days.	  Product	  	  140	  yield:	  28	  mg	  (35%).	  	  
Entry	  6,	  Table	  3	  According	  to	  GP2:	  N-­‐(Benzyloxycarbonyl)hydroxylamine	  (54	  mg,	  0.32	  mmol),	  1,3-­‐cyclohexadiene	  (130	  mg,	  1.61	  mmol)	  and	  CuCl2	  (2	  mg,	  0.02	  mmol)	  in	  toluene.	  The	  reaction	  was	  stirred	  for	  4	  days.	  Product	  	  140	  yield:	  40	  mg	  (50%).	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Entry	  7,	  Table	  3	  According	  to	  GP2:	  N-­‐(Benzyloxycarbonyl)hydroxylamine	  (55	  mg,	  0.33	  mmol),	  1,3-­‐cyclohexadiene	  (132	  mg,	  1.64	  mmol)	  and	  CuBr2	  (4	  mg,	  0.02	  mmol)	  in	  toluene.	  The	  reaction	  was	  stirred	  for	  4	  days.	  Product	  	  140	  yield:	  36	  mg	  (44%).	  	  
Entry	  8,	  Table	  3	  According	  to	  GP2:	  N-­‐(Benzyloxycarbonyl)hydroxylamine	  (56	  mg,	  0.34	  mmol),	  1,3-­‐cyclohexadiene	   (135	   mg,	   1.68	   mmol)	   and	   Cu(OAc)2	   (3	   mg,	   0.02	   mmol)	   in	  toluene.	  The	  reaction	  was	  stirred	  for	  7	  days.	  Product	  	  140	  yield:	  19	  mg	  (23%).	  	  
Entry	  9,	  Table	  3	  According	  to	  GP2:	  N-­‐(Benzyloxycarbonyl)hydroxylamine	  (56	  mg,	  0.33	  mmol),	  1,3-­‐cyclohexadiene	  (133	  mg,	  1.66	  mmol)	  and	  CuI	  (3	  mg,	  0.02	  mmol)	  in	  MeCN.	  The	  reaction	  was	  stirred	  for	  2	  days.	  Product	  	  140	  yield:	  8	  mg	  (10%).	  	  
Entry	  10,	  Table	  3	  According	  to	  GP2:	  N-­‐(Benzyloxycarbonyl)hydroxylamine	  (57	  mg,	  0.34	  mmol),	  1,3-­‐cyclohexadiene	   (136	  mg,	   1.69	  mmol)	   and	  CuCl2	   (2	  mg,	   0.02	  mmol)	   in	  MeCN.	  The	  reaction	  was	  stirred	  for	  22	  hours.	  Product	  	  140	  yield:	  22	  mg	  (27%).	  	  
Entry	  11,	  Table	  3	  According	  to	  GP2:	  N-­‐(Benzyloxycarbonyl)hydroxylamine	  (55	  mg,	  0.33	  mmol),	  1,3-­‐cyclohexadiene	   (132	  mg,	  1.64	  mmol)	  and	  CuBr2	   (4	  mg,	  0.02	  mmol)	   in	  MeCN.	  The	  reaction	  was	  stirred	  for	  2	  days.	  Product	  	  140	  yield:	  17	  mg	  (21%).	  	  
Entry	  12,	  Table	  3	  According	  to	  GP2:	  N-­‐(Benzyloxycarbonyl)hydroxylamine	  (57	  mg,	  0.34	  mmol),	  1,3-­‐cyclohexadiene	   (136	   mg,	   1.69	   mmol)	   and	   Cu(OAc)2	   (3	   mg,	   0.02	   mmol)	   in	  MeCN.	  The	  reaction	  was	  stirred	  for	  2	  days.	  Product	  	  140	  	  yield:	  4	  mg	  (5%).	  	  
Entry	  13,	  Table	  3	  According	  to	  GP2:	  N-­‐(Benzyloxycarbonyl)hydroxylamine	  (56	  mg,	  0.34	  mmol),	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1,3-­‐cyclohexadiene	  (135	  mg,	  1.68	  mmol)	  and	  CuI	  (3	  mg,	  0.02	  mmol)	   in	  THF.	  The	  reaction	  was	  stirred	  for	  26	  hours.	  Product	  	  140	  yield:	  17	  mg	  (20%).	  	  
Entry	  14,	  Table	  3	  According	  to	  GP2:	  N-­‐(Benzyloxycarbonyl)hydroxylamine	  (55	  mg,	  0.33	  mmol),	  1,3-­‐cyclohexadiene	  (131	  mg,	  1.63	  mmol)	  and	  CuCl2	  (2	  mg,	  0.02	  mmol)	  in	  THF.	  The	  reaction	  was	  stirred	  for	  26	  hours.	  Product	  	  140	  	  yield:	  22	  mg	  (28%).	  	  
Entry	  15,	  Table	  3	  According	  to	  GP2:	  N-­‐(Benzyloxycarbonyl)hydroxylamine	  (57	  mg,	  0.34	  mmol),	  1,3-­‐cyclohexadiene	  (135	  mg,	  1.69	  mmol)	  and	  CuBr2	  (4	  mg,	  0.02	  mmol)	  in	  THF.	  The	  reaction	  was	  stirred	  for	  26	  hours.	  Product	  	  140	  yield:	  21	  mg	  (25%).	  	  
Entry	  16,	  Table	  3	  According	  to	  GP2:	  N-­‐(Benzyloxycarbonyl)hydroxylamine	  (55	  mg,	  0.33	  mmol),	  1,3-­‐cyclohexadiene	  (131	  mg,	  1.64	  mmol)	  and	  Cu(OAc)2	  (3	  mg,	  0.02	  mmol)	  in	  THF.	  The	  reaction	  was	  stirred	  for	  26	  hours.	  Product	  140	  	  yield:	  9	  mg	  (11%).	  	  	  
Entry	  17,	  Table	  3	  According	  to	  GP2:	  N-­‐(Benzyloxycarbonyl)hydroxylamine	  (57	  mg,	  0.34	  mmol),	  1,3-­‐cyclohexadiene	   (137	   mg,	   1.70	   mmol)	   and	   CuI	   (3	   mg,	   0.02	   mmol)	   in	  MeOH/toluene	   (1:4	   v/v).	   The	   reaction	   was	   stirred	   for	   20	   hours.	   Product	   140	  	  yield:	  60	  mg	  (72%).	  	  
Entry	  18,	  Table	  3	  According	  to	  GP2:	  N-­‐(Benzyloxycarbonyl)hydroxylamine	  (58	  mg,	  0.35	  mmol),	  1,3-­‐cyclohexadiene	   (139	   mg,	   1.73	   mmol)	   and	   CuCl2	   (2	   mg,	   0.02	   mmol)	   in	  MeOH/toluene	   (1:4	   v/v).	   The	   reaction	   was	   stirred	   for	   15	   hours.	   Product	   140	  	  yield:	  64	  mg	  (75%)	  	  
Entry	  19,	  Table	  3	  According	  to	  GP2:	  N-­‐(Benzyloxycarbonyl)hydroxylamine	  (59	  mg,	  0.35	  mmol),	  
	   111	  	  	  	  
1,3-­‐cyclohexadiene	   (142	   mg,	   1.77	   mmol)	   and	   CuBr2	   (4	   mg,	   0.02	   mmol)	   in	  MeOH/toluene	   (1:4	   v/v).	   The	   reaction	   was	   stirred	   for	   20	   hours.	   Product	   140	  	  yield:	  60	  mg	  (69%)	  	  
Entry	  20,	  Table	  3	  According	  to	  GP2:	  N-­‐(Benzyloxycarbonyl)hydroxylamine	  (59	  mg,	  0.35	  mmol),	  1,3-­‐cyclohexadiene	   (141	   mg,	   1.76	   mmol)	   and	   Cu(OAc)2	   (3	   mg,	   0.02	   mmol)	   in	  MeOH/toluene	  (1:4	  v/v).	  The	  reaction	  was	  stirred	   for	  4	  days.	  Product	  140	  yield:	  43	  mg	  (50%).	  	  
Entry	  21,	  Table	  3	  According	  to	  GP2:	  N-­‐(Benzyloxycarbonyl)hydroxylamine	  (57	  mg,	  0.34	  mmol),	  1,3-­‐cyclohexadiene	  (137	  mg,	  1.70	  mmol)	  and	  CuI	  (3	  mg,	  0.02	  mmol)	  in	  chloroform.	  The	  reaction	  was	  stirred	  for	  4	  days.	  Product	  140	  yield:	  	  59	  mg	  (70%).	  	  
Entry	  22,	  Table	  3	  According	  to	  GP2:	  N-­‐(Benzyloxycarbonyl)hydroxylamine	  (55	  mg,	  0.33	  mmol),	  1,3-­‐cyclohexadiene	   (132	   mg,	   1.70	   mmol)	   and	   CuCl2	   (2	   mg,	   0.02	   mmol)	   in	  chloroform.	   The	   reaction	   was	   stirred	   for	   15	   hours.	   Product	   140	   yield:	   	   62	   mg	  (77%).	  	  
Entry	  23,	  Table	  3	  According	  to	  GP2:	  N-­‐(Benzyloxycarbonyl)hydroxylamine	  (50	  mg,	  0.30	  mmol),	  1,3-­‐cyclohexadiene	  (120	  mg,	  1.50	  mmol)	  and	  CuBr2	  (3	  mg,	  	  0.02	  mmol)	  in	  chloroform.	  The	  reaction	  was	  stirred	  for	  15	  hours.	  Product	  140	  yield	  :	  	  50	  mg	  (68%).	  	  
Entry	  24,	  Table	  3	  According	  to	  GP2:	  N-­‐(Benzyloxycarbonyl)hydroxylamine	  (54	  mg,	  0.32	  mmol),	  1,3-­‐cyclohexadiene	   (129	   mg,	   1.62	   mmol)	   and	   Cu(OAc)2	   (3	   mg,	   	   0.02	   mmol)	   in	  chloroform.	  The	  reaction	  was	  stirred	  for	  5	  days.	  Product	  140	  yield:	  41	  mg	  (52%).	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3.3	  Thiourea	  oxazoline	  ligands	  screening	  
	  
Entry	  1,	  Table	  4	  	  According	  to	  GP1:	  N-­‐(Benzyloxycarbonyl)hydroxylamine	  (127	  mg,	  0.76	  mmol)	  1,3-­‐cyclohexadiene	   (305	  mg,	  3.80	  mmol)	  and	  CuCl2	   (5	  mg,	  0.04	  mmol).	  The	   reaction	  was	  stirred	  for	  2	  days.	  Product	  140	  yield:	  140	  mg	  (75%).	  	  
Entry	  2,	  Table	  4	  According	   to	   GP1:	   N-­‐(Benzyloxycarbonyl)hydroxylamine	   (120	   mg,	   0.72	   mmol),	  1,3-­‐cyclohexadiene	  (287	  mg,	  3.58	  mmol),	  CuCl2	   (5	  mg,	  0.04	  mmol)	  and	  L2up	  (15	  mg,	  0.04	  mmol).	  The	  reaction	  was	  stirred	   for	  2	  days.	  Product	  140	   yield:	  142	  mg	  (81%).	  	  
Entry	  3,	  Table	  4	  According	   to	   GP1:	   N-­‐(Benzyloxycarbonyl)hydroxylamine	   (138	   mg,	   0.83	   mmol),	  1,3-­‐cyclohexadiene	   (331	  mg,	   4.13	  mmol),	   CuCl2	   (6	  mg,	   0.04	  mmol)	   and	   L2down	  (17	  mg,	  0.04	  mmol).	  The	  reaction	  was	  stirred	   for	  2	  days.	  Product	  140	  yield:	  142	  mg	  (70%).	  	  
Entry	  4,	  Table	  4	  	  According	   to	   GP1:	   N-­‐(Benzyloxycarbonyl)hydroxylamine	   (125	   mg,	   0.75	   mmol),	  1,3-­‐cyclohexadiene	  (300	  mg,	  3.74	  mmol),	  CuCl2	  (1	  mg,	  0.007	  mmol)	  and	  L11down	  (4	  mg,	  0.007	  mmol).	  The	  reaction	  was	  stirred	   for	  2	  days.	  Product	  140	  yield:	  138	  mg	  (75%).	  	  
Entry	  5,	  Table	  4	  According	   to	   GP1:	   N-­‐(Benzyloxycarbonyl)hydroxylamine	   (110	   mg,	   0.66	   mmol),	  1,3-­‐cyclohexadiene	  (264	  mg,	  3.30	  mmol),	  CuCl2	  (4	  mg,	  0.03	  mmol)	  and	  L6	  (13	  mg,	  0.03	  mmol).	  The	  reaction	  was	  stirred	  for	  2	  days.	  Product	  140	  yield:	  125	  mg	  (77%).	  	  The	   enantiomeric	   excess	   of	   cycloadduct	   140	   was	   determined	   by	   HPLC	   using	  Chiralcel	  OD	  column,	  254	  nm	  UV	  detector,	  IPA/hexane,	  1:9	  v/v,	  produce	  peaks	  at	  retention	  times	  of	  14.09	  and	  18.05	  minutes.	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3.4	   Reaction	   of	   N-­(benzyloxycarbonyl)-­hydroxylamine	   with	   1,3-­
cyclohexadiene	  using	  different	  Cu-­ligand(s)	  catalyst 
	  
GP	  3:	  General	  procedure	  for	  the	  nitroso-­Diels-­Alder	  reaction	  forming	  benzyl	  2-­oxa-­3-­
azabicyclo[2.2.2]oct-­5-­ene-­3-­carboxylate	  140	  using	  different	  ligands	  1,3-­‐Cyclohexadiene	  was	  added	  to	  a	  microwave	  tube,	  which	  contained	  the	  CuCl2	  (10	  mol%)	   and	   ligand	   in	   the	   chloroform	   (5	   mL).	   N-­‐(Benzyloxycarbonyl)-­‐hydroxylamine	  was	  added	  to	  the	  solution.	  The	  resulting	  solution	  was	  stirred	  and	  monitored	   by	   TLC.	   The	   completion	   of	   the	   reaction	   was	   confirmed	   by	   the	  disappearance	  of	  the	  starting	  material	  spot	  on	  the	  TLC.	  The	  solvent	  was	  removed	  under	   reduced	   pressure.	   The	   crude	   product	   was	   purified	   by	   silica	   gel	   column	  chromatography	  (hexane/EtOAc,	  6:1	  v/v,	  as	  the	  eluent)	  to	  obtain	  the	  product	  as	  a	  white	  solid.	  
	  
Entry	  1,	  Table	  5	  According	   to	   GP3:	   N-­‐(Benzyloxycarbonyl)hydroxylamine	   (101	   mg,	   0.60	   mmol),	  1,3-­‐cyclohexadiene	   (242	   mg,	   3.02	   mmol)	   and	   CuCl2	   (8	   mg,	   	   0.06	   mmol).	   The	  reaction	  was	  stirred	  for	  24	  hours.	  Product	  140	  yield:	  71	  mg	  (48%).	  	  
Entry	  2,	  Table	  5	  According	   to	   GP3:	   N-­‐(Benzyloxycarbonyl)hydroxylamine	   (104	   mg,	   0.62	   mmol),	  1,3-­‐cyclohexadiene	   (249mg,	   3.10	   mmol),	   CuCl2	   (8	   mg,	   	   0.06	   mmol)	   and	  tetramethylthiourea	   (8	   mg,	   0.06	   mmol).	   The	   reaction	   was	   stirred	   for	   15	   hours.	  Product	  140	  yield:	  91	  mg	  (60%).	  	  
Entry	  3,	  Table	  5	  According	   to	   GP3:	   N-­‐(Benzyloxycarbonyl)hydroxylamine	   (102	   mg,	   0.61	   mmol),	  1,3-­‐cyclohexadiene	   (244	   mg,	   3.05	   mmol),	   CuCl2	   (8	   mg,	   	   0.06	   mmol)	   and	  tetramethylthiourea	   (16	  mg,	   0.12	  mmol).	   The	   reaction	  was	   stirred	   for	   15	   hours.	  Product	  140	  yield:	  82	  mg	  (55%).	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Entry	  4,	  Table	  5	  According	   to	   GP3:	   N-­‐(Benzyloxycarbonyl)hydroxylamine	   (103	   mg,	   0.62	   mmol),	  1,3-­‐cyclohexadiene	  (247	  mg,	  3.08	  mmol),	  CuCl2	  (8	  mg,	  0.06	  mmol)	  and	  	  2-­‐ethyl-­‐2-­‐oxazoline	  (6	  mg,	  0.06	  mmol).	  The	  reaction	  was	  stirred	  for	  15	  hours.	  Product	  140	  yield:	  80	  mg	  (53%).	  	  
Entry	  5,	  Table	  5	  According	   to	   GP3:	   N-­‐(Benzyloxycarbonyl)hydroxylamine	   (104	   mg,	   0.62	   mmol),	  1,3-­‐cyclohexadiene	  (249	  mg,	  3.10	  mmol),	  CuCl2	  (8	  mg,	  	  0.06	  mmol)	  and	  2-­‐ethyl-­‐2-­‐oxazoline	  (12	  mg,	  0.12	  mmol).	  The	  reaction	  was	  stirred	  for	  3	  hours.	  Product	  140	  yield:	  110	  mg	  (72%).	  	  
Entry	  6,	  Table	  5	  According	   to	   GP3:	   N-­‐(Benzyloxycarbonyl)hydroxylamine	   (102	   mg,	   0.61	   mmol),	  1,3-­‐cyclohexadiene	   (245	   mg,	   3.05	   mmol),	   CuCl2	   (8	   mg,	   	   0.06	   mmol),	  tetramethylthiourea	  (8	  mg,	  0.06	  mmol)	  and	  2-­‐ethyl-­‐2-­‐oxazoline	  (6	  mg,	  0.06	  mmol).	  The	  reaction	  was	  stirred	  for	  15	  hours.	  Product	  140	  yield:	  102	  mg	  (68%).	  	  
Entry	  7,	  Table	  5	  According	  to	  GP3:	  N-­‐(Benzyloxycarbonyl)hydroxylamine	  (61	  mg,	  0.37	  mmol),	  1,3-­‐cyclohexadiene	   (123	   mg,	   1.53	   mmol),	   CuCl2	   (5	   mg,	   	   0.04	   mmol),	   and	   (+)-­2,2′-­‐Isopropylidenebis[(4R)-­‐4-­‐benzyl-­‐2-­‐oxazoline]	   145	   (13	   mg,	   0.04	   mmol).	   The	  reaction	  was	  stirred	  for	  2	  hours.	  Product	  140	  yield:	  63	  mg	  (70%).	  	  	  
3.5	  The	  reaction	  of	  N-­(benzyloxycarbonyl)hydroxylamine	   	  138	  with	  various	  
dienes	  
3.5.1	  Reaction	  in	  chloroform	  
	  
GP	  4:	  General	  procedure	  for	  the	  in	  situ	  nitroso-­generation-­Diels-­Alder	  reaction	  using	  
N-­(benzyloxycarbonyl)hydroxylamine	  	  138	  with	  various	  dienes	  in	  chloroform	  	  To	  a	  CHCl3	   (5	  ml)	   solution	  of	   the	  appropriate	  diene,	  CuCl2	  and	   ligand	   (2-­‐ethyl-­‐2-­‐oxazoline)	   was	   added	   N-­‐(benzyloxycarbonyl)hydroxylamine.	   The	   resulting	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solution	  was	  stirred	  at	   room	  temperature	   in	  air	  and	  was	  monitored	  by	  TLC.	  The	  completion	   of	   the	   reaction	   was	   confirmed	   by	   the	   disappearance	   of	   the	   starting	  material.	   The	   solvent	   was	   removed	   by	   evaporation	   and	   the	   crude	   product	   was	  purified	  by	  silica	  gel	  chromatography	  (hexane:	  ethyl	  acetate,	  6:1	  v/v,	  as	  eluent).	  	  	  
Entry	  1,	  Table	  6	  1-­‐(2-­‐Oxa-­‐3-­‐azabicyclo[2.2.1]hept-­‐5-­‐en-­‐3-­‐yl)-­‐2-­‐phenylethanone	  146	  
	  According	   to	   GP4:	   Using	   N-­‐(benzyloxycarbonyl)hydroxylamine	   (135	   mg,	   0.81	  mmol),	   freshly	   cracked	   cyclopentadiene	   (64	  mg,	   0.97	  mmol),	   CuCl2	   (11	  mg,	   0.08	  mmol)	  and	  2-­‐ethyl-­‐2-­‐oxazoline	  (16	  mg,	  0.16	  mmol),	  the	  reaction	  was	  stirred	  for	  4	  h	  giving	  146	  as	  a	  white	  solid	  (185	  mg,	  99%);	  m.p.	  76-­‐78	  °C	  (lit.	  58-­‐60	  °C).	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  7.37	  –	  7.32	  (m,	  5H),	  6.36	  (t,	  J	  =	  1.9	  Hz,	  2H),	  5.24	  –	  5.21	  (m,	  1H),	  5.18	  (d,	  J	  =	  12.2	  Hz,	  1H),	  5.11	  (d,	  J	  =	  12.2	  Hz,	  1H),	  5.03	  (dd,	  J	  =	  2.2,	  1.0	  Hz,	  1H),	  1.99	  (d,	   J	  =	  8.7	  Hz,	  1H),	  1.75	  –	  1.71	  (m,	  1H);	   13C{1H}	  NMR	  (101	  MHz,	  CDCl3)	  δ	  159.30,	  135.7,	  134.5,	  133.0,	  128.5,	  128.3,	  128.1,	  83.8,	  67.8,	  65.1,	  48.2;	  FTIR	  (thin	  film)	  inter	  
alia	  1737,	   1702,	   1333,	   1269,	   1176,	   1088,	   843,	   731,	   696	   cm-­‐1;	   LRMS	   (ESI+)	  m/z	  254.2	   (M+	   +	   Na);	   HRMS	   (ESI+)	   m/z	   Calcd	   for	   C13H13NO3Na	   254.0817	   found	  254.0809.17c	  	  
Entry	  2,	  Table	  6	  1-­‐((1R,4S)-­‐2-­‐Oxa-­‐3-­‐azabicyclo[2.2.2]oct-­‐5-­‐en-­‐3-­‐yl)-­‐2-­‐phenylethanone	  140	  
	  According	   to	   GP4:	   Using	   N-­‐(benzyloxycarbonyl)hydroxylamine	   (129	   mg,	   0.77	  mmol),	  1,3-­‐cyclohexadiene	  (77	  mg,	  0.96	  mmol),	  CuCl2	  (10	  mg,	  0.08	  mmol)	  and	  2-­‐ethyl-­‐2-­‐oxazoline	  (15	  mg,	  0.15	  mmol),	  the	  reaction	  was	  stirred	  for	  3	  h,	  giving	  140	  as	  a	  white	  solid	  (163	  mg,	  86%);	  m.p.	  84-­‐86	  °C;	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  7.45	  –	  7.28	  (m,	  5H),	  6.67	  –	  6.46	  (m,	  2H),	  5.24	  –	  5.17	  (m,	  1H),	  5.13	  (d,	  J	  =	  12.3	  Hz,	  1H),	  4.82	  
	   116	  	  	  	  
(dt,	  J	  =	  7.9,	  2.8	  Hz,	  1H),	  4.76	  (ddd,	  J	  =	  5.5,	  3.8,	  1.8	  Hz,	  1H),	  2.26	  –	  2.17	  (m,	  1H),	  2.12	  (ddt,	   J	   =	   12.4,	   9.0,	   3.1	  Hz,	   1H),	   1.53	  –	  1.44	   (m,	   1H),	   1.42	   –	  1.34	   (m,	   1H);	   13C{1H}	  NMR	  (101	  MHz,	  CDCl3)	  δ	  158.1,	  136.0,	  132.0,	  131.6,	  128.5,	  128.2,	  128.1,	  71.0,	  67.7,	  50.2,	  23.5,	  20.6;	  FTIR	  (thin	  film)	  inter	  alia	  1698,	  1265,	  1049,	  744,	  696	  cm-­‐1;	  LRMS	  (ESI+)	  m/z	  268.1	   (M+	  +	  Na);	  HRMS	  (ESI+)	  m/z	  Calcd	   for	  C14H15NO3Na	  268.0950	  found	  268.0928.	  
	  
Entry	  3,	  Table	  6	  1-­‐(4,5-­‐Dimethyl-­‐3,6-­‐dihydro-­‐2H-­‐1,2-­‐oxazin-­‐2-­‐yl)-­‐2-­‐phenylethanone	  147	  
	  According	   to	   GP4:	   Using	   N-­‐(benzyloxycarbonyl)hydroxylamine	   (135	   mg,	   0.81	  mmol),	  2,3-­‐dimethyl-­‐1,3-­‐butadiene	  (80	  mg,	  0.97	  mmol),	  CuCl2	  (11	  mg,	  0.08	  mmol)	  and	  2-­‐ethyl-­‐2-­‐oxazoline	  (16	  mg,	  0.16	  mmol),	  the	  reaction	  was	  stirred	  for	  24	  h.	  The	  ratio	  of	  147	   to	  148	  was	  determined	  on	   the	   crude	  product	  by	   1H	  NMR	  using	   the	  signals	  at	  δ	  1.66	  and	  1.58	  (CH3	  signals	  for	  147)	  versus	  the	  signal	  at	  δ	  1.92	  (CH3	  for	  
148),	  and	  the	  signals	  at	  δ	  3.97	  and	  4.22	  (each	  CH2	  in	  147)	  versus	  the	  signals	  δ 4.39	  (CH2	   in	  148).	  Purification	  of	   the	  crude	  product	  gave	  147	  as	  a	  colourless	  oil	   (150	  mg,	  75%).	  The	  ratio	  of	  147:148	  =	  7:1:	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  7.40	  –	  7.32	  (m,	  5H),	  5.21	  (s,	  2H),	  4.22	  (d,	  J	  =	  1	  Hz,	  2H),	  3.97	  (dd,	  J	  =	  2,	  1	  Hz,	  2H),	  1.66	  (dd,	  J	  =	  2,	  1	  Hz,	  3H),	  1.58	  (dd,	  J	  =	  2,	  1	  Hz,	  3H);	  13C{1H}	  NMR	  (101	  MHz,	  CDCl3)	  δ	  155.5,	  136.1,	  128.5,	  128.2,	  128.1,	  123.1,	  121.8,	  71.6,	  67.6,	  48.4,	  15.2,	  13.8;	  FTIR	  (thin	  film)	  inter	  
alia	  1709	   (C=O),	   1216,	   1087,	   752,	   696	   cm-­‐1;	   LRMS	   (ESI+)	  m/z	  270.2	   (M+	  +	  Na);	  HRMS	  (ESI+)	  m/z	  Calcd	  for	  C14H17NO3Na	  270.1106	  found	  270.1107.	  	  
	  
Entry	  4,	  Table	  6	  1-­‐(3,6-­‐Dimethyl-­‐3,6-­‐dihydro-­‐2H-­‐1,2-­‐oxazin-­‐2-­‐yl)-­‐2-­‐phenylethanone	  149	  
	  	  According	   to	   GP4:	   Using	   N-­‐(benzyloxycarbonyl)hydroxylamine	   (144	   mg,	   0.86	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mmol),	  2,4-­‐hexadiene	  (69	  mg,	  1.04	  mmol),	  CuCl2	  (12	  mg,	  0.09	  mmol)	  and	  2-­‐ethyl-­‐2-­‐oxazoline	  (17	  mg,	  0.17	  mmol),	  the	  reaction	  was	  stirred	  for	  5	  h,	  giving	  149	  (177	  mg,	  83%).	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  7.42	  –	  7.28	  (m,	  5H),	  5.77	  (ddt,	  J	  =	  8.8,	  4.4,	  2.2	  Hz,	  1H),	  5.69	  –	  5.64	  (m,	  1H),	  5.28	  –	  5.23	  (m,	  1H),	  5.17	  (d,	  J	  =	  12.4	  Hz,	  1H),	  4.64	  (d,	  J	  =	  6.0	  Hz,	  1H),	  4.49	  (ddd,	  J	  =	  8.5,	  4.2,	  2.0	  Hz,	  1H),	  1.34	  –	  1.29	  (m,	  3H),	  1.27	  (d,	  J	  =	  6.7	   Hz,	   3H);	   13C{1H}	   NMR	   (101	  MHz,	   CDCl3)	   δ	   154.7,	   136.3,	   128.8,	   128.5,	   128.1,	  127.9,	   127.7,	   73.9,	   67.3,	   50.1,	   18.8,	   18.2;	   FTIR	   (thin	   film)	   inter	   alia	  1698	   (C=O),	  1202,	  1286,	  1113,	  1064,	  751,	  696	  cm-­‐1;	  LRMS	  (ESI+)	  m/z	  270.9	  (M+	  +	  Na);	  HRMS	  (ESI+)	  m/z	  Calcd	  for	  C14H17NO3Na	  270.1106	  found	  270.1086.	  	  
Entry	  5,	  Table	  6	  1-­‐(4-­‐Methyl-­‐3,6-­‐dihydro-­‐2H-­‐1,2-­‐oxazin-­‐2-­‐yl)-­‐2-­‐phenylethanone	   150	   and	   1-­‐(5-­‐methyl-­‐3,6-­‐dihydro-­‐2H-­‐1,2-­‐oxazin-­‐2-­‐yl)-­‐2-­‐phenylethanone	  150’	  
	  According	   to	   GP4:	   Using	   N-­‐(benzyloxycarbonyl)hydroxylamine	   (140	   mg,	   0.837	  mmol),	   isoprene	   (68.5	  mg,	  1.00	  mmol),	  CuCl2	   (11	  mg,	  0.08	  mmol)	  and	  2-­‐ethyl-­‐2-­‐oxazoline	  (17	  mg,	  0.17	  mmol),	  the	  reaction	  was	  stirred	  for	  24	  h.	  The	  ratio	  of	  150	  to	  
150’	  to	  151	  was	  determined	  on	  the	  crude	  product	  by	  1H	  NMR	  using	  the	  signals	  at	  δ	  1.74	  to	  1.66	  (CH3	  resonances	  in	  150	  and	  150’	  respectively)	  to	  4.70	  (CH2	  in	  151).	  Purification	   of	   the	   crude	   product	   gave	   150	   and	   150’	   as	   a	   viscous	   oil	   (143	   mg,	  73%).	  The	  ratio	  of	  150:150’	  =	  2:1	  and	  ratio	  of	  150	  and	  150’:151	  =	  9:1;	  	  
150:	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  7.43	  –	  7.32	  (m,	  5H),	  5.57	  –	  5.54(m,	  1H),	  5.24	  (s,	  2H),	  4.41	  (td,	  J	  =	  4.5,	  2.2	  Hz,	  2H),	  4.04	  (td,	  J	  =	  3.3,	  2.4	  Hz,	  2H),	  1.80	  –	  1.72	  (m,	  3H);	  13C{1H}	  NMR	   (101	  MHz,	   CDCl3)	   δ	   155.5,	   136.1,	   130.1,	   128.5,	   128.2,	   128.1,	   118.0,	  68.5,	  67.7,	  48.5,	  19.7.	  
150’:	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  7.45	  –	  7.30	  (m,	  5H),	  5.54-­‐5.52	  (m,	  1H),	  5.23	  (s,	  2H),	  4.33	  –	  4.28	  (m,	  2H),	  4.16	  –	  4.10	  (m,	  2H),	  1.70-­‐1.66	  (m,	  3H);	  13C{1H}	  NMR	  (101	  MHz,	  CDCl3)	  δ	  155.5,	  136.1,	  131.6,	  128.5,	  128.2,	  128.1,	  116.3,	  71.6,	  67.7,	  44.8,	  18.2;	  	  FTIR	  (thin	  film)	  inter	  alia	  1706	  (C=O),	  1214,	  1097,	  751,	  696	  cm-­‐1;	  LRMS	  (ESI+)	  m/z	  256.5	   (M+	   +	   Na);	   HRMS	   (ESI+)	   m/z	   Calcd	   for	   C13H15NO3Na	   256.0950	   found	  256.0959.	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Entry	  6,	  Table	  6	  1-­‐((9s,10s)-­‐9,10-­‐Dimethyl-­‐9,10-­‐dihydro-­‐9,10-­‐(epoxyimino)anthracen-­‐11-­‐yl)-­‐2-­‐phenylethanone	  152	  
	  According	   to	   GP4:	   Using	   N-­‐(benzyloxycarbonyl)hydroxylamine	   (65	   mg,	   0.39	  mmol),	  9,10-­‐dimethylanthracene	  (67	  mg,	  0.32	  mmol),	  CuCl2	  (5	  mg,	  0.04	  mmol)	  and	  2-­‐ethyl-­‐2-­‐oxazoline	   (8	  mg,	   0.08	  mmol),	   the	   reaction	  was	   stirred	   for	   24	   h,	   giving	  
152	  as	  a	  white	  solid	  (124	  mg,	  86%);	  m.p.	  133-­‐	  134	  °C	  (lit.	  132	  –	  134	  °C).17c	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  7.49	  –	  7.45	  (m,	  2H),	  7.42	  –	  7.39	  (m,	  2H),	  7.29	  –	  7.26	  (m,	  4H),	  7.26-­‐7.22	   (m	   3H),	   7.01	   –	   6.95	   (m,	   2H),	   5.00	   (s,	   2H),	   2.63	   (s,	   3H),	   2.27	   (s,	   3H);	  13C{1H}	  NMR	   (101	  MHz,	   CDCl3)	   δ	   159.6,	   141.8,	   140.5,	   136.2,	   128.2,	   127.6,	   127.2,	  127.2,	   127.0,	   121.5,	   120.7,	   79.1,	   67.1,	   64.0,	   16.5,	   15.0;	   FTIR	   (thin	   film)	   inter	   alia	  1698,	  1278,	  1258,	  752,	  696	  cm-­‐1;	  LRMS	  (ESI+)	  m/z	  394.1	  (M+	  +	  Na);	  HRMS	  (ESI+)	  m/z	  Calcd	  for	  C24H21NO3Na	  394.1419	  found	  394.1425.	  	  
Entry	  7,	  Table	  6	  1-­‐(3,6-­‐Diphenyl-­‐3,6-­‐dihydro-­‐2H-­‐1,2-­‐oxazin-­‐2-­‐yl)-­‐2-­‐phenylethanone	  153	  
	  According	   to	   GP4:	   Using	   N-­‐(benzyloxycarbonyl)hydroxylamine	   (128	   mg,	   0.77	  mmol),	   1,4-­‐diphenyl-­‐1,3-­‐butadiene	   (132	   mg,	   0.64	   mmol),	   CuCl2	   (10	   mg,	   0.08	  mmol)	  and	  2-­‐ethyl-­‐2-­‐oxazoline	  (15	  mg,	  0.15	  mmol),	  the	  reaction	  was	  stirred	  for	  24	  h,	  giving	  153	  	  as	  a	  colourless	  oil	  (211	  mg,	  74%);	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  7.55	  –	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7.32	  (m,	  15H),	  6.18	  –	  6.13	  (m,	  1H),	  6.11	  –	  6.06	  (m,	  1H),	  5.66	  (s,	  1H),	  5.61	  (s,	  1H),	  5.32	  (d,	  J	  =	  12.4	  Hz,	  1H),	  5.18	  (d,	  J	  =	  12.4	  Hz,	  1H);	  13C{1H}	  NMR	  (101	  MHz,	  CDCl3)	  δ	  154.8,	   138.7,	   137.0,	   136.2,	   129.0,	   128.7,	   128.6,	   128.5,	   128.2,	   128.1,	   128.0,	   128.0,	  127.9,	  127.7,	  126.0,	  79.7,	  67.6,	  57.1;	  FTIR	  (thin	  film)	   inter	  alia	  1698	  (C=O),	  1272,	  1091,	  750,	  720,	  695;	  LRMS	  (ESI+)	  m/z	  394.2	  (M+	  +	  Na);	  HRMS	  (ESI+)	  m/z	  Calcd	  for	  C24H21NO3Na	  394.1419	  found	  394.1416.	  	  	  
3.5.2	  Reaction	  in	  methanol	  
GP5:	  General	  procedure	  for	  the	  in	  situ	  nitroso-­generation-­Diels-­Alder	  reaction	  using	  
N-­(benzyloxycarbonyl)hydroxylamine	  138	  with	  various	  dienes	  in	  methanol	  To	  a	  MeOH	  (5	  ml)	  solution	  of	  the	  appropriate	  diene,	  10	  mol%	  CuCl2	  and	  20	  mol%	  2-­‐ethyl-­‐2-­‐oxazoline	   was	   added	   N-­(benzyloxycarbonyl)hydroxylamine.	   The	  resulting	   solution	  was	   stirred	  at	   room	   temperature	   in	  air	   and	  was	  monitored	  by	  TLC.	   The	   completion	   of	   the	   reaction	  was	   confirmed	   by	   the	   disappearance	   of	   the	  starting	  material.	  The	  solvent	  was	  removed	  by	  evaporation	  and	  the	  crude	  product	  was	   purified	   by	   silica	   gel	   chromatography	   (hexane:	   ethyl	   acetate,	   6:1	   v/v,	   as	  eluent).	  	  	  
Entry	  1,	  Table	  7	  According	  to	  GP5:	  N-­‐(Benzyloxycarbonyl)hydroxylamine	  (132	  mg,	  0.79	  mmol),	  1.2	  equivalent	  of	  cyclopentadiene	  (63	  mg,	  0.95	  mmol),	  CuCl2	  (11	  mg,	  0.08	  mmol)	  and	  	  2-­‐ethyl-­‐2-­‐oxazoline	   (16	   mg,	   0.16	   mmol).	   The	   reaction	   was	   stirred	   for	   3	   hours.	  Product	  146	  yield:	  177	  mg	  (97%).	  	  
Entry	  2,	  Table	  7	  According	  to	  GP5:	  N-­‐(Benzyloxycarbonyl)hydroxylamine	  (137mg,	  0.82	  mmol),	  1.2	  equivalent	   of	   1,3-­‐cyclohexadiene	   (79	  mg,	   0.99	  mmol),	   CuCl2	   (11	  mg,	   0.08	  mmol)	  and	  	  2-­‐ethyl-­‐2-­‐oxazoline	  (16	  mg,	  0.16	  mmol).	  The	  reaction	  was	  stirred	  for	  3	  hours.	  Product	  140	  yield:	  185	  mg	  (92%).	  	  
Entry	  3,	  Table	  7	  According	  to	  GP5:	  N-­‐(Benzyloxycarbonyl)hydroxylamine	  (129	  mg,	  0.77	  mmol),	  1.2	  equivalent	  of	  2,3-­‐dimethyl-­‐1,3-­‐butadiene	  (76	  mg,	  0.93	  mmol),	  CuCl2	  (10	  mg,	  0.08	  
	   120	  	  	  	  
mmol)	  and	  	  2-­‐ethyl-­‐2-­‐oxazoline	  (15	  mg,	  0.15	  mmol).	  The	  reaction	  was	  stirred	  for	  2	  hours.	  The	  ratio	  of	  147:148	  =	  5:1.	  Total	  product	  yield:	  158	  mg	  (83%).	  	  
Entry	  4,	  Table	  7	  According	  to	  GP5:	  N-­‐(Benzyloxycarbonyl)hydroxylamine	  (134	  mg,	  0.80	  mmol),	  1.2	  equivalent	  of	  2,4-­‐hexadiene	  (79	  mg,	  0.96	  mmol),	  CuCl2	  (11	  mg,	  0.08	  mmol)	  and	  	  2-­‐ethyl-­‐2-­‐oxazoline	   (16	   mg,	   0.16	   mmol).	   The	   reaction	   was	   stirred	   for	   2	   hours.	  Product	  149	  yield:	  192	  mg	  (97%).	  	  
Entry	  5,	  Table	  7	  According	  to	  GP5:	  N-­‐(Benzyloxycarbonyl)hydroxylamine	  (140	  mg,	  0.84	  mmol),	  1.2	  equivalent	  of	  isoprene	  (69	  mg,	  1.00	  mmol),	  CuCl2	  (11	  	  mg,	  0.08	  mmol)	  and	  	  2-­‐ethyl-­‐2-­‐oxazoline	  (17	  mg,	  0.17	  mmol).	  The	  reaction	  was	  stirred	  for	  8	  hours.	  The	  ratio	  of	  cycloadduct	  150,	  150’	   to	   ene	  151	  was	   8.5:1	   and	   the	   ratio	   of	  150:150’	  was	   2:1.	  Total	  product	  yield:	  155	  mg	  (79%).	  	  
Entry	  6,	  Table	  7	  According	   to	   GP5:	   N-­‐(Benzyloxycarbonyl)hydroxylamine	   (55	   mg,	   0.33	   mmol),	  9,10-­‐dimethyl	   anthracene	   (57	  mg,	   0.28	  mmol),	   CuCl2	   (4	  mg,	   0.03	  mmol)	   and	   	   2-­‐ethyl-­‐2-­‐oxazoline	   (7	   mg,	   0.07	   mmol).	   The	   reaction	   was	   stirred	   for	   10	   hours.	  Product	  152	  yield:	  90	  mg	  (88%).	  	  
Entry	  7,	  Table	  7	  According	   to	   GP5:	   N-­‐(Benzyloxycarbonyl)hydroxylamine	   (104	   mg,	   0.62	   mmol),	  1,4-­‐diphenyl-­‐1,3-­‐butadiene(107	  mg,	  0.52	  mmol),	  CuCl2	  (8	  mg,	  0.06	  mmol)	  and	  	  2-­‐ethyl-­‐2-­‐oxazoline	   (12	   mg,	   0.12	   mmol).	   The	   reaction	   was	   stirred	   for	   18	   hours.	  Product	  153	  yield:	  152	  mg	  (79%).	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3.6	  Solvent	  effect	  of	  the	  nitroso-­Diels-­Alder	  versus	  ene	  reaction	  	  GP6:	  General	  procedure	  for	  the	  nitroso-­Diels-­Alder	  reaction	  forming	  benzyl	  2-­oxa-­3-­
azabicyclo[2.2.2]oct-­5-­ene-­3-­carboxylate	  146	  in	  various	  solvent	  
N-­‐(Benzyloxycarbonyl)hydroxylamine	   dissolved	   in	   solvent	   (10	   mL)	   was	   added	  dropwise	   to	   a	   solution	   of	   2,3-­‐dimethyl-­‐1,3-­‐butadiene	   (2	   equivalents),	   10%	  CuCl2	  and	   20%	   2-­‐ethyl-­‐2-­‐oxazoline	   in	   	   20	   mL	   of	   solvent	   at	   room	   temperature.	   The	  reaction	   mixture	   was	   stirred	   and	   monitored	   by	   TLC.	   The	   solvent	   was	   removed	  under	  vacuum.	  The	  crude	  product	  was	  purified	  by	  silica	  gel	  chromatography	  (6:1	  v/v,	  hexane/EtOAc)	  to	  obtain	  the	  product.	  	  
Entry	  1,	  Table	  8	  MeOH	  as	  a	  solvent	  According	  to	  GP6:	  N-­‐(Benzyloxycarbonyl)hydroxylamine(101	  mg,	  0.60	  mmol),	  2,3-­‐dimethyl-­‐1,3-­‐butadiene	  (96	  mg,	  1.20	  mmol),	  CuCl2	  (8	  mg,	  0.06	  mmol)	  and	  	  2-­‐ethyl-­‐2-­‐oxazoline	   (12	   mg,	   0.12	   mmol)	   the	   reaction	   was	   stirred	   for	   	   2	   h.	   The	   ratio	   of	  
147:148	  =	  5:1.	  Total	  product	  yield:	  	  125	  mg	  (84%).	  	  
Entry	  2,	  Table	  8	  	  MTBE	  as	  a	  solvent	  According	   to	   GP6:	   N-­‐(Benzyloxycarbonyl)hydroxylamine	   (103	   mg,	   0.62	   mmol),	  2,3-­‐dimethyl-­‐1,3-­‐butadiene	   (98	  mg,	  1.23	  mmol),	  CuCl2	   (8	  mg,	  0.06	  mmol)	  and	   	  2-­‐ethyl-­‐2-­‐oxazoline	  (12	  mg,	  0.12	  mmol)	  the	  reaction	  was	  stirred	  for	  20	  h.	  The	  ratio	  of	  147:148	  =	  15:1.	  Total	  product	  yield:	  130	  mg	  (85%).	  	  
Entry	  3,	  Table	  8	  	  MeCN	  as	  a	  solvent	  According	   to	   GP6:	   N-­‐(Benzyloxycarbonyl)hydroxylamine	   (108	   mg,	   0.65	   mmol),	  2,3-­‐dimethyl-­‐1,3-­‐butadiene	  (104	  mg,	  1.30	  mmol),	  CuCl2	  (9	  mg,	  0.07	  mmol)	  and	  	  2-­‐ethyl-­‐2-­‐oxazoline	  (13	  mg,	  0.13	  mmol)	  the	  reaction	  was	  stirred	  for	  144	  h.	  The	  ratio	  of	  147:148	  =	  25:1.	  Total	  product	  yield:	  128	  mg	  (80%).	  	  
Entry	  4,	  Table	  8	  EtOH	  as	  a	  solvent	  According	   to	   GP6:	   N-­‐(Benzyloxycarbonyl)hydroxylamine	   (105	   mg,	   0.63	   mmol),	  2,3-­‐dimethyl-­‐1,3-­‐butadiene	  (101	  mg,	  1.26	  mmol),	  CuCl2	  (9	  mg,	  0.06	  mmol)	  and	  	  2-­‐ethyl-­‐2-­‐oxazoline	  (13	  mg,	  0.13	  mmol)	  the	  reaction	  was	  stirred	  for	  7	  h.	  The	  ratio	  of	  
147:148	  =	  4:1.	  Total	  product	  yield:	  130	  mg	  (83%).	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Entry	  5,	  Table	  8	  EtOAc	  as	  a	  solvent	  According	   to	   GP6:	   N-­‐(Benzyloxycarbonyl)hydroxylamine	   (117	   mg,	   0.70	   mmol),	  2,3-­‐dimethyl-­‐1,3-­‐butadiene	  (112	  mg,	  1.40	  mmol),	  CuCl2	  (9	  mg,	  0.07	  mmol)	  and	  	  2-­‐ethyl-­‐2-­‐oxazoline	  (14	  mg,	  0.14	  mmol)	  the	  reaction	  was	  stirred	  for	  7	  h.	  The	  ratio	  of	  
147:148	  =	  4:1.	  Total	  product	  yield:	  	  141	  mg	  (81%).	  	  
Entry	  6,	  Table	  8	  	  IPA	  as	  a	  solvent	  According	   to	   GP6:	   N-­‐(Benzyloxycarbonyl)hydroxylamine	   (102	   mg,	   0.61	   mmol),	  2,3-­‐dimethyl-­‐1,3-­‐butadiene	   (98	  mg,	  1.22	  mmol),	  CuCl2	   (8	  mg,	  0.06	  mmol)	  and	   	  2-­‐ethyl-­‐2-­‐oxazoline	  (12	  mg,	  0.12	  mmol)	  the	  reaction	  was	  stirred	  for	  48	  h.	  The	  ratio	  of	  147:148	  =	  13:1.	  Total	  product	  yield:	  135	  mg	  (89%).	  	  
Entry	  7,	  Table	  8	  	  2Methyl-­‐THF	  as	  a	  solvent	  According	   to	   GP6:	   N-­‐(Benzyloxycarbonyl)hydroxylamine	   (107	   mg,	   0.64	   mmol),	  2,3-­‐dimethyl-­‐1,3-­‐butadiene	  (103	  mg,	  1.28	  mmol),	  CuCl2	  (9	  mg,	  0.06	  mmol)	  and	  	  2-­‐ethyl-­‐2-­‐oxazoline	  (13	  mg,	  0.13	  mmol)	  the	  reaction	  was	  stirred	  for	  20	  h.	  The	  ratio	  of	  147:148	  =	  12:1.	  Total	  product	  yield:	  	  140	  mg	  (88%).	  	  
Entry	  8,	  Table	  8	  	  Toluene	  as	  a	  solvent	  According	   to	   GP6:	   N-­‐(Benzyloxycarbonyl)hydroxylamine	   (107	   mg,	   0.64	   mmol),	  2,3-­‐dimethyl-­‐1,3-­‐butadiene	  (102	  mg,	  1.28	  mmol),	  CuCl2	  (9	  mg,	  0.06	  mmol)	  and	  	  2-­‐ethyl-­‐2-­‐oxazoline	  (13	  mg,	  0.13	  mmol)	  the	  reaction	  was	  stirred	  for	  4	  h.	  The	  ratio	  of	  
147:148	  =	  12:1.	  Total	  product	  yield:	  	  129	  mg	  (82%).	  	  
Entry	  9,	  Table	  8	  4:1	  Toluene/MeOH	  as	  a	  solvent	  According	   to	   GP6:	   N-­‐(Benzyloxycarbonyl)hydroxylamine	   (113	   mg,	   0.68	   mmol),	  2,3-­‐dimethyl-­‐1,3-­‐butadiene	  (108	  mg,	  1.35	  mmol),	  CuCl2	  (9	  mg,	  0.07	  mmol)	  and	  	  2-­‐ethyl-­‐2-­‐oxazoline	  (13	  mg,	  0.14	  mmol)	  the	  reaction	  was	  stirred	  for	  3	  h.	  The	  ratio	  of	  
147:148	  =	  5:1.	  Total	  product	  yield:	  	  137	  mg	  (82%).	  
	  
Entry	  10,	  Table	  8	  Chloroform	  as	  a	  solvent	  According	   to	   GP6:	   N-­‐(Benzyloxycarbonyl)hydroxylamine	   (116	   mg,	   0.69	   mmol),	  2,3-­‐dimethyl-­‐1,3-­‐butadiene	  (111	  mg,	  1.38	  mmol),	  CuCl2	  (9	  mg,	  0.07	  mmol)	  and	  	  2-­‐
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ethyl-­‐2-­‐oxazoline	  (14	  mg,	  0.14	  mmol)	  the	  reaction	  was	  stirred	  for	  3	  h.	  The	  ratio	  of	  
147:148	  =	  7:1.	  Total	  product	  yield:	  121	  mg	  (82%).	  	  
3.7	  Chiral	  oxazoline	  ligand	  screening	  
GP7	  :	  General	  procedure	  for	  10%	  CuCl2	  and	  chiral	  ligand	  catalytic	  system	  To	   a	   methanol	   (5	   ml)	   solution	   of	   the	   1,3-­‐cyclohexadiene,	   10%	   CuCl2	   and	   10%	  ligand	   was	   added	   hydroxamic	   acid.	   The	   resulting	   solution	   was	   stirred	   at	   room	  temperature	  in	  air	  and	  was	  monitored	  by	  TLC.	  The	  completion	  of	  the	  reaction	  was	  confirmed	  by	  the	  disappearance	  of	  the	  starting	  material.	  The	  solvent	  was	  removed	  by	  evaporation	  and	   the	  crude	  product	  was	  purified	  by	  silica	  gel	   chromatography	  (hexane:	  ethyl	  acetate,	  6:1	  v/v,	  as	  eluent).	  	  	  	  
Entry	  1,	  Table	  9	  According	  to	  GP7:	  N-­‐(Benzyloxycarbonyl)hydroxylamine	  (55	  mg,	  0.33	  mmol),	  1,3-­‐cyclohexadiene	  (48	  mg,	  0.60	  mmol),	  CuCl2	  (4	  mg,	  0.03	  mmol)	  and	  2,2′-­‐bis[(4S)-­‐4-­‐benzyl-­‐2-­‐oxazoline]	   157	   (12	   mg,	   0.03	   mmol).	   The	   reaction	   was	   completed	   in	   2	  hours	  to	  yield	  the	  product 140 as	  a	  white	  solid	  (74	  mg,	  98%).	  	  
Entry	  2,	  Table	  9	  According	  to	  GP7:	  N-­‐(Benzyloxycarbonyl)hydroxylamine	  (57	  mg,	  0.34	  mmol),	  1,3-­‐cyclohexadiene	   (54	   mg,	   0.68	   mmol),	   CuCl2	   (4	   mg,	   0.03	   mmol)	   and	   (+)-­‐2,2′-­‐isopropylidenebis[(4R)-­‐4-­‐benzyl-­‐2-­‐oxazoline]	   145	   (11	   mg,	   0.03	   mmol).	   The	  reaction	  was	  completed	   in	  2	  hours	   to	  yield	   the	  product 140	  as	  a	  white	  solid	   (77	  mg,	  99%).	  	  
Entry	  3,	  Table	  9	  According	  to	  GP7:	  N-­‐(Benzyloxycarbonyl)hydroxylamine	  (50	  mg,	  0.30	  mmol),	  1,3-­‐cyclohexadiene	  (48	  mg,	  0.60	  mmol),	  CuCl2	  (4	  mg,	  0.03	  mmol)	  and	  2,6-­‐bis[(4S)-­‐(−)-­‐isopropyl-­‐2-­‐oxazolin-­‐2-­‐yl]pyridine	   158	   (9	   mg,	   0.03	   mmol).	   The	   reaction	   was	  completed	  in	  2	  hours	  to	  yield	  the	  product	  140	  as	  a	  white	  solid	  (66	  mg,	  96%).	  The	  enantiomeric	  excess	  of	  cycloadduct	  140	  was	  determined	  by	  HPLC	  using	  Chiralcel	  OD	  column,	  254	  nm	  UV	  detector,	  IPA:hexane,	  1:9	  v/v,	  produced	  peaks	  at	  retention	  time	  14.09	  and	  18.05	  minutes.	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3.8	  Hydroxamic	  acids	  synthesis	  	  GP8:	  General	  procedure	  of	  hydroxamic	  acid	  synthesis:	  	  Four	   equivalents	   of	   sodium	   hydroxide	  were	   dissolved	   in	  water	   followed	   by	   two	  equivalents	   of	   hydroxylamine	   hydrochloride.	   Then	   this	   solution	   was	   added	  dropwise	  to	   the	  appropriate	  ester	   in	  methanol.	  The	  reaction	  was	  stirred	  at	  room	  temperature	   for	  4	  hours	   and	  monitored	  by	  TLC.	  When	   the	   reaction	   finished,	   the	  solution	  was	  acidified	  with	  5%	  HCl	  to	  pH	  5.5.	  The	  solvent	  was	  removed	  in	  vacuum	  to	   yield	   a	   mixture	   of	   product	   and	   sodium	   chloride,	   which	   then	   redissolved	   in	  methanol.	   The	   sodium	   chloride	   was	   removed	   by	   filtration.	   The	   methanol	   was	  removed	   in	  vacuum	  to	  give	  the	  corresponding	  product,	  which	  then	  recrystallised	  from	  hot	  water	  to	  give	  the	  pure	  product.	  	  
2-­Pyridinehydroxamic	  acid	  161	  	  
	  According	   to	  GP8:	   Ethyl-­‐2-­‐picolinate	   (5.00	   g,	   33	   mmol)	   in	   100	  ml	   of	   methanol,	  sodium	  hydroxide	   (5.29	   g,	   132	  mmol),	   hydroxylamine	   hydrochloride	   (4.60	   g,	   66	  mmol)	  in	  100	  ml	  of	  water.	  The	  product	  161	  was	  isolated	  as	  a	  white	  solid	  (3.00	  g,	  66%);	  m.p.	  119	  –	  120	  C;	  1H	  NMR	  (400	  MHz,	  DMSO-­‐d6)	  δ	  11.46	  (s,	  1H),	  9.24	  (s,	  1H),	  8.63	  (dt,	  J	  =	  4.8,	  1.3	  Hz,	  1H),	  8.04	  –	  7.97	  (m,	  2H),	  7.64	  –	  7.57	  (m,	  1H);	  13C{1H}	  NMR	  (101	  MHz,	  DMSO-­‐d6)	  δ	  162.2,	   151.0,	   149.4,	   138.5,	   127.2,	   122.7.;	   FTIR	   (thin	   film)	  
inter	  alia	  	  3264	  (broad),	  2778	  (broad),	  1662	  (C=O),	  1592,	  1570,	  1516,	  1475,	  1177,	  1030,	   816;	   LRMS	   (ESI-­‐)	   m/z	   161.4	   (M+	   Na);	   HRMS	   (ESI+)	   m/z	   Calcd	   for	  C6H6N2O2Na	  161.0327	  found	  161.0323.	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3-­Pyridinehydroxamic	  acid	  162	  
	  According	   to	   GP8:	   Ethyl	   nicotinate	   (5.00	   g,	   33	   mmol)	   in	   100	   ml	   of	   methanol,	  sodium	  hydroxide	   (5.29	   g,	   132	  mmol),	   hydroxylamine	   hydrochloride	   (4.60	   g,	   66	  mmol)	  in	  100	  ml	  of	  water.	  The	  product	  162	  was	  isolated	  as	  a	  white	  solid	  (2.70	  g,	  59%):	  m.p.	  160	  –	  161	  C;	  1H	  NMR	  (400	  MHz,	  DMSO-­‐d6)	  δ	  11.37	  (s,	  1H),	  9.59	  –	  8.99	  (m,	  1H),	  8.89	  (dt,	   J	  =	  20.8,	  10.4	  Hz,	  1H),	  8.74	  –	  8.61	  (m,	  1H),	  8.18	  –	  8.00	  (m,	  1H),	  7.49	   (ddd,	   J	   =	   7.9,	   4.8,	   0.8	   Hz,	   1H);	   13C{1H}	   NMR	   (101	   MHz,	   DMSO-­‐d6)	   δ	   162.9,	  152.3,	   148.3,	   135.1,	   128.9,	   124.0;	   FTIR	   (thin	   film)	   inter	   alia	   1634	   (C=O),	   1594,	  1495,	  1472,	  1422,	  1305,	  1024,	  700;	  LRMS	  (ESI-­‐)	  m/z	  137.1	  (M+	  -­‐H);	  HRMS	  (ESI-­‐)	  m/z	  Calcd	  for	  C6H5N2O2	  137.0351	  found	  137.0332.	  	  
N-­Hydroxy-­2-­(pyridin-­2-­yl)acetamide	  163	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2-­Amino-­N-­hydroxybenzamide	  164	  
	  According	   to	   GP8:	   Methyl	   2-­‐aminobenzoate	   (10.00	   g,	   66.2	   mmol)	   in	   200	   ml	   of	  methanol,	   sodium	  hydroxide	   (10.60	   g,	   265	  mmol),	   hydroxylamine	  hydrochloride	  (9.20	   g,	   132	  mmol)	   in	   200	  ml	   of	  water.	   The	   product	  164	  was	   isolated	   as	   a	   pale	  yellow	  solid	  (6.10	  g,	  60%):	  m.p.	  143-­‐145	  °C;	  1H	  NMR	  (400	  MHz,	  DMSO-­‐d6)	  δ	  10.91	  (s,	  1H),	  8.89	  (s,	  1H),	  7.30	  (dd,	   J	  =	  13.1,	  6.5	  Hz,	  1H),	  7.12	  (ddd,	  J	  =	  8.5,	  7.2,	  1.5	  Hz,	  1H),	  6.69	  (dd,	   J	  =	  8.2,	  1.0	  Hz,	  1H),	  6.51	  –	  6.44	  (m,	  1H),	  6.22	  (s,	  2H);	  13C{1H}	  NMR	  (101	  MHz,	  DMSO-­‐d6)	  δ	  166.8,	  149.2,	  131.5,	  127.5,	  116.2,	  114.7,	  113.2;	  FTIR	  (thin	  film)	  inter	  alia	  3163,	  2950,	  2856,	  1618,	  1560,	  1493,	  1449,	  1348,	  1249,	  1021,	  741,	  671;	   LRMS	   (ESI+)	  m/z	  175.1	   (M+	   +Na);	  HRMS	   (ESI+)	  m/z	  Calcd	   for	   C7H8N2O2Na	  175.0483	  	  found	  175.0473.	  
	  
N-­Hydroxybenzamide	  165	  
	  According	   to	  GP8:	   Methylbenzoate	   (5.30	   g,	   38.9	   mmol)	   in	   100	   ml	   of	   methanol,	  sodium	  hydroxide	  (6.23	  g,	  156	  mmol),	  hydroxylamine	  hydrochloride	  (5.41	  g,	  77.9	  mmol)	   in	  100	  ml	  of	  water.	  The	  product	  165	  was	   isolated	  as	  a	  white	  solid	   (3.4	  g,	  64%);	  m.p.	  121	  –	  123	  C;	  1H	  NMR	  (400	  MHz,	  DMSO-­‐d6)	  δ	  11.22	  (s,	  1H),	  9.05	  (s,	  1H),	  7.82	  –	  7.68	  (m,	  2H),	  7.54	  –	  7.48	  (m,	  1H),	  7.48	  –	  7.36	  (m,	  2H);	   13C{1H}	  NMR	  (101	  MHz,	  DMSO-­‐d6)	  δ	  164.7,	  133.3,	  131.6,	  128.8,	  127.3;	  FTIR	  (thin	  film)	  inter	  alia	  3292,	  3062,	   2746,	   1644,	   1602,	   1557,	   1490,	   1316,	   1163,	   1022,	   897,	   787,	   689;	   LRMS	  (ESI+)	  m/z	  138.2	   (M+	  +H);	  HRMS	   (ESI+)	  m/z	  Calcd	   for	  C7H8NO2	  138.0555	   found	  138.055.	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N-­Hydroxy-­2-­phenylacetamide	  166	  
	  According	  to	  GP8:	  Methylphenylacetate	  (10.2	  g,	  67.9	  mmol)	  in	  200	  ml	  of	  methanol,	  sodium	  hydroxide	   (10.9	   g,	   272	  mmol),	   hydroxylamine	   hydrochloride	   (9.4	   g,	   135	  mmol)	  in	  	  200	  ml	  of	  water.	  The	  product	  166	  was	  isolated	  as	  an	  off-­‐white	  solid	  (5.6	  g,	   54%);	  m.p.	   139–142C;	   1H	  NMR	   (400	  MHz,	  DMSO-­‐d6)	   δ	   10.67	   (s,	   1H),	   8.84	   (s,	  1H),	  7.32	  –	  7.19	  (m,	  5H),	  3.28	  (s,	  2H);	  13C{1H}	  NMR	  (101	  MHz,	  DMSO-­‐d6)	  δ	  167.0,	  136.1,	  128.9,	  128.1,	  126.4,	  39.4;	  FTIR	  (thin	  film)	  inter	  alia	  3186,	  3002,	  2902,	  1631	  (C=O),	  1548,	  1495,	  1455,	  1054,	  978,	  715;	  LRMS	  (ESI-­‐)	  m/z	  150.2	  (M+	   -­‐H);	  HRMS	  (ESI+)	  m/z	  Calcd	  for	  C8H8NO2	  150.0555	  found	  150.0555.	  	  
N-­Hydroxy-­3-­phenylpropanamide	  167	  
	  According	  to	  GP8:	  Ethylhydrocinnamate	  (9.4	  g,	  52.7	  mmol)	  in	  200	  ml	  of	  methanol,	  sodium	   hydroxide	   (8.4	   g,	   210	   mmol),	   hydroxylamine	   hydrochloride	   (7.3	   g,	   105	  mmol)	   in	  200	  ml	  of	  water.	  The	  product	  167	  was	   isolated	  as	  a	  white	  solid	   (4.9	  g,	  56%);	  m.p.	  75	  –	  77	  C;	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  9.20	  (s,	  2H),	  7.25	  –	  7.20	  (m,	  2H),	  7.18	  –	  7.10	  (m,	  3H),	  2.87	  (t,	  J	  =	  8	  Hz,	  2H),	  2.38	  (t,	  J	  =	  8	  Hz,	  2H);	  13C{1H}	  NMR	  (101	  MHz,	  CDCl3)	  δ	  171.1,	  140.2,	  128.6,	  128.3,	  126.4,	  34.6,	  31.3;	  FTIR	  (thin	   film)	   inter	  
alia	  3296,	  3062,	  2782,	  1662	  (C=O),	  1626,	  1557,	  1496,	  1455,	  1062,	  995,	  695;	  LRMS	  (ESI+)	   m/z	   188.2	   (M+	   +Na);	   HRMS	   (ESI+)	   m/z	   Calcd	   for	   C9H11NO2Na	   188.0687	  found	  188.0689.	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N-­Hydroxy-­4-­phenylbutanamide	  168	  
	  4-­‐Phenylbutyric	  acid	  (7.4	  g,	  45.1	  mmol),	  NMM	  (5.0	  g,	  50.5	  mmol),	  DMAP	  (0.06	  g,	  0.05	  mmol)	  and	  hydroxylamine	  hydrochloride	  (3.5	  g,	  50.5	  mmol)	  were	  dissolved	  in	   150	   ml	   of	   DCM	   in	   250	   ml	   round	   bottom	   flask.	   The	   mixture	   was	   stirred	   and	  cooled	  to	  0	  C.	  Then	  cyanuric	  chloride	  (2.5	  g,	  15.0	  mmol)	  was	  added	  to	  the	  solution	  and	  the	  mixture	  was	  warmed	  to	  room	  temperature.	  The	  reaction	  was	  stirred	  for	  24	  hours.	  After	  completion,	  the	  solution	  was	  filtered	  through	  Celite,	  then	  washed	  with	  45	  ml	  of	  1	  M	  HCl	  (3X).	  The	  organic	  layer	  was	  separated	  and	  dried	  over	  MgSO4.	  The	  solvent	  was	  evaporated	  in	  vacuum	  to	  yield	  a	  white	  solid	  product,	  which	  was	  then	  purified	   by	   siliga	   gel	   column	   chromatography	   (EtOAc	   as	   eluent)	   to	   give	   product	  	  	  
168	  (2.00	  g,	  25%);	  m.p.	  71	  –	  74	   C;	  1H	  NMR	  (400	  MHz,	  DMSO-­‐d6)	  δ	  10.36	  (s,	  1H),	  8.71	  (s,	  1H),	  7.28	  –	  7.23	  (m,	  2H),	  7.18	  –	  7.14	  (m,	  3H),	  2.54	  (t,	  J	  =	  8.0	  Hz,	  2H),	  1.95	  (t,	  
J	   =	   8.0	  Hz,	   2H),	   1.82	   –	   1.71	   (m,	   2H);	   13C{1H}	  NMR	   (101	  MHz,	  DMSO-­‐d6)	   δ	   168.8,	  141.6,	  128.3,	  128.3,	  125.7,	  34.6,	  31.8,	  27.0;	  FTIR	  (thin	  film)	   inter	  alia	  3170,	  3024,	  2908,	   1622	   (C=O),	   1542,	   1495,	   1459,	   1065,	   1016,	   742,	   694;	   LRMS	   (ESI+)	   m/z	  202.2	   (M+	   +Na);	   HRMS	   (ESI+)	   m/z	   Calcd	   for	   C10H13NO2Na	   202.0844	   found	  202.0849.	  	  
N-­Hydroxy-­5-­phenylpentanamide	  169	  
	  Hydrogen	   chloride	   gas	   generated	   from	   dropping	   36%	   HCl	   into	   98%	   H2SO4	   was	  bubbled	   into	   a	   solution	   of	   5-­‐phenylvaleric	   acid	   (5.0	   g,	   28.1	  mmol)	   in	   150	  ml	   of	  methanol	  at	  room	  temperature	  for	  15	  minutes.	  Then	  sodium	  hydroxide	  (4.5	  g,	  112	  mmol),	  hydroxylamine	  hydrochloride	   (3.9	  g,	  56.2	  mmol)	   in	  100	  ml	  of	  water	  was	  added	  dropwise	   to	   the	   solution.	   The	   reaction	  was	   stirred	   for	   24	   hours	   and	   then	  acidified	  to	  pH	  5.5	  using	  10%	  HCl.	  The	  solvents	  were	  removed	  under	  vacuum.	  The	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residue	   was	   redissolved	   in	   methanol	   and	   the	   sodium	   chloride	   was	   removed	   by	  filtration.	  The	  solvent	  then	  removed	  to	  yield	  a	  yellow	  oil,	  which	  was	  recrystalised	  from	  ether	   to	  yield	  a	  white	   solid	  product	  169	   (3.60	  g,	  67%);	  m.p.	  68	  –	  71	   C;	   1H	  NMR	  (400	  MHz,	  DMSO-­‐d6)	  δ	  10.32	  (s,	  1H),	  8.67	  (s,	  1H),	  7.27	  (t,	  J	  =	  7.5	  Hz,	  2H),	  7.20	  –	  7.14	  (m,	  3H)	  2.56	  (t,	  J	  =	  6.7	  Hz,	  2H),	  1.97	  (t,	  J	  =	  6.8	  Hz,	  2H),	  1.63	  –	  1.39	  (m,	  4H);	  13C{1H}	  NMR	  (101	  MHz,	  DMSO-­‐d6)	  δ	  169.0,	  142.0,	  128.2,	  128.2,	  125.6,	  34.8,	  32.1,	  30.5,	  24.8;	  FTIR	  (thin	   film)	   inter	  alia	  3186,	  3038,	  2910,	  1618	  (C=O),	  1434,	  1085,	  992,	  962,	  749,	  698;	  LRMS	  (ESI+)	  m/z	  216.2	  (M+	  +Na);	  HRMS	  (ESI+)	  m/z	  Calcd	  for	  C11H15NO2Na	  216.1000	  found	  216.1007.	  	  
	  
Phenyl	  hydroxycarbamate	  170	  
	  A	   solution	   of	   phenyl	   chloroformate	   (5.32	   g,	   34.0	   mmol)	   in	   ether	   was	   added	  dropwise	  in	  30	  minutes	  to	  a	  stirred	  solution	  of	  hydroxylamide	  hydrochloride	  (2.36	  g,	  34.0	  mmol)	  and	  potassium	  cabonate	  (5.17	  g,	  37.4	  mmol)	  in	  30	  ml	  of	  ether	  and	  5	  ml	   of	   water	   at	   5	   C.	   After	   the	   addition,	   the	   reaction	   was	   stirred	   at	   room	  temperature	  for	  4	  hours.	  The	  organic	   layer	  was	  separated	  and	  dried	  over	  MgSO4.	  The	   solvent	  was	  evaporated	   in	   vacuo	   to	  yield	  a	  white	   solid	  product	  170	   (3.10	  g,	  59%);	  m.p.	  98	  –	  101	  C;	  1H	  NMR	  (400	  MHz,	  DMSO-­‐d6)	  δ	  10.33	  (s,	  1H),	  9.08	  (s,	  1H),	  7.42	  –	  7.36	   (m,	  2H),	  7.25	  –	  7.19	   (m,	  1H),	  7.13	  –	  7.07	   (m,	  2H),	   13C{1H}	  NMR	  (101	  MHz,	  DMSO-­‐d6)	  δ	  155.5,	  150.7,	  129.4,	  125.1,	  121.5;	  FTIR	  (thin	  film)	  inter	  alia	  3299,	  1687	  (C=O),	  1511,	  1492,	  1284,	  1201,	  1105,	  795,	  687;	  LRMS	  (ESI+)	  m/z	  176.1	  (M+	  +Na);	  HRMS	  (ESI+)	  m/z	  Calcd	  for	  C7H7NO3Na	  176.0324	  found	  176.0333.	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1-­Hydroxy-­3-­phenylurea	  171	  
	  A	   solution	   of	   phenylisocyanate	   (4.00	   g,	   33.6	  mmol)	   in	   10	  ml	   of	  DCM	  was	   added	  dropwise	  over	  30	  minutes	  to	  a	  solution	  of	  sodium	  hydroxide	  (1.34	  g,	  33.6	  mmol)	  and	  hydroxylamine	  hydrochloride	  (2.33	  g,	  33.6	  mmol)	  in	  5	  ml	  of	  water	  and	  60	  ml	  of	   DCM	   at	   0	   C.	   After	   the	   addition,	   the	   reaction	   was	   warmed	   up	   to	   the	   room	  temperature	   and	   stirred	   for	   3	   hours	   to	   yield	   a	   white	   solid.	   The	   reaction	   was	  washed	   by	   20	   ml	   of	   water	   and	   20	   ml	   of	   DCM.	   The	   precipitate	   was	   filtered	   out	  recrystalised	  in	  ethyl	  acetate	  to	  give	  the	  product	  171	  as	  a	  white	  solid	  (2.53	  g,	  50	  %);	  m.p.	  148	  –	  150	   C;	   1H	  NMR	  (400	  MHz,	  DMSO-­‐d6)	  δ	  8.96	  (s,	  1H),	  8.81	  (s,	  1H),	  8.75	  (s,	  1H),	  7.59	  (d,	  J	  =	  8.5	  Hz,	  2H),	  7.23	  (t,	  J	  =	  7.9	  Hz,	  2H),	  6.95	  (t,	  J	  =	  7.3	  Hz,	  1H);	  13C{1H}	  NMR	  (101	  MHz,	  DMSO-­‐d6)	  δ	  159.0,	  139.8,	  128.9,	  122.6,	  119.6;	  FTIR	  (thin	  film)	   inter	  alia	  3221,	  2951,	  2894,	  1630,	  1595,	  1537,	  1501,	  1449,	  1074,	  755,	  688	  cm-­‐1;	  LRMS	   (ESI+)	  m/z	  175.1	   (M+	  +Na);	  HRMS	   (ESI+)	  m/z	  Calcd	   for	  C7H8N2O2Na	  175.0483	  found	  175.0483.	  	  
(S)-­1-­Hydroxy-­3-­(1-­phenylethyl)urea	  172	  	  
	  and	  	  	  	  	  	   	  A	  solution	  of	  (S)-­‐(1-­‐isocyanatoethyl)benzene	  (1.00	  g,	  6.79	  mmol)	  in	  10	  ml	  of	  DCM	  was	  added	  dropwise	  over	  30	  minutes	   to	  a	   solution	  of	   sodium	  hydroxide	   (0.27	  g,	  6.79	  mmol)	  and	  hydroxylamine	  hydrochloride	  (0.47	  g,	  6.79	  mmol)	  in	  1	  ml	  of	  water	  and	  20	  ml	  of	  DCM	  at	  0	   C.	  After	   the	  addition,	   the	  reaction	  was	  warmed	  up	  to	   the	  room	  temperature	  and	  stirred	  for	  3	  hours.	  The	  reaction	  was	  washed	  by	  20	  ml	  of	  water	  and	  20	  ml	  of	  DCM.	  The	  organic	  phase	  was	  separated	  and	  dry	  over	  MgSO4.	  The	  removal	  of	  solvent	  give	  a	  colourless	  oil	  which	  then	  was	  separated	  by	  column	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chromatography	   (ethyl	   acetate	   as	   eluent)	   to	   yield	   0.60	   g	   (49%)	   of	   product	  172;	  m.p.	  106-­‐108	  °C	  ;	  1H	  NMR	  (400	  MHz,	  DMSO-­‐d6)	  δ	  8.67	  (d,	  J	  =	  0.8	  Hz,	  1H),	  8.40	  (s,	  1H),	  7.42	  –	  7.34	  (m,	  4H),	  7.30	  –	  7.24	  (m,	  1H),	  7.00	  (d,	  J	  =	  8.7	  Hz,	  1H),	  4.94-­‐	  4.86	  (m,	  1H),	   1.45	   (d,	   J	   =	   7.1	   Hz,	   3H);	   13C{1H}	   NMR	   (101	  MHz,	   DMSO-­‐d6)	   δ	   161.0,	   145.8,	  128.6,	  126.9,	  126.5,	  48.6,	  23.1;	  FTIR	  (thin	  film)	  inter	  alia	  3311,	  2931,	  1649	  (C=O),	  1514,	  766,	  698	  cm-­‐1;	  LRMS	  (ESI+)	  m/z	  203.5	  (M+	  +Na);	  HRMS	  (ESI+)	  m/z	  Calcd	  for	  C9H12N2O2Na	  203.0796	  found	  203.0796	  and	  orange	  oil	  side	  product	  (0.31	  g)	  which	  is	   1-­‐[{[(1S)-­‐1-­‐phenylethyl]carbamoyl})amino]-­‐N-­‐[(1R)-­‐1-­‐phenylethyl]formamide	  
172s;	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  9.30	  (s,	  1H),	  7.32	  –	  7.08	  (m,	  12H),	  4.87	  (s,	  2H),	  1.45	   (s,	   6H);	   13C{1H}	  NMR	   (101	  MHz,	   CDCl3)	   δ	   153.1,	   142.0,	   127.7,	   126.4,	   124.9,	  49.2,	  21.7;	  FTIR	  (thin	   film)	   inter	  alia	  3270,	  3029,	  2971,	  1691	  (C=O),	  1658	  (C=O),	  1491,	  1209,	  696	  cm-­‐1;	  LRMS	  (ESI+)	  m/z	  350.7	  (M+	  +Na);	  HRMS	  (ESI+)	  m/z	  Calcd	  for	  C18H21N3O3Na	  350.	  1481	  found	  350.1472.	  	  
3.9	  Acyl	  cycloaducts	  synthesis	  using	  sodium	  periodate	  
	  
GP9:	  General	  procedure	  of	  acyl	  cycloaducts	  using	  sodium	  periodate	  Hydroxamic	  acid	  dissolved	  in	  methanol	  (10	  mL)	  was	  added	  dropwise	  to	  a	  solution	  of	  diene,	  sodium	  periodate	  in	  methanol	  (20	  mL)	  at	  room	  temperature.	  The	  reaction	  mixture	   was	   stirred	   for	   4	   hours	   and	   monitored	   by	   TLC.	   Then	   the	   solvent	   was	  removed	   under	   vacuum.	   The	   crude	   product	   was	   purified	   by	   silica	   gel	  chromatography	  (6:1	  v/v,	  hexane/EtOAc)	  to	  obtain	  the	  product.	  
3.9.1	  Reaction	  of	  hydroxamic	  acids	  with	  1,3-­cyclohexadiene	  
Entry	   1,	   Table	   10:	   2-­‐Oxa-­‐3-­‐azabicyclo[2.2.2]oct-­‐5-­‐en-­‐3-­‐yl(pyridin-­‐2-­‐yl)	  methanone	  	  173	  
	  According	   to	   GP9:	   2-­‐Pyridinehydroxamic	   acid	   (0.27	   g,	   2.0	   mmol),1,3-­‐cyclohexadiene	   (0.31	   mg,	   3.9	   mmol),	   sodium	   periodate	   (0.42	   g,	   2.0	   mmol)	   The	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reaction	  mixture	  was	  stirred	  for	  4	  hours	   	   to	  give	  a	  white	  solid	  product	  173	   (177	  mg,	  42%);	  m.p.	  	  110	  –	  112	  C;	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  8.77	  –	  8.50	  (m,	  1H),	  8.00	  –	  7.57	  (m,	  2H),	  7.49	  –	  7.29	  (m,	  1H),	  6.89	  –	  6.41	  (m,	  2H),	  5.66	  –	  5.37	  (m,	  1H),	  5.06	  –	  4.67	   (s,	   1H),	   2.50	   –	   2.18	   (m,	   2H),	   1.67	   –	   1.40	   (m,	   2H);	   13C{1H}	   NMR	   (101	  MHz,	  CDCl3)	   δ	   162.1,	   152.4,	   148.1,	   137.1,	   132.0,	   131.1,	   125.2,	   124.8,	   71.8,	   51.6,	   23.4,	  22.0;	  FTIR	  (thin	  film)	   inter	  alia	  2933,	  1632	  (C=O),	  1566,	  954,	  748,	  710,	  668	  cm-­‐1;	  LRMS	   (ESI+)	   m/z	   239.5	   (M+	   +Na);	   HRMS	   (ESI+)	   m/z	   Calcd	   for	   C12H12N2O2Na	  239.0796	  found	  239.0814.	  	  
Entry	  2,	  Table	  10:	  2-­‐Oxa-­‐3azabicyclo[2.2.2]oct-­‐5-­‐en-­‐3-­‐yl(pyridin-­‐3-­‐yl)methanone	  
174	  
	  According	   to	   GP9:	   3-­‐Pyridinehydroxamic	   acid	   (143	   mg,	   1.03	   mmol),	   1,3-­‐cyclohexadiene	  (166	  mg,	  2.06	  mmol),	  sodium	  periodate	  (221	  mg,	  1.03	  mmol).	  The	  reaction	  mixture	  was	  stirred	  for	  4	  hours.	  The	  product	  174	  was	  obtained	  as	  an	  off-­‐white	  solid	  (69	  mg,	  31	  %);	  m.p.	  105	  –	  107	  C;	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  8.92	  (s,	  1H),	  8.64	  (d,	  J	  =	  3.4	  Hz,	  1H),	  7.99	  (s,	  1H),	  7.30	  (dd,	  J	  =	  14.7,	  7.8	  Hz,	  1H),	  6.73	  (s,	  1H),	  6.54	  (s,	  1H),	  5.43	  (s,	  1H),	  4.78	  (s,	  1H),	  2.37	  –	  2.17	  (m,	  2H),	  1.56	  (p,	  J	  =	  11.2	  Hz,	  2H);	  13C{1H}	  NMR	   (101	  MHz,	   CDCl3)	   δ	   166.1,	   151.4,	   150.1,	   136.5,	   133.3,	   131.7,	   129.9,	  122.7,	   72.3,	   47.1,	   23.5,	   20.9;	   FTIR	   (thin	   film)	   inter	   alia	   1639	   (C=O),	   1586,	   1387,	  924,	  882,	  824,	  735,	  699	  cm-­‐1;	  LRMS	  (ESI+)	  m/z	  217.1	  (M+	  +H);	  HRMS	  (ESI+)	  m/z	  Calcd	  for	  C12H13N2O2	  217.0977	  found	  217.0993.	  	  
Entry	   5,	   Table	   10:	   2-­‐Oxa-­‐3-­‐azabicyclo[2.2.2]oct-­‐5-­‐en-­‐3-­‐yl(phenyl)metha-­‐none	  
177	  
	  According	  to	  GP9:	  N-­‐Hydroxybenzamide	  (594	  mg,	  4.33	  mmol),	  1,3-­‐cyclohexadiene	  (694	   mg,	   8.66	   mmol),	   sodium	   periodate	   (927	   mg,	   4.33	   mmol).	   The	   reaction	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mixture	  was	   stirred	   for	   4	   hours.	   The	   product	  177	  was	   obtained	   as	   an	   off-­‐white	  solid	  (317	  mg,	  53%);	  m.p.	  111	  –	  114	   C;	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  7.64	  (s,	  2H),	  7.46	  –	  7.33	  (m,	  3H),	  6.66	  (br,	  1H),	  6.54	  (s,	  1H),	  5.38	  (br,	  1H),	  4.79	  (s,	  1H),	  2.36	  –	  2.18	  (m,	  2H),	  1.58	  –	  1.45	  (m,	  2H);	  13C{1H}	  NMR	  (101	  MHz,	  CDCl3)	  δ	  168.9,	  134.4,	  132.8,	  131.8,	  130.7,	  128.5,	  128.0,	  71.9,	  47.4,	  23.5,	  21.2;	  FTIR	  (thin	  film)	   inter	  alia	  1638	  (C=O),	  929,	  881,	  788,	  726,	  703	  cm-­‐1;	  LRMS	  (ESI+)	  m/z	  216.2	  (M+	  +	  H);	  HRMS	  (ESI+)	  m/z	  Calcd	  for	  C13H14NO2	  216.1025	  found	  216.1037.	  	  
Entry	   6,	   Table	   10:	   2-­‐Oxa-­‐3-­‐azabicyclo[2.2.2]oct-­‐5-­‐en-­‐3-­‐yl)-­‐2-­‐phenyl-­‐ethanone	  
178	  
	  According	   to	   GP9:	   N-­‐Hydroxy-­‐2-­‐phenylacetamide	   (290	   mg,	   1.92	   mmol),	   1,3-­‐cyclohexadiene	  (307	  mg,	  3.84	  	  mmol),	  sodium	  periodate	  (410	  mg,	  1.92	  mmol).	  The	  reaction	  mixture	  was	  stirred	  for	  4	  hours.	  The	  product	  178	  was	  obtained	  as	  an	  off-­‐white	  solid	  (275	  mg,	  48	  %);	  m.p.	  74	  -­‐76	  C;	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  7.37	  –	  7.19	  (m,	  5H),	  6.66	  –	  6.56	  (m,	  1H),	  6.50	  –	  6.42	  (m,	  1H),	  5.33	  –	  5.22	  (m,	  1H),	  4.80	  –	  4.70	  (m,	  1H),	  3.70	  –	  3.57	  (m,	  2H),	  2.17	  –	  1.99	  (m,	  2H),	  1.50	  –	  1.39	  (m,	  2H);	  13C{1H}	  NMR	  (101	  MHz,	  CDCl3)	  δ	  170.5,	  134.8,	  132.9,	  131.3,	  129.5,	  128.2,	  126.5,	  71.9,	  46.6,	  40.1,	  23.4,	  21.0;	  FTIR	  (thin	  film)	  inter	  alia	  1640	  (C=O),	  1412,	  1086,	  955,	  900,	  828,	  734,	  698	  cm-­‐1;	  LRMS	  (ESI+)	  m/z	  252.3	  (M+	  +	  Na);	  HRMS	  (ESI+)	  m/z	  Calcd	  for	  C14H15NO2	  Na	  252.1000	  	  found	  252.1010.	  	  
Entry	  7,	  Table	  10:	  2-­‐Oxa-­‐3-­‐azabicyclo[2.2.2]oct-­‐5-­‐en-­‐3-­‐yl)-­‐3-­‐phenylpropan-­‐1-­‐one	  
179	  
	  According	   to	   GP9:	   N-­‐Hydroxy-­‐3-­‐phenylpropanamide	   (171	   mg,	   1.03	   mmol),	   1,3-­‐cyclohexadiene	  (166	  mg,	  2.06	  mmol),	  sodium	  periodate	  (221	  mg,	  1.03	  mmol).	  The	  reaction	   mixture	   was	   stirred	   for	   4	   hours.	   The	   product	   179	   was	   obtained	   as	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colourless	  oil	   (123	  mg,	  49	  %);	   1H	  NMR	   (400	  MHz,	  CDCl3)	   δ	  7.30	  –	  7.26	   (m,	  2H),	  7.24	  –	  7.18	  (m,	  3H),	  6.69	  –	  6.59	  (m,	  1H),	  6.53	  –	  6.48	  (m,	  1H),	  5.30	  (s,	  1H),	  4.74	  (s,	  1H),	  2.91	  (t,	  J	  =	  8.0	  Hz,	  2H),	  2.70	  –	  2.62	  (m,	  1H),	  2.59	  –	  2.51	  (m,	  1H),	  2.19	  –	  2.12	  (m,	  1H),	   2.12	   –	   2.05	   (m,	   1H),	   1.52	   –	   1.45	   (m,	   2H);	   13C{1H}	  NMR	   (101	  MHz,	   CDCl3)	   δ	  171.1,	   140.4,	   132.0,	   130.3,	   127.4,	   127.3,	   124.9,	   70.8,	   45.4,	   33.9,	   29.3,	   22.5,	   20.1;	  FTIR	  (thin	  film)	  inter	  alia	  1644	  (C=O),	  1453,	  1166,	  954,	  902,	  748,	  699	  cm-­‐1;	  LRMS	  (ESI+)	  m/z	  266.3	  (M+	  +	  Na);	  HRMS	  (ESI+)	  m/z	  Calcd	   for	  C15H17NO2	  Na	  266.1157	  found	  266.1169.	  	  
Entry	   8,	   Table	   10:	   2-­‐Oxa-­‐3-­‐azabicyclo[2.2.2]oct-­‐5-­‐en-­‐3-­‐yl)-­‐4-­‐phenylbutan-­‐1-­‐one	  
180	  
	  According	   to	   GP9:	   N-­‐Hydroxy-­‐4-­‐phenylbutanamide	   (153	   mg,	   0.85	   mmol),	   1,3-­‐cyclohexadiene	  (137	  mg,	  1.70	  mmol),	  sodium	  periodate	  (183	  mg,	  0.85	  mmol).	  The	  reaction	   mixture	   was	   stirred	   for	   4	   hours.	   The	   product	   180	   was	   obtained	   as	  colourless	  oil	  (70	  mg,	  32	  %);	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  7.24	  –	  7.16	  (m,	  2H),	  7.14	  –	  7.06	  (m,	  3H),	  6.55	  (t,	  J	  =	  6.6	  Hz,	  1H),	  6.42	  (t,	  J	  =	  6.6	  Hz,	  1H),	  5.20	  (s,	  1H),	  4.66	  (s,	  1H),	  2.60	  –	  2.51	  (m,	  2H),	  2.31	  –	  2.17	  (m,	  2H),	  2.13	  –	  1.94	  (m,	  2H),	  1.88	  –	  1.77	  (m,	  2H),	   1.47	   –	   1.35	   (m,	   2H);	   13C{1H}	   NMR	   (101	  MHz,	   CDCl3)	   δ	   171.9,	   141.0,	   132.1,	  130.2,	  127.5,	  127.3,	  124.8,	  70.8,	  45.4,	  34.4,	  31.7,	  24.8,	  22.6,	  20.1;	  FTIR	  (thin	  film)	  
inter	  alia	  1644	  (C=O),	  1453,	  955,	  902,	  833,	  746,	  699	  cm-­‐1;	  LRMS	  (ESI+)	  m/z	  280.3	  (M+	  +	  Na);	  HRMS	  (ESI+)	  m/z	  Calcd	  for	  C16H19NO2	  Na	  280.1313	  found	  280.1314.	  	  
Entry	  9,	  Table	  10:	  2-­‐Oxa-­‐3-­‐azabicyclo[2.2.2]oct-­‐5-­‐en-­‐3-­‐yl)-­‐5-­‐phenylpentan	  -­‐1-­‐one	  
181	  
	  According	   to	   GP9:	   N-­‐Hydroxy-­‐5-­‐phenylpentanamide	   (225	   mg,	   1.16	   mmol),	   1,3-­‐cyclohexadiene	  (187	  mg,	  2.32	  mmol),	  sodium	  periodate	  (249	  mg,	  1.16	  mmol).	  The	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reaction	   mixture	   was	   stirred	   for	   4	   hours.	   The	   product	   181	   was	   obtained	   as	  colourless	  oil	   (120	  mg,	  38	  %);	   1H	  NMR	   (400	  MHz,	  CDCl3)	   δ	  7.30	  –	  7.26	   (m,	  2H),	  7.21	  –	  7.17	  (m,	  3H),	  6.63	  (t,	  J	  =	  6.7	  Hz,	  1H),	  6.52	  –	  6.47	  (m,	  1H),	  5.29	  (s,	  1H),	  4.75	  (s,	  1H),	  2.63	  (t,	  J	  =	  7.2	  Hz,	  2H),	  2.39	  –	  2.27	  (m,	  2H),	  2.23	  –	  2.16	  (m,	  1H),	  2.12	  –	  2.07	  (m,	  1H),	   1.68	   –	   1.60	   (m,	   4H),	   1.53	   –	   1.47	   (m,	   2H);	   13C{1H}	  NMR	   (101	  MHz,	   CDCl3)	   δ	  173.2,	   142.5,	   133.1,	   131.2,	   128.4,	   128.2,	   125.6,	   71.7,	   46.4,	   35.7,	   33.0,	   31.1,	   23.9,	  23.6,	  21.1;	  FTIR	  (thin	  film)	  inter	  alia	  1648	  (C=O),	  1452,	  1166,	  956,	  901,	  834,	  746,	  698	  cm-­‐1;	  LRMS	  (ESI+)	  m/z	  294.3	  (M+	  +	  Na);	  HRMS	  (ESI+)	  m/z	  Calcd	  for	  C17H21NO2	  Na	  294.1470	  found	  294.1468.	  	  
Entry	  10,	  Table	  10:	  Phenyl-­‐2-­‐oxa-­‐3-­‐azabicyclo[2.2.2]oct-­‐5-­‐ene-­‐3-­‐carboxylate	  182	  
	  According	   to	   GP9:	   Phenyl	   hydroxycarbamate	   (128	   mg,	   0.83	   mmol),	   1,3-­‐cyclohexadiene	  (134	  mg,	  1.68	  mmol),	  sodium	  periodate	  (179	  mg,	  0.83	  mmol).	  The	  reaction	  mixture	  was	  stirred	  for	  2	  hours.	  The	  product	  182	  was	  obtained	  as	  a	  white	  solid	  (99	  mg,	  51	  %);	  m.p.	  127	  –	  129	  C;	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  7.37	  –	  7.28	  (m,	  2H),	  7.21	  –	  7.15	  (m,	  1H),	  7.14	  –	  7.06	  (m,	  2H),	  6.73	  –	  6.64	  (m,	  1H),	  6.63	  –	  6.57	  (m,	  1H),	  4.99	  –	  4.90	  (m,	  1H),	  4.88	  –	  4.80	  (m,	  1H),	  2.31	  –	  2.17	  (m,	  2H),	  1.59	  –	  1.52	  (m,	  1H),	   1.48	   –	   1.40	   (m,	   1H);	   13C{1H}	   NMR	   (101	  MHz,	   CDCl3)	   δ	   155.9,	   150.9,	   132.0,	  131.8,	   129.3,	   125.6,	   121.5,	   71.4,	   50.3,	   23.4,	   20.7;	   FTIR	   (thin	   film)	   inter	  alia	   1716	  (C=O),	  1389,	  1196,	  1067,	  994,	  750,	  691	  cm-­‐1;	  LRMS	  (ESI+)	  m/z	  254.2	  (M+	  +	  Na);	  HRMS	  (ESI+)	  m/z	  Calcd	  for	  C13H13NO3Na	  254.0793	  found	  254.0800.	  	  
Entry	   11,	   Table	   10:	  N-­‐Phenyl-­‐2-­‐oxa-­‐3-­‐azabicyclo[2.2.2]oct-­‐5-­‐ene-­‐3-­‐carboxamide	  
183	  
	  According	   to	   GP9:	   1-­‐Hydroxy-­‐3-­‐phenylurea	   (131	   mg,	   0.86	   mmol),	   1,3-­‐cyclohexadiene	  (138	  mg,	  1.72	  mmol),	  sodium	  periodate	  (184	  mg,	  0.86	  mmol).	  The	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reaction	  mixture	  was	  stirred	  for	  2	  hours.	  The	  product	  183	  was	  obtained	  as	  a	  white	  solid	   (97	  mg,	  49%);	  m.p.	  102	  –	  104	   C;	   1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  7.63	  (s,	  1H),	  7.44	  (dd,	  J	  =	  8.6,	  1.0	  Hz,	  2H),	  7.28	  (dd,	  J	  =	  10.9,	  5.4	  Hz,	  2H),	  7.10	  –	  7.01	  (m,	  1H),	  6.62	  –	  6.56	  (m,	  1H),	  6.55	  –	  6.47	  (m,	  1H),	  5.06	  –	  4.98	  (m,	  1H),	  4.83	  –	  4.75	  (m,	  1H),	  2.25	  –	  2.13	   (m,	   2H),	   1.61	   –	   1.53	   (m,	   1H),	   1.43	   –	   1.36	   (m,	   1H);	   13C{1H}	  NMR	   (101	  MHz,	  CDCl3)	  δ	  159.3,	  137.7,	  132.7,	  130.4,	  128.9,	  123.5,	  119.3,	  71.2,	  50.0,	  23.9,	  20.0;	  FTIR	  (thin	   film)	   inter	   alia	   1667	   (C=O),	   1594,	   1531,	   1445,	   1228,	   907,	   767,	   701	   cm-­‐1;	  LRMS	   (ESI+)	   m/z	   253.2	   (M+	   +	   Na);	   HRMS	   (ESI+)	   m/z	   Calcd	   for	   C13H14N2O2Na	  253.0953	  found	  253.0958.	  
	  
Entry	   12,	   Table	   10:	  N-­‐((R)-­‐1-­‐Phenylethyl)-­‐2-­‐oxa-­‐3-­‐azabicyclo[2.2.2]oct-­‐5-­‐ene-­‐3-­‐carboxamide	  184	  
	  According	  to	  GP9:	  (S)-­‐1-­‐Hydroxy-­‐3-­‐(1-­‐phenylethyl)urea	  (125	  mg,	  0.70	  mmol),	  1,3-­‐cyclohexadiene	  (112	  mg,	  1.39	  mmol),	  sodium	  periodate	  (149	  mg,	  0.70	  mmol).	  The	  reaction	  mixture	  was	  stirred	  for	  2	  hours.	  The	  product	  184	  was	  obtained	  as	  a	  white	  solid	   (76	  mg,	  42%);	  m.p.	  92	   -­‐	  94	   C;	   1H	  NMR	  (700	  MHz,	  CDCl3)	  δ	  7.33	  –	  7.22	  (m,	  3H),	  7.22	  –	  7.17	  (m,	  2H),	  6.54	  –	  6.40	  (m,	  2H),	  5.99	  (dd,	  J	  =	  22.7,	  7.1	  Hz,	  1H),	  4.96	  –	  4.84	  (m,	  2H),	  4.64	  (d,	  J	  =	  2.1	  Hz,	  1H),	  2.16	  –	  2.03	  (m,	  2H),	  1.52	  –	  1.45	  (m,	  1H),	  1.41	  (dd,	   J	   =	   12.6,	   6.9	  Hz,	   3H),	   1.34	   –	  1.28	   (m,	   1H);	   13C{1H}	  NMR	   (176	  MHz,	   CDCl3)	   δ	  161.5,	   161.4,	   143.7,	   143.5,	   132.2,	   132.1,	   130.2,	   130.2,	   128.5,	   128.4,	   127.1,	   127.0,	  126.0,	  125.9,	  70.5,	  50.3,	  50.1,	  49.1,	  49.1,	  23.9,	  23.9,	  22.4,	  22.3,	  20.1,	  20.0.	  FTIR	  (thin	  film)	  inter	  alia;	  1651,	  1515,	  1494,	  1230,	  906,	  766,	  699,	  667	  cm-­‐1;	  LRMS	  (ESI+)	  m/z	  281.2	   (M+	   +	   Na);	   HRMS	   (ESI+)	   m/z	   Calcd	   for	   C15H18N2O2Na	   281.1266found	  281.1268.	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3.9.2	  Reaction	  of	  hydroxamic	  acids	  with	  2,3-­dimethyl-­1,3-­butadiene	  
Entry	   1,	   Table	   11:	   (4,5-­‐Dimethyl-­‐3,6-­‐dihydro-­‐2H-­‐1,2-­‐oxazin-­‐2-­‐yl)(pyridin-­‐2-­‐yl)methanone	  185	  
	  	  According	  to	  GP9:	  2-­‐Pyridinehydroxamic	  acid	  (109	  mg,	  0.79	  mmol),	  2,3-­‐dimethyl-­‐1,3-­‐butadiene	   (130	  mg,	   1.58	  mmol),	   sodium	   periodate	   (169	   g,	   0.79	  mmol).	   The	  reaction	  mixture	  was	  stirred	  for	  4	  hours.	  The	  product	  185	  was	  obtained	  as	  an	  off-­‐white	  solid	  (36	  mg,	  21%);	  m.p.	  85-­‐87	   C;	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  8.63	  (d,	   J	  =	  4.5	  Hz,	  1H),	  7.78	  (td,	  J	  =	  7.8,	  1.4	  Hz,	  1H),	  7.61	  (s,	  1H),	  7.38	  –	  7.33	  (m,	  1H),	  4.24	  (s,	  4H),	  1.70	  (s,	  3H),	  1.60	  (d,	  J	  =	  0.8	  Hz,	  3H);	  13C{1H}	  NMR	  (101	  MHz,	  CDCl3)	  δ	  153.0,	  148.8,	  136.5,	  124.8,	  123.1,	  121.3,	  73.2,	  45.5,	  15.3,	  13.8;	  FTIR	  (thin	  film)	  inter	  alia;	  1638,	   1447,	   1415,	   1228,	   1191,	   1024,	   993,	   806,	   748,	   690	   cm-­‐1;	   LRMS	   (ESI+)	  m/z	  219.3	  (M+	  +	  H+);	  HRMS	  (ESI+)	  m/z	  Calcd	  for	  C12H15N2O2	  219.1134	  found	  219.1150.	  
	  
Entry	   2,	   Table	   11:	   (4,5-­‐Dimethyl-­‐3,6-­‐dihydro-­‐2H-­‐1,2-­‐oxazin-­‐2-­‐yl)(pyridin-­‐3-­‐yl)methanone	  186	  
	  According	  to	  GP9:	  3-­‐Pyridinehydroxamic	  acid	  (152	  mg,	  1.10	  mmol),	  2,3-­‐dimethyl-­‐1,3-­‐butadiene	   (181	  mg,	   2.20	  mmol),	   sodium	   periodate	   (235	   g,	   1.10	  mmol).	   The	  reaction	  mixture	  was	  stirred	  for	  2	  hours.	  The	  product	  186	  was	  obtained	  as	  an	  off-­‐white	  solid	  (43	  mg,	  18%);	  m.p.	  89-­‐91	   C;	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  8.96	  (d,	   J	  =	  1.5	  Hz,	  1H),	  8.68	  (dd,	  J	  =	  4.9,	  1.7	  Hz,	  1H),	  8.03	  (dt,	  J	  =	  7.9,	  1.9	  Hz,	  1H),	  7.36	  (ddd,	  J	  =	  7.9,	  4.9,	  0.9	  Hz,	  1H),	  4.20	  (s,	  2H),	  4.13	  (s,	  2H),	  1.73	  (d,	  J	  =	  0.8	  Hz,	  3H),	  1.59	  (dd,	  J	  =	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1.8,	  0.9	  Hz,	  3H);	  13C{1H}	  NMR	  (101	  MHz,	  CDCl3)	  δ	  166.9,	  151.5,	  149.6,	  136.4,	  129.5,	  123.0,	  122.5,	  121.7,	  73.0,	  46.1,	  15.4,	  13.7;	  FTIR	  (thin	   film)	   inter	  alia;	  1640,	  1415,	  1230,	  1021,	  826,	  729,	  697	  cm-­‐1;	  LRMS	  (ESI+)	  m/z	  241.1	  (M+	  +	  Na);	  HRMS	  (ESI+)	  m/z	  Calcd	  for	  C12H14N2O2Na	  	  241.0953	  found	  241.0964.	  
	  
Entry	  5,	  Table	  11:	  (4,5-­‐Dimethyl-­‐3,6-­‐dihydro-­‐2H-­‐1,2-­‐oxazin-­‐2-­‐yl)(phenyl)	  metha-­‐none	  	  189	  
	  According	   to	  GP9:	  N-­‐hydroxybenzamide	   (152	  mg,	   1.14	  mmol),	   2,3-­‐dimethyl-­‐1,3-­‐butadiene	   (186	   mg,	   2.28	   mmol),	   sodium	   periodate	   (243	   mg,	   1.14	   mmol).	   The	  product	  189	  was	  obtained	  as	  a	  white	  solid	  (113	  mg,	  46	  %);	  m.p.	  62	  -­‐	  64	  C;	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  7.72	  –	  7.65	  (m,	  2H),	  7.49	  –	  7.44	  (m,	  1H),	  7.43	  –	  7.38	  (m,	  2H),	  4.18	  (s,	  2H),	  4.14	  (s,	  2H),	  1.71	  (s,	  3H),	  1.59	  (dd,	   J	  =	  1.8,	  0.9	  Hz,	  3H);	  13C{1H}	  NMR	  (101	  MHz,	  CDCl3)	  δ	  169.5,	  133.8,	  130.8,	  128.5,	  127.9,	  122.7,	  121.9,	  72.8,	  46.6,15.4,	  13.7;	  FTIR	  (thin	  film)	  inter	  alia	  1640	  (C=O),	  1398,	  1222,	  1029,	  796,	  719,	  696	  cm-­‐1;	  LRMS	   (ESI+)	   m/z	   240.2	   (M+	   +	   Na);	   HRMS	   (ESI+)	   m/z	   	   Calcd	   for	   C13H15NO2	   Na	  240.1000	  found	  240.0097.	   
	  
Entry	  6,	  Table	  11:1-­‐(4,5-­‐Dimethyl-­‐3,6-­‐dihydro-­‐2H-­‐1,2-­‐oxazin-­‐2-­‐yl)-­‐2-­‐phenyletha-­‐none	  190	  
	  According	   to	   GP9:	   N-­‐hydroxy-­‐2-­‐phenylacetamide	   (164	   mg,	   1.09	   mmol),	   2,3-­‐dimethyl-­‐1,3-­‐butadiene	   (179	   mg,	   2.18	   mmol),	   sodium	   periodate	   (233	   mg,	   1.09	  mmol).	  The	  product	  190	  was	  obtained	  as	  colourless	  oil	  (105	  mg,	  42	  %);	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  7.38	  –	  7.26	  (m,	  4H),	  7.26	  –	  7.21	  (m,	  1H),	  4.03	  (s,	  4H),	  3.79	  (s,	  2H),	   1.66	   (s,	   3H),	   1.59	   –	   1.51	   (m,	   3H);	   13C{1H}	   NMR	   (101	  MHz,	   CDCl3)	   δ	   169.9,	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135.1,	  129.3,	  128.5,	  126.7,	  122.5,	  121.8,	  73.0,	  45.2,	  39.7,	  15.3,	  13.7;	  FTIR	  (thin	  film)	  
inter	   alia	   1652	   (C=O),	   1434,	  1223,	  711,	  694	   cm-­‐1;	   LRMS	   (ESI+)	  m/z	  254.3	   (M+	  +	  Na);	  HRMS	  (ESI+)	  m/z	  Calcd	  for	  C14H17NO2	  Na	  254.1157	  found	  254.1136.	  
	  
Entry	   7,	   Table	   11:1-­‐(4,5-­‐Dimethyl-­‐3,6-­‐dihydro-­‐2H-­‐1,2-­‐oxazin-­‐2-­‐yl)-­‐3-­‐phenylpro-­‐pan-­‐1-­‐one	  191	  
	  According	   to	   GP9:	   N-­‐hydroxy-­‐3-­‐phenylpropanamide	   (131	   mg,	   0.80	   mmol),	   2,3-­‐dimethyl-­‐1,3-­‐butadiene	   (131	   mg,	   1.59	   mmol),	   sodium	   periodate	   (170	   mg,	   0.80	  mmol).	   The	   product	  191	  was	   obtained	   as	   colourless	   oil	   (72	  mg,	   37%);	   1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  7.32	  –	  7.26	  (m,	  2H),	  7.25	  –	  7.17	  (m,	  3H),	  4.08	  (s,	  2H),	  4.04	  (s,	  2H),	   3.00	   –	   2.95	   (m,	   2H),	   2.82	   –	   2.71	   (m,	   2H),	   1.67	   (s,	   3H),	   1.58	   –	   1.54	   (m,	   3H);	  13C{1H}	  NMR	  (101	  MHz,	  CDCl3)	  δ	  170.3,	  140.44,	  127.5,	  127.5,	  125.1,	  121.5,	  121.0,	  72.0,	  44.0,	  32.9,	  29.8,	  14.3,	  12.8;	  FTIR	  (thin	  film)	  inter	  alia	  1651	  (C=O),	  1440,	  1212,	  750,	   699	   cm-­‐1;	   LRMS	   (ESI+)	   m/z	   268.3	   (M+	   +	   Na);	   HRMS	   (ESI+)	   m/z	   Calcd	   for	  C15H19NO2	  Na	  268.1313	  found	  268.1296.	  
	  
Entry	   8,	   Table	   11:	   1-­‐(4,5-­‐Dimethyl-­‐3,6-­‐dihydro-­‐2H-­‐1,2-­‐oxazin-­‐2-­‐yl)-­‐4-­‐phenylbu-­‐tan-­‐1-­‐one	  192	  
	  According	   to	   GP9:	   N-­‐hydroxy-­‐4-­‐phenylbutanamide	   (137	   mg,	   0.77	   mmol),	   2,3-­‐dimethyl-­‐1,3-­‐butadiene	   (126	   mg,	   1.54	   mmol),	   sodium	   periodate	   (164	   mg,	   0.77	  mmol).	   The	  product	  192	  was	  obtained	   as	   colourless	   oil	   (80	  mg,	   40	  %);	   1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  7.30	  –	  7.26	  (m,	  2H),	  7.23	  –	  7.16	  (m,	  3H),	  4.16	  (s,	  2H),	  4.02	  (s,	  2H),	  2.72	  –	  2.66	  (m,	  2H),	  2.47	  (t,	  J	  =	  7.5	  Hz,	  2H),	  2.03	  –	  1.95	  (m,	  2H),	  1.68	  (d,	  J	  =	  0.8	  Hz,	   3H),	   1.59	   (d,	   J	   =	   0.9	  Hz,	   3H);	   13C{1H}	  NMR	   (101	  MHz,	   CDCl3)	   δ	   171.9,	   141.8,	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128.5,	  128.3,	  125.8,	  122.5,	  122.1,	  72.9,	  45.0,	  35.4,	  31.4,	  26.1,	  15.3,	  13.8;	  FTIR	  (thin	  film)	  inter	  alia	  1654	  (C=O),	  1439,	  1216,	  749,	  699	  cm-­‐1;	  LRMS	  (ESI+)	  m/z	  282.3	  (M+	  +	  Na);	  HRMS	  (ESI+)	  m/z	  Calcd	  for	  C16H21NO2	  282.1470	  Na	  found	  282.1472.	  
	  
Entry	  9,	  Table	  11:	  1-­‐(4,5-­‐Dimethyl-­‐3,6-­‐dihydro-­‐2H-­‐1,2-­‐oxazin-­‐2-­‐yl)-­‐5-­‐phenylpen-­‐tan-­‐1-­‐one	  193	  
	  According	   to	   GP9:	   N-­‐hydroxy-­‐5-­‐phenylpentanamide	   (149	   mg,	   0.77	   mmol),	   2,3-­‐dimethyl-­‐1,3-­‐butadiene	   (126	   mg,	   1.54	   mmol),	   sodium	   periodate	   (164	   mg,	   0.77	  mmol).	   The	  product	  193	  was	  obtained	   as	   colourless	   oil	   (86	  mg,	   41	  %);	   1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  7.29	  –	  7.24	  (m,	  2H),	  7.24	  –	  7.13	  (m,	  3H),	  4.17	  (s,	  2H),	  4.02	  (s,	  2H),	  2.65	  (t,	  J	  =	  7.1	  Hz,	  2H),	  2.46	  (d,	  J	  =	  6.4	  Hz,	  2H),	  1.73	  –	  1.64	  (m,	  7H),	  1.59	  (d,	  J	  =	  0.9	   Hz,	   3H);	   13C{1H}	   NMR	   (101	   MHz,	   CDCl3)	   δ	   172.1,	   142.4,	   128.4,128.3,	   125.7,	  122.5,122.10,	  72.9,	  45.0,	  35.7,	  32.0,	  31.2,	  24.4,	  15.3,	  13.8;	  FTIR	  (thin	  film)	  inter	  alia	  1655	  (C=O),	  1435,	  1212,	  748,	  699	  cm-­‐1;	  LRMS	  (ESI+)	  m/z	  296.3	  (M+	  +	  Na);	  HRMS	  (ESI+)	  m/z	  Calcd	  for	  C17H23NO2	  Na	  296.1626	  found	  296.1629	  .	  
	  
Entry	   10,	   Table	   11:	   Phenyl-­‐4,5-­‐dimethyl-­‐3,6-­‐dihydro-­‐2H-­‐1,2-­‐oxazine-­‐2-­‐carboxy-­‐late	  194	  
	  According	  to	  GP9:	  Phenyl	  hydroxycarbamate	  (133	  mg,	  0.87	  mmol),	  2,3-­‐dimethyl-­‐1,3-­‐butadiene	  (143	  mg,	  1.74	  mmol),	  sodium	  periodate	  (186	  mg,	  0.87	  mmol).	  The	  product	  194	  was	   obtained	   as	   colourless	   oil	   (95.4	  mg,	   47%);	   1H	  NMR	   (400	  MHz,	  CDCl3)	  δ	  7.40	  –	  7.34	  (m,	  2H),	  7.24	  –	  7.19	  (m,	  1H),	  7.19	  –	  7.13	  (m,	  2H),	  4.34	  (s,	  2H),	  4.09	   (s,	   2H),	   1.73	   –	   1.69	   (m,	   3H),	   1.66	   –	   1.59	   (m,	   3H);	   13C{1H}	   NMR	   (101	  MHz,	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CDCl3)	  δ	  153.6,	  150.9,	  129.3,	  125.6,	  123.2,	  121.8,	  121.6,	  72.0,	  48.4,	  15.2,	  13.9;	  FTIR	  (thin	  film)	  inter	  alia	  1720	  (C=O),	  1388,	  1356,	  1202,	  1162,	  1068,	  755,	  726,	  688	  cm-­‐1;	   LRMS	   (ESI+)	   m/z	   256.2	   (M+	   +	   Na);	   HRMS	   (ESI+)	   m/z	   Calcd	   for	   C13H15NO3Na	  256.0950	  	  found	  256.0955.	  	  
Entry	  11,	  Table	  11:	  4,5-­‐Dimethyl-­‐N-­‐phenyl-­‐3,6-­‐dihydro-­‐2H-­‐1,2-­‐oxazine-­‐2-­‐carbox-­‐amide	  195	  
	  According	   to	  GP9:	   1-­‐Hydroxy-­‐3-­‐phenylurea	   (138	  mg,	   0.91	  mmol),	   2,3-­‐dimethyl-­‐1,3-­‐butadiene	  (149	  mg,	  1.81	  mmol),	  sodium	  periodate	  (194	  mg,	  0.91	  mmol).	  The	  product	  195	  was	  obtained	  as	  a	  white	  solid	  (95	  mg,	  45%);	  m.p.	  99-­‐102	  C;	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  7.66	  (s,	  1H),	  7.46	  (dd,	  J	  =	  19.3,	  8.2	  Hz,	  2H),	  7.31	  (t,	  J	  =	  7.9	  Hz,	  2H),	  7.06	  (t,	  J	  =	  7.4	  Hz,	  1H),	  4.29	  (t,	  J	  =	  9.9	  Hz,	  2H),	  3.97	  (t,	  J	  =	  10.1	  Hz,	  2H),	  1.78	  –	  1.68	  (m,	  3H),	  1.63	  –	  1.61	  (m,	  3H);	  13C{1H}	  NMR	  (101	  MHz,	  CDCl3)	  δ	  155.5,	  138.0,	  129.0,	  123.4,	  122.6,	  119.3,	  119.3,	  72.5,	  47.7,	  15.5,	  13.7;	  FTIR	  (thin	  film)	   inter	  alia	  1652	  (C=O),	  1594,	  1527,	  1446,	  1435,	  1221,	  758,	  731,	  692	  cm-­‐1;	  LRMS	  (ESI+)	  m/z	  255.3	   (M+	   +	   Na);	   HRMS	   (ESI+)	   m/z	   Calcd	   for	   C13H16N2O2Na	   255.1109	   found	  255.1121.	  
	  
Entry	   12,	   Table	   11:	   (R)-­‐4,5-­‐Dimethyl-­‐N-­‐(1-­‐phenylethyl)-­‐3,6-­‐dihydro-­‐2H-­‐1,2-­‐oxazine-­‐2-­‐carboxamide	  196	  	  
	  (S)-­‐1-­‐Hydroxy-­‐3-­‐(1-­‐phenylethyl)urea	   (98	   mg,	   0.54	   mmol),	   2,3-­‐dimethyl-­‐1,3-­‐butadiene	   (89	   mg,	   1.09	   mmol),	   sodium	   periodate	   (116	   mg,	   0.54	   mmol).	   The	  product	  196	  was	  obtained	  as	  a	  colourless	  oil	  (18	  mg,	  13	  %);	  1H NMR (400 MHz, 
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CDCl3) δ 7.39 – 7.30 (m, 4H), 7.29 – 7.22 (m, 1H), 5.99 (d, J = 8.0 Hz, 1H), 5.07 – 4.98 
(m, 1H), 4.25 – 4.15 (m, 2H), 3.87 (dt, J = 19.8, 9.9 Hz, 2H), 1.71 – 1.64 (m, 3H), 1.61 
– 1.56 (m, 3H), 1.52 (d, J = 6.9 Hz, 3H); 13C{1H}	  NMR (101 MHz, CDCl3) δ 157.8, 
143.9, 128.6, 128.6, 127.2, 126.1, 122.7, 122.6, 72.0, 49.2, 48.2, 22.5, 15.5, 13.7; FTIR	  (thin	   film)	   inter	   alia	   3308	   (NH),	   1652	   (C=O),	   1510,	   1209,	   1026,	   762,	   699	   cm-­‐1;	  LRMS	   (ESI+)	   m/z	   261.1	   (M+	   +	   H);	   HRMS	   (ESI+)	   m/z	   Calcd	   for	   C15H21N2O2	  	  261.1603	  found	  261.1619. 
	  
3.10	  Reaction	  of	   hydroxamic	   acids	  with	  1,3-­cyclohexadiene	  using	  10	  mol%	  
CuCl2	  and	  20	  mol%	  of	  2-­ethyl-­2-­oxazoline	  in	  methanol	  
GP10:	   General	   procedure	   of	   copper-­oxazoline	   catalyzed	   oxidation	   of	   hydroxamic	  
acids	  	  To	  a	  MeOH	   (5	  ml)	   solution	  of	   1.2	   equivalent	   1,3-­‐cyclohexadiene,	   10	  mol%	  CuCl2	  and	   20	   mol%	   2-­‐ethyl-­‐2-­‐oxazoline	   was	   added	   hydroxamic	   acid.	   The	   resulting	  solution	  was	  stirred	  at	   room	  temperature	   in	  air	  and	  was	  monitored	  by	  TLC.	  The	  completion	   of	   the	   reaction	   was	   confirmed	   by	   the	   disappearance	   of	   the	   starting	  material.	   The	   solvent	   was	   removed	   by	   evaporation	   and	   the	   crude	   product	   was	  purified	  by	  silica	  gel	  chromatography	  (hexane:ethyl	  acetate,	  6:1	  v/v,	  as	  eluent).	  	  
	  
Entry	   10,	   Table	   12:	   (1R,4S)-­‐Phenyl-­‐2-­‐oxa-­‐3-­‐azabicyclo[2.2.2]oct-­‐5-­‐ene-­‐3-­‐car-­‐boxylate	  182	  According	   to	   GP10:	   Phenyl	   hydroxycarbamate	   (103	   mg,	   0.67	   mmol),	   1,3-­‐cyclohexadiene	   (66	   mg,	   0.80	   mmol),	   CuCl2	   (9	   mg,	   0.07	   mmol)	   and	   2-­‐ethyl-­‐2-­‐oxazoline	  (13	  mg,	  0.13	  mmol),	  the	  reaction	  completed	  in	  2	  h	  giving	  182	  (152	  mg,	  98	  %)	  as	  a	  white	  solid.	  
	  
Entry	   11,	   Table	   12:	   (1R,4S)-­‐N-­‐Phenyl-­‐2-­‐oxa-­‐3-­‐azabicyclo[2.2.2]oct-­‐5-­‐ene-­‐3-­‐carboxamide	  183	  According	   to	   GP10:	   1-­‐Hydroxy-­‐3-­‐phenylurea	   (105	   mg,	   0.69	   mmol),	   1,3-­‐cyclohexadiene	   (68	   mg,	   0.83	   mmol),	   CuCl2	   (9	   mg,	   0.07	   mmol)	   and	   2-­‐ethyl-­‐2-­‐
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oxazoline	  (14	  mg,	  0.14	  mmol),	  the	  reaction	  completed	  in	  4	  h	  giving	  183	  (156	  mg,	  	  98%)	  as	  a	  white	  solid.	  
	  
Entry	   12,	   Table	   12:	  N-­‐((R)-­‐1-­‐Phenylethyl)-­‐2-­‐oxa-­‐3-­‐azabicyclo[2.2.2]oct-­‐5-­‐ene-­‐3-­‐carboxamide	  184	  According	  to	  GP10:	  (S)-­‐1-­‐Hydroxy-­‐3-­‐(1-­‐phenylethyl)urea	  (99	  mg,	  0.55	  mmol),	  1,3-­‐cyclohexadiene	   (53	   mg,	   0.66	   mmol),	   CuCl2	   (7	   mg,	   0.05	   mmol)	   and	   2-­‐ethyl-­‐2-­‐oxazoline	  (11	  mg,	  0.11	  mmol),	  the	  reaction	  completed	  in	  4	  h	  giving	  184	  (141	  mg,	  	  97%)	  as	  a	  white	  solid.	  
	  
3.11	  Reaction	  of	  phenyl	  hydroxycarbamate	  170	  with	  various	  dienes.	  
GP11:	   General	   procedure	   of	   copper-­oxazoline	   catalyzed	   oxidation	   of	   phenyl	  
hydroxycarbamate	  170	  To	   a	   MeOH	   (5	   ml)	   solution	   of	   diene	   (1.2	   equivalent	   for	   Entry	   1-­‐5	   and	   0.83	  equivalent	   for	   Entry	   5-­‐6),	   10	  mol%	  CuCl2	   and	   20	  mol%	  2-­‐ethyl-­‐2-­‐oxazoline	  was	  added	  phenyl	  hydroxycarbamate	  170.	  The	  resulting	  solution	  was	  stirred	  at	  room	  temperature	  in	  air	  and	  was	  monitored	  by	  TLC.	  The	  completion	  of	  the	  reaction	  was	  confirmed	  by	  the	  disappearance	  of	  the	  starting	  material.	  The	  solvent	  was	  removed	  by	  evaporation	  and	   the	  crude	  product	  was	  purified	  by	  silica	  gel	   chromatography	  (hexane:ethyl	  acetate,	  6:1	  v/v,	  as	  eluent).	  	  	  
Entry	  1,	  Table	  13:	  Phenyl	  2-­‐oxa-­‐3-­‐azabicyclo[2.2.1]hept-­‐5-­‐ene-­‐3-­‐carboxylate	  197	  
	  According	  to	  GP11:	  Using	  phenyl	  hydroxycarbamate	  (162	  mg,	  1.06	  mmol),	  freshly	  cracked	   cyclopentadiene	   (84	  mg,	   1.27	  mmol),	   CuCl2	   (14	  mg,	   0.11	  mmol)	   and	   2-­‐ethyl-­‐2-­‐oxazoline	  (21	  mg,	  0.21	  mmol),	  the	  reaction	  was	  stirred	  for	  2	  h	  giving	  197	  (228	  mg,	  99%)	  as	  a	  white	  solid;	  m.p.	  113	  –	  114	  C;	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  7.39	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–	  7.33	  (m,	  2H),	  7.24	  –	  7.19	  (m,	  1H),	  7.14	  –	  7.08	  (m,	  2H),	  6.61	  (dt,	  J	  =	  5.5,	  1.9	  Hz,	  1H),	  6.52	  –	  6.47	  (m,	  1H),	  5.35	  (d,	  J	  =	  1.4	  Hz,	  1H),	  5.21	  (s,	  1H),	  2.12	  (dt,	   J	  =	  8.8,	  1.9	  Hz,	  1H),	  1.86	  (d,	  J	  =	  8.8	  Hz,	  1H);	  13C{1H}	  NMR	  (101	  MHz,	  CDCl3)	  δ	  156.4,	  149.7,	  133.6,	  132.4,	  128.4,	  124.8,	  120.4,	  83.3,	  64.4,	  47.4;	  FTIR	  (thin	  film)	  inter	  alia	  1749	  (C=O),	  1587,	  1489,	  1332,	  1271,	  1192,	  1181,	  770,	  746,	  691	  cm-­‐1;	  LRMS	  (ESI+)	  m/z	  240.2	  (M+	  +	  Na);	  HRMS	  (ESI+)	  m/z	  Calcd	  for	  C12H11NO3Na	  240.0637	  	  found	  240.0650.	  	  
Entry	   2,	   Table	   13:	   	   (1R,4S)-­‐Phenyl	   2-­‐oxa-­‐3-­‐azabicyclo[2.2.2]oct-­‐5-­‐ene-­‐3-­‐carboxylate	  182	  According	   to	  GP11: Using	   phenyl	   hydroxycarbamate	   (158	  mg,	   1.03	  mmol),	   1,3-­‐cyclohexadiene	   (99	   mg,	   1.24	   mmol),	   CuCl2	   (14	   mg,	   0.11	   mmol)	   and	   2-­‐ethyl-­‐2-­‐oxazoline	  (21	  mg,	  0.21	  mmol),	  the	  reaction	  was	  stirred	  for	  2	  h	  giving	  182	  (234	  mg,	  98	  %)	  as	  a	  white	  solid.	  	  
Entry	   3,	   Table	   13:	   	   Phenyl	   4,5-­‐dimethyl-­‐3,6-­‐dihydro-­‐2H-­‐1,2-­‐oxazine-­‐2-­‐carboxyl-­‐ate	  194	  According	   to	  GP11:	   Using	   phenyl	   hydroxycarbamate	   (173	  mg,	   1.13	  mmol),	   2,3-­‐dimethyl-­‐1,3-­‐butadiene	   (111	  mg,	   1.36	  mmol),	   CuCl2	   (15	  mg,	   0.11	  mmol)	   and	   2-­‐ethyl-­‐2-­‐oxazoline	  (22	  mg,	  0.22	  mmol),	  the	  reaction	  was	  stirred	  for	  3	  h	  giving	  194	  (250	  mg,	  95%)	  in	  colourless	  oil.	  The	  ratio	  of	  194:198	  is	  6:1.	  	  
Entry	  4,	  Table	  13:	  Phenyl	  3,6-­‐dimethyl-­‐3,6-­‐dihydro-­‐2H-­‐1,2-­‐oxazine-­‐2-­‐carboxylate	  
199	  
	  According	   to	  GP11:	   Using	   phenyl	   hydroxycarbamate	   (131	  mg,	   0.86	  mmol),	   2,4-­‐hexadiene	  (84	  mg,	  1.03	  mmol),	  CuCl2	  (12	  mg,	  0.09	  mmol)	  and	  2-­‐ethyl-­‐2-­‐oxazoline	  (17	  mg,	  0.17	  mmol),	  the	  reaction	  was	  stirred	  for	  3	  h	  giving	  199	  (185	  mg,	  93%)	  as	  a	  colourless	  oil;	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  7.39	  –	  7.35	  (m,	  2H),	  7.22	  (dd,	  J	  =	  10.6,	  4.3	  Hz,	  1H),	  7.18	  –	  7.14	  (m,	  2H),	  5.84	  (ddd,	  J	  =	  10.2,	  4.3,	  2.1	  Hz,	  1H),	  5.79	  –	  5.71	  (m,	  1H),	  4.85	  –	  4.73	  (m,	  1H),	  4.64	  –	  4.57	  (m,	  1H),	  1.42	  (d,	  J	  =	  6.7	  Hz,	  3H),	  1.33	  (d,	  J	  =	  6.7	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Hz,	  3H);	  13C{1H}	  NMR	  (101	  MHz,	  CDCl3)	  δ	  152.8,	  150.8,	  129.2,	  128.6,	  127.5,	  125.4,	  121.5,	   74.3,	   50.2,	   18.7,	   18.1;	   FTIR	   (thin	   film)	   inter	   alia	  1715	   (C=O),	   1366,	   1189,	  1037,	   748,	   725,	   689	   cm-­‐1;	   LRMS	   (ESI+)	  m/z	   256.3	   (M+	   +	  Na);	  HRMS	   (ESI+)	  m/z	  Calcd	  for	  C13H15NO3Na	  256.0950	  found	  256.0926.	  	  
Entry	   5,	   Table	   13:	   	   Phenyl	   4-­‐methyl-­‐3,6-­‐dihydro-­‐2H-­‐1,2-­‐oxazine-­‐2-­‐carboxylate	  	  
200	  and	  phenyl	  5-­‐methyl-­‐3,6-­‐dihydro-­‐2H-­‐1,2-­‐oxazine-­‐2-­‐carboxylate	  200’	  
	  According	   to	   GP11:	   Using	   phenyl	   hydroxycarbamate	   (142	   mg,	   0.93	   mmol),	  isoprene	   (70	  mg,	  1.11	  mmol),	  CuCl2	   (12	  mg,	  0.09	  mmol)	  and	  2-­‐ethyl-­‐2-­‐oxazoline	  (18	  mg,	  0.18	  mmol),	   the	  reaction	  was	  stirred	  for	  3.5	  h	  giving	  200/200’	  (183	  mg,	  90	  %)	   as	   a	   colourless	   oil.	   The	   ratio	   of	  200	   and	  200’:201	   =	   3:1	   and	   the	   ratio	   of	  
200:200’	  =	  1.79:1;	  	  
200:	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  7.40	  –	  7.35	  (m,	  2H),	  7.25	  –	  7.20	  (m,	  1H),	  7.19	  –	  7.14	  (m,	  2H),	  5.64	  –	  5.60	  (m,	  1H),	  4.54	  –	  4.47	  (m,	  2H),	  4.18	  –	  4.09	  (m,	  2H),	  1.81	  –	  1.75	   (m,	  3H);	   13C{1H}	  NMR	  (101	  MHz,	  CDCl3)	  δ	  150.8,	  129.4,	  125.7,	  121.6,	  121.6,	  118.0,	  116.2,	  68.9,	  48.5,	  19.9.	  
200’:	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  7.41	  –	  7.34	  (m,	  2H),	  7.25	  –	  7.19	  (m,	  1H),	  7.19	  –	  7.13	  (m,	  2H),	  5.60	  –	  5.57	  (m,	  1H),	  4.42	  –	  4.37	  (m,	  2H),	  4.26	  –	  4.20	  (m,	  2H),	  1.74	  –	  1.70	   (m,	  3H);	   13C{1H}	  NMR	  (101	  MHz,	  CDCl3)	  δ	  153.6,	  131.6,	  130.1,	  125.7,	  121.6,	  118.0,	  115.3,	  72.0,	  44.8,	  18.3;	  FTIR	  (thin	   film)	   inter	  alia	  1717	  (C=O),	  1383,	  1200,	  1163,	  1070,	  752,	  688	  cm-­‐1;	  LRMS	  (ESI+)	  m/z	  242.2	  (M+	  +	  Na);	  HRMS	  (ESI+)	  m/z	  Calcd	  for	  C12H13NO3Na	  242.0793	  found	  242.0771.	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Entry	   6,	   Table	   13:	   	   	   (9S,10S)-­‐Phenyl-­‐9,10-­‐dimethyl-­‐9,10-­‐dihydro-­‐9,10-­‐(epoxy-­‐imino)-­‐anthracene-­‐11-­‐carboxylate	  202	  
	  According	   to	  GP11:	   Using	   phenyl	   hydroxycarbamate	   (39	  mg,	   0.25	  mmol),	   9,10-­‐dimethylanthracene	  (47	  mg,	  0.23	  mmol),	  CuCl2	  (3	  mg,	  0.03	  mmol)	  and	  2-­‐ethyl-­‐2-­‐oxazoline	  (5	  mg,	  0.05	  mmol),	  the	  reaction	  was	  stirred	  for	  24	  h	  giving	  202	  (70	  mg,	  80%)	  in	  colourless	  oil;	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  7.57	  –	  7.52	  (m,	  2H),	  7.49	  –	  7.45	  (m,	  2H),	  7.38	  –	  7.32	  (m,	  4H),	  7.29	  –	  7.25	  (m,	  2H),	  7.17	  –	  7.14	  (m,	  1H),	  6.78	  –	  6.69	  (m,	  2H),	  2.67	   (d,	   J	  =	  13.8	  Hz,	  3H),	  2.34	   (s,	  3H);	   13C{1H}	  NMR	  (101	  MHz,	  CDCl3)	  δ	  158.1,	  150.8,	  141.6,	  140.4,	  129.2,	  127.4,	  125.6,	  121.6,	  121.6,	  120.8,	  79.7,	  64.5,	  16.4,	  15.0;	  FTIR	  (thin	  film)	  inter	  alia	  1725	  (C=O),	  1274,	  1229,	  1194,	  1016,	  741,	  688	  cm-­‐1;	  LRMS	  (ESI+)	  m/z	  380.2	  (M+	  +	  Na);	  HRMS	  (ESI+)	  m/z	  C23H19NO3Na	  380.1263	  found	  380.1257.	  	  
Entry	   7,	   Table	   13:	   	   Phenyl	   3,6-­‐diphenyl-­‐3,6-­‐dihydro-­‐2H-­‐1,2-­‐oxazine-­‐2-­‐carboxylate	  203	  
	  According	   to	   GP11:	   Using	   phenyl	   hydroxycarbamate	   (92	   mg,	   0.60	   mmol),	   1,4-­‐diphenyl-­‐1,3-­‐butadiene	   (111	   mg,	   0.54	   mmol),	   CuCl2	   (8	   mg,	   0.06	   mmol)	   and	   2-­‐ethyl-­‐2-­‐oxazoline	  (12	  mg,	  0.12	  mmol),	  the	  reaction	  was	  stirred	  for	  24	  h	  giving	  203	  (172	  mg,	  82%);	  m.p.	  144	  –	  147	  C;	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  7.61	  –	  7.57	  (m,	  2H),	  7.50	  –	  7.46	  (m,	  2H),	  7.44	  –	  7.34	  (m,	  8H),	  7.24	  –	  7.20	  (m,	  1H),	  7.15	  (d,	  J	  =	  7.6	  Hz,	  2H),	  6.25	  –	  6.15	  (m,	  2H),	  5.81	  –	  5.73	  (m,	  2H);	  13C{1H}	  NMR	  (101	  MHz,	  CDCl3)	  δ	  188.5,	  
	   147	  	  	  	  
153.1,	   150.9,	   138.4,	   136.8,	   129.3,	   129.2,	   128.8,	   128.7,	   128.2,	   128.1,	   127.9,	   125.9,	  125.7,	  121.7,	  80.3,	  77.2;	  FTIR	  (thin	  film)	  inter	  alia	  1716	  (C=O),	  1360,	  1272,	  1194,	  868,	   747,	   726,	   689	   cm-­‐1;	   LRMS	   (ESI+)	   m/z	   380.2	   (M+	   +	   Na);	   HRMS	   (ESI+)	   m/z	  Calcd	  for	  C23H19NO3Na	  380.1263	  	  found	  380.1227.	  	  	  
Entry	  8,	  Table	  13:	   	  Phenyl-­‐3-­‐(hydroxymethyl)-­‐6-­‐methyl-­‐3,6-­‐dihydro-­‐2H-­‐1,2-­‐oxa-­‐zine-­‐2-­‐carboxylate	  204	   and	   phenyl	   6-­‐(hydroxymethyl)-­‐3-­‐methyl-­‐3,6-­‐dihydro-­‐2H-­‐1,2-­‐oxazine	  -­‐2-­‐carboxylate	  	  204’	  
	  According	   to	  GP11:	   Using	   phenyl	   hydroxycarbamate	   (140	  mg,	   0.91	  mmol),	   2,4-­‐hexadiene-­‐1-­‐ol	   (90	   mg,	   0.91mmol),	   CuCl2	   (12	   mg,	   0.09	   mmol)	   and	   2-­‐ethyl-­‐2-­‐oxazoline	   (18	  mg,	   0.18	  mmol),	   the	   reaction	  was	   stirred	   for	   3	   h	   giving	  204/204’	  (210	  mg,	  93	  %)	  in	  yellow	  oil.	  The	  ratio	  of	  204:204’	  =	  1:1;	  	  
204:	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  7.46	  –	  7.34	  (m,	  2H),	  7.28	  –	  7.21	  (m,	  1H),	  7.21	  –	  7.11	  (m,	  2H),	  6.06	  –	  6.02	  (m,	  1H)	  ,	  5.87	  –	  5.83	  (m,	  1H)	  ,	  4.63	  –	  4.56	  (m,	  1H)	  ,	  4.55	  –	  4.45	  (m,	  2H),	  4.11	  (dd,	  J	  =	  7.2,	  2.3	  Hz,	  1H)	  ,	  1.94	  (s,	  1H),	  1.53	  (d,	  J	  =	  7.0	  Hz,	  3H);	  13C{1H}	  NMR	  (101	  MHz,	  CDCl3)	  δ	  153.1,	  150.8,	  131.26,	  129.4,	  125.7,	  123.0,	  121.6,	  75.89,	  65.6,	  63.52,	  50.5,	  21.0	  
204’:	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  7.46	  –	  7.34	  (m,	  2H),	  7.28	  –	  7.21	  (m,	  1H),	  7.21	  –	  7.11	  (m,	  2H)	   ,	  6.02	  –	  5.97	  (m,	  1H),	  5.79	  (dt,	  J	  =	  10.3,	  1.5	  Hz,	  1H)	   ,	  4.86	  –	  4.80	  (m,	  1H)	  ,	  4.71	  –	  4.63	  (m,	  1H)	  ,	  3.86	  (dd,	  J	  =	  12.5,	  3.0	  Hz,	  1H),	  3.75	  (dd,	  J	  =	  12.4,	  6.3	  Hz,	  1H),	  2.45	  (br,	  1H),	  1.45	  (d,	  J	  =	  6.7	  Hz,	  3H);	  13C{1H}	  NMR	  (101	  MHz,	  CDCl3)	  δ	  153.1,	  150.8,	  130.1,	  129.4,	  125.7,	  123.8,	  121.6,	  79.3,	  63.6,	  50.8,	  18.3;	  FTIR	  (thin	  film)	  inter	  
alia	  1715	  (C=O),	  1369,	  1312,	  1188,	  1164,	  1065,	  749,	  689	  cm-­‐1;	  LRMS	  (ESI+)	  m/z	  272.3	   (M+	   +	   Na);	   HRMS	   (ESI+)	   m/z	   Calcd	   for	   C13H15NO4Na	   272.0899	   found	  272.0907.	  	  
	  
	  
	   148	  	  	  	  
3.12	  Reaction	  of	  1-­hydroxy-­3-­phenylurea	  171	  with	  various	  dienes.	  
GP12:	   General	   procedure	   of	   copper-­oxazoline	   catalyzed	   oxidation	   of	   1-­hydroxy-­3-­
phenylurea	  171	  To	   a	   MeOH	   (5	   ml)	   solution	   of	   diene	   (1.2	   equivalent	   for	   Entry	   1-­‐5	   and	   0.83	  equivalent	   for	   Entry	   5-­‐6),	   10	  mol%	  CuCl2	   and	   20	  mol%	  2-­‐ethyl-­‐2-­‐oxazoline	  was	  added	   1-­‐hydroxy-­‐3-­‐phenylurea	   171.	  The	   resulting	   solution	   was	   stirred	   at	   room	  temperature	  in	  air	  and	  was	  monitored	  by	  TLC.	  The	  completion	  of	  the	  reaction	  was	  confirmed	  by	  the	  disappearance	  of	  the	  starting	  material.	  The	  solvent	  was	  removed	  by	  evaporation	  and	   the	  crude	  product	  was	  purified	  by	  silica	  gel	   chromatography	  (hexane:ethyl	  acetate,	  6:1	  v/v,	  as	  eluent).	  	  	  
Entry	  1,	  Table	  14:	   	  N-­‐Phenyl-­‐2-­‐oxa-­‐3-­‐azabicyclo[2.2.1]hept-­‐5-­‐ene-­‐3-­‐carboxamide	  
205	  
	  According	   to	  GP12:	  Using	  1-­‐hydroxy-­‐3-­‐phenylurea	   (182	  mg,	  1.20	  mmol),	   freshly	  cracked	   cyclopentadiene	   (95	  mg,	   1.44	  mmol),	   CuCl2	   (16	  mg,	   0.12	  mmol)	   and	   2-­‐ethyl-­‐2-­‐oxazoline	  (24	  mg,	  0.24	  mmol),	  the	  reaction	  was	  stirred	  for	  4	  h	  giving	  205	  (249	  mg,	  96	  %)	  as	  a	  white	  solid;	  m.p.	  108	  -­‐112	  C;	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  7.48	  (t,	  J	  =	  16.2	  Hz,	  1H),	  7.42	  (dt,	  J	  =	  8.7,	  1.7	  Hz,	  2H),	  7.31	  –	  7.26	  (m,	  2H),	  7.08	  –	  7.03	  (m,	  1H),	  6.52	  (dt,	  J	  =	  5.5,	  1.9	  Hz,	  1H),	  6.39	  (ddd,	  J	  =	  5.6,	  2.3,	  1.6	  Hz,	  1H),	  2.08	  (dt,	  J	  =	  8.8,	  1.9	  Hz,	  1H),	  1.83	  (d,	  J	  =	  8.8	  Hz,	  1H);	  13C{1H}	  NMR	  (101	  MHz,	  CDCl3)	  δ	  159.7,	  137.4,	  135.6,	  132.0,	  129.0,	  123.8,	  119.3,	  84.4,	  65.2,	  48.7.	  FTIR	  (thin	  film)	   inter	  alia	  1660	  (C=O),	  1596,	  1522,	  1448,	  1338,	  753,	  690	  cm-­‐1;	  LRMS	  (ESI+)	  m/z	  270.2	  (M+	  +	  Na);	  HRMS	  (ESI+)	  m/z	  Calcd	  for	  C12H12N2O2Na	  239.0796	  found	  239.0782.	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Entry	   2,	   Table	   14:	   	   (1R,4S)-­‐N-­‐Phenyl-­‐2-­‐oxa-­‐3-­‐azabicyclo[2.2.2]oct-­‐5-­‐ene-­‐3-­‐carboxamide	  183	  
	  According	   to	   GP12:	   Using	   1-­‐hydroxy-­‐3-­‐phenylurea	   (150	   mg,	   0.98	   mmol),	   1,3-­‐cyclohexadiene	   (95	   mg,	   1.18	   mmol),	   CuCl2	   (13	   mg,	   0.098	   mmol)	   and	   2-­‐ethyl-­‐2-­‐oxazoline	  (19	  mg,	  0.19	  mmol),	  the	  reaction	  was	  stirred	  for	  4	  h	  giving	  183	  (222	  mg,	  98%)	  as	  a	  white	  solid;	  m.p.	  102	  –	  104	  C;	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  7.63	  (s,	  1H),	  7.44	  (dd,	  J	  =	  8.6,	  1.0	  Hz,	  2H),	  7.28	  (dd,	  J	  =	  10.9,	  5.4	  Hz,	  2H),	  7.10	  –	  7.01	  (m,	  1H),	  6.62	  –	  6.56	  (m,	  1H),	  6.55	  –	  6.47	  (m,	  1H),	  5.06	  –	  4.98	  (m,	  1H),	  4.83	  –	  4.75	  (m,	  1H),	  2.25	  –	  2.13	   (m,	   2H),	   1.61	   –	   1.53	   (m,	   1H),	   1.43	   –	   1.36	   (m,	   1H);	   13C{1H}	  NMR	   (101	  MHz,	  CDCl3)	  δ	  159.3,	  137.7,	  132.7,	  130.4,	  128.9,	  123.5,	  119.3,	  71.2,	  50.0,	  23.9,	  20.0;	  FTIR	  (thin	   film)	   inter	   alia	   1667	   (C=O),	   1594,	   1531,	   1445,	   1228,	   907,	   767,	   701	   cm-­‐1;	  LRMS	   (ESI+)	   m/z	   253.2	   (M+	   +	   Na);	   HRMS	   (ESI+)	   m/z	   Calcd	   for	   C13H14N2O2Na	  253.0953	  found	  253.0958.	  	  
Entry	   3,	   Table	   14:	   	   4,5-­‐Dimethyl-­‐N-­‐phenyl-­‐3,6-­‐dihydro-­‐2H-­‐1,2-­‐oxazine-­‐2-­‐carboxamide	  195	  	  
	  According	   to	   GP12:	   Using	   1-­‐hydroxy-­‐3-­‐phenylurea	   (186	   mg,	   1.22	   mmol),	   2,3-­‐dimethyl-­‐1,3-­‐butadiene	   (125	  mg,	   1.47	  mmol),	   CuCl2	   (16	  mg,	   0.12	  mmol)	   and	   2-­‐ethyl-­‐2-­‐oxazoline	  (24	  mg,	  0.24	  mmol),	  the	  reaction	  was	  stirred	  for	  6	  h	  giving	  195	  (255	  mg,	  90	  %)	  as	   a	  white	   solid.	  The	   ratio	  of	  195:206	   =	  9:1;	  m.p.	  99-­‐102	   C;	   1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  7.66	  (s,	  1H),	  7.46	  (dd,	  J	  =	  19.3,	  8.2	  Hz,	  2H),	  7.31	  (t,	  J	  =	  7.9	  Hz,	  2H),	  7.06	  (t,	  J	  =	  7.4	  Hz,	  1H),	  4.29	  (t,	  J	  =	  9.9	  Hz,	  2H),	  3.97	  (t,	  J	  =	  10.1	  Hz,	  2H),	  1.78	  –	  1.68	  (m,	  3H),	  1.63	  –	  1.61	  (m,	  3H);	  13C{1H}	  NMR	  (101	  MHz,	  CDCl3)	  δ	  155.5,	  138.0,	  129.0,	  123.4,	  122.6,	  119.3,	  119.3,	  72.5,	  47.7,	  15.5,	  13.7;	  FTIR	  (thin	  film)	   inter	  alia	  1652	  (C=O),	  1594,	  1527,	  1446,	  1435,	  1221,	  758,	  731,	  692	  cm-­‐1;	  LRMS	  (ESI+)	  m/z	  
	   150	  	  	  	  
255.3	   (M+	   +	   Na);	   HRMS	   (ESI+)	   m/z	   Calcd	   for	   C13H16N2O2Na	   255.1109	   found	  255.1121.	  
Entry	   4,	   Table	   14:	   3,6-­‐Dimethyl-­‐N-­‐phenyl-­‐3,6-­‐dihydro-­‐2H-­‐1,2-­‐oxazine-­‐2-­‐carboxamide	  207	  
	  According	   to	   GP12:	   Using	   1-­‐hydroxy-­‐3-­‐phenylurea	   (120	   mg,	   0.79	   mmol),	   2,4-­‐hexadiene	  (78	  mg,	  0.95	  mmol),	  CuCl2	  (11	  mg,	  0.08	  mmol)	  and	  2-­‐ethyl-­‐2-­‐oxazoline	  (16	  mg,	  0.16	  mmol).	  The	  reaction	  was	  stirred	  for	  4	  h	  giving	  207	  (177	  mg,	  97%)	  as	  colourless	  oil;	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  7.60	  (s,	  1H),	  7.49	  (d,	  J	  =	  8.6,	  2H),	  7.34	  –	  7.27	  (m,	  3H),	  7.09	  –	  7.02	  (m,	  2H),	  5.91	  –	  5.85	  (m,	  1H),	  5.75	  –	  5.67	  (m,	  1H),	  4.74	  –	  4.59	   (m,	  2H),	  1.34	   (d,	   J	  =	  6.7	  Hz,	  3H),	  1.30	   (d,	   J	  =	  6.7	  Hz,	  3H);	   13C{1H}	  NMR	  (101	  MHz,	  CDCl3)	  δ	  154.4,	  138.1,	  128.9,	  128.6,	  128.1,	  123.2,	  119.3,	  75.2,	  49.0,	  19.0,	  16.9;	  FTIR	  (thin	  film)	  inter	  alia	  1669	  (C=O),	  1649,	  1594,	  1522,	  1444,	  1231,	  751,	  727,	  692	  	  cm-­‐1;	   LRMS	   (ESI+)	  m/z	   233.2	   (M+	   +	   H);	   HRMS	   (ESI+)	  m/z	   Calcd	   for	   C13H17N2O2	  233.1290	  	  found	  233.1315.	  	  
Entry	  5,	  Table	  14:	  4-­‐Methyl-­‐N-­‐phenyl-­‐3,6-­‐dihydro-­‐2H-­‐1,2-­‐oxazine-­‐2-­‐carboxamide	  
208	  and	  5-­‐methyl-­‐N-­‐phenyl-­‐3,6-­‐dihydro-­‐2H-­‐1,2-­‐oxazine-­‐2-­‐carboxamide	  208’	  
	   	  Using	  1-­‐hydroxy-­‐3-­‐phenylurea	  (140	  mg,	  0.92	  mmol),	  isoprene	  (75	  mg,	  1.10	  mmol),	  CuCl2	   (12	   mg,	   0.092	   mmol)	   and	   2-­‐ethyl-­‐2-­‐oxazoline	   (18	   mg,	   0.18	   mmol),	   the	  reaction	  was	  stirred	  for	  6	  h	  giving	  208/208’	  (191	  mg,	  95%)	  as	  a	  white	  solid.	  The	  ratio	  of	  208:208’	  =	  4.45:1	  and	  the	  ratio	  of	  208	  and	  208’:209	  =	  9:1;	  m.p.	  69	  –	  72	  C;	  	  
208:	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  7.68	  (s,	  1H),	  7.48	  (dt,	  J	  =	  8.8,	  1.7	  Hz,	  2H),	  7.31	  (tq,	  
J	  =	  5.8,	  1.9	  Hz,	  2H),	  7.11	  –	  7.02	  (m,	  1H),	  5.55	  (ddt,	  J	  =	  4.5,	  3.0,	  1.6	  Hz,	  1H),	  4.47	  (dp,	  J	  =	  4.3,	  2.1	  Hz,	  2H),	  4.02	  (d,	  J	  =	  0.8	  Hz,	  2H),	  1.82	  –	  1.77	  (m,	  3H);	  13C{1H}	  NMR	  (101	  MHz,	  CDCl3)	  δ	  155.5,	  138.0,	  131.0,	  129.0,	  123.4,	  119.3,	  117.5,	  69.4,	  47.8,	  19.9.	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208’:	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  7.68	  (s,	  1H),	  7.48	  (dt,	   J	  =	  8.8,	  1.7	  Hz,	  2H),	  7.31	  (tq,	  J	  =	  5.8,	  1.9	  Hz,	  2H),	  7.10	  –	  7.03	  (m,	  1H),	  5.61	  (dd,	  J	  =	  3.3,	  1.7	  Hz,	  1H),	  4.36	  (d,	  J	  =	  0.7	  Hz,	  2H),	  4.10	  (dd,	  J	  =	  3.4,	  2.1	  Hz,	  2H),	  1.71	  (d,	  J	  =	  1.5	  Hz,	  3H);	  13C{1H}	  NMR	  (101	  MHz,	  CDCl3)	  δ	  155.6,	  137.9,	  131.1,	  129.0,	  123.4,	  119.3,	  117.0,	  72.5,	  44.0,	  18.2;	  FTIR	  (thin	   film)	   inter	   alia	   1644	   (C=O),	   1593,	   1514,	   1447,	   1215,	   751,	   725,	   689	   	   cm-­‐1;	  LRMS	   (ESI+)	   m/z	   241.3	   (M+	   +	   Na);	   HRMS	   (ESI+)	   m/z	   Calcd	   for	   C12H14N2O2Na	  241.0953	  found	  241.0940.	  	  
Entry	  6,	  Table	  14:	  210	  According	   to	   GP12:	   Using	   1-­‐hydroxy-­‐3-­‐phenylurea	   (37	   mg,	   0.24	   mmol),	   9,10-­‐dimethylanthracene	  (45	  mg,	  0.22	  mmol),	  CuCl2	  (3	  mg,	  0.02	  mmol)	  and	  2-­‐ethyl-­‐2-­‐oxazoline	   (5	  mg,	   0.05	  mmol),	   the	   reaction	  was	   stirred	   for	  48	  h	   giving	  4h	   (9	  mg,	  10%)	  	  
Entry	   7,	   Table	   14:	   N,3,6-­‐Triphenyl-­‐3,6-­‐dihydro-­‐2H-­‐1,2-­‐oxazine-­‐2-­‐carboxamide	  
211	  
	  According	  to	  GP12:	  Using	  1-­‐hydroxy-­‐3-­‐phenylurea	  (79	  mg,	  0.52	  mmol),	  1,4-­‐diphenyl-­‐1,3-­‐butadiene	  (96	  mg,	  0.47	  mmol),	  CuCl2	  (7	  mg,	  0.05	  mmol)	  and	  2-­‐ethyl-­‐2-­‐oxazoline	  (10	  mg,	  0.10	  mmol),	  the	  reaction	  was	  stirred	  for	  48	  h	  211	  (50	  mg,	  30	  %)	  as	  colourless	  oil;	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  7.64	  –	  7.58	  (m,	  3H),	  7.55	  –	  7.49	  (m,	  4H),	  7.34	  –	  7.31	  (m,	  4H),	  7.14	  –	  7.02	  (m,	  4H),	  6.72	  (s,	  1H),	  6.29	  –	  6.18	  (m,	  1H),	  6.15	  –	  6.08	  (m,	  1H),	  5.92	  –	  5.83	  (m,	  1H),	  5.74	  –	  5.67	  (m,	  1H);	  13C{1H}	  NMR	  (101	  MHz,	  CDCl3)	  δ	  153.8,	  138.5,	  137.9,	  136.9,	  129.5,	  129.0,	  128.9,	  128.5,	  128.3,	  128.1,	  128.0,	  127.5,	  126.9,	  123.4,	  119.4,	  81.3,	  55.7;	  FTIR	  (thin	  film)	  inter	  alia	  1710	  (C=O),	  1599,	  1526,	  1500,	  1446,	  1314,1225,	  1068,	  752,	  723,	  691	  cm-­‐1;	  LRMS	  (ESI+)	  m/z	  379.3	  (M+	  +	  Na);	  HRMS	  (ESI+)	  m/z	  Calcd	  for	  C23H20N2O2Na	  379.1422	  found	  379.1428.	  	  
	   152	  	  	  	  
	  	  	  
Entry	   8,	   Table	   14:	   6-­‐(Hydroxymethyl)-­‐3-­‐methyl-­‐N-­‐phenyl-­‐3,6-­‐dihydro-­‐2H-­‐1,2-­‐oxa	   -­‐zine-­‐2-­‐carboxamide	   212	   and	   3-­‐(hydroxymethyl)-­‐6-­‐methyl-­‐N-­‐phenyl-­‐3,6-­‐dihydro-­‐2H-­‐1,2-­‐oxazine-­‐2-­‐carboxamide	  212’	  
	  	   	  According	   to	   GP12:	   Using	   1-­‐hydroxy-­‐3-­‐phenylurea	   (70	   mg,	   0.46	   mmol),	   2,4-­‐Hexadien-­‐1-­‐ol	   (45	   mg,	   0.46	   mmol),	   CuCl2	   (7	   mg,	   0.05	   mmol)	   and	   2-­‐ethyl-­‐2-­‐oxazoline	   (9	  mg,	   0.09	  mmol).	   The	   reaction	  was	   stirred	   for	   3	   h	   giving	  212/212’	  (103	  mg,	  90%)	  as	  colourless	  oil. The	  ratio	  of	  212:212’	  =	  1.5:1;	  	  
212:	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  7.88	  (s,	  1H),	  7.52	  –	  7.43	  (m,	  2H),	  7.36	  –	  7.29	  (m,	  2H),	  7.13	  –	  7.03	  (m,	  1H),	  6.02	  (ddd,	  J	  =	  10.2,	  4.6,	  2.3	  Hz,	  1H),	  	  5.66	  (dt,	  J	  =	  10.2,	  1.5	  Hz,	  1H),	  4.70	  (ddd,	  J	  =	  11.0,	  5.5,	  3.4	  Hz,	  2H),	   ,	  3.89	  –	  3.82	  (m,	  2H),	  2.42	  (br,	  1H),	   ,	  1.26	  (d,	  J	  =	  6.6	  Hz,	  3H);	  13C{1H}	  NMR	  (151	  MHz,	  CDCl3)	  δ	  154.6,	  137.6,	  130.4	  (ene),	  129.0,	  123.7,	  123.2(ene),	  119.7,	  74.5,	  63.8,	  54.6,	  18.9;	  	  
212’:	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  7.67	  (s,	  1H),	  7.44	  (d,	  J	  =	  8.0	  Hz,	  2H),	  7.28	  (t,	  J	  =	  7.7	  Hz,	  2H),	  7.05	  (t,	   J	  =	  7.4	  Hz,	  1H),	  5.85	  (d,	   J	  =	  10.6	  Hz,	  1H),	  5.80	  (d,	  J	  =	  10.3	  Hz,	  1H),	  4.78	  (s,	  1H),	  4.67	  (dd,	  J	  =	  12.6,	  6.2	  Hz,	  1H),	  3.84	  (s,	  1H),	  3.76	  (s,	  1H),	  3.18	  (s,	  1H),	  1.31	  (d,	  J	  =	  6.7	  Hz,	  3H);	  13C{1H}	  NMR	  (151	  MHz,	  CDCl3)	  δ	  155.1,	  138.0,	  131.3	  (ene),	  128.9,	  123.4,	  122.9	  (ene),	  119.6,	  80.0,	  63.7,	  49.3,	  17.0;	  FTIR	  (thin	  film)	  inter	  
alia	   1707	   (C=O),	  1600,	  1534,	  1501,	  1446,	  1314,	  1224,	  1067,	  753,	  724,	  691	  cm-­‐1;	  LRMS	   (ESI+)	   m/z	   271.2	   (M+	   +	   Na);	   HRMS	   (ESI+)	   m/z	   Calcd	   for	   C13H16N2O3Na	  271.1083	  found	  271.1069.	  	  
	  
3.13	  Reaction	  of	  1-­hydroxy-­3-­phenylurea	  171	  and	  1,3-­cyclohexadiene	  using	  
10%	  CuCl2	  and	  chiral	  ligand	  
GP13:	  General	  procedure	  for	  10%CuCl2	  and	  chiral	  ligand	  catalytic	  system	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To	   a	   methanol	   (5	   ml)	   solution	   of	   the	   1,3-­‐cyclohexadiene,	   10%	   CuCl2	   and	   10%	  ligand	   was	   added	   hydroxamic	   acid.	   The	   resulting	   solution	   was	   stirred	   at	   room	  temperature	  in	  air	  and	  was	  monitored	  by	  TLC.	  The	  completion	  of	  the	  reaction	  was	  confirmed	  by	  the	  disappearance	  of	  the	  starting	  material.	  The	  solvent	  was	  removed	  by	  evaporation	  and	   the	  crude	  product	  was	  purified	  by	  silica	  gel	   chromatography	  (hexane:	  ethyl	  acetate,	  6:1	  v/v,	  as	  eluent).	  
	  
Entry	  1,	  Table	  15	  According	   to	   GP13:	   1-­‐Hydroxy-­‐3-­‐phenylurea	   (94	   mg,	   0.62	   mmol),	   1,3-­‐cyclohexadiene	  (101	  mg,	  1.24	  mmol),	  CuCl2	  (8	  mg,	  0.06	  mmol)	  and	  2,2′-­‐bis[(4S)-­‐4-­‐benzyl-­‐2-­‐oxazoline]	   (20	  mg,	  0.06	  mmol).	  The	  reaction	  was	   finished	   in	  4	  hours	   to	  yield	  the	  white	  solid	  product	  171	  (135	  mg,	  95%).	  
	  
Entry	  2,	  Table	  15	  According	   to	   GP13:	   1-­‐Hydroxy-­‐3-­‐phenylurea	   (47	   mg,	   0.31mmol),	   1,3-­‐cyclohexadiene	   (50	   mg,	   0.62	   mmol),	   CuCl2	   (4	   mg,	   0.03	   mmol)	   and	   (+)-­‐2,2′-­‐isopropylidenebis[(4R)-­‐4-­‐benzyl-­‐2-­‐oxazoline]	   (11	   mg,	   0.03	   mmol).	   The	   reaction	  was	  completed	  in	  3	  hours	  to	  yield	  the	  white	  solid	  product	  171	  (69	  mg,	  98%).	  
	  
Entry	  3,	  Table	  15	  According	   to	   GP13:	   1-­‐Hydroxy-­‐3-­‐phenylurea	   (36	   mg,	   0.24	   mmol),	   1,3-­‐cyclohexadiene	  (38	  mg,	  0.48	  mmol),	  CuCl2	  (3	  mg,	  0.04	  mmol)	  and	  2,6-­‐bis[(4S)-­‐(−)-­‐isopropyl-­‐2-­‐oxazolin-­‐2-­‐yl]pyridine	  (7	  mg,	  0.04	  mmol).	  The	  reaction	  was	  completed	  in	  4	  hours	  to	  yield	  the	  white	  solid	  product	  171	  (53	  mg,	  96	  %).	  The	  enantiomeric	  excess	   of	   cycloadduct	  183	  was	   determined	   by	  HPLC	   using	   Chiralcel	   OD	   column,	  254	  nm	  UV	  detector,	  IPA/hexane,	  3.5:6.5	  v/v,	  giving	  peaks	  at	  retention	  times	  9.06	  and	  19.90	  minutes.	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3.14	   Reaction	   of	   (S)-­1-­Hydroxy-­3-­(1-­phenylethyl)urea	   172	   and	   1,3-­cyclo-­
hexadiene	  using	  10%	  CuCl2	  and	  chiral	  ligand	  
Entry	  1,	  Table	  16	  According	  to	  GP13:	  (S)-­‐1-­‐Hydroxy-­‐3-­‐(1-­‐phenylethyl)urea	  (97	  mg,	  0.54	  mmol),	  1,3-­‐cyclohexadiene	  (86	  mg,	  1.08	  mmol),	  CuCl2	  (7	  mg,	  0.05	  mmol)	  and	  2,2′-­‐bis[(4S)-­‐4-­‐benzyl-­‐2-­‐oxazoline]	   (17	   mg,	   0.05	   mmol).	   The	   reaction	   completed	   in	   2	   hours	   to	  yield	  the	  white	  solid	  product	  172	  (136	  mg,	  98%).	  	  
Entry	  2,	  Table	  16	  According	  to	  GP13:	  (S)-­‐1-­‐Hydroxy-­‐3-­‐(1-­‐phenylethyl)urea	  (94	  mg,	  0.52	  mmol),	  1,3-­‐cyclohexadiene	   (83	   mg,	   1.04	   mmol),	   CuCl2	   (7	   mg,	   0.05	   mmol)	   and	   (+)-­‐2,2′-­‐isopropylidene-­‐bis[(4R)-­‐4-­‐benzyl-­‐2-­‐oxazoline]	   (19	  mg,	   0.05	  mmol).	   The	   reaction	  completed	  in	  2	  hours	  to	  yield	  the	  white	  solid	  product	  172	  (133	  mg,	  99%).	  
	  
Entry	  3,	  Table	  16	  According	  to	  GP13:	  (S)-­‐1-­‐Hydroxy-­‐3-­‐(1-­‐phenylethyl)urea	  (71	  mg,	  0.39	  mmol),	  1,3-­‐cyclohexadiene	  (63	  mg,	  0.78	  mmol),	  CuCl2	  (5	  mg,	  0.04	  mmol)	  and	  2,6-­‐bis[(4S)-­‐(−)-­‐isopropyl-­‐2-­‐oxazolin-­‐2-­‐yl]pyridine	  (12	  mg,	  0.04	  mmol).	  The	  reaction	  completed	  in	  2	  hours	  to	  yield	  the	  white	  solid	  product	  172	  (99	  mg,	  98%).	  	  
Entry	  4,	  Table	  16	  According	  to	  GP13:	  (S)-­‐1-­‐Hydroxy-­‐3-­‐(1-­‐phenylethyl)urea	  (82	  mg,	  0.46	  mmol),	  1,3-­‐cyclohexadiene	  (73	  mg,	  0.92	  mmol),	  CuCl2	  (6	  mg,	  0.05	  mmol)	  and	  2,6-­‐bis[(4R)-­‐(−)-­‐isopropyl-­‐2-­‐oxazolin-­‐2-­‐yl]pyridine	  (14	  mg,	  0.05	  mmol).	  The	  reaction	  completed	  in	  2	  hours	  to	  yield	  the	  white	  solid	  product	  172	  (116	  mg,	  99%).	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3.15	  Reaction	  of	  (S)-­1-­Hydroxy-­3-­(1-­phenylethyl)urea	  172	  and	  2,3-­dimethyl-­
1,3-­butadiene	  using	  10%	  CuCl2	  and	  20%	  2-­ethyl-­2-­oxazoline	  (R)-­‐4,5-­‐Dimethyl-­‐N-­‐(1-­‐phenylethyl)-­‐3,6-­‐dihydro-­‐2H-­‐1,2-­‐oxazine-­‐2-­‐carboxamide	  
196	  To	   a	   MeOH	   (5	   ml)	   solution	   of	   2,3-­‐dimethyl-­‐1,3-­‐butadiene	   (58	   mg,	   0.71	   mmol),	  CuCl2	   (5	  mg,	  0.04	  mmol)	   	  and	  2-­‐ethyl-­‐2-­‐oxazoline	  (7	  mg,	  0.07	  mmol)	   	  was	  added	  (S)-­‐1-­‐Hydroxy-­‐3-­‐(1-­‐phenylethyl)urea	   (64	  mg,	   0.36	  mmol).	  The	   resulting	   solution	  was	  stirred	  at	   room	  temperature	   in	  air	  and	  was	  monitored	  by	  TLC.	  The	  reaction	  completed	   in	   6	   hours.	   The	   solvent	   was	   removed	   by	   evaporation	   and	   the	   crude	  product	  was	  purified	  by	  silica	  gel	  chromatography	  (hexane:ethyl	  acetate,	  6:1	  v/v,	  as	  eluent).	  The	  product	  196	  was	  obtained	  as	  a	  colourless	  oil	  (92	  mg,	  99%).	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Benzyl	  2-­‐oxa-­‐3-­‐azabicyclo[2.2.2]oct-­‐5-­‐ene-­‐3-­‐carboxylate	  140	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1-­‐(4,5-­‐Dimethyl-­‐3,6-­‐dihydro-­‐2H-­‐1,2-­‐oxazin-­‐2-­‐yl)-­‐2-­‐phenylethanone	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1-­‐(3,6-­‐Dimethyl-­‐3,6-­‐dihydro-­‐2H-­‐1,2-­‐oxazin-­‐2-­‐yl)-­‐2-­‐phenylethanone	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1-­‐((9s,10s)-­‐9,10-­‐Dimethyl-­‐9,10-­‐dihydro-­‐9,10-­‐(epoxyimino)anthracen-­‐11-­‐yl)-­‐2-­‐phenylethanone	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1-­‐(3,6-­‐Diphenyl-­‐3,6-­‐dihydro-­‐2H-­‐1,2-­‐oxazin-­‐2-­‐yl)-­‐2-­‐phenylethanone	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N-­‐Hydroxy-­‐2-­‐(pyridin-­‐2-­‐yl)acetamide	  163	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N-­‐Hydroxybenzamide	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1-­‐[{[(1S)-­‐1-­‐phenylethyl]carbamoyl})amino]-­‐N-­‐[(1R)-­‐1-­‐phenylethyl]formamide	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2-­‐Oxa-­‐3-­‐azabicyclo[2.2.2]oct-­‐5-­‐en-­‐3-­‐yl(pyridin-­‐2-­‐yl)	  methanone	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2-­‐Oxa-­‐3azabicyclo[2.2.2]oct-­‐5-­‐en-­‐3-­‐yl(pyridin-­‐3-­‐yl)methanone	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2-­‐Oxa-­‐3-­‐azabicyclo[2.2.2]oct-­‐5-­‐en-­‐3-­‐yl(phenyl)metha-­‐none	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  2-­‐Oxa-­‐3-­‐azabicyclo[2.2.2]oct-­‐5-­‐en-­‐3-­‐yl)-­‐2-­‐phenyl-­‐ethanone	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2-­‐Oxa-­‐3-­‐azabicyclo[2.2.2]oct-­‐5-­‐en-­‐3-­‐yl)-­‐4-­‐phenylbutan-­‐1-­‐one	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2-­‐Oxa-­‐3-­‐azabicyclo[2.2.2]oct-­‐5-­‐en-­‐3-­‐yl)-­‐5-­‐phenylpentan	  -­‐1-­‐one	  181	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Phenyl-­‐2-­‐oxa-­‐3-­‐azabicyclo[2.2.2]oct-­‐5-­‐ene-­‐3-­‐carboxylate	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N-­‐Phenyl-­‐2-­‐oxa-­‐3-­‐azabicyclo[2.2.2]oct-­‐5-­‐ene-­‐3-­‐carboxamide	  183	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N-­‐((R)-­‐1-­‐Phenylethyl)-­‐2-­‐oxa-­‐3-­‐azabicyclo[2.2.2]oct-­‐5-­‐ene-­‐3-­‐carboxamide	  184	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(4,5-­‐Dimethyl-­‐3,6-­‐dihydro-­‐2H-­‐1,2-­‐oxazin-­‐2-­‐yl)(pyridin-­‐2-­‐yl)methanone	  185	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(4,5-­‐Dimethyl-­‐3,6-­‐dihydro-­‐2H-­‐1,2-­‐oxazin-­‐2-­‐yl)(pyridin-­‐3-­‐yl)methanone	  186	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(4,5-­‐Dimethyl-­‐3,6-­‐dihydro-­‐2H-­‐1,2-­‐oxazin-­‐2-­‐yl)(phenyl)	  metha-­‐none	  	  189	  
	  	  	  	  














































































































	   194	  	  	  	  
1-­‐(4,5-­‐Dimethyl-­‐3,6-­‐dihydro-­‐2H-­‐1,2-­‐oxazin-­‐2-­‐yl)-­‐2-­‐phenyletha-­‐none	  190	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1-­‐(4,5-­‐Dimethyl-­‐3,6-­‐dihydro-­‐2H-­‐1,2-­‐oxazin-­‐2-­‐yl)-­‐5-­‐phenylpen-­‐tan-­‐1-­‐one	  193	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  (R)-­‐4,5-­‐Dimethyl-­‐N-­‐(1-­‐phenylethyl)-­‐3,6-­‐dihydro-­‐2H-­‐1,2-­‐oxazine-­‐2-­‐carboxamide	  
196	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Phenyl	  2-­‐oxa-­‐3-­‐azabicyclo[2.2.1]hept-­‐5-­‐ene-­‐3-­‐carboxylate	  197	  
	  	  	  	  











































































































































	   202	  	  	  	  
Phenyl	  3,6-­‐dimethyl-­‐3,6-­‐dihydro-­‐2H-­‐1,2-­‐oxazine-­‐2-­‐carboxylate	  199	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Phenyl	  4-­‐methyl-­‐3,6-­‐dihydro-­‐2H-­‐1,2-­‐oxazine-­‐2-­‐carboxylate	  	  200	  and	  phenyl	  5-­‐methyl-­‐3,6-­‐dihydro-­‐2H-­‐1,2-­‐oxazine-­‐2-­‐carboxylate	  200’	  
	  	  	  	  

















































































































































































































































































































































































	   205	  	  	  	  
Phenyl	  3,6-­‐diphenyl-­‐3,6-­‐dihydro-­‐2H-­‐1,2-­‐oxazine-­‐2-­‐carboxylate	  203	  
	  
	  	  	  	  



























































































































































	   206	  	  	  	  
Phenyl-­‐3-­‐(hydroxymethyl)-­‐6-­‐methyl-­‐3,6-­‐dihydro-­‐2H-­‐1,2-­‐oxa-­‐zine-­‐2-­‐carboxylate	  
204	  and	  phenyl	  6-­‐(hydroxymethyl)-­‐3-­‐methyl-­‐3,6-­‐dihydro-­‐2H-­‐1,2-­‐oxazine	  -­‐2-­‐carboxylate	  	  204’	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Table	  1	  Crystal	  data	  and	  structure	  refinement	  for	  09srv331	  Identification	  code	   09srv331	  Empirical	  formula	   C14H15NO3	  Formula	  weight	   245.27	  Temperature/K	   120.0	  Crystal	  system	   Triclinic	  Space	  group	   P-­‐1	  a/Å,	  b/Å,	  c/Å	   6.0126(3),	  10.4102(5),	  10.6716(5)	  α/°,	  β/°,	  γ/°	   65.453(6),	  88.454(6),	  84.712(7)	  Volume/Å3	   604.96(5)	  Z	   2	  ρcalcmg/mm3	   1.346	  m/mm‑1	   0.095	  F(000)	   260	  Crystal	  size/mm3	   0.52	  ×	  0.33	  ×	  0.31	  Theta	  range	  for	  data	  collection	   2.10	  to	  30.00°	  Index	  ranges	   -­‐8	  ≤	  h	  ≤	  8,	  -­‐14	  ≤	  k	  ≤	  14,	  -­‐15	  ≤	  l	  ≤	  15	  Reflections	  collected	   11016	  Independent	  reflections	   3525[R(int)	  =	  0.0483]	  Data/restraints/parameters	   3525/0/223	  Goodness-­‐of-­‐fit	  on	  F2	   1.062	  Final	  R	  indexes	  [I>2σ	  (I)]	   R1	  =	  0.0407,	  wR2	  =	  0.1122	  Final	  R	  indexes	  [all	  data]	   R1	  =	  0.0436,	  wR2	  =	  0.1154	  Largest	  diff.	  peak/hole	  /	  e	  Å-­‐3	   0.444/-­‐0.201	  	  
Table	  2	  Atomic	  Coordinates	  (Å×104)	  and	  Equivalent	  Isotropic	  
Displacement	  Parameters	  (Å2×103)	  for	  09srv331.	  Ueq	  is	  defined	  as	  1/3	  of	  of	  
the	  trace	  of	  the	  orthogonalised	  UIJ	  tensor.	  
Atom	   x	   y	   z	   U(eq)	  O1	   3590(11)	   4154.8(6)	   2706(7)	   21.22(15)	  O2	   6763.6(12)	   4004.2(6)	   4260.1(7)	   24.46(16)	  O3	   3963.9(12)	   1802.9(7)	   3220.7(7)	   25.17(16)	  N3	   6536.7(13)	   2770.2(7)	   4004.3(8)	   20.49(16)	  C1	   7487.8(15)	   3565.9(9)	   5693.7(9)	   22.12(18)	  C4	   7160(14)	   1429.4(8)	   5231.7(9)	   19.97(17)	  C5	   5704.5(16)	   1431.3(10)	   6404.5(10)	   24.71(19)	  
	   214	  	  	  	  
C6	   5869.1(17)	   2611.3(11)	   6636.5(11)	   29.7(2)	  C7	   9784.3(15)	   2758.4(10)	   5866.5(10)	   23.97(18)	  C8	   9591.7(15)	   1476.1(10)	   5558.4(10)	   24.44(19)	  C9	   4582.5(14)	   2833.5(9)	   3321.8(9)	   18.7(17)	  C10	   1608.1(16)	   4263.8(9)	   1893.2(9)	   22.74(18)	  C11	   984.6(15)	   5809.6(9)	   1037.9(9)	   20.91(18)	  C12	   2447.7(17)	   6623.1(11)	   52.9(11)	   30(2)	  C13	   1839(2)	   8046.2(11)	   -­‐767.7(12)	   34.5(2)	  C14	   -­‐237(2)	   8660.7(10)	   -­‐612.6(10)	   32.1(2)	  C15	   -­‐1710.1(19)	   7856.1(11)	   354(11)	   31.7(2)	  C16	   -­‐1094.4(17)	   6429.3(10)	   1183.1(10)	   25.99(19)	  
	  
	  
Table	  3	  Anisotropic	  Displacement	  Parameters	  (Å2×103)	  for	  09srv331.	  The	  
Anisotropic	  displacement	  factor	  exponent	  takes	  the	  form:	  -­
2π2[h2a*2U11+...+2hka×b×U12]	  
Atom	   U11	   U22	   U33	   U23	   U13	   U12	  O1	   25.4(3)	   15.3(3)	   22.2(3)	   -­‐7.1(2)	   -­‐6.9(2)	   0.9(2)	  O2	   31.8(3)	   12.9(3)	   26.2(3)	   -­‐4.7(2)	   -­‐9(3)	   -­‐3.5(2)	  O3	   31.2(4)	   17(3)	   28.2(3)	   -­‐10(3)	   -­‐4(3)	   -­‐2.8(2)	  N3	   23.3(4)	   13.1(3)	   22.7(3)	   -­‐4.9(3)	   -­‐3.3(3)	   -­‐1.5(2)	  C1	   25.4(4)	   18(4)	   22.9(4)	   -­‐8.6(3)	   -­‐2.1(3)	   -­‐0.3(3)	  C4	   22.1(4)	   13.7(3)	   21(4)	   -­‐4.5(3)	   -­‐0.1(3)	   0.6(3)	  C5	   22.5(4)	   21.4(4)	   27(4)	   -­‐6.8(3)	   5.6(3)	   -­‐3.7(3)	  C6	   28.3(5)	   26.3(5)	   30.3(5)	   -­‐8.8(4)	   7.9(4)	   1.2(4)	  C7	   21.2(4)	   23.4(4)	   27.2(4)	   -­‐10.1(3)	   -­‐3.8(3)	   -­‐2(3)	  C8	   19.3(4)	   25.9(4)	   22.8(4)	   -­‐5.7(3)	   -­‐0.3(3)	   2.7(3)	  C9	   21.7(4)	   15.9(3)	   17.6(3)	   -­‐6.2(3)	   0.8(3)	   -­‐0.9(3)	  C10	   26(4)	   18.6(4)	   22.5(4)	   -­‐7.1(3)	   -­‐7.4(3)	   -­‐1.2(3)	  C11	   25.9(4)	   19(4)	   17.5(4)	   -­‐7.1(3)	   -­‐4.8(3)	   -­‐1.1(3)	  C12	   27(5)	   26.4(5)	   30.3(5)	   -­‐5.7(4)	   0.3(4)	   -­‐2.5(4)	  C13	   40.2(6)	   25.7(5)	   29.4(5)	   -­‐2.6(4)	   1.9(4)	   -­‐7.4(4)	  C14	   48.9(6)	   20(4)	   22.9(4)	   -­‐5(3)	   -­‐5.5(4)	   1.7(4)	  C15	   40.4(6)	   25.9(5)	   26.3(5)	   -­‐10.5(4)	   -­‐0.3(4)	   7.5(4)	  C16	   32.5(5)	   23.5(4)	   20.5(4)	   -­‐8.3(3)	   1.8(3)	   0.7(3)	  
	  
	  
Table	  4	  Bond	  Lengths	  for	  09srv331.	  
Atom	   Atom	   Length/Å	   Atom	   Atom	   Length/Å	  O1	   C9	   1.3411(10)	   C4	   C8	   1.5220(13)	  O1	   C10	   1.4609(10)	   C5	   C6	   1.3625(14)	  O2	   N3	   1.4383(9)	   C7	   C8	   1.5161(13)	  O2	   C1	   1.4689(11)	   C10	   C11	   1.5001(12)	  O3	   C9	   1.2137(10)	   C11	   C16	   1.3881(13)	  N3	   C9	   1.3811(11)	   C11	   C12	   1.3942(13)	  N3	   C4	   1.4885(11)	   C12	   C13	   1.3911(14)	  C1	   C6	   1.4972(13)	   C13	   C14	   1.3871(17)	  C1	   C7	   1.5226(13)	   C14	   C15	   1.3856(16)	  C4	   C5	   1.5083(13)	   C15	   C16	   1.3966(13)	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Table	  5	  Bond	  Angles	  for	  09srv331.	  
Atom	   Atom	   Atom	   Angle/˚	   Atom	   Atom	   Atom	   Angle/˚	  C9	   O1	   C10	   113.73(7)	   C7	   C8	   C4	   108.79(7)	  N3	   O2	   C1	   109.64(6)	   O3	   C9	   O1	   124.90(8)	  C9	   N3	   O2	   113.92(7)	   O3	   C9	   N3	   122.12(8)	  C9	   N3	   C4	   116.70(7)	   O1	   C9	   N3	   112.75(7)	  O2	   N3	   C4	   112.21(7)	   O1	   C10	   C11	   107.41(7)	  O2	   C1	   C6	   109.09(7)	   C16	   C11	   C12	   119.38(8)	  O2	   C1	   C7	   107.30(7)	   C16	   C11	   C10	   120.15(8)	  C6	   C1	   C7	   109.71(7)	   C12	   C11	   C10	   120.41(8)	  N3	   C4	   C5	   107.58(7)	   C13	   C12	   C11	   120.33(10)	  N3	   C4	   C8	   106.14(7)	   C14	   C13	   C12	   119.99(10)	  C5	   C4	   C8	   109.87(8)	   C15	   C14	   C13	   120.05(9)	  C6	   C5	   C4	   111.79(8)	   C14	   C15	   C16	   119.96(10)	  C5	   C6	   C1	   112.48(8)	   C11	   C16	   C15	   120.28(9)	  C8	   C7	   C1	   108.71(7)	   	  	   	  	   	  	   	  	  
	  
	  
Table	  6	  Hydrogen	  Atom	  Coordinates	  (Å×104)	  and	  Isotropic	  Displacement	  
Parameters	  (Å2×103)	  for	  09srv331.	  
Atom	   x	   y	   z	   U(eq)	  H1	   7490(2)	   4457(14)	   5776(14)	   24(3)	  H4	   6940(2)	   668(14)	   4960(14)	   26(3)	  H5	   4690(3)	   746(19)	   6823(18)	   52(5)	  H6	   5040(3)	   2880(19)	   7270(19)	   54(5)	  H7A	   10870(3)	   3370(2)	   5320(2)	   58(5)	  H7B	   10350(3)	   2510(18)	   6774(19)	   51(5)	  H8A	   10500(3)	   1465(17)	   4806(17)	   43(4)	  H8B	   10130(3)	   548(19)	   6318(19)	   51(4)	  H10B	   430(2)	   3810(14)	   2545(15)	   28(3)	  H10A	   1980(2)	   3756(14)	   1312(14)	   28(3)	  H12	   3940(3)	   6176(16)	   -­‐34(16)	   41(4)	  H13	   2910(3)	   8581(18)	   -­‐1443(18)	   50(4)	  H14	   -­‐690(3)	   9667(17)	   -­‐1191(18)	   46(4)	  H15	   -­‐3230(3)	   8310(19)	   448(18)	   51(4)	  H16	   -­‐2150(2)	   5853(16)	   1912(16)	   37(4)	  	  
Experimental	  Single	   crystals	   of	   C14H15NO3	   [09srv331]	   were	   recrystallised	   from	  
[solvents]	   mounted	   in	   inert	   oil	   and	   transferred	   to	   the	   cold	   gas	   stream	   of	   the	  diffractometer.	  
Crystal	  structure	  determination	  of	  [09srv331]	  
Crystal	   Data.	   C14H15NO3,	   M	  =245.27,	   Triclinic,	   a	  =	   6.0126(3)	  Å,	   b	  =	  10.4102(5)	  Å,	   c	  =	   10.6716(5)	  Å,	  α	  =	   65.453(6)°,	   β	  =	   88.454(6)°,	   γ	  =	   84.712(7)°,	  
U	  =	   604.96(5)	  Å3,	  T	  =	   120.0,	   space	   group	   P-­‐1	   (no.	   2),	   Z	  =	   2,	   μ(Mo-­‐Kα)	  =	   0.095,	  11016	  reflections	  measured,	  3525	  unique	  (Rint	  =	  0.0483)	  which	  were	  used	  in	  all	  calculations.	  The	  final	  wR(F2)	  was	  0.1154	  (all	  data).	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  This	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  has	  been	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  with	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  30	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1-­‐((9s,10s)-­‐9,10-­‐Dimethyl-­‐9,10-­‐dihydro-­‐9,10-­‐(epoxyimino)anthracen-­‐11-­‐yl)-­‐2-­‐phenylethanone	  152	  	  	  	  	  
10srv180	  
	  	  	  	  	  
10srv180	  	  
Table	  1:	  Crystal	  data	  and	  structure	  refinement	  for	  10srv180	  Identification	  code	   10srv180	  Empirical	  formula	   C24H21NO3	  Formula	  weight	   371.42	  Temperature  /  K	   120	  Crystal	  system	   monoclinic	  Space	  group	   P21/c	  a  /  Å,	  b  /  Å,	  c  /  Å	   8.3176(3),	  16.6568(4),	  13.6584(4)	  α/°,	  β/°,	  γ/°	   90.00,	  90.566(7),	  90.00	  Volume  /  Å3	   1892.21(10)	  Z	   4	  ρcalc  /  mg	  mm-­‐3	   1.304	  μ  /  mm‑1	   0.086	  F(000)	   784	  Crystal	  size  /  mm3	   0.6	  ×	  0.08	  ×	  0.07	  2Θ	  range	  for	  data	  collection	   4.9	  to	  55°	  Index	  ranges	   -­‐10	  ≤	  h	  ≤	  10,	  -­‐21	  ≤	  k	  ≤	  21,	  -­‐17	  ≤	  l	  ≤	  17	  Reflections	  collected	   21447	  Independent	  reflections	   4332[R(int)	  =	  0.0309]	  Data/restraints/parameters	   4332/0/337	  Goodness-­‐of-­‐fit	  on	  F2	   1.024	  Final	  R	  indexes	  [I>2σ	  (I)]	   R1	  =	  0.0390,	  wR2	  =	  0.0968	  Final	  R	  indexes	  [all	  data]	   R1	  =	  0.0503,	  wR2	  =	  0.1061	  Largest	  diff.	  peak/hole  /  e	  Å-­‐3	   0.306/-­‐0.192	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Table	  2	  Fractional	  Atomic	  Coordinates	  (×104)	  and	  Equivalent	  Isotropic	  
Displacement	  Parameters	  (Å2×103)	  for	  10srv180.	  Ueq	  is	  defined	  as	  1/3	  of	  of	  
the	  trace	  of	  the	  orthogonalised	  UIJ	  tensor.	  
Atom	   x	   y	   z	   U(eq)	  O1	   2546.9(12)	   5651.1(5)	   1919.8(7)	   28.0(2)	  O2	   3689.7(10)	   4331.4(5)	   1528.8(6)	   22.5(2)	  O3	   2523.4(11)	   5447.7(5)	   3551.8(6)	   25.3(2)	  N	   3002.6(12)	   4405.2(6)	   2489.2(7)	   19.2(2)	  C1	   5154.4(15)	   3822.5(7)	   1539.9(9)	   21.7(3)	  C2	   2736.0(14)	   5207.1(7)	   2726.7(9)	   20.0(2)	  C3	   1882(2)	   6448.2(8)	   2075.1(10)	   30.9(3)	  C4	   3766.2(14)	   3839.2(7)	   3225.2(8)	   18.7(2)	  C5	   5517.3(14)	   4103.7(7)	   3278.9(9)	   19.2(2)	  C6	   6246.4(14)	   4115.3(7)	   2355.9(9)	   20.7(2)	  C7	   4554.0(15)	   2999.6(7)	   1831.9(9)	   20.9(2)	  C8	   3740.2(14)	   3017.4(7)	   2724.1(9)	   20.2(2)	  C9	   1123.7(15)	   6704.5(8)	   1122.9(9)	   22.5(3)	  C10	   101.5(16)	   6187.5(9)	   607.9(10)	   28.3(3)	  C11	   -­‐605.3(18)	   6435.7(10)	   -­‐265.2(11)	   35.9(3)	  C12	   -­‐300.1(19)	   7194.4(10)	   -­‐632.2(11)	   37.9(4)	  C13	   703.1(19)	   7708.6(9)	   -­‐125.1(11)	   33.7(3)	  C14	   1412.6(16)	   7465.4(8)	   753.8(10)	   26.0(3)	  C15	   5798.1(18)	   3897.5(9)	   516(1)	   28.9(3)	  C16	   7837.3(16)	   4356.2(8)	   2267.7(11)	   26.7(3)	  C17	   8689.6(16)	   4582.6(8)	   3107.8(11)	   29.7(3)	  C18	   7971.6(16)	   4572.2(8)	   4013.3(11)	   27.6(3)	  C19	   6367.3(15)	   4337.1(7)	   4108.7(10)	   22.5(3)	  C20	   4719.2(16)	   2285.7(8)	   1320.7(10)	   26.3(3)	  C21	   4054.2(17)	   1587.3(8)	   1704.2(11)	   30.1(3)	  C22	   3219.7(17)	   1608.5(8)	   2574.7(11)	   30.1(3)	  C23	   3052.1(16)	   2326.1(8)	   3094.7(10)	   25.8(3)	  C24	   2867.2(16)	   3832.7(8)	   4183.9(9)	   23.2(3)	  	  
Table	  3	  Anisotropic	  Displacement	  Parameters	  (Å2×103)	  for	  10srv180.	  The	  
Anisotropic	  displacement	  factor	  exponent	  takes	  the	  form:	  -­
2π2[h2a*2U11+...+2hka×b×U12]	  
Atom	   U11	   U22	   U33	   U23	   U13	   U12	  O1	   39.9(5)	   21.5(5)	   22.4(5)	   2.1(4)	   0.5(4)	   9.0(4)	  O2	   24.7(4)	   25.9(5)	   16.9(4)	   0.2(3)	   1.1(3)	   5.9(4)	  O3	   32.0(5)	   22.6(4)	   21.1(5)	   -­‐1.6(4)	   -­‐1.0(4)	   1.1(4)	  N	   19.2(5)	   22.0(5)	   16.3(5)	   -­‐0.7(4)	   0.4(4)	   2.4(4)	  C1	   21.3(6)	   22.2(6)	   21.5(6)	   -­‐1.3(5)	   1.6(5)	   2.6(5)	  C2	   16.3(5)	   22.1(6)	   21.6(6)	   0.1(5)	   -­‐2.1(4)	   -­‐0.6(4)	  C3	   46.8(9)	   20.3(6)	   25.6(7)	   -­‐1.4(5)	   -­‐5.9(6)	   8.7(6)	  C4	   19.0(6)	   18.8(6)	   18.2(6)	   0.6(4)	   -­‐1.1(4)	   1.0(4)	  C5	   18.0(6)	   15.4(5)	   24.4(6)	   -­‐0.2(4)	   -­‐1.3(4)	   2.0(4)	  
	   219	  	  	  	  
C6	   20.0(6)	   17.1(5)	   24.8(6)	   -­‐0.6(5)	   0.7(5)	   1.9(4)	  C7	   20.1(6)	   20.7(6)	   21.8(6)	   -­‐1.9(5)	   -­‐3.5(5)	   1.2(5)	  C8	   18.5(6)	   20.3(6)	   21.8(6)	   -­‐1.0(5)	   -­‐4.1(4)	   -­‐0.2(4)	  C9	   24.0(6)	   22.1(6)	   21.4(6)	   -­‐1.1(5)	   0.9(5)	   3.6(5)	  C10	   26.0(7)	   27.2(7)	   31.9(7)	   -­‐4.4(6)	   4.1(5)	   -­‐2.8(5)	  C11	   24.8(7)	   46.6(9)	   36.1(8)	   -­‐14.5(7)	   -­‐5.4(6)	   3.3(6)	  C12	   40.2(8)	   47.8(9)	   25.5(7)	   -­‐3.3(6)	   -­‐7.3(6)	   19.6(7)	  C13	   43.7(8)	   29.0(7)	   28.6(7)	   3.9(6)	   2.8(6)	   11.4(6)	  C14	   28.5(7)	   21.6(6)	   28.0(7)	   -­‐1.6(5)	   0.6(5)	   2.5(5)	  C15	   33.3(7)	   31.1(7)	   22.3(6)	   -­‐0.5(5)	   6.8(5)	   3.4(6)	  C16	   21.7(6)	   22.1(6)	   36.5(8)	   0.7(5)	   4.7(5)	   1.1(5)	  C17	   16.8(6)	   24.2(6)	   48.2(9)	   -­‐2.1(6)	   -­‐1.2(6)	   -­‐1.2(5)	  C18	   23.4(6)	   20.8(6)	   38.4(8)	   -­‐5.6(5)	   -­‐8.8(6)	   1.9(5)	  C19	   23.4(6)	   18.1(6)	   25.9(6)	   -­‐2.4(5)	   -­‐3.8(5)	   3.3(5)	  C20	   26.5(6)	   27.1(7)	   25.1(7)	   -­‐5.2(5)	   -­‐4.5(5)	   3.0(5)	  C21	   34.3(7)	   21.3(6)	   34.3(7)	   -­‐6.5(6)	   -­‐8.4(6)	   2.2(5)	  C22	   32.9(7)	   20.7(6)	   36.5(8)	   1.2(6)	   -­‐6.2(6)	   -­‐4.2(5)	  C23	   25.9(6)	   23.5(6)	   27.9(7)	   1.2(5)	   -­‐2.6(5)	   -­‐2.9(5)	  C24	   25.2(6)	   23.6(6)	   20.7(6)	   1.7(5)	   2.4(5)	   1.2(5)	  	  
Table	  4	  Bond	  Lengths	  for	  10srv180.	  
Atom	   Atom	   Length/Å	   Atom	   Atom	   Length/Å	  O1	   C2	   1.3352(15)	   C6	   C16	   1.3892(17)	  O1	   C3	   1.4548(16)	   C7	   C8	   1.4001(17)	  O2	   N	   1.4413(13)	   C7	   C20	   1.3865(17)	  O2	   C1	   1.4841(14)	   C8	   C23	   1.3839(18)	  O3	   C2	   1.2106(15)	   C9	   C10	   1.3955(18)	  N	   C2	   1.3928(15)	   C9	   C14	   1.3860(18)	  N	   C4	   1.5133(15)	   C10	   C11	   1.387(2)	  C1	   C6	   1.5117(17)	   C11	   C12	   1.384(2)	  C1	   C7	   1.5136(17)	   C12	   C13	   1.378(2)	  C1	   C15	   1.5075(18)	   C13	   C14	   1.393(2)	  C3	   C9	   1.5016(18)	   C16	   C17	   1.395(2)	  C4	   C5	   1.5227(16)	   C17	   C18	   1.379(2)	  C4	   C8	   1.5306(17)	   C18	   C19	   1.3980(19)	  C4	   C24	   1.5144(17)	   C20	   C21	   1.393(2)	  C5	   C6	   1.4044(17)	   C21	   C22	   1.383(2)	  C5	   C19	   1.3855(17)	   C22	   C23	   1.3980(19)	  
	  
Table	  5	  Bond	  Angles	  for	  10srv180.	  
Atom	   Atom	   Atom	   Angle/˚	   	  	   Atom	   Atom	   Atom	   Angle/˚	  C2	   O1	   C3	   115.28(10)	   	  	   C16	   C6	   C1	   126.52(12)	  N	   O2	   C1	   111.85(8)	   	  	   C16	   C6	   C5	   120.13(12)	  O2	   N	   C4	   112.57(8)	   	  	   C8	   C7	   C1	   111.95(10)	  C2	   N	   O2	   111.06(9)	   	  	   C20	   C7	   C1	   127.54(12)	  C2	   N	   C4	   120.62(10)	   	  	   C20	   C7	   C8	   120.50(12)	  O2	   C1	   C6	   108.09(9)	   	  	   C7	   C8	   C4	   113.78(10)	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O2	   C1	   C7	   104.30(9)	   	  	   C23	   C8	   C4	   125.79(11)	  O2	   C1	   C15	   104.02(10)	   	  	   C23	   C8	   C7	   120.39(12)	  C6	   C1	   C7	   107.17(10)	   	  	   C10	   C9	   C3	   120.64(12)	  C15	   C1	   C6	   116.16(11)	   	  	   C14	   C9	   C3	   120.14(12)	  C15	   C1	   C7	   116.14(11)	   	  	   C14	   C9	   C10	   119.21(12)	  O1	   C2	   N	   110.89(10)	   	  	   C11	   C10	   C9	   120.01(13)	  O3	   C2	   O1	   124.61(11)	   	  	   C12	   C11	   C10	   120.39(14)	  O3	   C2	   N	   124.01(11)	   	  	   C13	   C12	   C11	   119.85(14)	  O1	   C3	   C9	   106.87(10)	   	  	   C12	   C13	   C14	   120.13(14)	  N	   C4	   C5	   104.29(9)	   	  	   C9	   C14	   C13	   120.40(13)	  N	   C4	   C8	   104.84(9)	   	  	   C6	   C16	   C17	   118.92(13)	  N	   C4	   C24	   111.80(10)	   	  	   C18	   C17	   C16	   120.89(12)	  C5	   C4	   C8	   106.83(9)	   	  	   C17	   C18	   C19	   120.62(12)	  C24	   C4	   C5	   116.14(10)	   	  	   C5	   C19	   C18	   118.83(12)	  C24	   C4	   C8	   112.04(10)	   	  	   C7	   C20	   C21	   119.04(13)	  C6	   C5	   C4	   112.46(10)	   	  	   C22	   C21	   C20	   120.44(12)	  C19	   C5	   C4	   126.92(11)	   	  	   C21	   C22	   C23	   120.79(13)	  C19	   C5	   C6	   120.59(11)	   	  	   C8	   C23	   C22	   118.81(13)	  C5	   C6	   C1	   113.31(10)	   	  	   	  	   	  	   	  	   	  	  
	  
Table	  6	  Hydrogen	  Atom	  Coordinates	  (Å×104)	  and	  Isotropic	  Displacement	  
Parameters	  (Å2×103)	  for	  10srv180.	  
Atom	   x	   y	   z	   U(eq)	  H3A	   1090.0(2)	   6428(11)	   2638(13)	   43(5)	  H3B	   2760.0(2)	   6809(10)	   2276(12)	   37(4)	  H10	   -­‐100.0(2)	   5642(10)	   870(12)	   37(4)	  H11	   -­‐1290.0(2)	   6077(11)	   -­‐614(13)	   45(5)	  H12	   -­‐780.0(2)	   7367(11)	   -­‐1234(13)	   45(5)	  H13	   950.0(2)	   8241(12)	   -­‐390(13)	   50(5)	  H14	   2110.0(2)	   7833(10)	   1121(12)	   33(4)	  H15A	   4970.0(2)	   3712(10)	   33(12)	   35(4)	  H15B	   6730.0(2)	   3548(10)	   447(12)	   38(4)	  H15C	   6090.0(2)	   4467(10)	   382(12)	   37(4)	  H16	   8332(18)	   4358(9)	   1627(11)	   26(4)	  H17	   9800.0(2)	   4749(10)	   3057(11)	   35(4)	  H18	   8574(19)	   4725(9)	   4599(11)	   29(4)	  H19	   5839(19)	   4328(9)	   4766(12)	   29(4)	  H20	   5331(19)	   2276(9)	   713(12)	   30(4)	  H21	   4170.0(2)	   1079(10)	   1364(12)	   34(4)	  H22	   2750.0(2)	   1127(10)	   2824(12)	   33(4)	  H23	   2476(19)	   2321(9)	   3716(12)	   31(4)	  H24A	   1690.0(2)	   3729(10)	   4061(11)	   30(4)	  H24B	   3267(18)	   3386(9)	   4590(11)	   26(4)	  H24C	   2989(19)	   4348(10)	   4548(12)	   31(4)	  	  
Experimental	  Single	   crystals	   of	   C24H21NO3	   [10srv180]	   were	   recrystallised	   from	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[solvents]	   mounted	   in	   inert	   oil	   and	   transferred	   to	   the	   cold	   gas	   stream	   of	   the	  diffractometer.	  
Crystal	  structure	  determination	  of	  [10srv180]	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1-­‐Hydroxy-­‐3-­‐phenylurea	  171	  	  	  	  	  	  	  	  
12srv074	  	  
	  
Table	  1	  Crystal	  data	  and	  structure	  refinement	  for	  12srv074	  Identification	  code	   12srv074	  Empirical	  formula	   C7H8N2O2	  Formula	  weight	   152.15	  Temperature/K	   120	  Crystal	  system	   triclinic	  Space	  group	   P-­‐1	  a/Å	   5.3049(4)	  b/Å	   5.9648(5)	  c/Å	   24.0989(18)	  α/°	   94.598(18)	  β/°	   90.430(18)	  γ/°	   110.027(16)	  Volume/Å3	   713.64(10)	  Z	   4	  ρcalcmg/mm3	   1.416	  m/mm‑1	   0.106	  F(000)	   320.0	  Crystal	  size/mm3	   0.26	  ×	  0.12	  ×	  0.06	  2Θ	  range	  for	  data	  collection	   1.7	  to	  49.98°	  Index	  ranges	   -­‐6	  ≤	  h	  ≤	  6,	  -­‐7	  ≤	  k	  ≤	  7,	  -­‐28	  ≤	  l	  ≤	  28	  Reflections	  collected	   8767	  Independent	  reflections	   2514[R(int)	  =	  0.0620]	  Data/restraints/parameters	   2514/0/223	  Goodness-­‐of-­‐fit	  on	  F2	   0.995	  Final	  R	  indexes	  [I>=2σ	  (I)]	   R1	  =	  0.0383,	  wR2	  =	  0.0897	  Final	  R	  indexes	  [all	  data]	   R1	  =	  0.0546,	  wR2	  =	  0.0962	  Largest	  diff.	  peak/hole	  /	  e	  Å-­‐3	   0.18/-­‐0.21	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Table	  2	  Fractional	  Atomic	  Coordinates	  (×104)	  and	  Equivalent	  Isotropic	  
Displacement	  Parameters	  (Å2×103)	  for	  12srv074.	  Ueq	  is	  defined	  as	  1/3	  of	  of	  
the	  trace	  of	  the	  orthogonalised	  UIJ	  tensor.	  
Atom	   x	   y	   z	   U(eq)	  O1A	   12948(2)	   6160(2)	   4741.0(5)	   27.5(3)	  O2A	   7984(2)	   8484(2)	   4401.6(5)	   25.6(3)	  N1A	   11773(3)	   7936(3)	   4681.2(7)	   25.0(4)	  N2A	   8926(3)	   5227(3)	   4020.5(6)	   24.1(4)	  C1A	   9443(3)	   7220(3)	   4370.7(7)	   21.8(4)	  C2A	   6537(3)	   4192(3)	   3680.2(7)	   22.4(4)	  C3A	   5578(3)	   5568(3)	   3357.7(7)	   25.2(4)	  C4A	   3249(3)	   4497(3)	   3031.2(7)	   27.7(4)	  C5A	   1881(3)	   2053(3)	   3023.3(8)	   28.9(4)	  C6A	   2876(3)	   683(3)	   3338.9(8)	   30.2(5)	  C7A	   5195(3)	   1744(3)	   3669.3(7)	   27.5(4)	  O1B	   8044(2)	   6363(2)	   256.2(5)	   26.7(3)	  O2B	   3195(2)	   8926(2)	   598.7(5)	   24.6(3)	  N1B	   6888(3)	   8171(3)	   318.0(7)	   23.6(4)	  N2B	   4298(3)	   5985(3)	   981.8(6)	   23.3(4)	  C1B	   4678(3)	   7702(3)	   627.8(7)	   20.7(4)	  C2B	   2031(3)	   5183(3)	   1320.5(7)	   21.7(4)	  C3B	   1195(3)	   6788(3)	   1651.0(7)	   24.8(4)	  C4B	   -­‐1020(3)	   5933(3)	   1974.2(7)	   26.5(4)	  C5B	   -­‐2401(3)	   3484(3)	   1974.9(8)	   28.1(4)	  C6B	   -­‐1525(3)	   1916(3)	   1646.1(8)	   28.5(4)	  C7B	   672(3)	   2745(3)	   1318.8(7)	   26.0(4)	  	  	  
Table	  3	  Anisotropic	  Displacement	  Parameters	  (Å2×103)	  for	  12srv074.	  The	  
Anisotropic	  displacement	  factor	  exponent	  takes	  the	  form:	  -­
2π2[h2a*2U11+...+2hka×b×U12]	  
Atom	   U11	   U22	   U33	   U23	   U13	   U12	  O1A	   20.1(7)	   32.1(7)	   33.7(8)	   3.3(6)	   0.4(6)	   13.3(6)	  O2A	   20.4(6)	   30.6(7)	   28.0(7)	   -­‐1.1(5)	   -­‐0.5(5)	   12.4(5)	  N1A	   21.4(8)	   28.5(9)	   27.6(9)	   -­‐1.8(7)	   -­‐0.6(7)	   12.7(7)	  N2A	   20.6(8)	   27.5(8)	   26.6(8)	   -­‐2.4(7)	   -­‐1.8(6)	   12.7(7)	  C1A	   18.1(9)	   26.9(10)	   20.8(9)	   5.9(8)	   4.1(7)	   7.3(7)	  C2A	   19.5(9)	   28.3(10)	   20.0(9)	   -­‐1.0(7)	   1.6(7)	   9.6(7)	  C3A	   25.7(9)	   26.2(10)	   23.8(10)	   0.3(8)	   1.3(8)	   9.4(8)	  C4A	   30.3(10)	   36.6(11)	   20.6(9)	   1.3(8)	   0.5(8)	   17.7(9)	  C5A	   22.9(9)	   37.2(11)	   25.3(10)	   -­‐2.9(9)	   -­‐1.7(8)	   10.0(8)	  C6A	   26.5(10)	   28.6(10)	   31.2(11)	   1.4(8)	   1.5(8)	   4.1(8)	  C7A	   29.4(10)	   27.7(10)	   27.7(10)	   5.5(8)	   0.6(8)	   12.3(8)	  O1B	   19.9(7)	   29.1(7)	   34.3(8)	   0.8(6)	   0.8(6)	   12.8(6)	  O2B	   20.5(6)	   30.1(7)	   26.5(7)	   5.2(5)	   1.9(5)	   12.6(5)	  N1B	   21.4(8)	   27.3(8)	   26.3(9)	   6.1(7)	   1.8(7)	   12.7(6)	  N2B	   20.2(8)	   27.8(8)	   25.6(8)	   3.8(7)	   2.0(6)	   12.7(7)	  C1B	   16.0(8)	   23.8(9)	   20.7(9)	   -­‐2.2(8)	   -­‐3.5(7)	   5.9(7)	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C2B	   17.9(9)	   27.4(10)	   21.1(9)	   4.3(8)	   -­‐0.9(7)	   9.1(7)	  C3B	   25.1(10)	   24.9(10)	   24.7(9)	   3.0(8)	   -­‐1.0(8)	   8.8(8)	  C4B	   28.1(10)	   31.7(10)	   22.8(10)	   1.1(8)	   2.4(8)	   14.4(8)	  C5B	   21.8(9)	   38.1(11)	   24.6(10)	   5.4(8)	   2.2(8)	   9.7(8)	  C6B	   28.2(10)	   26.3(10)	   28.1(10)	   2.3(8)	   -­‐1.7(8)	   6.0(8)	  C7B	   27.6(10)	   26.9(10)	   24.8(10)	   -­‐1.1(8)	   -­‐0.3(8)	   12.0(8)	  	  	  
Table	  4	  Bond	  Lengths	  for	  12srv074.	  
Atom	   Atom	   Length/Å	   Atom	   Atom	   Length/Å	  O1A	   N1A	   1.4166(17)	   O1B	   N1B	   1.4106(18)	  O2A	   C1A	   1.2506(19)	   O2B	   C1B	   1.2478(18)	  N1A	   C1A	   1.358(2)	   N1B	   C1B	   1.354(2)	  N2A	   C1A	   1.347(2)	   N2B	   C1B	   1.349(2)	  N2A	   C2A	   1.424(2)	   N2B	   C2B	   1.423(2)	  C2A	   C3A	   1.385(2)	   C2B	   C3B	   1.386(2)	  C2A	   C7A	   1.386(2)	   C2B	   C7B	   1.384(2)	  C3A	   C4A	   1.385(2)	   C3B	   C4B	   1.384(2)	  C4A	   C5A	   1.387(3)	   C4B	   C5B	   1.392(3)	  C5A	   C6A	   1.383(3)	   C5B	   C6B	   1.380(2)	  C6A	   C7A	   1.385(3)	   C6B	   C7B	   1.381(2)	  	  	  
Table	  5	  Bond	  Angles	  for	  12srv074.	  
Atom	   Atom	   Atom	   Angle/˚	   Atom	   Atom	   Atom	   Angle/˚	  C1A	   N1A	   O1A	   115.79(14)	   C1B	   N1B	   O1B	   116.34(14)	  C1A	   N2A	   C2A	   123.94(14)	   C1B	   N2B	   C2B	   124.36(14)	  O2A	   C1A	   N1A	   119.24(15)	   O2B	   C1B	   N1B	   119.92(16)	  O2A	   C1A	   N2A	   123.82(15)	   O2B	   C1B	   N2B	   123.35(15)	  N2A	   C1A	   N1A	   116.84(15)	   N2B	   C1B	   N1B	   116.61(15)	  C3A	   C2A	   N2A	   121.46(16)	   C3B	   C2B	   N2B	   121.28(15)	  C3A	   C2A	   C7A	   120.13(16)	   C7B	   C2B	   N2B	   118.60(15)	  C7A	   C2A	   N2A	   118.41(16)	   C7B	   C2B	   C3B	   120.12(16)	  C4A	   C3A	   C2A	   119.80(17)	   C4B	   C3B	   C2B	   119.45(16)	  C3A	   C4A	   C5A	   120.35(17)	   C3B	   C4B	   C5B	   120.83(16)	  C6A	   C5A	   C4A	   119.53(17)	   C6B	   C5B	   C4B	   118.81(17)	  C5A	   C6A	   C7A	   120.45(17)	   C5B	   C6B	   C7B	   120.97(17)	  C6A	   C7A	   C2A	   119.73(17)	   C6B	   C7B	   C2B	   119.82(16)	  	  	  
Table	  6	  Hydrogen	  Bonds	  for	  12srv074.	  
D	   H	   A	   d(D-­H)/Å	   d(H-­A)/Å	   d(D-­A)/Å	   D-­H-­A/°	  O1A	   H1A	   O2A1	   0.95(2)	   1.77(2)	   2.7214(17)	   174.4(18)	  N1A	   H1	   O2A2	   0.90(2)	   2.03(2)	   2.918(2)	   166.8(18)	  O1B	   H1B	   O2B1	   0.89(2)	   1.83(2)	   2.7178(17)	   175(2)	  N1B	   H2	   O2B3	   0.855(19)	   2.07(2)	   2.923(2)	   172.4(16)	  11+X,+Y,+Z;	  22-­‐X,2-­‐Y,1-­‐Z;	  31-­‐X,2-­‐Y,-­‐Z	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Table	  7	  Hydrogen	  Atom	  Coordinates	  (Å×104)	  and	  Isotropic	  Displacement	  
Parameters	  (Å2×103)	  for	  12srv074.	  
Atom	   x	   y	   z	   U(eq)	  H1A	   14700(40)	   6880(40)	   4608(9)	   45(6)	  H1	   11760(40)	   8840(40)	   4998(9)	   39(6)	  H2A	   9950(30)	   4310(30)	   4083(7)	   21(5)	  H3A	   6514	   7241	   3361	   30	  H4A	   2586	   5441	   2811	   33	  H5A	   271	   1324	   2803	   35	  H6A	   1964	   -­‐997	   3329	   36	  H7A	   5863	   798	   3888	   33	  H1B	   9730(40)	   7140(40)	   383(10)	   55(7)	  H2	   6840(30)	   8900(30)	   29(8)	   19(5)	  H2B	   5270(40)	   5070(30)	   931(8)	   30(5)	  H3B	   2136	   8462	   1655	   30	  H4B	   -­‐1605	   7031	   2199	   32	  H5B	   -­‐3920	   2904	   2198	   34	  H6B	   -­‐2447	   241	   1645	   34	  H7B	   1248	   1646	   1093	   31	  	  	  
Experimental	  Single	   crystals	   of	   C7H8N2O2	   [12srv074]	   were	   [].	   A	   suitable	   crystal	   was	  selected	  and	  []	  on	  a	  Bruker	  SMART	  CCD	  6000	  diffractometer.	  The	  crystal	  was	  kept	  at	  120	  K	  during	  data	  collection.	  Using	  Olex2	   [1],	   the	   structure	  was	  solved	  with	   the	   XS	   [2]	   structure	   solution	   program	   using	   Direct	   Methods	   and	   refined	  with	  the	  XL	  [3]	  refinement	  package	  using	  Least	  Squares	  minimisation.	  1. O.	  V.	  Dolomanov,	  L.	  J.	  Bourhis,	  R.	  J.	  Gildea,	  J.	  A.	  K.	  Howard	  and	  H.	  Puschmann,	  OLEX2:	  a	  complete	  structure	  solution,	  refinement	  and	  analysis	  program.	  J.	  Appl.	  Cryst.	  (2009).	  42,	  339-­‐341.	  2. XS,	  G.M.	  Sheldrick,	  Acta	  Cryst.	  (2008).	  A64,	  112-­‐122	  3. XL,	  G.M.	  Sheldrick,	  Acta	  Cryst.	  (2008).	  A64,	  112-­‐122	  
Crystal	  structure	  determination	  of	  [12srv074]	  
Crystal	   Data.	   C7H8N2O2,	   M	  =152.15,	   triclinic,	   a	  =	   5.3049(4)	  Å,	   b	  =	  5.9648(5)	  Å,	   c	  =	   24.0989(18)	  Å,	   α	  =	   94.598(18)°,	   β	  =	   90.430(18)°,	   γ	  =	  110.027(16)°,	   V	  =	   713.64(10)	  Å3,	   T	  =	   120,	   space	   group	   P-­‐1	   (no.	   2),	   Z	  =	   4,	  μ(MoKα)	  =	  0.106,	  8767	  reflections	  measured,	  2514	  unique	  (Rint	  =	  0.0620)	  which	  were	   used	   in	   all	   calculations.	   The	   final	  wR2	   was	   0.0962	   (all	   data)	   and	  R1	   was	  0.0383	  (>2sigma(I)).	  	  This	  report	  has	  been	  created	  with	  Olex2,	  compiled	  on	  2011.11.01	  svn.r2039.	  Please	  let	  us	  know	  if	  there	  are	  any	  errors	  or	  if	  you	  would	  like	  to	  have	  additional	  featrues.	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(S)-­‐1-­‐Hydroxy-­‐3-­‐(1-­‐phenylethyl)urea	  172	  	  	  	  	  	  	  	  	  	  	  
13srv109	  
	  	  
Table	  1	  Crystal	  data	  and	  structure	  refinement	  for	  13srv109	  Identification	  code	   13srv109	  Empirical	  formula	   C9H12N2O2	  Formula	  weight	   180.21	  Temperature/K	   120	  Crystal	  system	   orthorhombic	  Space	  group	   P212121	  a/Å	   7.2202(3)	  b/Å	   10.5445(5)	  c/Å	   25.0280(13)	  α/°	   90	  β/°	   90	  γ/°	   90	  Volume/Å3	   1905.47(16)	  Z	   8	  ρcalcmg/mm3	   1.256	  m/mm‑1	   0.090	  F(000)	   768.0	  Crystal	  size/mm3	   0.53	  ×	  0.3	  ×	  0.2	  2Θ	  range	  for	  data	  collection	   3.254	  to	  60.002°	  Index	  ranges	   -­‐10	  ≤	  h	  ≤	  10,	  -­‐14	  ≤	  k	  ≤	  14,	  -­‐35	  ≤	  l	  ≤	  35	  Reflections	  collected	   20707	  Independent	  reflections	   5554[R(int)	  =	  0.0363]	  Data/restraints/parameters	   5554/0/263	  Goodness-­‐of-­‐fit	  on	  F2	   1.053	  Final	  R	  indexes	  [I>=2σ	  (I)]	   R1	  =	  0.0397,	  wR2	  =	  0.0971	  Final	  R	  indexes	  [all	  data]	   R1	  =	  0.0506,	  wR2	  =	  0.1035	  Largest	  diff.	  peak/hole	  /	  e	  Å-­‐3	   0.24/-­‐0.21	  Flack	  parameter	   -­‐1.0(5)	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Table	  2	  Fractional	  Atomic	  Coordinates	  (×104)	  and	  Equivalent	  Isotropic	  
Displacement	  Parameters	  (Å2×103)	  for	  13srv109.	  Ueq	  is	  defined	  as	  1/3	  of	  of	  
the	  trace	  of	  the	  orthogonalised	  UIJ	  tensor.	  
Atom	   x	   y	   z	   U(eq)	  O1A	   10788(2)	   5504.4(13)	   2960.2(6)	   25.4(3)	  O2A	   10402.7(19)	   8731.9(12)	   2704.3(5)	   25.3(3)	  N1A	   10867(2)	   6625.8(15)	   2650.9(6)	   23.1(3)	  N2A	   8693(2)	   7413.1(15)	   3240.1(6)	   22.7(3)	  C1A	   6090(3)	   7706.9(18)	   3823.8(7)	   22.9(4)	  C2A	   4204(3)	   7693.9(19)	   3713.6(7)	   26.9(4)	  C3A	   2977(3)	   7085(2)	   4052.3(9)	   33.6(5)	  C4A	   3612(3)	   6486(2)	   4507.6(9)	   35.2(5)	  C5A	   5497(3)	   6476(2)	   4618.7(8)	   36.0(5)	  C6A	   6722(3)	   7086(2)	   4279.7(8)	   30.0(4)	  C7A	   7434(3)	   8386.4(18)	   3457.3(7)	   23.4(4)	  C8A	   8477(3)	   9442(2)	   3745.2(9)	   34.7(5)	  C9A	   9987(3)	   7649.0(17)	   2869.1(7)	   20.8(3)	  O1B	   5708(2)	   5324.3(12)	   2948.5(6)	   25.7(3)	  O2B	   5487.9(19)	   2064.9(12)	   2755.1(5)	   26.2(3)	  N1B	   5887(2)	   4179.1(14)	   2659.2(6)	   22.9(3)	  N2B	   3504(2)	   3406.2(16)	   3184.9(6)	   24.4(3)	  C1B	   3719(3)	   2002.9(18)	   3972.5(7)	   23.5(4)	  C2B	   3515(3)	   783.4(19)	   4172.1(8)	   26.4(4)	  C3B	   4508(3)	   386(2)	   4616.7(8)	   31.7(4)	  C4B	   5702(3)	   1221(2)	   4869.1(8)	   36.8(5)	  C5B	   5910(4)	   2435(2)	   4676.3(9)	   40.3(5)	  C6B	   4923(3)	   2827(2)	   4230.8(8)	   32.9(4)	  C7B	   2575(3)	   2413.4(18)	   3490.9(7)	   22.8(3)	  C8B	   661(3)	   2889(2)	   3661.9(8)	   28.7(4)	  C9B	   4972(3)	   3160.6(17)	   2876.1(7)	   21.0(3)	  	  	  
Table	  3	  Anisotropic	  Displacement	  Parameters	  (Å2×103)	  for	  13srv109.	  The	  
Anisotropic	  displacement	  factor	  exponent	  takes	  the	  form:	  -­
2π2[h2a*2U11+...+2hka×b×U12]	  
Atom	   U11	   U22	   U33	   U23	   U13	   U12	  O1A	   29.2(7)	   17.7(6)	   29.3(7)	   0.7(5)	   0.4(6)	   -­‐0.4(6)	  O2A	   26.2(7)	   20.7(6)	   29.1(7)	   3.2(5)	   3.7(5)	   0.7(6)	  N1A	   24.0(7)	   18.9(7)	   26.6(7)	   0.3(6)	   4.6(6)	   -­‐1.0(6)	  N2A	   22.3(7)	   19.2(7)	   26.5(7)	   -­‐1.3(6)	   4.1(6)	   -­‐1.3(6)	  C1A	   22.0(8)	   23.2(9)	   23.5(7)	   -­‐3.3(7)	   3.3(6)	   0.0(7)	  C2A	   25.0(9)	   30.1(10)	   25.6(8)	   -­‐3.2(7)	   -­‐0.4(7)	   -­‐0.1(8)	  C3A	   22.0(9)	   39.6(12)	   39.3(11)	   -­‐7.4(9)	   3.0(8)	   -­‐6.9(9)	  C4A	   36.1(11)	   33.3(11)	   36.3(10)	   -­‐0.6(9)	   14.4(9)	   -­‐7.5(9)	  C5A	   38.2(12)	   40.5(12)	   29.4(10)	   8.0(9)	   4.3(9)	   0.9(10)	  C6A	   25.0(9)	   36.4(11)	   28.5(9)	   3.4(8)	   0.4(7)	   1.4(8)	  C7A	   20.5(8)	   23.8(9)	   26.0(8)	   -­‐2.3(7)	   3.9(7)	   0.4(7)	  C8A	   35.5(11)	   29(1)	   39.5(11)	   -­‐11.5(9)	   9.9(9)	   -­‐7.8(9)	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C9A	   20.8(8)	   21.8(8)	   19.8(7)	   -­‐0.7(6)	   -­‐0.8(6)	   -­‐0.4(7)	  O1B	   29.1(7)	   18.8(6)	   29.3(7)	   -­‐2.3(5)	   0.6(6)	   1.3(6)	  O2B	   27.1(7)	   20.8(6)	   30.8(7)	   -­‐3.2(5)	   5.5(5)	   0.7(5)	  N1B	   24.1(8)	   19.2(7)	   25.5(7)	   -­‐2.6(6)	   3.3(6)	   -­‐0.2(6)	  N2B	   25.7(8)	   21.2(8)	   26.3(7)	   2.1(6)	   6.1(6)	   3.0(6)	  C1B	   21.4(8)	   26.3(9)	   22.7(8)	   -­‐0.7(7)	   2.2(6)	   1.5(7)	  C2B	   25.4(9)	   24.7(9)	   29.0(9)	   -­‐1.0(7)	   1.5(7)	   1.6(8)	  C3B	   36.9(11)	   29.6(10)	   28.5(9)	   3.0(8)	   4.3(8)	   9.9(9)	  C4B	   40.4(12)	   44.3(12)	   25.5(9)	   -­‐4.2(8)	   -­‐4.8(9)	   14.1(11)	  C5B	   43.5(13)	   40.0(12)	   37.2(11)	   -­‐8.5(9)	   -­‐12.8(9)	   -­‐1.0(11)	  C6B	   37.5(11)	   28.1(10)	   33(1)	   -­‐1.7(8)	   -­‐4.9(9)	   -­‐4.5(9)	  C7B	   23.9(8)	   23.3(9)	   21.3(7)	   1.0(7)	   1.1(6)	   -­‐2.5(7)	  C8B	   23.5(9)	   36.6(11)	   26.1(8)	   3.2(8)	   2.1(7)	   1.4(9)	  C9B	   20.3(8)	   23.3(8)	   19.5(8)	   0.1(6)	   -­‐0.4(6)	   1.1(7)	  	  	  
Table	  4	  Bond	  Lengths	  for	  13srv109.	  
Atom	   Atom	   Length/Å	   Atom	   Atom	   Length/Å	  O1A	   N1A	   1.414(2)	   O1B	   N1B	   1.4140(19)	  O2A	   C9A	   1.251(2)	   O2B	   C9B	   1.251(2)	  N1A	   C9A	   1.366(2)	   N1B	   C9B	   1.373(2)	  N2A	   C7A	   1.475(2)	   N2B	   C7B	   1.460(2)	  N2A	   C9A	   1.341(2)	   N2B	   C9B	   1.337(2)	  C1A	   C2A	   1.390(3)	   C1B	   C2B	   1.387(3)	  C1A	   C6A	   1.393(3)	   C1B	   C6B	   1.389(3)	  C1A	   C7A	   1.516(3)	   C1B	   C7B	   1.524(3)	  C2A	   C3A	   1.384(3)	   C2B	   C3B	   1.389(3)	  C3A	   C4A	   1.381(3)	   C3B	   C4B	   1.385(3)	  C4A	   C5A	   1.389(3)	   C4B	   C5B	   1.377(3)	  C5A	   C6A	   1.384(3)	   C5B	   C6B	   1.386(3)	  C7A	   C8A	   1.525(3)	   C7B	   C8B	   1.531(3)	  	  	  
Table	  5	  Bond	  Angles	  for	  13srv109.	  
Atom	   Atom	   Atom	   Angle/˚	   Atom	   Atom	   Atom	   Angle/˚	  C9A	   N1A	   O1A	   115.01(14)	   C9B	   N1B	   O1B	   114.94(14)	  C9A	   N2A	   C7A	   123.76(16)	   C9B	   N2B	   C7B	   121.91(16)	  C2A	   C1A	   C6A	   118.63(18)	   C2B	   C1B	   C6B	   118.61(18)	  C2A	   C1A	   C7A	   120.81(17)	   C2B	   C1B	   C7B	   119.38(17)	  C6A	   C1A	   C7A	   120.56(17)	   C6B	   C1B	   C7B	   121.98(17)	  C3A	   C2A	   C1A	   120.68(18)	   C1B	   C2B	   C3B	   120.91(19)	  C4A	   C3A	   C2A	   120.33(19)	   C4B	   C3B	   C2B	   119.7(2)	  C3A	   C4A	   C5A	   119.6(2)	   C5B	   C4B	   C3B	   120.0(2)	  C6A	   C5A	   C4A	   120.0(2)	   C4B	   C5B	   C6B	   120.2(2)	  C5A	   C6A	   C1A	   120.76(19)	   C5B	   C6B	   C1B	   120.7(2)	  N2A	   C7A	   C1A	   106.78(15)	   N2B	   C7B	   C1B	   111.68(15)	  N2A	   C7A	   C8A	   112.22(16)	   N2B	   C7B	   C8B	   109.04(15)	  C1A	   C7A	   C8A	   112.06(15)	   C1B	   C7B	   C8B	   111.17(14)	  O2A	   C9A	   N1A	   118.54(16)	   O2B	   C9B	   N1B	   118.93(16)	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O2A	   C9A	   N2A	   124.41(16)	   O2B	   C9B	   N2B	   123.68(17)	  N2A	   C9A	   N1A	   117.03(16)	   N2B	   C9B	   N1B	   117.29(16)	  	  	  
Table	  6	  Hydrogen	  Bonds	  for	  13srv109.	  
D	   H	   A	   d(D-­H)/Å	   d(H-­A)/Å	   d(D-­A)/Å	   D-­H-­A/°	  O1A	   H01A	   O2A1	   0.88(3)	   1.77(3)	   2.6455(19)	   174(3)	  N1A	   H1NA	   O2B2	   0.88(3)	   1.98(3)	   2.859(2)	   175(2)	  N2A	   H2NA	   O1B	   0.90(3)	   2.47(3)	   3.166(2)	   134(2)	  O1B	   H01B	   O2B3	   0.89(3)	   1.80(3)	   2.6863(19)	   173(3)	  N1B	   H1NB	   O2A1	   0.88(3)	   1.99(3)	   2.868(2)	   171(2)	  N2B	   H2NB	   O1A4	   0.89(3)	   2.30(3)	   3.010(2)	   136(2)	  12-­‐X,-­‐1/2+Y,1/2-­‐Z;	  22-­‐X,1/2+Y,1/2-­‐Z;	  31-­‐X,1/2+Y,1/2-­‐Z;	  4-­‐1+X,+Y,+Z	  	  	  
Table	  7	  Torsion	  Angles	  for	  13srv109.	  
A	   B	   C	   D	   Angle/˚	   A	   B	   C	   D	   Angle/˚	  O1A	   N1A	   C9A	   O2A	   160.73(16)	   O1B	   N1B	   C9B	   O2B	   -­‐158.01(17)	  O1A	   N1A	   C9A	   N2A	   -­‐20.9(2)	   O1B	   N1B	   C9B	   N2B	   25.5(2)	  C1A	   C2A	   C3A	   C4A	   0.4(3)	   C1B	   C2B	   C3B	   C4B	   0.8(3)	  C2A	   C1A	   C6A	   C5A	   -­‐0.5(3)	   C2B	   C1B	   C6B	   C5B	   0.5(3)	  C2A	   C1A	   C7A	   N2A	   -­‐117.20(19)	   C2B	   C1B	   C7B	   N2B	   -­‐152.88(17)	  C2A	   C1A	   C7A	   C8A	   119.5(2)	   C2B	   C1B	   C7B	   C8B	   85.1(2)	  C2A	   C3A	   C4A	   C5A	   -­‐1.3(3)	   C2B	   C3B	   C4B	   C5B	   -­‐0.5(3)	  C3A	   C4A	   C5A	   C6A	   1.4(4)	   C3B	   C4B	   C5B	   C6B	   0.2(4)	  C4A	   C5A	   C6A	   C1A	   -­‐0.5(3)	   C4B	   C5B	   C6B	   C1B	   -­‐0.2(4)	  C6A	   C1A	   C2A	   C3A	   0.5(3)	   C6B	   C1B	   C2B	   C3B	   -­‐0.8(3)	  C6A	   C1A	   C7A	   N2A	   63.0(2)	   C6B	   C1B	   C7B	   N2B	   29.3(2)	  C6A	   C1A	   C7A	   C8A	   -­‐60.2(2)	   C6B	   C1B	   C7B	   C8B	   -­‐92.8(2)	  C7A	   N2A	   C9A	   O2A	   7.5(3)	   C7B	   N2B	   C9B	   O2B	   11.8(3)	  C7A	   N2A	   C9A	   N1A	   -­‐170.85(16)	   C7B	   N2B	   C9B	   N1B	   -­‐171.95(16)	  C7A	   C1A	   C2A	   C3A	   -­‐179.25(17)	   C7B	   C1B	   C2B	   C3B	   -­‐178.72(17)	  C7A	   C1A	   C6A	   C5A	   179.30(18)	   C7B	   C1B	   C6B	   C5B	   178.38(19)	  C9A	   N2A	   C7A	   C1A	   174.96(16)	   C9B	   N2B	   C7B	   C1B	   73.6(2)	  C9A	   N2A	   C7A	   C8A	   -­‐61.9(2)	   C9B	   N2B	   C7B	   C8B	   -­‐163.15(17)	  	  	  
Table	  8	  Hydrogen	  Atom	  Coordinates	  (Å×104)	  and	  Isotropic	  Displacement	  
Parameters	  (Å2×103)	  for	  13srv109.	  
Atom	   x	   y	   z	   U(eq)	  H01A	   10470(40)	   4890(20)	   2738(11)	   38(7)	  H1NA	   12000(40)	   6800(20)	   2540(9)	   29(6)	  H2NA	   8320(40)	   6600(30)	   3286(10)	   38(7)	  H2A	   3752	   8107	   3402	   32	  H3A	   1691	   7079	   3971	   40	  H4A	   2764	   6084	   4743	   42	  H5A	   5945	   6050	   4927	   43	  H6A	   8009	   7081	   4359	   36	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H7A	   6721	   8768	   3155	   28	  H81A	   9171	   9083	   4046	   43(4)	  H82A	   7592	   10072	   3879	   43(4)	  H83A	   9339	   9850	   3496	   43(4)	  H01B	   5400(40)	   5890(20)	   2700(11)	   43(7)	  H1NB	   7050(40)	   4010(20)	   2581(10)	   36(7)	  H2NB	   3170(40)	   4210(20)	   3238(10)	   33(6)	  H2B	   2684	   213	   4002	   32	  H3B	   4368	   -­‐455	   4747	   38	  H4B	   6377	   955	   5175	   44	  H5B	   6733	   3006	   4849	   48	  H6B	   5071	   3668	   4101	   39	  H7B	   2401	   1661	   3253	   27	  H81B	   793	   3696	   3852	   37(4)	  H82B	   81	   2263	   3898	   37(4)	  H83B	   -­‐115	   3013	   3345	   37(4)	  
	  
Experimental	  Single	   crystals	   of	   C9H12N2O2	   [13srv109]	   were	   [].	   A	   suitable	   crystal	   was	  selected	   and	   []	   on	   a	  Bruker	   SMART	   CCD	   6000	   diffractometer.	   The	   crystal	  was	  kept	  at	  120	  K	  during	  data	  collection.	  Using	  Olex2	  [1],	  the	  structure	  was	  solved	  with	  the	  XS	  [2]	  structure	  solution	  program	  using	  Direct	  Methods	  and	  refined	  with	   the	  ShelXL-­‐2012	  [3]	  refinement	  package	  using	  Least	  Squares	  minimisation.	  4. O.	  V.	  Dolomanov,	  L.	  J.	  Bourhis,	  R.	  J.	  Gildea,	  J.	  A.	  K.	  Howard	  and	  H.	  Puschmann,	  OLEX2:	  a	  complete	  structure	  solution,	  refinement	  and	  analysis	  program.	  J.	  Appl.	  Cryst.	  (2009).	  42,	  339-­‐341.	  5. XS,	  G.M.	  Sheldrick,	  Acta	  Cryst.	  (2008).	  A64,	  112-­‐122	  6. SHELXL-­‐2012,	  G.M.	  Sheldrick,	  Acta	  Cryst.	  (2008).	  A64,	  112-­‐122	  
Crystal	  structure	  determination	  of	  [13srv109]	  
Crystal	   Data	   for	   C9H12N2O2	   (M	  =180.21):	   orthorhombic,	   space	   group	  P212121	   (no.	   19),	   a	  =	   7.2202(3)	  Å,	   b	  =	   10.5445(5)	  Å,	   c	  =	   25.0280(13)	  Å,	   V	  =	  1905.47(16)	  Å3,	   Z	  =	   8,	   T	  =	   120	  K,	   μ(MoKα)	  =	   0.090	   mm-­‐1,	   Dcalc	  =	   1.256	  g/mm3,	  20707	   reflections	  measured	   (3.254	   ≤	   2Θ	   ≤	   60.002),	   5554	   unique	   (Rint	  =	   0.0363)	  which	  were	  used	   in	   all	   calculations.	  The	   final	  R1	  was	  0.0397	   (I	  >	  2σ(I))	   and	  wR2	  was	  0.1035	  (all	  data).	  	  This	  report	  has	  been	  created	  with	  Olex2,	  compiled	  on	  Mar	  21	  2013	  11:16:32.	  Please	  let	  us	  know	  if	  there	  are	  any	  errors	  or	  if	  you	  would	  like	  to	  have	  additional	  featrues.	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12srv020	  
	  	  
Table	  1	  Crystal	  data	  and	  structure	  refinement	  for	  12srv020	  Identification	  code	   12srv020	  Empirical	  formula	   C13H13NO2	  Formula	  weight	   215.24	  Temperature/K	   120	  Crystal	  system	   monoclinic	  Space	  group	   P21/c	  a/Å	   9.0358(9)	  b/Å	   10.3716(13)	  c/Å	   11.8962(14)	  α/°	   90.00	  β/°	   108.091(10)	  γ/°	   90.00	  Volume/Å3	   1059.7(2)	  Z	   4	  ρcalcmg/mm3	   1.349	  m/mm‑1	   0.091	  F(000)	   456.0	  Crystal	  size/mm3	   0.4	  ×	  0.3	  ×	  0.2	  2Θ	  range	  for	  data	  collection	   4.74	  to	  60°	  Index	  ranges	   -­‐11	  ≤	  h	  ≤	  12,	  -­‐14	  ≤	  k	  ≤	  14,	  -­‐16	  ≤	  l	  ≤	  16	  Reflections	  collected	   11139	  Independent	  reflections	   3094[R(int)	  =	  0.0274]	  Data/restraints/parameters	   3094/0/145	  Goodness-­‐of-­‐fit	  on	  F2	   1.053	  Final	  R	  indexes	  [I>=2σ	  (I)]	   R1	  =	  0.0465,	  wR2	  =	  0.1252	  Final	  R	  indexes	  [all	  data]	   R1	  =	  0.0534,	  wR2	  =	  0.1317	  Largest	  diff.	  peak/hole	  /	  e	  Å-­‐3	   0.41/-­‐0.20	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Table	  2	  Fractional	  Atomic	  Coordinates	  (×104)	  and	  Equivalent	  Isotropic	  
Displacement	  Parameters	  (Å2×103)	  for	  12srv020.	  Ueq	  is	  defined	  as	  1/3	  of	  of	  
the	  trace	  of	  the	  orthogonalised	  UIJ	  tensor.	  
Atom	   x	   y	   z	   U(eq)	  O1	   4140.9(9)	   2532.4(7)	   1001.4(8)	   22.64(19)	  O2	   7086.7(10)	   299.5(8)	   2190.2(7)	   24.5(2)	  N1	   4833.1(11)	   1269.7(8)	   1151.3(8)	   19.6(2)	  C1	   6419.7(12)	   1259.9(10)	   1665.2(9)	   17.9(2)	  C2	   3871.6(13)	   307.3(10)	   1527.8(10)	   21.0(2)	  C3	   3791.8(14)	   751.3(12)	   2716.6(10)	   24.7(2)	  C4	   3259.1(14)	   1961.1(12)	   2679.8(10)	   24.8(2)	  C5	   2801.3(13)	   2536.7(11)	   1464.5(10)	   21.3(2)	  C6	   1550.5(13)	   1706.3(12)	   618.2(10)	   24.8(2)	  C7	   2243.7(13)	   353.0(11)	   610(1)	   23.4(2)	  C8	   7307.4(12)	   2403.6(10)	   1462.9(9)	   17.5(2)	  C9	   8619.6(13)	   2788.5(11)	   2374.9(10)	   21.4(2)	  C10	   9515.8(14)	   3817.8(11)	   2207.5(10)	   24.1(2)	  C11	   9122.8(14)	   4439.0(11)	   1120.4(10)	   24.7(2)	  C12	   7834.1(14)	   4041.6(11)	   200(1)	   23.9(2)	  C13	   6912.5(13)	   3032.2(11)	   372.1(9)	   20.7(2)	  	  	  
Table	  3	  Anisotropic	  Displacement	  Parameters	  (Å2×103)	  for	  12srv020.	  The	  
Anisotropic	  displacement	  factor	  exponent	  takes	  the	  form:	  -­
2π2[h2a*2U11+...+2hka×b×U12]	  
Atom	   U11	   U22	   U33	   U23	   U13	   U12	  O1	   19.5(4)	   17.5(4)	   32.4(4)	   6.3(3)	   10.2(3)	   3.9(3)	  O2	   23.3(4)	   22.0(4)	   27.7(4)	   6.6(3)	   7.2(3)	   4.5(3)	  N1	   18.9(4)	   15.1(4)	   25.3(4)	   2.5(3)	   7.6(4)	   0.8(3)	  C1	   19.5(5)	   18.2(5)	   16.9(4)	   0.1(3)	   7.0(4)	   0.8(3)	  C2	   20.3(5)	   17.7(5)	   25.2(5)	   1.1(4)	   7.6(4)	   -­‐3.1(4)	  C3	   21.9(5)	   30.6(6)	   20.7(5)	   2.5(4)	   5.3(4)	   -­‐6.8(4)	  C4	   22.2(5)	   32.2(6)	   20.0(5)	   -­‐6.9(4)	   6.3(4)	   -­‐5.6(4)	  C5	   17.8(5)	   21.4(5)	   25.0(5)	   -­‐3.3(4)	   6.8(4)	   0.5(4)	  C6	   18.8(5)	   30.2(6)	   23.7(5)	   -­‐4.6(4)	   4.1(4)	   -­‐1.0(4)	  C7	   21.5(5)	   23.6(5)	   24.0(5)	   -­‐5.6(4)	   5.8(4)	   -­‐4.1(4)	  C8	   17.0(5)	   18.6(5)	   18.2(4)	   0.6(3)	   7.3(4)	   0.8(3)	  C9	   18.3(5)	   26.1(5)	   19.6(5)	   0.2(4)	   5.4(4)	   -­‐0.1(4)	  C10	   18.9(5)	   28.4(6)	   25.2(5)	   -­‐4.3(4)	   7.2(4)	   -­‐4.2(4)	  C11	   25.3(6)	   23.5(5)	   30.0(6)	   -­‐2.8(4)	   15.6(5)	   -­‐5.1(4)	  C12	   28.9(6)	   23.9(5)	   21.7(5)	   2.5(4)	   12.1(4)	   -­‐2.3(4)	  C13	   21.5(5)	   22.6(5)	   18.0(4)	   0.4(4)	   6.0(4)	   -­‐1.8(4)	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Table	  4	  Bond	  Lengths	  for	  12srv020.	  
Atom	   Atom	   Length/Å	   Atom	   Atom	   Length/Å	  O1	   N1	   1.4383(11)	   C4	   C5	   1.4988(16)	  O1	   C5	   1.4775(13)	   C5	   C6	   1.5252(16)	  O2	   C1	   1.2295(13)	   C6	   C7	   1.5383(16)	  N1	   C1	   1.3729(14)	   C8	   C9	   1.3940(15)	  N1	   C2	   1.4810(13)	   C8	   C13	   1.3960(14)	  C1	   C8	   1.4927(14)	   C9	   C10	   1.3912(16)	  C2	   C3	   1.5102(16)	   C10	   C11	   1.3886(16)	  C2	   C7	   1.5364(16)	   C11	   C12	   1.3903(17)	  C3	   C4	   1.3397(18)	   C12	   C13	   1.3918(15)	  	  	  	  
Table	  5	  Bond	  Angles	  for	  12srv020.	  
Atom	   Atom	   Atom	   Angle/˚	   Atom	   Atom	   Atom	   Angle/˚	  N1	   O1	   C5	   109.37(7)	   O1	   C5	   C6	   106.09(9)	  O1	   N1	   C2	   112.20(8)	   C4	   C5	   C6	   109.74(9)	  C1	   N1	   O1	   114.56(8)	   C5	   C6	   C7	   107.44(9)	  C1	   N1	   C2	   119.33(9)	   C2	   C7	   C6	   109.00(9)	  O2	   C1	   N1	   120.77(10)	   C9	   C8	   C1	   118.15(9)	  O2	   C1	   C8	   121.50(10)	   C9	   C8	   C13	   119.99(10)	  N1	   C1	   C8	   117.48(9)	   C13	   C8	   C1	   121.73(9)	  N1	   C2	   C3	   106.31(9)	   C10	   C9	   C8	   120.04(10)	  N1	   C2	   C7	   106.64(9)	   C11	   C10	   C9	   119.83(10)	  C3	   C2	   C7	   110.03(9)	   C10	   C11	   C12	   120.36(10)	  C4	   C3	   C2	   112.09(10)	   C11	   C12	   C13	   120.01(10)	  C3	   C4	   C5	   113.16(10)	   C12	   C13	   C8	   119.74(10)	  O1	   C5	   C4	   110.23(9)	   	  	   	  	   	  	   	  	  	  	  
Table	  6	  Hydrogen	  Atom	  Coordinates	  (Å×104)	  and	  Isotropic	  Displacement	  
Parameters	  (Å2×103)	  for	  12srv020.	  
Atom	   x	   y	   z	   U(eq)	  H2	   4335	   -­‐575	   1580	   25	  H3	   4085	   233	   3409	   30	  H4	   3180	   2409	   3355	   30	  H5	   2410	   3436	   1481	   26	  H6A	   1241	   2081	   -­‐187	   30	  H6B	   618	   1659	   886	   30	  H7A	   1563	   -­‐301	   804	   28	  H7B	   2316	   158	   -­‐186	   28	  H9	   8902	   2348	   3111	   26	  H10	   10394	   4095	   2835	   29	  H11	   9738	   5139	   1005	   30	  H12	   7582	   4459	   -­‐547	   29	  H13	   6018	   2772	   -­‐250	   25	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Experimental	  Single	   crystals	   of	   C13H13NO2	   [12srv020]	   were	   [].	   A	   suitable	   crystal	   was	  selected	   and	   []	   on	   a	  Bruker	   SMART	   CCD	   6000	   diffractometer.	   The	   crystal	  was	  kept	  at	  120	  K	  during	  data	  collection.	  Using	  Olex2	  [1],	  the	  structure	  was	  solved	  with	  the	  XS	  [2]	  structure	  solution	  program	  using	  Direct	  Methods	  and	  refined	  with	   the	  XL	  [3]	  refinement	  package	  using	  Least	  Squares	  minimisation.	  7. O.	  V.	  Dolomanov,	  L.	  J.	  Bourhis,	  R.	  J.	  Gildea,	  J.	  A.	  K.	  Howard	  and	  H.	  Puschmann,	  OLEX2:	  a	  complete	  structure	  solution,	  refinement	  and	  analysis	  program.	  J.	  Appl.	  Cryst.	  (2009).	  42,	  339-­‐341.	  8. SHELXS-­‐97	  (Sheldrick,	  1990)	  9. XL,	  G.M.	  Sheldrick,	  Acta	  Cryst.	  (2008).	  A64,	  112-­‐122	  
Crystal	  structure	  determination	  of	  [12srv020]	  
Crystal	   Data.	   C13H13NO2,	   M	  =215.24,	   monoclinic,	   a	  =	   9.0358(9)	  Å,	   b	  =	  10.3716(13)	  Å,	   c	  =	   11.8962(14)	  Å,	   β	  =	   108.091(10)°,	   V	  =	   1059.7(2)	  Å3,	   T	  =	   120,	  space	  group	  P21/c	   (no.	  14),	  Z	  =	  4,	  μ(MoKα)	  =	  0.091,	  11139	  reflections	  measured,	  3094	  unique	  (Rint	  =	  0.0274)	  which	  were	  used	  in	  all	  calculations.	  The	  final	  wR2	  was	  0.1317	  (all	  data)	  and	  R1	  was	  0.0465	  (>2sigma(I)).	  	  This	  report	  has	  been	  created	  with	  Olex2,	  compiled	  on	  2011.11.01	  svn.r2039.	  Please	  let	  us	  know	  if	  there	  are	  any	  errors	  or	  if	  you	  would	  like	  to	  have	  additional	  featrues.	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12srv025	  
	  	  
Table	  1	  Crystal	  data	  and	  structure	  refinement	  for	  12srv025	  Identification	  code	   12srv025	  Empirical	  formula	   C14H15NO2	  Formula	  weight	   229.27	  Temperature/K	   120	  Crystal	  system	   monoclinic	  Space	  group	   P21/c	  a/Å	   13.7130(10)	  b/Å	   5.8495(5)	  c/Å	   14.8249(12)	  α/°	   90.00	  β/°	   100.428(13)	  γ/°	   90.00	  Volume/Å3	   1169.53(16)	  Z	   4	  ρcalcmg/mm3	   1.302	  m/mm‑1	   0.087	  F(000)	   488.0	  Crystal	  size/mm3	   0.45	  ×	  0.36	  ×	  0.26	  2Θ	  range	  for	  data	  collection	   3.02	  to	  60°	  Index	  ranges	   -­‐19	  ≤	  h	  ≤	  19,	  -­‐8	  ≤	  k	  ≤	  8,	  -­‐20	  ≤	  l	  ≤	  20	  Reflections	  collected	   20862	  Independent	  reflections	   3411[R(int)	  =	  0.0390]	  Data/restraints/parameters	   3411/14/156	  Goodness-­‐of-­‐fit	  on	  F2	   1.080	  Final	  R	  indexes	  [I>=2σ	  (I)]	   R1	  =	  0.0668,	  wR2	  =	  0.1720	  Final	  R	  indexes	  [all	  data]	   R1	  =	  0.0806,	  wR2	  =	  0.1847	  Largest	  diff.	  peak/hole	  /	  e	  Å-­‐3	   0.50/-­‐0.34	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Table	  2	  Fractional	  Atomic	  Coordinates	  (×104)	  and	  Equivalent	  Isotropic	  
Displacement	  Parameters	  (Å2×103)	  for	  12srv025.	  Ueq	  is	  defined	  as	  1/3	  of	  of	  
the	  trace	  of	  the	  orthogonalised	  UIJ	  tensor.	  
Atom	   x	   y	   z	   U(eq)	  O1	   8364.1(11)	   4082(3)	   2979(1)	   60.2(5)	  O2A	   7538(3)	   2602(5)	   722(3)	   41.2(8)	  N1A	   8145(5)	   2751(6)	   1608(4)	   39.9(10)	  O2B	   7416(4)	   1673(7)	   803(4)	   41.2(8)	  N1B	   8071(6)	   1885(9)	   1672(6)	   39.9(10)	  C1	   7826.9(11)	   3761(3)	   2238.6(11)	   37.5(4)	  C2	   8032.8(12)	   1100(3)	   123.2(11)	   39.6(4)	  C3A	   8286(3)	   -­‐1116(6)	   597(3)	   41.3(8)	  C4A	   8841(3)	   -­‐1002(6)	   1459(3)	   43.1(8)	  C3B	   8818(4)	   2755(9)	   87(4)	   49.7(15)	  C4B	   9408(4)	   2817(8)	   929(3)	   44.0(11)	  C5	   9099.3(11)	   1390(3)	   1670.5(12)	   39.0(4)	  C6A	   9691(3)	   2527(7)	   1028(2)	   42.8(9)	  C7A	   9026(3)	   2375(8)	   98(3)	   44.5(11)	  C6B	   9086(4)	   -­‐1090(6)	   1268(3)	   41.8(10)	  C7B	   8427(3)	   -­‐1324(6)	   336(3)	   36.7(8)	  C8	   6814.0(13)	   4855(4)	   1960.0(12)	   47.8(5)	  C9	   6434.0(11)	   5899(3)	   2755.6(11)	   33.5(3)	  C10	   6780.8(15)	   7987(3)	   3130.8(16)	   50.8(5)	  C11	   6405(2)	   8883(4)	   3877.5(17)	   65.1(8)	  C12	   5696.9(18)	   7713(4)	   4236.9(14)	   59.6(7)	  C13	   5348.0(15)	   5687(4)	   3861.9(13)	   47.9(5)	  C14	   5711.7(12)	   4777(3)	   3129.1(11)	   33.9(3)	  	  	  
Table	  3	  Anisotropic	  Displacement	  Parameters	  (Å2×103)	  for	  12srv025.	  The	  
Anisotropic	  displacement	  factor	  exponent	  takes	  the	  form:	  -­
2π2[h2a*2U11+...+2hka×b×U12]	  
Atom	   U11	   U22	   U33	   U23	   U13	   U12	  O1	   40.5(7)	   89.7(12)	   42.3(7)	   -­‐17.7(7)	   -­‐13.7(6)	   16.3(7)	  O2A	   32.0(12)	   60(2)	   27.3(9)	   -­‐7.0(18)	   -­‐5.6(8)	   16.3(18)	  N1A	   30.2(11)	   58(3)	   27.7(11)	   -­‐4(2)	   -­‐5.9(8)	   14(2)	  O2B	   32.0(12)	   60(2)	   27.3(9)	   -­‐7.0(18)	   -­‐5.6(8)	   16.3(18)	  N1B	   30.2(11)	   58(3)	   27.7(11)	   -­‐4(2)	   -­‐5.9(8)	   14(2)	  C1	   24.8(7)	   57.2(10)	   29.0(7)	   3.7(7)	   0.9(5)	   -­‐0.7(7)	  C2	   39.2(8)	   47(1)	   31.2(7)	   -­‐3.4(7)	   2.8(6)	   12.0(7)	  C5	   24.3(7)	   47.6(10)	   41.6(8)	   1.7(7)	   -­‐3.4(6)	   4.8(6)	  C8	   28.7(8)	   83.3(15)	   29.9(8)	   -­‐0.7(9)	   1.1(6)	   9.7(9)	  C9	   28.7(7)	   38.9(8)	   30.2(7)	   2.2(6)	   -­‐1.7(5)	   2.1(6)	  C10	   43.6(10)	   38.7(9)	   61.3(12)	   9.0(9)	   -­‐13.9(8)	   -­‐7.4(8)	  C11	   75.1(15)	   33.9(9)	   68.6(14)	   -­‐18.7(9)	   -­‐34.5(12)	   16.8(10)	  C12	   62.0(13)	   69.3(15)	   40.9(10)	   -­‐16.5(10)	   -­‐8.2(9)	   33.1(12)	  C13	   43.2(9)	   65.8(13)	   35.1(9)	   5.4(8)	   8.6(7)	   16.5(9)	  C14	   33.6(7)	   32.6(7)	   34.2(8)	   0.1(6)	   2.5(6)	   3.2(6)	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Table	  4	  Bond	  Lengths	  for	  12srv025.	  
Atom	   Atom	   Length/Å	   Atom	   Atom	   Length/Å	  O1	   C1	   1.221(2)	   C4A	   C5	   1.464(3)	  O2A	   N1A	   1.425(8)	   C3B	   C4B	   1.361(6)	  O2A	   C2	   1.496(5)	   C4B	   C5	   1.500(4)	  N1A	   C1	   1.249(7)	   C5	   C6A	   1.513(3)	  N1A	   C5	   1.520(6)	   C5	   C6B	   1.567(4)	  O2B	   N1B	   1.436(10)	   C6A	   C7A	   1.512(5)	  O2B	   C2	   1.467(6)	   C6B	   C7B	   1.514(5)	  N1B	   C1	   1.458(8)	   C8	   C9	   1.503(2)	  N1B	   C5	   1.440(9)	   C9	   C10	   1.390(3)	  C1	   C8	   1.517(2)	   C9	   C14	   1.385(2)	  C2	   C3A	   1.485(3)	   C10	   C11	   1.404(4)	  C2	   C3B	   1.456(4)	   C11	   C12	   1.372(4)	  C2	   C7A	   1.559(3)	   C12	   C13	   1.359(3)	  C2	   C7B	   1.530(3)	   C13	   C14	   1.381(2)	  C3A	   C4A	   1.365(5)	   	  	   	  	   	  	  	  	  
Table	  5	  Bond	  Angles	  for	  12srv025.	  
Atom	   Atom	   Atom	   Angle/˚	   Atom	   Atom	   Atom	   Angle/˚	  N1A	   O2A	   C2	   109.3(4)	   C4B	   C3B	   C2	   107.7(4)	  O2A	   N1A	   C5	   112.1(5)	   C3B	   C4B	   C5	   117.2(4)	  C1	   N1A	   O2A	   119.6(5)	   N1A	   C5	   C6B	   120.7(3)	  C1	   N1A	   C5	   128.0(5)	   N1B	   C5	   N1A	   20.3(3)	  N1B	   O2B	   C2	   106.9(5)	   N1B	   C5	   C4A	   89.6(3)	  O2B	   N1B	   C1	   114.2(5)	   N1B	   C5	   C4B	   107.2(3)	  O2B	   N1B	   C5	   115.8(6)	   N1B	   C5	   C6A	   123.3(3)	  C5	   N1B	   C1	   118.7(5)	   N1B	   C5	   C6B	   104.1(3)	  O1	   C1	   N1A	   120.6(3)	   C4A	   C5	   N1A	   108.4(3)	  O1	   C1	   N1B	   118.0(3)	   C4A	   C5	   C4B	   117.7(3)	  O1	   C1	   C8	   123.63(17)	   C4A	   C5	   C6A	   115.0(3)	  N1A	   C1	   N1B	   20.7(4)	   C4A	   C5	   C6B	   17.8(2)	  N1A	   C1	   C8	   115.0(3)	   C4B	   C5	   N1A	   91.0(3)	  N1B	   C1	   C8	   117.1(3)	   C4B	   C5	   C6A	   16.2(2)	  O2A	   C2	   C7A	   103.0(3)	   C4B	   C5	   C6B	   102.8(3)	  O2A	   C2	   C7B	   127.1(2)	   C6A	   C5	   N1A	   106.6(3)	  O2B	   C2	   O2A	   22.84(19)	   C6A	   C5	   C6B	   97.9(3)	  O2B	   C2	   C3A	   89.4(3)	   C7A	   C6A	   C5	   104.1(3)	  O2B	   C2	   C7A	   121.5(3)	   C6A	   C7A	   C2	   113.1(3)	  O2B	   C2	   C7B	   107.2(3)	   C7B	   C6B	   C5	   113.2(3)	  C3A	   C2	   O2A	   108.9(2)	   C6B	   C7B	   C2	   103.6(3)	  C3A	   C2	   C7A	   107.4(2)	   C9	   C8	   C1	   112.84(14)	  C3A	   C2	   C7B	   18.17(18)	   C10	   C9	   C8	   121.94(18)	  C3B	   C2	   O2A	   92.8(3)	   C14	   C9	   C8	   119.74(16)	  C3B	   C2	   O2B	   113.3(3)	   C14	   C9	   C10	   118.32(17)	  C3B	   C2	   C3A	   119.1(3)	   C9	   C10	   C11	   119.7(2)	  C3B	   C2	   C7A	   13.1(3)	   C12	   C11	   C10	   120.44(19)	  C3B	   C2	   C7B	   112.8(3)	   C13	   C12	   C11	   119.8(2)	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C7B	   C2	   C7A	   99.8(3)	   C12	   C13	   C14	   120.5(2)	  C4A	   C3A	   C2	   116.3(3)	   C13	   C14	   C9	   121.19(17)	  C3A	   C4A	   C5	   108.6(3)	   	  	   	  	   	  	   	  	  	  	  
Table	  6	  Hydrogen	  Atom	  Coordinates	  (Å×104)	  and	  Isotropic	  Displacement	  
Parameters	  (Å2×103)	  for	  12srv025.	  
Atom	   x	   y	   z	   U(eq)	  H2	   7624	   900	   -­‐502	   47	  H3A	   8075	   -­‐2539	   320	   50	  H4A	   9034	   -­‐2258	   1858	   52	  H3B	   8901	   3618	   -­‐437	   60	  H4B	   9989	   3737	   1036	   53	  H5	   9539	   1575	   2282	   47	  H6AA	   10326	   1710	   1040	   51	  H6AB	   9838	   4137	   1210	   51	  H7AA	   9393	   1562	   -­‐322	   53	  H7AB	   8884	   3943	   -­‐141	   53	  H6BA	   9768	   -­‐1536	   1209	   50	  H6BB	   8852	   -­‐2173	   1696	   50	  H7BA	   7876	   -­‐2408	   355	   44	  H7BB	   8804	   -­‐1843	   -­‐136	   44	  H8A	   6853	   6055	   1497	   57	  H8B	   6337	   3683	   1671	   57	  H10	   7270	   8805	   2884	   61	  H11	   6643	   10307	   4136	   78	  H12	   5451	   8319	   4747	   71	  H13	   4850	   4890	   4106	   57	  H14	   5462	   3355	   2877	   41	  	  
Experimental	  Single	   crystals	   of	   C14H15NO2	   [12srv025]	   were	   [].	   A	   suitable	   crystal	   was	  selected	   and	   []	   on	   a	  Bruker	   SMART	   CCD	   6000	   diffractometer.	   The	   crystal	  was	  kept	  at	  120	  K	  during	  data	  collection.	  Using	  Olex2	  [1],	  the	  structure	  was	  solved	  with	  the	  XS	  [2]	  structure	  solution	  program	  using	  Direct	  Methods	  and	  refined	  with	   the	  XL	  [3]	  refinement	  package	  using	  Least	  Squares	  minimisation.	  10. O.	  V.	  Dolomanov,	  L.	  J.	  Bourhis,	  R.	  J.	  Gildea,	  J.	  A.	  K.	  Howard	  and	  H.	  Puschmann,	  OLEX2:	  a	  complete	  structure	  solution,	  refinement	  and	  analysis	  program.	  J.	  Appl.	  Cryst.	  (2009).	  42,	  339-­‐341.	  11. SHELXS-­‐97	  (Sheldrick,	  1990)	  12. XL,	  G.M.	  Sheldrick,	  Acta	  Cryst.	  (2008).	  A64,	  112-­‐122	  
Crystal	  structure	  determination	  of	  [12srv025]	  
Crystal	   Data.	   C14H15NO2,	   M	  =229.27,	   monoclinic,	   a	  =	   13.7130(10)	  Å,	   b	  =	  5.8495(5)	  Å,	   c	  =	   14.8249(12)	  Å,	   β	  =	   100.428(13)°,	   V	  =	   1169.53(16)	  Å3,	   T	  =	   120,	  space	  group	  P21/c	   (no.	  14),	  Z	  =	  4,	  μ(MoKα)	  =	  0.087,	  20862	  reflections	  measured,	  3411	  unique	  (Rint	  =	  0.0390)	  which	  were	  used	  in	  all	  calculations.	  The	  final	  wR2	  was	  0.1847	  (all	  data)	  and	  R1	  was	  0.0668	  (>2sigma(I)).	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This	  report	  has	  been	  created	  with	  Olex2,	  compiled	  on	  2011.11.01	  svn.r2039.	  Please	  let	  us	  know	  if	  there	  are	  any	  errors	  or	  if	  you	  would	  like	  to	  have	  additional	  featrues.	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  




Table	  1	  Crystal	  data	  and	  structure	  refinement	  for	  13srv073	  Identification	  code	   13srv073	  Empirical	  formula	   C12H14N2O2	  Formula	  weight	   218.25	  Temperature/K	   156	  Crystal	  system	   triclinic	  Space	  group	   P-­‐1	  a/Å	   7.7458(6)	  b/Å	   8.3388(6)	  c/Å	   9.2703(7)	  α/°	   77.293(3)	  β/°	   68.194(3)	  γ/°	   84.734(3)	  Volume/Å3	   542.28(7)	  Z	   2	  ρcalcmg/mm3	   1.337	  m/mm‑1	   0.093	  F(000)	   232.0	  Crystal	  size/mm3	   0.33	  ×	  0.17	  ×	  0.04	  2Θ	  range	  for	  data	  collection	   4.8	  to	  50.0°	  Index	  ranges	   -­‐9	  ≤	  h	  ≤	  9,	  -­‐9	  ≤	  k	  ≤	  9,	  -­‐11	  ≤	  l	  ≤	  10	  Reflections	  collected	   4329	  Independent	  reflections	   1896[R(int)	  =	  0.0275]	  Data/restraints/parameters	   1896/0/149	  Goodness-­‐of-­‐fit	  on	  F2	   0.950	  Final	  R	  indexes	  [I>=2σ	  (I)]	   R1	  =	  0.0399,	  wR2	  =	  0.0924	  Final	  R	  indexes	  [all	  data]	   R1	  =	  0.0607,	  wR2	  =	  0.1010	  Largest	  diff.	  peak/hole	  /	  e	  Å-­‐3	   0.22/-­‐0.18	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Table	  2	  Fractional	  Atomic	  Coordinates	  (×104)	  and	  Equivalent	  Isotropic	  
Displacement	  Parameters	  (Å2×103)	  for	  13srv073.	  Ueq	  is	  defined	  as	  1/3	  of	  of	  
the	  trace	  of	  the	  orthogonalised	  UIJ	  tensor.	  
Atom	   x	   y	   z	   U(eq)	  O1	   5721.6(16)	   4635.5(13)	   3353.3(14)	   32.7(3)	  O2	   3336.0(17)	   8336.1(14)	   3805.4(16)	   41.3(4)	  N3	   7881(2)	   7541.4(17)	   1686.1(18)	   35.5(4)	  N4	   4369.4(19)	   5855.8(17)	   3245.0(17)	   30.7(4)	  C5	   2580(2)	   5174(2)	   3578(2)	   32.4(4)	  C6	   4477(2)	   3328(2)	   1831(2)	   30.9(4)	  C7	   6171(2)	   3850(2)	   2029(2)	   32.9(4)	  C8	   6594(2)	   7855.5(19)	   3037(2)	   30.0(4)	  C9	   2801(2)	   3918(2)	   2569(2)	   31.8(4)	  C10	   6957(3)	   8710(2)	   4013(2)	   34.6(5)	  C11	   4631(2)	   7362(2)	   3428(2)	   31.1(4)	  C12	   9590(3)	   8109(2)	   1303(2)	   39.5(5)	  C13	   8738(3)	   9263(2)	   3596(2)	   40.2(5)	  C14	   4903(3)	   2104(2)	   766(2)	   40.5(5)	  C15	   998(3)	   3434(2)	   2540(2)	   41.8(5)	  C16	   10078(3)	   8963(2)	   2208(2)	   40.9(5)	  	  	  
Table	  3	  Anisotropic	  Displacement	  Parameters	  (Å2×103)	  for	  13srv073.	  The	  
Anisotropic	  displacement	  factor	  exponent	  takes	  the	  form:	  -­
2π2[h2a*2U11+...+2hka×b×U12]	  
Atom	   U11	   U22	   U33	   U23	   U13	   U12	  O1	   33.7(7)	   34.3(7)	   34.6(7)	   -­‐11.1(5)	   -­‐16.3(6)	   4.4(6)	  O2	   37.2(8)	   38.2(7)	   53.4(9)	   -­‐18.2(6)	   -­‐18.3(7)	   5.6(6)	  N3	   33.7(9)	   39.0(9)	   36.2(10)	   -­‐9.7(7)	   -­‐13.9(7)	   -­‐1.2(7)	  N4	   29.4(8)	   31.1(8)	   35.1(9)	   -­‐10.2(6)	   -­‐14.1(7)	   1.7(6)	  C5	   28(1)	   34.9(10)	   34.9(11)	   -­‐7.7(8)	   -­‐11.3(8)	   -­‐2.0(8)	  C6	   36.2(10)	   29.6(9)	   27.8(10)	   -­‐4.1(7)	   -­‐12.7(8)	   -­‐3.7(8)	  C7	   33.5(10)	   33.9(10)	   33.1(11)	   -­‐11.2(8)	   -­‐12.0(8)	   2.0(8)	  C8	   34.7(10)	   26.1(9)	   31.3(11)	   -­‐4.7(7)	   -­‐15.0(9)	   1.1(8)	  C9	   35(1)	   31.5(10)	   29.2(10)	   -­‐3.4(7)	   -­‐12.6(8)	   -­‐4.9(8)	  C10	   41.9(11)	   31.6(10)	   33.3(11)	   -­‐5.9(8)	   -­‐17.1(9)	   -­‐1.6(8)	  C11	   33.1(10)	   34.3(10)	   29.1(11)	   -­‐8.1(8)	   -­‐13.9(8)	   0.0(8)	  C12	   33.4(11)	   40.0(11)	   42.8(12)	   -­‐8.9(9)	   -­‐10.6(9)	   -­‐0.6(9)	  C13	   50.5(12)	   32.6(10)	   49.1(13)	   -­‐7.9(9)	   -­‐31.0(11)	   -­‐2.1(9)	  C14	   45.6(12)	   41.9(11)	   38.4(12)	   -­‐13.7(9)	   -­‐17(1)	   -­‐0.4(9)	  C15	   38.5(11)	   43.2(11)	   46.2(13)	   -­‐12.2(9)	   -­‐14.6(10)	   -­‐7.9(9)	  C16	   36.0(11)	   34.8(10)	   54.5(14)	   -­‐3.8(9)	   -­‐21.8(10)	   -­‐3.4(9)	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Table	  4	  Bond	  Lengths	  for	  13srv073.	  
Atom	   Atom	   Length/Å	   Atom	   Atom	   Length/Å	  O1	   N4	   1.4072(16)	   C6	   C9	   1.329(2)	  O1	   C7	   1.432(2)	   C6	   C14	   1.504(2)	  O2	   C11	   1.226(2)	   C8	   C10	   1.384(2)	  N3	   C8	   1.342(2)	   C8	   C11	   1.500(2)	  N3	   C12	   1.339(2)	   C9	   C15	   1.500(2)	  N4	   C5	   1.445(2)	   C10	   C13	   1.381(2)	  N4	   C11	   1.347(2)	   C12	   C16	   1.379(3)	  C5	   C9	   1.510(2)	   C13	   C16	   1.377(3)	  C6	   C7	   1.505(2)	   	  	   	  	   	  	  	  	  
Table	  5	  Bond	  Angles	  for	  13srv073.	  
Atom	   Atom	   Atom	   Angle/˚	   Atom	   Atom	   Atom	   Angle/˚	  N4	   O1	   C7	   107.56(11)	   C10	   C8	   C11	   118.84(16)	  C12	   N3	   C8	   116.26(15)	   C6	   C9	   C5	   120.18(16)	  O1	   N4	   C5	   112.57(12)	   C6	   C9	   C15	   126.10(17)	  C11	   N4	   O1	   117.80(13)	   C15	   C9	   C5	   113.71(15)	  C11	   N4	   C5	   124.88(14)	   C13	   C10	   C8	   118.88(18)	  N4	   C5	   C9	   109.87(14)	   O2	   C11	   N4	   121.62(16)	  C9	   C6	   C7	   120.85(16)	   O2	   C11	   C8	   120.84(15)	  C9	   C6	   C14	   125.83(17)	   N4	   C11	   C8	   117.40(15)	  C14	   C6	   C7	   113.32(15)	   N3	   C12	   C16	   124.16(19)	  O1	   C7	   C6	   112.89(14)	   C16	   C13	   C10	   118.56(18)	  N3	   C8	   C10	   123.49(16)	   C13	   C16	   C12	   118.65(18)	  N3	   C8	   C11	   117.49(15)	   	  	   	  	   	  	   	  	  	  	  
Table	  6	  Hydrogen	  Atom	  Coordinates	  (Å×104)	  and	  Isotropic	  Displacement	  
Parameters	  (Å2×103)	  for	  13srv073.	  
Atom	   x	   y	   z	   U(eq)	  H5A	   1724	   6064	   3349	   39	  H5B	   2038	   4649	   4714	   39	  H7A	   6962	   2871	   2172	   39	  H7B	   6899	   4615	   1051	   39	  H10	   5998	   8913	   4954	   41	  H12	   10525	   7910	   348	   47	  H13	   9032	   9838	   4251	   48	  H14A	   6005	   2455	   -­‐180	   63(4)	  H14B	   3841	   2040	   449	   63(4)	  H14C	   5140	   1021	   1336	   63(4)	  H15A	   208	   2905	   3611	   62(4)	  H15B	   1245	   2664	   1823	   62(4)	  H15C	   362	   4415	   2166	   62(4)	  H16	   11314	   9336	   1881	   49	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Experimental	  Single	  crystals	  of	  C12H14N2O2	  [13srv073]	  were	  [].	  A	  suitable	  crystal	  was	  selected	  and	  []	  on	  a	  Bruker	  SMART	  CCD	  6000	  diffractometer.	  The	  crystal	  was	  kept	  at	  156	  K	  during	  data	  collection.	  Using	  Olex2	  [1],	  the	  structure	  was	  solved	  with	  the	  XS	  [2]	  structure	  solution	  program	  using	  Direct	  Methods	  and	  refined	  with	  the	  ShelXLMP-­‐2012	  [3]	  refinement	  package	  using	  Least	  Squares	  minimisation.	  13. O.	  V.	  Dolomanov,	  L.	  J.	  Bourhis,	  R.	  J.	  Gildea,	  J.	  A.	  K.	  Howard	  and	  H.	  Puschmann,	  OLEX2:	  a	  complete	  structure	  solution,	  refinement	  and	  analysis	  program.	  J.	  Appl.	  Cryst.	  (2009).	  42,	  339-­‐341.	  14. XS,	  G.M.	  Sheldrick,	  Acta	  Cryst.	  (2008).	  A64,	  112-­‐122	  15. SHELXL-­‐2012,	  G.M.	  Sheldrick,	  Acta	  Cryst.	  (2008).	  A64,	  112-­‐122	  Crystal	  structure	  determination	  of	  [13srv073]	  
Crystal	  Data	  for	  C12H14N2O2	  (M	  =218.25):	  triclinic,	  space	  group	  P-­‐1	  (no.	  2),	  a	  =	  7.7458(6)	  Å,	  b	  =	  8.3388(6)	  Å,	  c	  =	  9.2703(7)	  Å,	  α	  =	  77.293(3)°,	  β	  =	  68.194(3)°,	  γ	  =	  84.734(3)°,	  V	  =	  542.28(7)	  Å3,	  Z	  =	  2,	  T	  =	  156	  K,	  μ(MoKα)	  =	  0.093	  mm-­‐1,	  Dcalc	  =	  1.337	  g/mm3,	  4329	  reflections	  measured	  (4.832	  ≤	  2Θ	  ≤	  49.996),	  1896	  unique	  (Rint	  =	  0.0275)	  which	  were	  used	  in	  all	  calculations.	  The	  final	  R1	  was	  0.0399	  (I	  >	  2σ(I))	  and	  wR2	  was	  0.1010	  (all	  data).	  	  This	  report	  has	  been	  created	  with	  Olex2,	  compiled	  on	  Mar	  21	  2013	  11:16:32.	  Please	  let	  us	  know	  if	  there	  are	  any	  errors	  or	  if	  you	  would	  like	  to	  have	  additional	  featrues.	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  




Table	  1	  Crystal	  data	  and	  structure	  refinement	  for	  12srv073	  Identification	  code	   12srv073	  Empirical	  formula	   C13H13NO3	  Formula	  weight	   231.24	  Temperature/K	   120	  Crystal	  system	   orthorhombic	  Space	  group	   Pnma	  a/Å	   7.6572(6)	  b/Å	   9.1842(8)	  c/Å	   15.6746(12)	  α/°	   90.00	  β/°	   90.00	  γ/°	   90.00	  Volume/Å3	   1102.32(15)	  Z	   4	  ρcalcmg/mm3	   1.393	  m/mm‑1	   0.100	  F(000)	   488.0	  Crystal	  size/mm3	   0.58	  ×	  0.57	  ×	  0.21	  2Θ	  range	  for	  data	  collection	   5.14	  to	  59.92°	  Index	  ranges	   -­‐10	  ≤	  h	  ≤	  10,	  -­‐12	  ≤	  k	  ≤	  12,	  -­‐22	  ≤	  l	  ≤	  22	  Reflections	  collected	   14382	  Independent	  reflections	   1692[R(int)	  =	  0.0265]	  Data/restraints/parameters	   1692/14/116	  Goodness-­‐of-­‐fit	  on	  F2	   1.081	  Final	  R	  indexes	  [I>=2σ	  (I)]	   R1	  =	  0.0415,	  wR2	  =	  0.1110	  Final	  R	  indexes	  [all	  data]	   R1	  =	  0.0465,	  wR2	  =	  0.1149	  Largest	  diff.	  peak/hole	  /	  e	  Å-­‐3	   0.33/-­‐0.28	  	  	  	  	  
	   245	  	  	  	  
Table	  2	  Fractional	  Atomic	  Coordinates	  (×104)	  and	  Equivalent	  Isotropic	  
Displacement	  Parameters	  (Å2×103)	  for	  12srv073.	  Ueq	  is	  defined	  as	  1/3	  of	  of	  
the	  trace	  of	  the	  orthogonalised	  UIJ	  tensor.	  
Atom	   x	   y	   z	   U(eq)	  O1	   2898.6(12)	   2500	   5431.6(6)	   23.3(2)	  O2	   4319.4(12)	   2500	   4151.8(6)	   25.9(2)	  O3	   1346.1(16)	   2719(7)	   3330.4(8)	   30.7(13)	  N1	   1373.2(18)	   2816.8(16)	   4240.2(9)	   21.2(5)	  C1	   2982.1(16)	   2500	   4558.2(8)	   18.6(2)	  C2	   -­‐473.9(18)	   2500	   3053.1(9)	   31.4(3)	  C3	   -­‐1555(5)	   3804(6)	   3380(3)	   26.8(7)	  C4	   -­‐1562(4)	   3743(4)	   4353(2)	   23.1(6)	  C5	   -­‐340.0(16)	   2500	   4643.6(8)	   21.5(3)	  C6	   -­‐1017(4)	   1115(5)	   4294(3)	   33.3(8)	  C7	   -­‐1091(5)	   1131(6)	   3442(4)	   42.0(12)	  C8	   4525.2(16)	   2500	   5853.0(8)	   21.0(3)	  C9	   5275.1(13)	   1185.0(12)	   6071.4(6)	   26.8(2)	  C10	   6844.6(14)	   1191.4(13)	   6523.6(7)	   32.2(3)	  C11	   7621(2)	   2500	   6749.4(9)	   33.0(3)	  	  	  
Table	  3	  Anisotropic	  Displacement	  Parameters	  (Å2×103)	  for	  12srv073.	  The	  
Anisotropic	  displacement	  factor	  exponent	  takes	  the	  form:	  -­
2π2[h2a*2U11+...+2hka×b×U12]	  
Atom	   U11	   U22	   U33	   U23	   U13	   U12	  O1	   15.7(4)	   36.2(5)	   18.1(4)	   0	   -­‐1.7(3)	   0	  O2	   17.1(4)	   39.1(6)	   21.5(4)	   0	   0.6(3)	   0	  O3	   17.7(5)	   61(4)	   13.9(4)	   -­‐2.4(8)	   -­‐0.7(4)	   -­‐0.7(8)	  N1	   16.3(6)	   33.2(14)	   14.1(5)	   0.0(5)	   -­‐0.4(4)	   -­‐0.9(5)	  C1	   17.5(5)	   19.7(5)	   18.6(5)	   0	   -­‐1.7(4)	   0	  C2	   17.8(6)	   57.8(10)	   18.7(6)	   0	   -­‐3.7(5)	   0	  C3	   18.7(18)	   36.6(14)	   25.1(12)	   9.1(9)	   -­‐1.8(13)	   7.2(14)	  C4	   19.4(15)	   26.7(13)	   23.2(10)	   -­‐4.6(8)	   -­‐2.6(12)	   5.0(13)	  C5	   14.7(5)	   30.8(6)	   18.9(5)	   0	   0.6(4)	   0	  C6	   21.5(17)	   27.4(13)	   51.0(18)	   4.8(11)	   -­‐2.7(16)	   -­‐0.8(14)	  C7	   21(2)	   44.2(18)	   60(2)	   -­‐26.5(15)	   -­‐8.7(17)	   -­‐3.8(16)	  C8	   16.1(5)	   31.3(7)	   15.6(5)	   0	   -­‐0.5(4)	   0	  C9	   25.0(5)	   30.1(5)	   25.4(4)	   0.2(4)	   -­‐1.1(3)	   1.7(4)	  C10	   27.4(5)	   44.0(6)	   25.0(5)	   4.7(4)	   -­‐2.0(4)	   9.1(4)	  C11	   20.5(6)	   58.2(10)	   20.4(6)	   0	   -­‐3.6(5)	   0	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Table	  4	  Bond	  Lengths	  for	  12srv073.	  
Atom	   Atom	   Length/Å	   Atom	   Atom	   Length/Å	  O1	   C1	   1.3706(15)	   C3	   C4	   1.526(6)	  O1	   C8	   1.4098(15)	   C4	   C5	   1.545(4)	  O2	   C1	   1.2060(15)	   C5	   N11	   1.4850(18)	  O3	   N1	   1.4290(18)	   C5	   C41	   1.545(4)	  O3	   C2	   1.474(2)	   C5	   C61	   1.479(5)	  N1	   C1	   1.3604(17)	   C5	   C6	   1.479(5)	  N1	   C5	   1.4850(18)	   C6	   C7	   1.336(8)	  C1	   N11	   1.3604(17)	   C8	   C91	   1.3804(12)	  C2	   O31	   1.474(2)	   C8	   C9	   1.3804(12)	  C2	   C3	   1.543(4)	   C9	   C10	   1.3952(14)	  C2	   C31	   1.543(4)	   C10	   C11	   1.3868(14)	  C2	   C71	   1.475(5)	   C11	   C101	   1.3868(14)	  C2	   C7	   1.475(5)	   	  	   	  	   	  	  1+X,1/2-­‐Y,+Z	  	  
	  
Table	  5	  Bond	  Angles	  for	  12srv073.	  
Atom	   Atom	   Atom	   Angle/˚	   Atom	   Atom	   Atom	   Angle/˚	  C1	   O1	   C8	   115.26(10)	   C4	   C3	   C2	   107.8(3)	  N1	   O3	   C2	   108.46(11)	   C3	   C4	   C5	   108.6(2)	  O3	   N1	   C5	   113.57(13)	   N1	   C5	   N11	   22.60(12)	  C1	   N1	   O3	   111.43(13)	   N1	   C5	   C4	   105.34(14)	  C1	   N1	   C5	   127.02(12)	   N11	   C5	   C4	   123.65(15)	  O2	   C1	   O1	   124.56(11)	   N11	   C5	   C41	   105.34(14)	  O2	   C1	   N1	   125.13(12)	   N1	   C5	   C41	   123.65(15)	  O2	   C1	   N11	   125.13(12)	   C41	   C5	   C4	   95.3(3)	  N1	   C1	   O1	   108.89(11)	   C6	   C5	   N1	   108.67(17)	  N11	   C1	   O1	   108.89(11)	   C61	   C5	   N1	   89.03(15)	  N11	   C1	   N1	   24.70(13)	   C61	   C5	   N11	   108.67(17)	  O3	   C2	   O31	   15.7(5)	   C6	   C5	   N11	   89.03(15)	  O3	   C2	   C31	   121.0(3)	   C61	   C5	   C4	   16.81(15)	  O31	   C2	   C31	   107.7(3)	   C6	   C5	   C41	   16.81(15)	  O31	   C2	   C3	   121.0(3)	   C61	   C5	   C41	   108.29(16)	  O3	   C2	   C3	   107.7(3)	   C6	   C5	   C4	   108.29(16)	  O3	   C2	   C7	   107.3(3)	   C6	   C5	   C61	   118.6(4)	  O31	   C2	   C7	   93.7(3)	   C7	   C6	   C5	   112.1(4)	  O3	   C2	   C71	   93.7(3)	   C6	   C7	   C2	   114.1(4)	  O31	   C2	   C71	   107.3(3)	   C91	   C8	   O1	   118.93(6)	  C31	   C2	   C3	   101.8(4)	   C9	   C8	   O1	   118.93(6)	  C71	   C2	   C3	   14.0(3)	   C9	   C8	   C91	   122.07(12)	  C7	   C2	   C3	   110.61(16)	   C8	   C9	   C10	   118.73(10)	  C71	   C2	   C31	   110.61(16)	   C11	   C10	   C9	   120.17(10)	  C7	   C2	   C31	   14.0(3)	   C10	   C11	   C101	   120.14(13)	  C7	   C2	   C71	   116.9(5)	   	  	   	  	   	  	   	  	  1+X,1/2-­‐Y,+Z	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Table	  6	  Hydrogen	  Atom	  Coordinates	  (Å×104)	  and	  Isotropic	  Displacement	  
Parameters	  (Å2×103)	  for	  12srv073.	  
Atom	   x	   y	   z	   U(eq)	  H2	   -­‐539	   2500	   2417	   38	  H3A	   -­‐2760	   3740	   3154	   32	  H3B	   -­‐1030	   4725	   3174	   32	  H4A	   -­‐1147	   4686	   4582	   28	  H4B	   -­‐2764	   3569	   4562	   28	  H5	   -­‐156	   2500	   5262	   25(4)	  H6	   -­‐1350	   319	   4645	   40	  H7	   -­‐1528	   327	   3127	   50	  H9	   4734	   293	   5916	   32	  H10	   7382	   297	   6677	   39	  H11	   8687	   2500	   7060	   40	  	  
Experimental	  Single	   crystals	   of	   C13H13NO3	   [12srv073]	   were	   [].	   A	   suitable	   crystal	   was	  selected	   and	   []	   on	   a	  Bruker	   SMART	   CCD	   6000	   diffractometer.	   The	   crystal	  was	  kept	  at	  120	  K	  during	  data	  collection.	  Using	  Olex2	  [1],	  the	  structure	  was	  solved	  with	  the	  XS	  [2]	  structure	  solution	  program	  using	  Direct	  Methods	  and	  refined	  with	   the	  XL	  [3]	  refinement	  package	  using	  Least	  Squares	  minimisation.	  16. O.	  V.	  Dolomanov,	  L.	  J.	  Bourhis,	  R.	  J.	  Gildea,	  J.	  A.	  K.	  Howard	  and	  H.	  Puschmann,	  OLEX2:	  a	  complete	  structure	  solution,	  refinement	  and	  analysis	  program.	  J.	  Appl.	  Cryst.	  (2009).	  42,	  339-­‐341.	  17. XS,	  G.M.	  Sheldrick,	  Acta	  Cryst.	  (2008).	  A64,	  112-­‐122	  18. XL,	  G.M.	  Sheldrick,	  Acta	  Cryst.	  (2008).	  A64,	  112-­‐122	  
Crystal	  structure	  determination	  of	  [12srv073]	  
Crystal	   Data.	   C13H13NO3,	   M	  =231.24,	   orthorhombic,	   a	  =	   7.6572(6)	  Å,	   b	  =	  9.1842(8)	  Å,	   c	  =	   15.6746(12)	  Å,	   V	  =	   1102.32(15)	  Å3,	   T	  =	   120,	   space	   group	   Pnma	  (no.	  62),	  Z	  =	  4,	  μ(MoKα)	  =	  0.100,	  14382	  reflections	  measured,	  1692	  unique	  (Rint	  =	  0.0265)	  which	  were	  used	   in	   all	   calculations.	   The	   final	  wR2	  was	  0.1149	   (all	   data)	  and	  R1	  was	  0.0415	  (>2sigma(I)).	  	  This	  report	  has	  been	  created	  with	  Olex2,	  compiled	  on	  2011.11.01	  svn.r2039.	  Please	  let	  us	  know	  if	  there	  are	  any	  errors	  or	  if	  you	  would	  like	  to	  have	  additional	  featrues.	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N-­‐Phenyl-­‐2-­‐oxa-­‐3-­‐azabicyclo[2.2.2]oct-­‐5-­‐ene-­‐3-­‐carboxamide	  183	  	  	  	  	  	  
12srv065	  
	  	  
Table	  1	  Crystal	  data	  and	  structure	  refinement	  for	  12srv065	  Identification	  code	   12srv065	  Empirical	  formula	   C13H14N2O2	  Formula	  weight	   230.26	  Temperature/K	   120	  Crystal	  system	   orthorhombic	  Space	  group	   Pna21	  a/Å	   10.0933(6)	  b/Å	   8.9883(5)	  c/Å	   12.7337(8)	  α/°	   90.00	  β/°	   90.00	  γ/°	   90.00	  Volume/Å3	   1155.22(12)	  Z	   4	  ρcalcmg/mm3	   1.324	  m/mm‑1	   0.091	  F(000)	   488.0	  Crystal	  size/mm3	   0.6	  ×	  0.5	  ×	  0.4	  2Θ	  range	  for	  data	  collection	   5.54	  to	  59.98°	  Index	  ranges	   -­‐14	  ≤	  h	  ≤	  14,	  -­‐12	  ≤	  k	  ≤	  12,	  -­‐17	  ≤	  l	  ≤	  17	  Reflections	  collected	   20058	  Independent	  reflections	   1741[R(int)	  =	  0.0251]	  Data/restraints/parameters	   1741/1/157	  Goodness-­‐of-­‐fit	  on	  F2	   1.053	  Final	  R	  indexes	  [I>=2σ	  (I)]	   R1	  =	  0.0321,	  wR2	  =	  0.0853	  Final	  R	  indexes	  [all	  data]	   R1	  =	  0.0333,	  wR2	  =	  0.0869	  Largest	  diff.	  peak/hole	  /	  e	  Å-­‐3	   0.20/-­‐0.28	  Flack	  parameter	   -­‐10(10)	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Table	  2	  Fractional	  Atomic	  Coordinates	  (×104)	  and	  Equivalent	  Isotropic	  
Displacement	  Parameters	  (Å2×103)	  for	  12srv065.	  Ueq	  is	  defined	  as	  1/3	  of	  of	  
the	  trace	  of	  the	  orthogonalised	  UIJ	  tensor.	  
Atom	   x	   y	   z	   U(eq)	  O1	   5919.8(9)	   667.1(11)	   1719(1)	   25.2(2)	  O2	   2866.7(10)	   2050.1(12)	   2560.1(10)	   29.7(2)	  N1	   4515(1)	   937.6(12)	   1646.4(10)	   20.2(2)	  N2	   5005.6(10)	   2817.8(12)	   2854.4(10)	   20.5(2)	  C1	   4061.7(12)	   1948.7(14)	   2407.9(10)	   19.8(2)	  C2	   6186.4(15)	   -­‐936.3(16)	   1815.9(13)	   29.1(3)	  C3	   5770.4(16)	   -­‐1647.9(19)	   781.2(14)	   33.5(3)	  C4	   4290.9(16)	   -­‐1311(2)	   621.8(14)	   33.9(3)	  C5	   3762.4(13)	   -­‐483.2(15)	   1583.1(12)	   24.8(3)	  C6	   4071.5(18)	   -­‐1348.5(17)	   2564.1(14)	   33.5(3)	  C7	   5377(2)	   -­‐1558.4(19)	   2694.8(14)	   38.3(4)	  C8	   4776.4(13)	   3992.0(14)	   3571.5(10)	   20.1(2)	  C9	   3526.9(13)	   4603.0(15)	   3763.6(11)	   23.4(3)	  C10	   3402.1(16)	   5749.4(16)	   4493.8(12)	   28.4(3)	  C11	   4486.9(18)	   6288.4(17)	   5040.2(13)	   32.1(3)	  C12	   5729.1(17)	   5677.6(18)	   4845.7(13)	   31.0(3)	  C13	   5880.2(14)	   4544.4(16)	   4114.5(12)	   25.1(3)	  	  	  
Table	  3	  Anisotropic	  Displacement	  Parameters	  (Å2×103)	  for	  12srv065.	  The	  
Anisotropic	  displacement	  factor	  exponent	  takes	  the	  form:	  -­
2π2[h2a*2U11+...+2hka×b×U12]	  
Atom	   U11	   U22	   U33	   U23	   U13	   U12	  O1	   15.5(4)	   23.0(4)	   37.0(5)	   -­‐4.0(4)	   3.9(4)	   1.7(3)	  O2	   15.4(4)	   28.9(5)	   44.9(6)	   -­‐10.6(5)	   2.6(4)	   0.3(4)	  N1	   15.5(4)	   19.3(4)	   25.9(5)	   -­‐1.1(4)	   1.0(4)	   0.4(3)	  N2	   14.9(4)	   20.6(5)	   25.9(5)	   -­‐3.0(4)	   1.4(4)	   -­‐0.7(4)	  C1	   16.7(5)	   18.5(5)	   24.1(5)	   -­‐0.1(4)	   0.5(4)	   0.3(4)	  C2	   25.4(6)	   26.1(6)	   36.0(7)	   -­‐6.2(6)	   -­‐6.4(6)	   8.9(5)	  C3	   27.8(6)	   33.7(8)	   38.9(8)	   -­‐14.2(6)	   -­‐1.2(6)	   5.7(6)	  C4	   26.8(6)	   36.8(8)	   38.0(8)	   -­‐17.7(7)	   -­‐4.2(6)	   3.2(6)	  C5	   20.8(5)	   22.3(5)	   31.2(7)	   -­‐5.9(5)	   -­‐0.3(5)	   -­‐2.5(4)	  C6	   42.3(9)	   22.1(6)	   36.1(8)	   3.2(6)	   7.1(6)	   -­‐5.1(6)	  C7	   52.4(10)	   27.6(7)	   34.9(8)	   6.4(6)	   -­‐6.4(7)	   7.6(7)	  C8	   22.0(6)	   17.7(5)	   20.5(5)	   1.3(4)	   0.9(4)	   -­‐1.6(4)	  C9	   22.9(6)	   20.5(5)	   26.8(6)	   0.0(5)	   1.1(5)	   1.5(4)	  C10	   34.1(7)	   23.1(6)	   28.0(6)	   -­‐1.4(5)	   4.4(6)	   2.8(5)	  C11	   45.6(9)	   24.9(7)	   25.8(6)	   -­‐3.5(5)	   -­‐0.4(6)	   -­‐1.9(6)	  C12	   37.0(8)	   27.8(7)	   28.2(7)	   0.2(5)	   -­‐6.6(6)	   -­‐7.5(6)	  C13	   24.4(6)	   24.5(6)	   26.6(6)	   2.6(5)	   -­‐3.6(5)	   -­‐4.2(5)	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Table	  4	  Bond	  Lengths	  for	  12srv065.	  
Atom	   Atom	   Length/Å	   Atom	   Atom	   Length/Å	  O1	   N1	   1.4415(13)	   C4	   C5	   1.529(2)	  O1	   C2	   1.4713(17)	   C5	   C6	   1.504(2)	  O2	   C1	   1.2251(15)	   C6	   C7	   1.342(3)	  N1	   C1	   1.4056(17)	   C8	   C9	   1.3972(17)	  N1	   C5	   1.4881(17)	   C8	   C13	   1.4020(18)	  N2	   C1	   1.3568(16)	   C9	   C10	   1.3936(19)	  N2	   C8	   1.4147(17)	   C10	   C11	   1.385(2)	  C2	   C3	   1.524(2)	   C11	   C12	   1.391(2)	  C2	   C7	   1.494(3)	   C12	   C13	   1.388(2)	  C3	   C4	   1.537(2)	   	  	   	  	   	  	  	  	  
Table	  5	  Bond	  Angles	  for	  12srv065.	  
Atom	   Atom	   Atom	   Angle/˚	   	  	   Atom	   Atom	   Atom	   Angle/˚	  N1	   O1	   C2	   110.52(9)	   	  	   N1	   C5	   C4	   106.45(12)	  O1	   N1	   C5	   111.15(10)	   	  	   N1	   C5	   C6	   107.03(12)	  C1	   N1	   O1	   112.64(10)	   	  	   C6	   C5	   C4	   109.92(12)	  C1	   N1	   C5	   115.22(11)	   	  	   C7	   C6	   C5	   112.30(14)	  C1	   N2	   C8	   125.81(10)	   	  	   C6	   C7	   C2	   113.05(14)	  O2	   C1	   N1	   118.54(12)	   	  	   C9	   C8	   N2	   123.63(12)	  O2	   C1	   N2	   125.60(12)	   	  	   C9	   C8	   C13	   119.46(13)	  N2	   C1	   N1	   115.64(10)	   	  	   C13	   C8	   N2	   116.91(12)	  O1	   C2	   C3	   106.75(13)	   	  	   C10	   C9	   C8	   119.27(13)	  O1	   C2	   C7	   109.23(12)	   	  	   C11	   C10	   C9	   121.50(14)	  C7	   C2	   C3	   109.88(13)	   	  	   C10	   C11	   C12	   119.02(14)	  C2	   C3	   C4	   107.42(13)	   	  	   C13	   C12	   C11	   120.53(14)	  C5	   C4	   C3	   109.22(13)	   	  	   C12	   C13	   C8	   120.21(14)	  	  	  
Table	  6	  Hydrogen	  Bonds	  for	  12srv065.	  
D	   H	   A	   d(D-­H)/Å	   d(H-­A)/Å	   d(D-­A)/Å	   D-­H-­A/°	  N2	   H2	   O21	   0.897(19)	   2.056(19)	   2.9144(14)	   159.6(18)	  11/2+X,1/2-­‐Y,+Z	  	  	  
Table	  7	  Hydrogen	  Atom	  Coordinates	  (Å×104)	  and	  Isotropic	  Displacement	  
Parameters	  (Å2×103)	  for	  12srv065.	  
Atom	   x	   y	   z	   U(eq)	  H2	   5860(18)	   2620(20)	   2716(16)	   25	  H2A	   7150	   -­‐1112	   1948	   35	  H3A	   5919	   -­‐2736	   806	   40	  H3B	   6295	   -­‐1230	   194	   40	  H4A	   4169	   -­‐694	   -­‐15	   41	  H4B	   3795	   -­‐2252	   525	   41	  H5	   2789	   -­‐294	   1519	   30	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H6	   3417	   -­‐1706	   3037	   40	  H7	   5749	   -­‐2052	   3285	   46	  H9	   2771	   4241	   3400	   28	  H10	   2554	   6171	   4620	   34	  H11	   4384	   7064	   5541	   39	  H12	   6480	   6039	   5216	   37	  H13	   6734	   4142	   3982	   30	  	   	  
Experimental	  Single	   crystals	   of	   C13H14N2O2	   [12srv065]	   were	   [].	   A	   suitable	   crystal	   was	  selected	   and	   []	   on	   a	  Bruker	   SMART	   CCD	   6000	   diffractometer.	   The	   crystal	  was	  kept	  at	  120	  K	  during	  data	  collection.	  Using	  Olex2	  [1],	  the	  structure	  was	  solved	  with	  the	  XS	  [2]	  structure	  solution	  program	  using	  Direct	  Methods	  and	  refined	  with	   the	  XL	  [3]	  refinement	  package	  using	  Least	  Squares	  minimisation.	  19. O.	  V.	  Dolomanov,	  L.	  J.	  Bourhis,	  R.	  J.	  Gildea,	  J.	  A.	  K.	  Howard	  and	  H.	  Puschmann,	  OLEX2:	  a	  complete	  structure	  solution,	  refinement	  and	  analysis	  program.	  J.	  Appl.	  Cryst.	  (2009).	  42,	  339-­‐341.	  20. XS,	  G.M.	  Sheldrick,	  Acta	  Cryst.	  (2008).	  A64,	  112-­‐122	  21. XL,	  G.M.	  Sheldrick,	  Acta	  Cryst.	  (2008).	  A64,	  112-­‐122	  
Crystal	  structure	  determination	  of	  [12srv065]	  
Crystal	  Data.	  C13H14N2O2,	  M	  =230.26,	  orthorhombic,	  a	  =	  10.0933(6)	  Å,	  b	  =	  8.9883(5)	  Å,	  c	  =	  12.7337(8)	  Å,	  V	  =	  1155.22(12)	  Å3,	  T	  =	  120,	  space	  group	  Pna21	  (no.	  33),	   Z	  =	   4,	   μ(MoKα)	  =	   0.091,	   20058	   reflections	   measured,	   1741	   unique	   (Rint	  =	  0.0251)	  which	  were	  used	   in	   all	   calculations.	   The	   final	  wR2	  was	  0.0869	   (all	   data)	  and	  R1	  was	  0.0321	  (>2sigma(I)).	  	  This	  report	  has	  been	  created	  with	  Olex2,	  compiled	  on	  2011.11.01	  svn.r2039.	  Please	  let	  us	  know	  if	  there	  are	  any	  errors	  or	  if	  you	  would	  like	  to	  have	  additional	  featrues.	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Phenyl	  2-­‐oxa-­‐3-­‐azabicyclo[2.2.1]hept-­‐5-­‐ene-­‐3-­‐carboxylate	  197	  	  	  	  	  	  	  
12srv083	  
	  	  
Table	  1	  Crystal	  data	  and	  structure	  refinement	  for	  12srv083	  Identification	  code	   12srv083	  Empirical	  formula	   C12H11NO3	  Formula	  weight	   217.22	  Temperature/K	   120	  Crystal	  system	   monoclinic	  Space	  group	   P21/c	  a/Å	   5.8418(5)	  b/Å	   8.6844(7)	  c/Å	   20.7247(19)	  α/°	   90.00	  β/°	   91.658(15)	  γ/°	   90.00	  Volume/Å3	   1050.98(16)	  Z	   4	  ρcalcmg/mm3	   1.373	  m/mm‑1	   0.100	  F(000)	   456.0	  Crystal	  size/mm3	   0.42	  ×	  0.42	  ×	  0.24	  2Θ	  range	  for	  data	  collection	   3.94	  to	  59.96°	  Index	  ranges	   -­‐8	  ≤	  h	  ≤	  8,	  -­‐12	  ≤	  k	  ≤	  12,	  -­‐29	  ≤	  l	  ≤	  29	  Reflections	  collected	   12722	  Independent	  reflections	   3069[R(int)	  =	  0.0420]	  Data/restraints/parameters	   3069/0/145	  Goodness-­‐of-­‐fit	  on	  F2	   1.072	  Final	  R	  indexes	  [I>=2σ	  (I)]	   R1	  =	  0.0493,	  wR2	  =	  0.1396	  Final	  R	  indexes	  [all	  data]	   R1	  =	  0.0619,	  wR2	  =	  0.1506	  Largest	  diff.	  peak/hole	  /	  e	  Å-­‐3	   0.41/-­‐0.22	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Table	  2	  Fractional	  Atomic	  Coordinates	  (×104)	  and	  Equivalent	  Isotropic	  
Displacement	  Parameters	  (Å2×103)	  for	  12srv083.	  Ueq	  is	  defined	  as	  1/3	  of	  of	  
the	  trace	  of	  the	  orthogonalised	  UIJ	  tensor.	  
Atom	   x	   y	   z	   U(eq)	  O1	   3837.2(16)	   4015.4(10)	   5899.2(4)	   22.5(2)	  O2	   2296.1(16)	   1687.1(10)	   6134.2(4)	   23.0(2)	  O3	   -­‐21.7(15)	   1707.2(10)	   5016.2(4)	   21.5(2)	  N1	   1169.3(17)	   3079.8(12)	   5223.2(5)	   18.3(2)	  C1	   2462.3(19)	   2777.3(13)	   5782.2(6)	   17.7(2)	  C2	   686(2)	   1493.3(14)	   4339.5(6)	   22.4(3)	  C3	   3211(2)	   1123.9(16)	   4373.9(6)	   26.6(3)	  C4	   4287(2)	   2422.6(16)	   4549.0(6)	   23.9(3)	  C5	   2447(2)	   3618.9(14)	   4639.9(6)	   19.4(2)	  C6	   686(2)	   3174.9(14)	   4112.0(6)	   21.6(3)	  C7	   5174(2)	   4004.1(14)	   6477.2(6)	   20.5(3)	  C8	   4511(2)	   4964.6(16)	   6969.2(7)	   28.3(3)	  C9	   5914(3)	   5066.4(19)	   7522.3(7)	   35.3(4)	  C10	   7914(3)	   4215.5(18)	   7571.6(7)	   30.9(3)	  C11	   8532(2)	   3250.8(16)	   7072.6(7)	   26.4(3)	  C12	   7156(2)	   3145.7(14)	   6516.1(6)	   22.6(3)	  	  	  
Table	  3	  Anisotropic	  Displacement	  Parameters	  (Å2×103)	  for	  12srv083.	  The	  
Anisotropic	  displacement	  factor	  exponent	  takes	  the	  form:	  -­
2π2[h2a*2U11+...+2hka×b×U12]	  
Atom	   U11	   U22	   U33	   U23	   U13	   U12	  O1	   27.5(5)	   19.6(4)	   20.1(4)	   1.5(3)	   -­‐6.2(3)	   -­‐6.8(3)	  O2	   26.7(5)	   20.4(4)	   21.6(4)	   3.7(3)	   -­‐3.8(3)	   -­‐4.6(3)	  O3	   22.4(4)	   21.2(4)	   20.6(4)	   1.2(3)	   -­‐3.3(3)	   -­‐8.7(3)	  N1	   18.7(5)	   17.0(5)	   19.0(5)	   1.0(4)	   -­‐1.3(4)	   -­‐3.2(3)	  C1	   17.0(5)	   17.6(5)	   18.5(5)	   -­‐1.0(4)	   0.7(4)	   -­‐0.7(4)	  C2	   29.3(6)	   20.1(5)	   17.8(6)	   0.0(4)	   -­‐2.8(5)	   -­‐5.1(5)	  C3	   32.2(7)	   24.0(6)	   23.6(6)	   -­‐1.4(5)	   1.4(5)	   5.8(5)	  C4	   20.0(5)	   30.0(6)	   22.0(6)	   1.9(5)	   2.5(4)	   1.5(5)	  C5	   21.7(6)	   19.4(5)	   17.1(5)	   2.4(4)	   0.7(4)	   -­‐3.7(4)	  C6	   23.1(6)	   21.7(6)	   19.9(6)	   3.2(4)	   -­‐3.8(4)	   -­‐2.2(4)	  C7	   22.7(6)	   20.6(5)	   18.0(5)	   0.0(4)	   -­‐2.6(4)	   -­‐5.1(4)	  C8	   27.4(7)	   31.2(7)	   25.9(7)	   -­‐7.4(5)	   -­‐3.3(5)	   4.1(5)	  C9	   36.4(8)	   43.3(9)	   25.8(7)	   -­‐14.0(6)	   -­‐3.8(6)	   4.2(6)	  C10	   31.9(7)	   38.5(8)	   21.9(6)	   -­‐2.2(5)	   -­‐7.5(5)	   -­‐0.8(6)	  C11	   22.8(6)	   29.0(7)	   27.2(7)	   1.5(5)	   -­‐3.1(5)	   -­‐0.2(5)	  C12	   25.0(6)	   22.0(6)	   21.0(6)	   -­‐1.5(4)	   1.5(5)	   -­‐2.3(5)	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Table	  4	  Bond	  Lengths	  for	  12srv083.	  
Atom	   Atom	   Length/Å	   Atom	   Atom	   Length/Å	  O1	   C1	   1.3597(14)	   C3	   C4	   1.3363(19)	  O1	   C7	   1.4110(14)	   C4	   C5	   1.5107(17)	  O2	   C1	   1.2009(15)	   C5	   C6	   1.5295(16)	  O3	   N1	   1.4394(13)	   C7	   C8	   1.3815(18)	  O3	   C2	   1.4851(15)	   C7	   C12	   1.3773(18)	  N1	   C1	   1.3897(15)	   C8	   C9	   1.392(2)	  N1	   C5	   1.5132(15)	   C9	   C10	   1.384(2)	  C2	   C3	   1.5095(19)	   C10	   C11	   1.387(2)	  C2	   C6	   1.5346(17)	   C11	   C12	   1.3897(18)	  	  	  
Table	  5	  Bond	  Angles	  for	  12srv083.	  
Atom	   Atom	   Atom	   Angle/˚	   Atom	   Atom	   Atom	   Angle/˚	  C1	   O1	   C7	   117.10(9)	   N1	   C5	   C6	   98.99(9)	  N1	   O3	   C2	   103.87(8)	   C4	   C5	   N1	   104.83(9)	  O3	   N1	   C5	   105.28(8)	   C4	   C5	   C6	   101.76(10)	  C1	   N1	   O3	   109.77(9)	   C5	   C6	   C2	   91.50(9)	  C1	   N1	   C5	   117.11(9)	   C8	   C7	   O1	   117.53(11)	  O1	   C1	   N1	   107.65(9)	   C12	   C7	   O1	   119.81(11)	  O2	   C1	   O1	   124.95(11)	   C12	   C7	   C8	   122.48(12)	  O2	   C1	   N1	   127.15(11)	   C7	   C8	   C9	   118.35(13)	  O3	   C2	   C3	   106.27(10)	   C10	   C9	   C8	   120.17(13)	  O3	   C2	   C6	   100.00(10)	   C9	   C10	   C11	   120.32(13)	  C3	   C2	   C6	   102.01(10)	   C10	   C11	   C12	   120.12(13)	  C4	   C3	   C2	   106.56(11)	   C7	   C12	   C11	   118.56(12)	  C3	   C4	   C5	   106.46(11)	   	  	   	  	   	  	   	  	  	  	  
Table	  6	  Hydrogen	  Atom	  Coordinates	  (Å×104)	  and	  Isotropic	  Displacement	  
Parameters	  (Å2×103)	  for	  12srv083.	  
Atom	   x	   y	   z	   U(eq)	  H2	   -­‐285	   773	   4073	   27	  H3	   3900	   157	   4288	   32	  H4	   5893	   2565	   4605	   29	  H5	   2961	   4717	   4644	   23	  H6A	   1253	   3306	   3670	   26	  H6B	   -­‐811	   3694	   4156	   26	  H8	   3131	   5541	   6931	   34	  H9	   5496	   5722	   7867	   42	  H10	   8869	   4293	   7949	   37	  H11	   9899	   2661	   7111	   32	  H12	   7573	   2496	   6170	   27	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Experimental	  Single	   crystals	   of	   C12H11NO3	   [12srv083]	   were	   [].	   A	   suitable	   crystal	   was	  selected	   and	   []	   on	   a	  Bruker	   SMART	   CCD	   6000	   diffractometer.	   The	   crystal	  was	  kept	  at	  120	  K	  during	  data	  collection.	  Using	  Olex2	  [1],	  the	  structure	  was	  solved	  with	  the	  XS	  [2]	  structure	  solution	  program	  using	  Direct	  Methods	  and	  refined	  with	   the	  XL	  [3]	  refinement	  package	  using	  Least	  Squares	  minimisation.	  22. O.	  V.	  Dolomanov,	  L.	  J.	  Bourhis,	  R.	  J.	  Gildea,	  J.	  A.	  K.	  Howard	  and	  H.	  Puschmann,	  OLEX2:	  a	  complete	  structure	  solution,	  refinement	  and	  analysis	  program.	  J.	  Appl.	  Cryst.	  (2009).	  42,	  339-­‐341.	  23. XS,	  G.M.	  Sheldrick,	  Acta	  Cryst.	  (2008).	  A64,	  112-­‐122	  24. XL,	  G.M.	  Sheldrick,	  Acta	  Cryst.	  (2008).	  A64,	  112-­‐122	  
Crystal	  structure	  determination	  of	  [12srv083]	  
Crystal	   Data.	   C12H11NO3,	   M	  =217.22,	   monoclinic,	   a	  =	   5.8418(5)	  Å,	   b	  =	  8.6844(7)	  Å,	   c	  =	   20.7247(19)	  Å,	   β	  =	   91.658(15)°,	   V	  =	   1050.98(16)	  Å3,	   T	  =	   120,	  space	  group	  P21/c	   (no.	  14),	  Z	  =	  4,	  μ(MoKα)	  =	  0.100,	  12722	  reflections	  measured,	  3069	  unique	  (Rint	  =	  0.0420)	  which	  were	  used	  in	  all	  calculations.	  The	  final	  wR2	  was	  0.1506	  (all	  data)	  and	  R1	  was	  0.0493	  (>2sigma(I)).	  	  This	  report	  has	  been	  created	  with	  Olex2,	  compiled	  on	  2011.11.01	  svn.r2039.	  Please	  let	  us	  know	  if	  there	  are	  any	  errors	  or	  if	  you	  would	  like	  to	  have	  additional	  featrues.	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4,5-­‐Dimethyl-­‐N-­‐phenyl-­‐3,6-­‐dihydro-­‐2H-­‐1,2-­‐oxazine-­‐2-­‐carbox-­‐amide	  195	  	  	  
12srv066	  
	  	  
Table	  1	  Crystal	  data	  and	  structure	  refinement	  for	  12srv066	  Identification	  code	   12srv066	  Empirical	  formula	   C13H16N2O2	  Formula	  weight	   232.28	  Temperature/K	   120	  Crystal	  system	   orthorhombic	  Space	  group	   Pbca	  a/Å	   13.5078(8)	  b/Å	   9.1660(5)	  c/Å	   19.8312(13)	  α/°	   90.00	  β/°	   90.00	  γ/°	   90.00	  Volume/Å3	   2455.4(3)	  Z	   8	  ρcalcmg/mm3	   1.257	  m/mm‑1	   0.086	  F(000)	   992.0	  Crystal	  size/mm3	   0.85	  ×	  0.8	  ×	  0.4	  2Θ	  range	  for	  data	  collection	   4.1	  to	  60.02°	  Index	  ranges	   -­‐18	  ≤	  h	  ≤	  19,	  -­‐12	  ≤	  k	  ≤	  12,	  -­‐27	  ≤	  l	  ≤	  27	  Reflections	  collected	   27298	  Independent	  reflections	   3576[R(int)	  =	  0.0318]	  Data/restraints/parameters	   3576/0/161	  Goodness-­‐of-­‐fit	  on	  F2	   1.021	  Final	  R	  indexes	  [I>=2σ	  (I)]	   R1	  =	  0.0426,	  wR2	  =	  0.1151	  Final	  R	  indexes	  [all	  data]	   R1	  =	  0.0528,	  wR2	  =	  0.1258	  Largest	  diff.	  peak/hole	  /	  e	  Å-­‐3	   0.34/-­‐0.18	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Table	  2	  Fractional	  Atomic	  Coordinates	  (×104)	  and	  Equivalent	  Isotropic	  
Displacement	  Parameters	  (Å2×103)	  for	  12srv066.	  Ueq	  is	  defined	  as	  1/3	  of	  of	  
the	  trace	  of	  the	  orthogonalised	  UIJ	  tensor.	  
Atom	   x	   y	   z	   U(eq)	  O1	   6455.8(6)	   4001.6(8)	   4465.1(4)	   27.45(18)	  O2	   6640.6(5)	   458.3(8)	   3812.6(4)	   26.36(17)	  N1	   6384.1(6)	   2471.9(9)	   4450.1(4)	   25.02(19)	  N2	   7451.6(6)	   2587.7(10)	   3542.1(4)	   24.17(18)	  C1	   6812.7(7)	   1758.9(10)	   3910.9(5)	   21.80(19)	  C2	   5683.7(8)	   4633.9(11)	   4056.6(6)	   29.1(2)	  C3	   4680.7(8)	   4000.3(12)	   4195.5(5)	   29.8(2)	  C4	   4581.6(8)	   2772.3(13)	   4544.9(5)	   29.1(2)	  C5	   5484.6(8)	   1935.7(12)	   4764.5(5)	   28.3(2)	  C6	   3613.3(9)	   2070.6(17)	   4733.6(7)	   43.2(3)	  C7	   3841.2(10)	   4844.8(18)	   3888.2(7)	   45.6(3)	  C8	   8069.1(7)	   2031.9(11)	   3026.2(5)	   23.4(2)	  C9	   9003.8(8)	   2665.9(11)	   2949.5(6)	   28.5(2)	  C10	   9646.8(8)	   2154.8(12)	   2456.4(6)	   33.6(2)	  C11	   9370.1(9)	   1013.7(13)	   2039.2(6)	   34.8(3)	  C12	   8437.7(9)	   398.5(13)	   2111.3(6)	   33.9(2)	  C13	   7778.1(8)	   911.3(12)	   2597.0(5)	   28.3(2)	  	  	  
Table	  3	  Anisotropic	  Displacement	  Parameters	  (Å2×103)	  for	  12srv066.	  The	  
Anisotropic	  displacement	  factor	  exponent	  takes	  the	  form:	  -­
2π2[h2a*2U11+...+2hka×b×U12]	  
Atom	   U11	   U22	   U33	   U23	   U13	   U12	  O1	   27.7(4)	   22.7(4)	   31.9(4)	   -­‐3.7(3)	   2.4(3)	   -­‐2.4(3)	  O2	   24.8(4)	   20.3(3)	   34.0(4)	   1.2(3)	   1.7(3)	   0.0(3)	  N1	   23.1(4)	   22.3(4)	   29.6(4)	   0.5(3)	   3.7(3)	   -­‐0.8(3)	  N2	   22.8(4)	   20.7(4)	   29.0(4)	   -­‐1.9(3)	   4.3(3)	   -­‐1.5(3)	  C1	   18.3(4)	   22.5(4)	   24.6(4)	   1.4(3)	   -­‐1.4(3)	   2.0(3)	  C2	   34.5(5)	   24.3(5)	   28.4(5)	   0.6(4)	   6.3(4)	   4.7(4)	  C3	   27.7(5)	   36.7(6)	   24.9(5)	   -­‐2.5(4)	   2.1(4)	   7.9(4)	  C4	   22.7(5)	   38.1(6)	   26.5(5)	   -­‐2.5(4)	   5.2(4)	   0.6(4)	  C5	   27.0(5)	   29.3(5)	   28.7(5)	   4.2(4)	   7.1(4)	   -­‐0.2(4)	  C6	   26.8(6)	   58.8(8)	   43.9(7)	   -­‐0.8(6)	   10.4(5)	   -­‐5.5(5)	  C7	   38.8(7)	   59.5(8)	   38.5(7)	   4.9(6)	   -­‐0.9(5)	   20.3(6)	  C8	   21.8(4)	   22.7(4)	   25.7(4)	   3.4(3)	   2.1(3)	   4.1(3)	  C9	   24.9(5)	   24.1(5)	   36.5(5)	   1.7(4)	   5.3(4)	   -­‐0.5(4)	  C10	   27.5(5)	   31.2(5)	   41.9(6)	   6.9(5)	   11.1(4)	   3.3(4)	  C11	   36.0(6)	   36.5(6)	   31.9(5)	   3.8(4)	   9.8(4)	   11.2(5)	  C12	   37.4(6)	   35.9(6)	   28.5(5)	   -­‐4.6(4)	   0.9(4)	   6.2(5)	  C13	   25.8(5)	   31.8(5)	   27.2(5)	   -­‐1.0(4)	   -­‐0.5(4)	   2.0(4)	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Table	  4	  Bond	  Lengths	  for	  12srv066.	  
Atom	   Atom	   Length/Å	   Atom	   Atom	   Length/Å	  O1	   N1	   1.4057(11)	   C3	   C7	   1.5022(16)	  O1	   C2	   1.4421(14)	   C4	   C5	   1.5051(15)	  O2	   C1	   1.2301(12)	   C4	   C6	   1.5048(16)	  N1	   C1	   1.3805(13)	   C8	   C9	   1.3981(14)	  N1	   C5	   1.4515(13)	   C8	   C13	   1.3907(14)	  N2	   C1	   1.3626(13)	   C9	   C10	   1.3892(15)	  N2	   C8	   1.4150(13)	   C10	   C11	   1.3851(18)	  C2	   C3	   1.4997(16)	   C11	   C12	   1.3873(18)	  C3	   C4	   1.3285(16)	   C12	   C13	   1.3937(15)	  	  	  
Table	  5	  Bond	  Angles	  for	  12srv066.	  
Atom	   Atom	   Atom	   Angle/˚	   Atom	   Atom	   Atom	   Angle/˚	  N1	   O1	   C2	   109.83(8)	   C3	   C4	   C5	   120.06(9)	  O1	   N1	   C5	   112.73(8)	   C3	   C4	   C6	   125.40(11)	  C1	   N1	   O1	   117.37(8)	   C6	   C4	   C5	   114.50(10)	  C1	   N1	   C5	   121.57(9)	   N1	   C5	   C4	   112.43(9)	  C1	   N2	   C8	   124.11(8)	   C9	   C8	   N2	   117.48(9)	  O2	   C1	   N1	   120.15(9)	   C13	   C8	   N2	   122.80(9)	  O2	   C1	   N2	   125.10(9)	   C13	   C8	   C9	   119.71(9)	  N2	   C1	   N1	   114.67(8)	   C10	   C9	   C8	   120.07(10)	  O1	   C2	   C3	   113.23(9)	   C11	   C10	   C9	   120.42(11)	  C2	   C3	   C7	   114.07(10)	   C10	   C11	   C12	   119.37(10)	  C4	   C3	   C2	   120.99(10)	   C11	   C12	   C13	   120.96(11)	  C4	   C3	   C7	   124.90(11)	   C8	   C13	   C12	   119.43(10)	  	  	  
Table	  6	  Hydrogen	  Bonds	  for	  12srv066.	  
D	   H	   A	   d(D-­H)/Å	   d(H-­A)/Å	   d(D-­A)/Å	   D-­H-­A/°	  N2	   H2N	   O21	   0.825(15)	   2.168(15)	   2.9520(11)	   158.8(13)	  13/2-­‐X,1/2+Y,+Z	  	  	  
Table	  7	  Hydrogen	  Atom	  Coordinates	  (Å×104)	  and	  Isotropic	  Displacement	  
Parameters	  (Å2×103)	  for	  12srv066.	  
Atom	   x	   y	   z	   U(eq)	  H2N	   7563(11)	   3428(16)	   3671(7)	   29(3)	  H2A	   5847	   4483	   3575	   35	  H2B	   5662	   5699	   4139	   35	  H5A	   5552	   2008	   5261	   34	  H5B	   5397	   893	   4649	   34	  H6A	   3081	   2795	   4704	   64(3)	  H6B	   3654	   1698	   5196	   64(3)	  H6C	   3474	   1263	   4424	   64(3)	  H7A1	   3772	   4575	   3412	   49(4)	  H7A2	   3978	   5892	   3923	   49(4)	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H7A3	   3226	   4618	   4128	   49(4)	  H7B1	   3488	   5539	   4178	   49(4)	  H7B2	   3987	   5375	   3471	   49(4)	  H7B3	   3321	   4197	   3718	   49(4)	  H9	   9199	   3447	   3235	   34	  H10	   10280	   2591	   2405	   40	  H11	   9814	   656	   1707	   42	  H12	   8246	   -­‐384	   1825	   41	  H13	   7135	   499	   2635	   34	  	  
Experimental	  Single	   crystals	   of	   C13H16N2O2	   [12srv066]	   were	   [].	   A	   suitable	   crystal	   was	  selected	   and	   []	   on	   a	  Bruker	   SMART	   CCD	   6000	   diffractometer.	   The	   crystal	  was	  kept	  at	  120	  K	  during	  data	  collection.	  Using	  Olex2	  [1],	  the	  structure	  was	  solved	  with	  the	  XS	  [2]	  structure	  solution	  program	  using	  Direct	  Methods	  and	  refined	  with	   the	  XL	  [3]	  refinement	  package	  using	  Least	  Squares	  minimisation.	  25. O.	  V.	  Dolomanov,	  L.	  J.	  Bourhis,	  R.	  J.	  Gildea,	  J.	  A.	  K.	  Howard	  and	  H.	  Puschmann,	  OLEX2:	  a	  complete	  structure	  solution,	  refinement	  and	  analysis	  program.	  J.	  Appl.	  Cryst.	  (2009).	  42,	  339-­‐341.	  26. XS,	  G.M.	  Sheldrick,	  Acta	  Cryst.	  (2008).	  A64,	  112-­‐122	  27. XL,	  G.M.	  Sheldrick,	  Acta	  Cryst.	  (2008).	  A64,	  112-­‐122	  
Crystal	  structure	  determination	  of	  [12srv066]	  
Crystal	  Data.	  C13H16N2O2,	  M	  =232.28,	  orthorhombic,	  a	  =	  13.5078(8)	  Å,	  b	  =	  9.1660(5)	  Å,	  c	  =	  19.8312(13)	  Å,	  V	  =	  2455.4(3)	  Å3,	  T	  =	  120,	   space	   group	  Pbca	   (no.	  61),	   Z	  =	   8,	   μ(MoKα)	  =	   0.086,	   27298	   reflections	   measured,	   3576	   unique	   (Rint	  =	  0.0318)	  which	  were	  used	   in	   all	   calculations.	   The	   final	  wR2	  was	  0.1258	   (all	   data)	  and	  R1	  was	  0.0426	  (>2sigma(I)).	  	  This	  report	  has	  been	  created	  with	  Olex2,	  compiled	  on	  2011.11.01	  svn.r2039.	  Please	  let	  us	  know	  if	  there	  are	  any	  errors	  or	  if	  you	  would	  like	  to	  have	  additional	  featrues.	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N-­‐((R)-­‐1-­‐Phenylethyl)-­‐2-­‐oxa-­‐3-­‐azabicyclo[2.2.2]oct-­‐5-­‐ene-­‐3-­‐carboxamide	  184	  	  	  	  	  	  	  
12srv114	  	  
	  
Table	  1	  Crystal	  data	  and	  structure	  refinement	  for	  12srv114	  	  Identification	  code	  	   12srv114	  Empirical	  formula	  	   C15H18N2O2	  Formula	  weight	  	   258.31	  Temperature/K	  	   120	  Crystal	  system	  	   tetragonal	  Space	  group	  	   P41212	  a/Å	  	   10.2990(2)	  b/Å	  	   10.2990(2)	  c/Å	  	   51.7187(14)	  α/°	  	   90.00	  β/°	  	   90.00	  γ/°	  	   90.00	  Volume/Å3	  	   5485.8(2)	  Z	  	   16	  ρcalcmg/mm3	  	   1.251	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m/mm-­‐1	  	   0.084	  F(000)	  	   2208.0	  Crystal	  size/mm3	  	   0.45	  ×	  0.4	  ×	  0.03	  2Θ	  range	  for	  data	  collection	  	   3.14	  to	  59°	  Index	  ranges	  	   -­‐14	  ≤	  h	  ≤	  14,	  -­‐12	  ≤	  k	  ≤	  13,	  -­‐70	  ≤	  l	  ≤	  71	  Reflections	  collected	  	   86666	  Independent	  reflections	  	   7584[R(int)	  =	  0.0443]	  Data/restraints/parameters	  	   7584/0/487	  Goodness-­‐of-­‐fit	  on	  F2	  	   1.028	  Final	  R	  indexes	  [I>=2σ	  (I)]	  	   R1	  =	  0.0444,	  wR2	  =	  0.1054	  Final	  R	  indexes	  [all	  data]	  	   R1	  =	  0.0548,	  wR2	  =	  0.1113	  Largest	  diff.	  peak/hole	  /	  e	  Å-­‐3	  	   0.26/-­‐0.19	  Flack	  parameter	   0.1(8)	  	  	  	  Table	  2	  Fractional	  Atomic	  Coordinates	  (×104)	  and	  Equivalent	  Isotropic	  
Displacement	  Parameters	  (Å2×103)	  for	  12srv114.	  Ueq	  is	  defined	  as	  1/3	  of	  of	  
the	  trace	  of	  the	  orthogonalised	  UIJ	  tensor.	  
Atom	   x	   y	   z	   U(eq)	  O1	   7058.2(10)	   7835(1)	   4229.99(19)	   24.2(2)	  O2	   4441.8(10)	   6073.6(11)	   4483.4(2)	   29.9(2)	  N1	   5700.4(11)	   7592.6(12)	   4279.8(2)	   23.0(2)	  N2	   6640.0(13)	   5955.5(12)	   4531.9(2)	   24.4(2)	  C1	   4980.7(15)	   7545.3(15)	   4028.1(3)	   26.5(3)	  C2	   5517.9(16)	   6410.3(16)	   3879.0(3)	   29.8(3)	  C3	   6801.2(17)	   6487.7(16)	   3846.6(3)	   31.9(3)	  C4	   7371.6(15)	   7711.5(15)	   3952.8(3)	   27.6(3)	  C5	   6738.9(17)	   8879.7(17)	   3823.3(3)	   32.2(3)	  C6	   5282.7(16)	   8821.7(16)	   3887.6(3)	   31.0(3)	  C7	   5546.2(14)	   6458.1(14)	   4434.6(3)	   23.9(3)	  C8	   6596.5(15)	   4930.2(15)	   4726.2(3)	   26.3(3)	  C9	   7715.3(18)	   5122.6(16)	   4917.0(3)	   32.3(3)	  C10	   6619.8(14)	   3569.3(14)	   4613.3(3)	   25.4(3)	  C11	   7400.2(16)	   3241.7(15)	   4403.2(3)	   28.9(3)	  C12	   7461.3(17)	   1957.5(16)	   4319.2(3)	   32.8(3)	  C13	   6758.6(18)	   994.9(16)	   4442.3(3)	   35.8(4)	  C14	   5970(2)	   1320.5(17)	   4648.3(3)	   40.8(4)	  C15	   5901.6(19)	   2599.6(17)	   4732.0(3)	   36.5(4)	  O21	   2160.6(10)	   7915.5(11)	   4346.2(2)	   32.0(2)	  O22	   -­‐639.7(10)	   6016.7(11)	   4371.2(2)	   34.7(3)	  N21	   789.6(12)	   7680.0(13)	   4322.5(2)	   27.5(3)	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N22	   1514.3(13)	   5557.9(13)	   4396.1(3)	   29.9(3)	  C21	   50.3(16)	   8604.2(15)	   4489.5(3)	   32.0(3)	  C22	   448.2(18)	   8325.3(18)	   4764.5(3)	   38.2(4)	  C23	   1740.7(19)	   8386.6(19)	   4797.7(3)	   41.3(4)	  C24	   2442.4(16)	   8812.8(16)	   4559.4(3)	   34.0(3)	  C25	   1934.2(19)	   10124.3(17)	   4471.0(5)	   43.8(4)	  C26	   500.2(19)	   9967.4(17)	   4412.0(4)	   42.1(4)	  C27	   504.6(14)	   6358.3(15)	   4371.6(3)	   26.7(3)	  C28	   1315.8(16)	   4161.4(14)	   4432.6(3)	   29.9(3)	  C29	   1700(3)	   3769(2)	   4706.2(4)	   49.5(5)	  C30	   2019.2(15)	   3382.2(14)	   4228.7(3)	   25.4(3)	  C31	   3369.4(16)	   3288.1(16)	   4225.7(3)	   32.8(3)	  C32	   3984.0(18)	   2526.9(17)	   4040.5(4)	   37.9(4)	  C33	   3271.0(18)	   1874.7(16)	   3855.6(3)	   36.9(4)	  C34	   1939.0(19)	   1979.8(17)	   3854.9(3)	   35.3(4)	  C35	   1317.2(16)	   2731.1(15)	   4040.2(3)	   29.7(3)	  	  	  
Table	  3	  Anisotropic	  Displacement	  Parameters	  (Å2×103)	  for	  12srv114.	  The	  
Anisotropic	  displacement	  factor	  exponent	  takes	  the	  form:	  -­
2π2[h2a*2U11+...+2hka×b×U12]	  
Atom	   U11	   U22	   U33	   U23	   U13	   U12	  O1	   19.9(5)	   26.3(5)	   26.5(5)	   1.2(4)	   -­‐1.5(4)	   -­‐1.4(4)	  O2	   23.2(5)	   31.4(6)	   35.1(5)	   1.2(4)	   1.8(4)	   -­‐2.7(4)	  N1	   19.3(5)	   23.1(6)	   26.7(5)	   -­‐0.3(4)	   -­‐1.2(4)	   1.0(5)	  N2	   22.9(6)	   23.7(6)	   26.6(5)	   3.9(5)	   1.4(5)	   1.2(5)	  C1	   21.2(7)	   28.3(7)	   30.0(7)	   -­‐1.8(6)	   -­‐5.1(5)	   1.6(6)	  C2	   33.4(8)	   28.2(7)	   27.8(7)	   -­‐4.9(6)	   -­‐5.3(6)	   0.2(7)	  C3	   36.3(8)	   28.0(8)	   31.5(7)	   -­‐6.3(6)	   2.8(6)	   2.9(7)	  C4	   25.6(7)	   29.6(8)	   27.6(6)	   -­‐1.1(5)	   3.1(6)	   0.2(6)	  C5	   38.5(9)	   31.2(8)	   27.0(7)	   3.9(6)	   -­‐2.3(6)	   -­‐1.7(7)	  C6	   33.5(8)	   28.3(8)	   31.2(7)	   3.7(6)	   -­‐6.8(6)	   4.9(6)	  C7	   24.1(7)	   22.3(7)	   25.2(6)	   -­‐4.7(5)	   0.0(5)	   0.9(5)	  C8	   30.4(8)	   23.6(7)	   24.9(6)	   2.4(5)	   3.9(6)	   2.2(6)	  C9	   42.5(10)	   28.0(8)	   26.3(7)	   0.1(6)	   -­‐4.8(6)	   3.5(7)	  C10	   26.6(7)	   24.7(7)	   25.0(6)	   2.0(5)	   -­‐1.6(5)	   0.7(6)	  C11	   27.4(7)	   28.5(8)	   30.8(7)	   0.5(6)	   3.0(6)	   -­‐0.4(6)	  C12	   34.1(8)	   31.3(8)	   32.9(7)	   -­‐5.0(6)	   -­‐1.2(6)	   3.4(7)	  C13	   44.1(10)	   23.7(7)	   39.7(8)	   -­‐2.9(6)	   -­‐9.2(7)	   0.2(7)	  C14	   54.5(11)	   29.3(8)	   38.4(8)	   5.0(7)	   3.3(8)	   -­‐10.2(8)	  C15	   45.2(10)	   31.5(8)	   32.8(7)	   1.0(6)	   8.5(7)	   -­‐5.1(7)	  O21	   23.2(5)	   26.4(5)	   46.5(6)	   1.4(5)	   5.3(5)	   -­‐1.6(4)	  O22	   22.9(5)	   30.5(6)	   50.8(7)	   1.8(5)	   -­‐1.1(5)	   -­‐0.9(5)	  N21	   22.1(6)	   24.6(6)	   35.8(6)	   2.6(5)	   2.1(5)	   1.2(5)	  N22	   24.2(6)	   21.5(6)	   44.0(7)	   -­‐2.4(5)	   -­‐0.1(5)	   -­‐0.1(5)	  C21	   23.1(7)	   26.2(8)	   46.7(9)	   0.1(7)	   -­‐0.9(6)	   6.0(6)	  C22	   38.0(9)	   38.9(9)	   37.8(8)	   -­‐3.6(7)	   9.9(7)	   2.0(7)	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C23	   46.2(10)	   42.7(10)	   35.1(8)	   -­‐0.5(7)	   -­‐6.8(7)	   2.2(8)	  C24	   26.2(8)	   28.3(8)	   47.5(9)	   2.0(7)	   -­‐6.3(7)	   0.7(7)	  C25	   37.8(9)	   21.3(8)	   72.3(13)	   3.5(8)	   -­‐2.8(9)	   1.4(7)	  C26	   35.9(9)	   23.7(8)	   66.8(12)	   5.7(8)	   -­‐10.0(9)	   5.9(7)	  C27	   25.8(7)	   26.2(7)	   28.0(6)	   -­‐0.1(5)	   2.8(5)	   -­‐1.2(6)	  C28	   31.7(8)	   20.6(7)	   37.4(8)	   -­‐2.0(6)	   1.9(6)	   0.1(6)	  C29	   83.5(17)	   31.0(9)	   34.0(9)	   -­‐3.7(7)	   2.5(9)	   9.5(10)	  C30	   26.1(7)	   18.7(6)	   31.5(7)	   0.8(5)	   -­‐2.2(5)	   1.3(5)	  C31	   26.6(7)	   27.7(8)	   44.1(8)	   -­‐0.1(6)	   -­‐5.7(7)	   -­‐3.8(6)	  C32	   27.0(8)	   32.7(8)	   54(1)	   7.4(7)	   7.4(7)	   3.8(7)	  C33	   45.9(10)	   27.5(8)	   37.4(8)	   2.7(6)	   11.0(7)	   4.7(7)	  C34	   46.2(10)	   28.4(8)	   31.4(7)	   -­‐0.9(6)	   -­‐6.7(7)	   1.7(7)	  C35	   26.6(8)	   26.4(7)	   35.9(7)	   2.6(6)	   -­‐6.1(6)	   2.4(6)	  	  	  
Table	  4	  Bond	  Lengths	  for	  12srv114.	  
Atom	   Atom	   Length/Å	   Atom	   Atom	   Length/Å	  O1	   N1	   1.4437(15)	   O21	   N21	   1.4380(16)	  O1	   C4	   1.4748(17)	   O21	   C24	   1.468(2)	  O2	   C7	   1.2305(18)	   O22	   C27	   1.2300(18)	  N1	   C1	   1.4989(18)	   N21	   C21	   1.494(2)	  N1	   C7	   1.4252(18)	   N21	   C27	   1.4155(19)	  N2	   C7	   1.3380(19)	   N22	   C27	   1.333(2)	  N2	   C8	   1.4584(19)	   N22	   C28	   1.465(2)	  C1	   C2	   1.506(2)	   C21	   C22	   1.508(2)	  C1	   C6	   1.534(2)	   C21	   C26	   1.532(2)	  C2	   C3	   1.335(2)	   C22	   C23	   1.344(3)	  C3	   C4	   1.495(2)	   C23	   C24	   1.494(3)	  C4	   C5	   1.523(2)	   C24	   C25	   1.519(2)	  C5	   C6	   1.537(2)	   C25	   C26	   1.517(3)	  C8	   C9	   1.530(2)	   C28	   C29	   1.524(2)	  C8	   C10	   1.519(2)	   C28	   C30	   1.511(2)	  C10	   C11	   1.393(2)	   C30	   C31	   1.394(2)	  C10	   C15	   1.386(2)	   C30	   C35	   1.386(2)	  C11	   C12	   1.393(2)	   C31	   C32	   1.390(2)	  C12	   C13	   1.383(2)	   C32	   C33	   1.380(3)	  C13	   C14	   1.381(3)	   C33	   C34	   1.376(3)	  C14	   C15	   1.388(2)	   C34	   C35	   1.388(2)	  	  	  
Table	  5	  Bond	  Angles	  for	  12srv114.	  
Atom	   Atom	   Atom	   Angle/˚	   Atom	   Atom	   Atom	   Angle/˚	  N1	   O1	   C4	   111.75(10)	   N21	   O21	   C24	   111.38(11)	  O1	   N1	   C1	   109.24(10)	   O21	   N21	   C21	   110.10(11)	  C7	   N1	   O1	   110.49(10)	   C27	   N21	   O21	   110.52(11)	  
	   264	  	  	  	  
C7	   N1	   C1	   113.96(11)	   C27	   N21	   C21	   113.79(12)	  C7	   N2	   C8	   120.89(13)	   C27	   N22	   C28	   120.70(14)	  N1	   C1	   C2	   106.76(12)	   N21	   C21	   C22	   106.59(13)	  N1	   C1	   C6	   106.46(12)	   N21	   C21	   C26	   106.18(14)	  C2	   C1	   C6	   110.38(13)	   C22	   C21	   C26	   109.82(15)	  C3	   C2	   C1	   112.44(14)	   C23	   C22	   C21	   112.37(16)	  C2	   C3	   C4	   113.16(14)	   C22	   C23	   C24	   112.82(16)	  O1	   C4	   C3	   110.11(12)	   O21	   C24	   C23	   109.81(13)	  O1	   C4	   C5	   105.41(12)	   O21	   C24	   C25	   105.40(14)	  C3	   C4	   C5	   109.64(13)	   C23	   C24	   C25	   110.05(16)	  C4	   C5	   C6	   106.94(13)	   C26	   C25	   C24	   107.53(15)	  C1	   C6	   C5	   109.49(13)	   C25	   C26	   C21	   109.86(14)	  O2	   C7	   N1	   118.81(13)	   O22	   C27	   N21	   118.26(13)	  O2	   C7	   N2	   125.21(14)	   O22	   C27	   N22	   124.80(15)	  N2	   C7	   N1	   115.76(12)	   N22	   C27	   N21	   116.74(13)	  N2	   C8	   C9	   109.12(13)	   N22	   C28	   C29	   110.10(14)	  N2	   C8	   C10	   113.75(11)	   N22	   C28	   C30	   111.38(13)	  C10	   C8	   C9	   110.83(12)	   C30	   C28	   C29	   112.53(14)	  C11	   C10	   C8	   122.18(13)	   C31	   C30	   C28	   121.54(14)	  C15	   C10	   C8	   119.09(13)	   C35	   C30	   C28	   119.85(14)	  C15	   C10	   C11	   118.61(14)	   C35	   C30	   C31	   118.61(14)	  C10	   C11	   C12	   119.93(15)	   C32	   C31	   C30	   120.07(15)	  C13	   C12	   C11	   120.89(15)	   C33	   C32	   C31	   120.63(17)	  C14	   C13	   C12	   119.27(16)	   C34	   C33	   C32	   119.60(16)	  C13	   C14	   C15	   120.04(16)	   C33	   C34	   C35	   120.13(16)	  C10	   C15	   C14	   121.23(16)	   C30	   C35	   C34	   120.94(16)	  	  Table	  6	  Hydrogen	  Bonds	  for	  12srv114.	  	  
D	   H	   A	   d(D-­H)/Å	   d(H-­A)/Å	   d(D-­A)/Å	   D-­H-­A/°	  N2	   H2	   O221	   0.84(2)	   2.15(2)	   2.9231(17)	   153.4(17)	  N22	   H22	   O2	   0.86(2)	   2.26(2)	   3.0946(18)	   163.5(18)	  
11+X,+Y,+Z	  	  	  
Table	  7	  Hydrogen	  Atom	  Coordinates	  (Å×104)	  and	  Isotropic	  Displacement	  
Parameters	  (Å2×103)	  for	  12srv114.	  
Atom	   x	   y	   z	   U(eq)	  H1	   4103(18)	   7482(17)	   4078(3)	   25(4)	  H6A	   5033(19)	   9553(19)	   3993(4)	   32(5)	  H2	   7351(19)	   6232(18)	   4477(3)	   28(5)	  H2A	   4980(20)	   5690(20)	   3822(4)	   52(6)	  H3	   7290(20)	   5850(20)	   3774(4)	   50(6)	  H4	   8302(18)	   7716(18)	   3949(3)	   26(4)	  H5A	   6882(18)	   8850(19)	   3642(4)	   33(5)	  H5B	   7124(19)	   9702(19)	   3884(4)	   33(5)	  
	   265	  	  	  	  
H6B	   4754(17)	   8883(18)	   3726(3)	   29(4)	  H8	   5776(17)	   5047(16)	   4824(3)	   22(4)	  H9A	   7660(20)	   4504(19)	   5055(4)	   38(5)	  H9B	   7708(17)	   6024(18)	   4982(3)	   29(4)	  H9C	   8560(20)	   5006(19)	   4832(4)	   37(5)	  H11	   7845(18)	   3902(19)	   4312(3)	   29(4)	  H12	   8000(20)	   1764(19)	   4170(4)	   37(5)	  H13	   6770(20)	   130(20)	   4385(4)	   44(5)	  H14	   5480(20)	   650(20)	   4738(5)	   61(7)	  H15	   5330(20)	   2840(20)	   4875(4)	   46(6)	  H23	   2170(20)	   8240(20)	   4955(5)	   60(7)	  H24	   3380(20)	   8757(19)	   4569(3)	   36(5)	  H21	   -­‐874(18)	   8441(17)	   4455(3)	   29(4)	  H26A	   290(20)	   10120(20)	   4232(4)	   51(6)	  H22	   2280(20)	   5868(19)	   4415(3)	   33(5)	  H22A	   -­‐160(30)	   8050(20)	   4885(5)	   60(7)	  H25A	   2460(20)	   10440(20)	   4321(4)	   54(6)	  H25B	   2100(30)	   10790(30)	   4615(5)	   70(8)	  H26B	   -­‐60(30)	   10580(30)	   4524(5)	   78(8)	  H28	   403(19)	   4030(19)	   4408(4)	   33(5)	  H29A	   2670(30)	   3910(20)	   4730(4)	   55(6)	  H29B	   1240(30)	   4270(30)	   4820(5)	   65(7)	  H29C	   1560(20)	   2840(30)	   4742(5)	   67(7)	  H31	   3830(19)	   3741(19)	   4352(4)	   36(5)	  H32	   4880(20)	   2460(20)	   4036(4)	   38(5)	  H33	   3680(20)	   1290(20)	   3725(4)	   51(6)	  H34	   1430(20)	   1590(20)	   3724(4)	   46(6)	  H35	   402(19)	   2791(18)	   4039(3)	   31(5)	  	  	  	  
	  
